trial_id,patient_id,patient_json,is_eligible,reasoning
NCT00009971,P001,"{""age"":68,""gender"":""M"",""diagnosis"":""recurrent extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":5,""brain_mets"":""yes, treated with WBRT 14 months ago, asymptomatic"",""wbc"":4200,""platelets"":125000,""bilirubin_mgdl"":1.1,""ast_ul"":45,""creatinine_mgdl"":1.2,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":1}",true,"Eligible: recurrent SCLC post-platinum, >3 weeks since chemo, ≤2 prior lines, brain mets treated & stable, all labs met, no disallowed meds or retinal disease."
NCT00009971,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""recurrent limited-stage SCLC"",""prior_lines"":2,""last_chemo_weeks_ago"":4,""brain_mets"":""none"",""wbc"":3100,""platelets"":85000,""bilirubin_mgdl"":0.9,""ast_ul"":38,""creatinine_mgdl"":0.8,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":1}",true,"Eligible: meets all disease, line count, washout, and lab criteria; no brain mets, no exclusions triggered."
NCT00009971,P003,"{""age"":72,""gender"":""M"",""diagnosis"":""recurrent SCLC"",""prior_lines"":3,""last_chemo_weeks_ago"":6,""brain_mets"":""none"",""wbc"":3800,""platelets"":98000,""bilirubin_mgdl"":1.3,""ast_ul"":52,""creatinine_mgdl"":1.4,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":2}",false,"Ineligible: received 3 prior chemotherapy regimens (protocol allows max 2)."
NCT00009971,P004,"{""age"":45,""gender"":""F"",""diagnosis"":""recurrent SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":2,""brain_mets"":""yes, asymptomatic, treated >12mo ago"",""wbc"":2900,""platelets"":72000,""bilirubin_mgdl"":1.0,""ast_ul"":40,""creatinine_mgdl"":1.1,""on_anticonvulsants"":true,""retinal_disease"":false,""pregnant"":false,""ecog"":1}",false,"Ineligible: only 2 weeks since last chemo (<3 weeks required) AND concurrent anticonvulsant use (explicitly disallowed)."
NCT00009971,P005,"{""age"":61,""gender"":""M"",""diagnosis"":""recurrent SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":8,""brain_mets"":""yes, new symptomatic lesions"",""wbc"":3500,""platelets"":110000,""bilirubin_mgdl"":1.2,""ast_ul"":48,""creatinine_mgdl"":1.3,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":2}",false,"Ineligible: symptomatic/uncontrolled brain metastases (explicit exclusion)."
NCT00009971,P006,"{""age"":55,""gender"":""F"",""diagnosis"":""recurrent SCLC"",""prior_lines"":2,""last_chemo_weeks_ago"":5,""brain_mets"":""none"",""wbc"":2200,""platelets"":68000,""bilirubin_mgdl"":1.6,""ast_ul"":70,""creatinine_mgdl"":1.7,""on_anticonvulsants"":false,""retinal_disease"":true,""pregnant"":false,""ecog"":1}",false,"Ineligible: multiple violations – platelets <70k, bilirubin >1.5 mg/dL, AST >2×ULN, and pre-existing retinal degenerative disease."
NCT00009971,P007,"{""age"":39,""gender"":""F"",""diagnosis"":""recurrent SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":10,""brain_mets"":""none"",""wbc"":5100,""platelets"":180000,""bilirubin_mgdl"":0.8,""ast_ul"":35,""creatinine_mgdl"":0.9,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":true,""ecog"":0}",false,"Ineligible: currently pregnant (strict exclusion)."
NCT00009971,P008,"{""age"":67,""gender"":""M"",""diagnosis"":""recurrent SCLC"",""prior_lines"":2,""last_chemo_weeks_ago"":4,""brain_mets"":""yes, stable >12mo"",""wbc"":3200,""platelets"":95000,""bilirubin_mgdl"":1.4,""ast_ul"":50,""creatinine_mgdl"":1.4,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":2,""recent_mi"":true}",false,"Ineligible: myocardial infarction within past 6 months (cardiac exclusion)."
NCT00009971,P009,"{""age"":52,""gender"":""M"",""diagnosis"":""recurrent SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":12,""brain_mets"":""yes, treated & stable"",""wbc"":4800,""platelets"":160000,""bilirubin_mgdl"":1.0,""ast_ul"":42,""creatinine_mgdl"":1.1,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":1}",true,"Eligible: all inclusion criteria met, brain mets treated & stable, >3 weeks since chemo, ≤2 lines, labs adequate, no exclusions."
NCT00009971,P010,"{""age"":64,""gender"":""F"",""diagnosis"":""recurrent SCLC"",""prior_lines"":2,""last_chemo_weeks_ago"":3.5,""brain_mets"":""none"",""wbc"":3300,""platelets"":88000,""bilirubin_mgdl"":1.2,""ast_ul"":55,""creatinine_mgdl"":1.3,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":1}",true,"Eligible: exactly meets washout (≥3 weeks), max 2 prior lines, adequate labs and performance status."
NCT03836352,P001,"{""age"":62,""gender"":""F"",""diagnosis"":""recurrent ovarian cancer"",""prior_lines"":1,""last_chemo_weeks_ago"":6,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":10,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""ovarian"",""ecog"":1,""life_expectancy_months"":9,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":4.2,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",true,"Eligible: post-1L ovarian ca, MSI-H, >4w since chemo, >2w since RT, ECOG 1, measurable disease, no brain mets, no immune-related tox history, no disallowed conditions/meds."
NCT03836352,P002,"{""age"":58,""gender"":""M"",""diagnosis"":""metastatic HCC"",""prior_lines"":1,""last_chemo_weeks_ago"":8,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""HCC"",""ecog"":0,""life_expectancy_months"":12,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":6.1,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",true,"Eligible: post-1L HCC, MSI-H, adequate washouts, no exclusions apply."
NCT03836352,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":5,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":3,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""NSCLC"",""ecog"":1,""life_expectancy_months"":8,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":3.8,""egfr_alk_status"":""EGFR exon 19 del"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",false,"Ineligible: NSCLC with known EGFR mutation (explicitly excluded regardless of MSI status)."
NCT03836352,P004,"{""age"":54,""gender"":""F"",""diagnosis"":""recurrent ovarian cancer"",""prior_lines"":1,""last_chemo_weeks_ago"":3,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""yes, active"",""msi_status"":""MSI-H"",""tumor_type"":""ovarian"",""ecog"":1,""life_expectancy_months"":10,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":6.8,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",false,"Ineligible: active CNS metastases AND largest lesion >5 cm in ovarian cancer patient (two independent exclusions)."
NCT03836352,P005,"{""age"":60,""gender"":""M"",""diagnosis"":""urothelial carcinoma"",""prior_lines"":1,""last_chemo_weeks_ago"":12,""last_immuno_weeks_ago"":5,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""urothelial"",""ecog"":1,""life_expectancy_months"":7,""active_autoimmune"":true,""on_steroids"":true,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":4.0,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",false,"Ineligible: ongoing systemic steroid therapy/immunosuppression AND active autoimmune disease requiring treatment."
NCT03836352,P006,"{""age"":49,""gender"":""F"",""diagnosis"":""recurrent ovarian cancer"",""prior_lines"":1,""last_chemo_weeks_ago"":6,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSS"",""tumor_type"":""ovarian"",""ecog"":1,""life_expectancy_months"":9,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":true,""largest_lesion_cm"":4.5,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",false,"Ineligible: MSS (not MSI-H) AND history of malignant bowel obstruction."
NCT03836352,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":8,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""NSCLC"",""ecog"":1,""life_expectancy_months"":6,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":true,""bowel_obstruction"":false,""largest_lesion_cm"":3.9,""egfr_alk_status"":""wild-type"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",false,"Ineligible: history of non-infectious pneumonitis requiring steroids."
NCT03836352,P008,"{""age"":55,""gender"":""F"",""diagnosis"":""recurrent ovarian cancer"",""prior_lines"":1,""last_chemo_weeks_ago"":5,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""ovarian"",""ecog"":2,""life_expectancy_months"":10,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":4.8,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",false,"Ineligible: ECOG 2 (protocol requires ECOG 0–1)."
NCT03836352,P009,"{""age"":61,""gender"":""M"",""diagnosis"":""metastatic urothelial"",""prior_lines"":1,""last_chemo_weeks_ago"":7,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""urothelial"",""ecog"":0,""life_expectancy_months"":14,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":3.5,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":true,""live_vaccine_last_30d"":false,""pregnant"":false}",false,"Ineligible: prior receipt of survivin-based vaccine (explicit exclusion)."
NCT03836352,P010,"{""age"":59,""gender"":""F"",""diagnosis"":""recurrent ovarian cancer"",""prior_lines"":1,""last_chemo_weeks_ago"":6,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":4,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""ovarian"",""ecog"":1,""life_expectancy_months"":11,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":4.9,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",true,"Eligible: post-1L ovarian ca, MSI-H, all washouts met, ECOG 1, largest lesion <5 cm, no exclusions triggered."
NCT04421352,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":12,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":20,""brain_mets"":""yes, treated with SRT 14 weeks ago, stable"",""ecog"":1,""life_expectancy_months"":5,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",true,"Eligible: post-1L platinum ES-SCLC, prior ICI-naïve, brain mets treated & stable >12w ago, ECOG 1, extracranial measurable lesion, no exclusions."
NCT04421352,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""LS-SCLC relapsed"",""prior_lines"":1,""last_chemo_weeks_ago"":10,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":16,""brain_mets"":""none"",""ecog"":0,""life_expectancy_months"":8,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",true,"Eligible: relapsed LS-SCLC post-platinum + radical RT, >12w since RT, ICI-naïve, ECOG 0, all criteria met."
NCT04421352,P003,"{""age"":61,""gender"":""M"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":8,""last_immuno_weeks_ago"":6,""last_radiation_weeks_ago"":18,""brain_mets"":""none"",""ecog"":1,""life_expectancy_months"":4,""prior_ici"":true,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",false,"Ineligible: prior immune checkpoint inhibitor therapy (explicitly disallowed)."
NCT04421352,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":15,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":9,""brain_mets"":""yes, treated 9 weeks ago"",""ecog"":1,""life_expectancy_months"":6,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",false,"Ineligible: brain metastases treated <12 weeks ago (requires ≥3 months stability post-RT)."
NCT04421352,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":11,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":30,""brain_mets"":""yes, asymptomatic but new lesion"",""ecog"":2,""life_expectancy_months"":4,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",false,"Ineligible: unstable/active brain metastases AND ECOG 2 (protocol requires ECOG 0–1)."
NCT04421352,P006,"{""age"":49,""gender"":""F"",""diagnosis"":""LS-SCLC relapsed"",""prior_lines"":1,""last_chemo_weeks_ago"":14,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":8,""brain_mets"":""none"",""ecog"":1,""life_expectancy_months"":7,""prior_ici"":false,""active_autoimmune"":true,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",false,"Ineligible: active autoimmune disease requiring treatment."
NCT04421352,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":20,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":25,""brain_mets"":""none"",""ecog"":1,""life_expectancy_months"":5,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":true,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",false,"Ineligible: history of grade ≥3 radiation pneumonitis."
NCT04421352,P008,"{""age"":53,""gender"":""F"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":13,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":22,""brain_mets"":""meningeal metastases"",""ecog"":1,""life_expectancy_months"":6,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",false,"Ineligible: meningeal metastases (explicit exclusion)."
NCT04421352,P009,"{""age"":60,""gender"":""M"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":16,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":28,""brain_mets"":""yes, treated 20 weeks ago, stable"",""ecog"":0,""life_expectancy_months"":9,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":true,""allergic_asthma"":false,""pregnant"":false}",false,"Ineligible: active chronic hepatitis C."
NCT04421352,P010,"{""age"":57,""gender"":""F"",""diagnosis"":""LS-SCLC relapsed"",""prior_lines"":1,""last_chemo_weeks_ago"":18,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":24,""brain_mets"":""yes, treated 18 weeks ago, stable"",""ecog"":1,""life_expectancy_months"":7,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",true,"Eligible: all criteria met – post-platinum relapse, ICI-naïve, brain mets stable >12w post-RT, ECOG 1, adequate organ function assumed."
NCT01774526,P001,"{""age"":48,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",true,"Eligible: Asian never-smoker female with metastatic adenocarcinoma and malignant pleural effusion, ECOG 1, fit and willing for pleuroscopy and systemic therapy."
NCT01774526,P002,"{""age"":52,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Malay"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":2,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",true,"Eligible: meets all strict demographic and disease criteria, ECOG 2 allowed."
NCT01774526,P003,"{""age"":45,""gender"":""M"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Indian"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",true,"Eligible: Asian ethnicity (Indian), never-smoker, malignant pleural effusion, all other criteria satisfied."
NCT01774526,P004,"{""age"":38,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":false,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",false,"Ineligible: unwilling to undergo pleuroscopy and biopsy (explicit requirement)."
NCT01774526,P005,"{""age"":55,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Caucasian"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",false,"Ineligible: non-Asian ethnicity (strict exclusion)."
NCT01774526,P006,"{""age"":50,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""ex-smoker 10 pack-years"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",false,"Ineligible: smoking history (protocol restricted to never-smokers only)."
NCT01774526,P007,"{""age"":60,""gender"":""M"",""diagnosis"":""lung squamous cell carcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""squamous"",""stage"":""IV""}",false,"Ineligible: histology is squamous cell carcinoma, not adenocarcinoma."
NCT01774526,P008,"{""age"":42,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":false,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",false,"Ineligible: no malignant pleural effusion (mandatory for this trial)."
NCT01774526,P009,"{""age"":19,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Malay"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",false,"Ineligible: age <21 years (minimum age 21 required)."
NCT01774526,P010,"{""age"":67,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":3,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":false,""histology"":""adenocarcinoma"",""stage"":""IV""}",false,"Ineligible: ECOG 3 AND deemed not suitable for palliative chemotherapy or EGFR-TKI."
NCT01780675,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":6,""last_radiation_weeks_ago"":8,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",true,"Eligible: LS-SCLC in remission after chemo-RT, no brain mets, no progression, fluent in Dutch, no prior brain RT, no systemic therapy planned during PCI."
NCT01780675,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":5,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",true,"Eligible: ES-SCLC in remission after chemo, no brain mets, no progression, Dutch fluent, all criteria met."
NCT01780675,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":4,""last_radiation_weeks_ago"":7,""brain_mets"":""yes, asymptomatic"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",false,"Ineligible: clinical evidence of brain metastases (strict exclusion, even if asymptomatic)."
NCT01780675,P004,"{""age"":60,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":2,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":true,""recent_malignancy"":false,""pregnant"":false}",false,"Ineligible: planned systemic anticancer treatment during or within 3 weeks before PCI."
NCT01780675,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":10,""last_radiation_weeks_ago"":12,""brain_mets"":""none"",""progressive_extracranial_disease"":true,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",false,"Ineligible: evidence of progressive extracranial disease (excludes PCI candidacy)."
NCT01780675,P006,"{""age"":48,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":7,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":false,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",false,"Ineligible: insufficient proficiency in Dutch (mandatory for neurocognitive assessments)."
NCT01780675,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":9,""last_radiation_weeks_ago"":10,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":true,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",false,"Ineligible: prior radiotherapy to the brain (strict exclusion)."
NCT01780675,P008,"{""age"":52,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":6,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":true,""pregnant"":false}",false,"Ineligible: previous malignancy within past 2 years (except allowed skin/cervical in situ)."
NCT01780675,P009,"{""age"":39,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":8,""last_radiation_weeks_ago"":9,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":true}",false,"Ineligible: currently pregnant (explicit exclusion)."
NCT01780675,P010,"{""age"":63,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":7,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",true,"Eligible: ES-SCLC in remission post-chemo, no brain mets, stable disease, fluent in Dutch, no exclusions apply."
NCT03231111,P001,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Tarceva"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",true,"Eligible: female, age >20, first-time Tarceva, stage IV NSCLC, Chinese-literate, has home computer with DVD, treated at Taipei Medical Center."
NCT03231111,P002,"{""age"":65,""gender"":""F"",""diagnosis"":""stage IIIB NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Iressa"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",true,"Eligible: meets all criteria including first-time EGFR-TKI use and Chinese literacy."
NCT03231111,P003,"{""age"":72,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":true,""current_tki_planned"":""Tarceva"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",false,"Ineligible: prior EGFR-TKI exposure (trial restricted to TKI-naïve patients)."
NCT03231111,P004,"{""age"":55,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Iressa"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",false,"Ineligible: male patient (trial exclusively for women)."
NCT03231111,P005,"{""age"":19,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Tarceva"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",false,"Ineligible: age <20 years."
NCT03231111,P006,"{""age"":61,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Tarceva"",""has_home_computer"":false,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",false,"Ineligible: no computer equipment at home to play multimedia disc."
NCT03231111,P007,"{""age"":50,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Iressa"",""has_home_computer"":true,""language"":""English only"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",false,"Ineligible: cannot speak/read/write Chinese fluently."
NCT03231111,P008,"{""age"":68,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Tarceva"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""dementia"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",false,"Ineligible: cognitive impairment (excludes clear consciousness requirement)."
NCT03231111,P009,"{""age"":59,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""none"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Kaohsiung Hospital"",""pregnant"":false}",false,"Ineligible: not receiving treatment at Taipei Medical Center."
NCT03231111,P010,"{""age"":63,""gender"":""F"",""diagnosis"":""stage III NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Iressa"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",true,"Eligible: female, first-time Iressa, stage III allowed, all logistical and language criteria met."
NCT00447421,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":0,""life_expectancy_months"":6,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",true,"Eligible: treatment-naïve LS-SCLC, ECOG 0, no prior chemo/RT, adequate organ/pulmonary function assumed, no cardiac events, no exclusions."
NCT00447421,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":5,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",true,"Eligible: treatment-naïve SCLC (stage not restricted), ECOG 1, all key criteria met."
NCT00447421,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""prior_chemo"":true,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":4,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",false,"Ineligible: prior chemotherapy (protocol requires completely treatment-naïve status)."
NCT00447421,P004,"{""age"":60,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":true,""ecog"":0,""life_expectancy_months"":7,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",false,"Ineligible: prior thoracic radiotherapy (explicitly disallowed)."
NCT00447421,P005,"{""age"":55,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":2,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",false,"Ineligible: life expectancy <12 weeks."
NCT00447421,P006,"{""age"":68,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":2,""life_expectancy_months"":6,""recent_mi"":true,""significant_weight_loss"":true,""prior_lower_neck_abdominal_rt"":true,""concurrent_other_antitumor"":false,""pregnant"":false}",false,"Ineligible: multiple: ECOG 2, recent MI, significant weight loss, prior abdominal RT."
NCT00447421,P007,"{""age"":17,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":8,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",false,"Ineligible: age <18 years."
NCT00447421,P008,"{""age"":61,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":9,""recent_mi"":false,""significant_weight_loss"":true,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",false,"Ineligible: significant weight loss (≥10% in 3 months assumed)."
NCT00447421,P009,"{""age"":59,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":10,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":true,""pregnant"":false}",false,"Ineligible: concurrent administration of other antitumor therapy."
NCT00447421,P010,"{""age"":64,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":0,""life_expectancy_months"":12,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",true,"Eligible: fully treatment-naïve LS-SCLC, ECOG 0, life expectancy ≥12 weeks, no exclusion criteria triggered."
NCT00084487,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""yes, stable, no steroids"",""ecog"":1,""anc"":2200,""platelets"":165000,""hemoglobin"":10.2,""creatinine_clearance"":72,""bilirubin_mgdl"":1.1,""ast"":48,""nyha_class"":1,""active_infection"":false,""pregnant"":false}",true,"Eligible: sensitive relapse after 1 prior regimen, stable treated brain mets (no steroids), ECOG 1, all labs and cardiac criteria met."
NCT00084487,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""none"",""ecog"":0,""anc"":1900,""platelets"":140000,""hemoglobin"":9.8,""creatinine_clearance"":68,""bilirubin_mgdl"":0.9,""ast"":55,""nyha_class"":2,""active_infection"":false,""pregnant"":false}",true,"Eligible: sensitive relapse, no brain mets, ECOG 0, adequate organ function."
NCT00084487,P003,"{""age"":61,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":2,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""none"",""ecog"":1,""anc"":1800,""platelets"":120000,""hemoglobin"":10.5,""creatinine_clearance"":75,""bilirubin_mgdl"":1.0,""ast"":60,""nyha_class"":1,""active_infection"":false,""pregnant"":false}",false,"Ineligible: received 2 prior chemotherapy regimens (max 1 allowed)."
NCT00084487,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""relapse_type"":""refractory"",""measurable_disease"":true,""brain_mets"":""none"",""ecog"":1,""anc"":2100,""platelets"":155000,""hemoglobin"":9.9,""creatinine_clearance"":70,""bilirubin_mgdl"":1.2,""ast"":50,""nyha_class"":1,""active_infection"":false,""pregnant"":false}",false,"Ineligible: refractory relapse (protocol requires sensitive relapse only)."
NCT00084487,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""yes, progressing, on steroids"",""ecog"":2,""anc"":1600,""platelets"":110000,""hemoglobin"":9.5,""creatinine_clearance"":65,""bilirubin_mgdl"":1.3,""ast"":70,""nyha_class"":3,""active_infection"":false,""pregnant"":false}",false,"Ineligible: unstable/symptomatic brain mets requiring steroids AND NYHA class III heart disease."
NCT00084487,P006,"{""age"":59,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""yes, stable but on dexamethasone"",""ecog"":1,""anc"":1400,""platelets"":95000,""hemoglobin"":8.8,""creatinine_clearance"":58,""bilirubin_mgdl"":1.6,""ast"":110,""nyha_class"":1,""active_infection"":true,""pregnant"":false}",false,"Ineligible: multiple labs below threshold (ANC<1500, Plt<100k, Hb<9, CrCl<60) + steroid requirement for brain mets + active infection."
NCT00084487,P007,"{""age"":52,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""none"",""ecog"":2,""anc"":3000,""platelets"":180000,""hemoglobin"":11.0,""creatinine_clearance"":80,""bilirubin_mgdl"":0.8,""ast"":40,""nyha_class"":4,""active_infection"":false,""pregnant"":true}",false,"Ineligible: pregnant AND NYHA class IV heart failure."
NCT00084487,P008,"{""age"":70,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""yes, stable, no steroids"",""ecog"":1,""anc"":1700,""platelets"":105000,""hemoglobin"":9.2,""creatinine_clearance"":62,""bilirubin_mgdl"":1.4,""ast"":90,""nyha_class"":2,""active_infection"":false,""pregnant"":false}",true,"Eligible: sensitive relapse, stable brain mets off steroids, all other criteria satisfied."
NCT00084487,P009,"{""age"":63,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":false,""brain_mets"":""none"",""ecog"":1,""anc"":2500,""platelets"":200000,""hemoglobin"":10.8,""creatinine_clearance"":85,""bilirubin_mgdl"":1.0,""ast"":45,""nyha_class"":1,""active_infection"":false,""pregnant"":false}",false,"Ineligible: no measurable disease by protocol criteria."
NCT00084487,P010,"{""age"":57,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""yes, stable, no steroids"",""ecog"":0,""anc"":2800,""platelets"":190000,""hemoglobin"":11.5,""creatinine_clearance"":90,""bilirubin_mgdl"":0.9,""ast"":50,""nyha_class"":1,""active_infection"":false,""pregnant"":false}",true,"Eligible: textbook sensitive relapse case with stable treated brain mets, excellent performance status and labs."
NCT05958199,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""EGFR-mutant NSCLC"",""stage"":""IV"",""prior_lines"":3,""ecog"":1,""brain_mets"":""yes, stable >3mo, asymptomatic"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: EGFR-mutant NSCLC, refractory, ECOG 1, stable brain mets, no unresolved ≥G2 tox, no active autoimmune on high-dose steroids."
NCT05958199,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""triple-negative breast cancer"",""stage"":""IV"",""prior_lines"":4,""ecog"":0,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: TNBC metastatic, ECOG 0, all criteria met."
NCT05958199,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""renal cell carcinoma"",""stage"":""IV"",""prior_lines"":2,""ecog"":2,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: ECOG 2 (protocol allows only 0–1)."
NCT05958199,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""urothelial carcinoma"",""stage"":""IV"",""prior_lines"":3,""ecog"":1,""brain_mets"":""yes, progressing"",""unresolved_tox_gte2"":true,""autoimmune_on_steroids_gt10mg"":true,""prior_grade3_ir_pneumonitis"":true,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: unstable brain mets + unresolved ≥G2 toxicity + active autoimmune requiring >10mg prednisone + prior G3 ir-pneumonitis/colitis."
NCT05958199,P005,"{""age"":60,""gender"":""M"",""diagnosis"":""colorectal carcinoma"",""stage"":""IV"",""prior_lines"":3,""ecog"":1,""brain_mets"":""none"",""unresolved_tox_gte2"":true,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: unresolved Grade ≥2 toxicity from prior treatment (except allowed exceptions)."
NCT05958199,P006,"{""age"":48,""gender"":""F"",""diagnosis"":""cervical cancer"",""stage"":""IVB"",""prior_lines"":2,""ecog"":1,""brain_mets"":""yes, stable"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":true,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":false,""pregnant"":false}",false,"Ineligible: active autoimmune disease requiring >10mg prednisone equivalent AND not using effective contraception."
NCT05958199,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""pancreatic adenocarcinoma"",""stage"":""IV"",""prior_lines"":2,""ecog"":0,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":true,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: history of grade 3 immune-related pneumonitis or colitis."
NCT05958199,P008,"{""age"":52,""gender"":""F"",""diagnosis"":""endometrial carcinoma"",""stage"":""IV"",""prior_lines"":3,""ecog"":1,""brain_mets"":""yes, stable"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":true}",false,"Ineligible: currently pregnant."
NCT05958199,P009,"{""age"":66,""gender"":""M"",""diagnosis"":""NSCLC"",""stage"":""IV"",""prior_lines"":4,""ecog"":1,""brain_mets"":""yes, stable"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: NSCLC (EGFR status not required), refractory, stable brain mets, ECOG 1, no exclusions."
NCT05958199,P010,"{""age"":59,""gender"":""F"",""diagnosis"":""cholangiocarcinoma"",""stage"":""IV"",""prior_lines"":2,""ecog"":0,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: metastatic CCA, ECOG 0, clean toxicity/autoimmune history, contraception compliant."
NCT02015416,P001,"{""age"":58,""gender"":""F"",""diagnosis"":""ovarian cancer"",""stage"":""recurrent platinum-resistant"",""prior_lines"":2,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":10,""brain_mets"":""yes, stable >6mo"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":6,""recent_investigational_weeks_ago"":8,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",true,"Eligible: recurrent ovarian ca, NY-ESO-1+, low burden, ≥1 prior therapy, ECOG 1, stable brain mets, adequate washout."
NCT02015416,P002,"{""age"":62,""gender"":""M"",""diagnosis"":""NSCLC"",""stage"":""IV"",""prior_lines"":3,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":0,""life_expectancy_months"":12,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":5,""recent_investigational_weeks_ago"":10,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",true,"Eligible: NSCLC with ≥2 prior systemic therapies, NY-ESO-1+, ECOG 0, low burden, washouts met."
NCT02015416,P003,"{""age"":55,""gender"":""F"",""diagnosis"":""melanoma"",""stage"":""IV"",""prior_lines"":1,""ny_eso1_positive"":false,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":9,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":7,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",false,"Ineligible: tumor does not express NY-ESO-1 (mandatory biomarker)."
NCT02015416,P004,"{""age"":60,""gender"":""M"",""diagnosis"":""breast cancer"",""stage"":""IV"",""prior_lines"":1,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":8,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":6,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",false,"Ineligible: breast cancer with only 1 prior systemic therapy (requires ≥2 for breast cancer)."
NCT02015416,P005,"{""age"":48,""gender"":""F"",""diagnosis"":""sarcoma"",""stage"":""metastatic"",""prior_lines"":2,""ny_eso1_positive"":true,""disease_burden"":""high"",""rapid_progression"":true,""ecog"":1,""life_expectancy_months"":7,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":8,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",false,"Ineligible: rapidly progressive, high disease burden (protocol requires low/minimal burden)."
NCT02015416,P006,"{""age"":65,""gender"":""M"",""diagnosis"":""NSCLC"",""stage"":""IV"",""prior_lines"":3,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":11,""brain_mets"":""yes, progressing"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":4,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":true,""active_infection"":true,""recent_mi"":true,""pregnant"":false}",false,"Ineligible: unstable brain metastases + significant autoimmune + active infection + recent MI."
NCT02015416,P007,"{""age"":52,""gender"":""F"",""diagnosis"":""ovarian cancer"",""stage"":""recurrent"",""prior_lines"":3,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":5,""brain_mets"":""none"",""prior_ny_eso1_therapy"":true,""recent_chemo_weeks_ago"":12,""recent_investigational_weeks_ago"":4,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",false,"Ineligible: prior NY-ESO-1 directed therapy AND recent investigational agent <3 weeks."
NCT02015416,P008,"{""age"":70,""gender"":""M"",""diagnosis"":""uveal melanoma"",""stage"":""IV"",""prior_lines"":2,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":0,""life_expectancy_months"":9,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":10,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",false,"Ineligible: uveal melanoma (explicitly excluded)."
NCT02015416,P009,"{""age"":44,""gender"":""F"",""diagnosis"":""melanoma"",""stage"":""IV"",""prior_lines"":2,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":14,""brain_mets"":""yes, stable"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":5,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":true}",false,"Ineligible: currently pregnant."
NCT02015416,P010,"{""age"":59,""gender"":""M"",""diagnosis"":""breast cancer"",""stage"":""IV"",""prior_lines"":4,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":0,""life_expectancy_months"":15,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":7,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",true,"Eligible: metastatic breast ca with ≥2 prior therapies, NY-ESO-1+, low burden, ECOG 0, all criteria met."
NCT06607185,P001,"{""age"":63,""gender"":""M"",""diagnosis"":""metastatic pancreatic adenocarcinoma"",""kras_mutation"":""G12D"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, treated SRT 4mo ago, asymptomatic"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",true,"Eligible: KRAS G12D PDAC, measurable disease, ECOG 1, stable treated brain mets, no exclusions."
NCT06607185,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_mutation"":""G12C"",""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",true,"Eligible: classic KRAS G12C NSCLC, ECOG 0, all criteria cleanly met."
NCT06607185,P003,"{""age"":67,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""kras_mutation"":""G12V"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_g1"":true,""history_ild_pneumonitis"":true,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":true,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",false,"Ineligible: unresolved ≥G2 toxicity + prior steroid-requiring ILD/pneumonitis + significant cardiac disease."
NCT06607185,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_mutation"":""G12C"",""ecog"":2,""measurable_disease"":true,""brain_mets"":""yes, active symptomatic"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",false,"Ineligible: ECOG 2 AND active/symptomatic CNS metastases."
NCT06607185,P005,"{""age"":61,""gender"":""M"",""diagnosis"":""metastatic pancreatic cancer"",""kras_mutation"":""wild-type"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",false,"Ineligible: no qualifying KRAS mutation (G12C/D/V/A/S or G13D required)."
NCT06607185,P006,"{""age"":49,""gender"":""F"",""diagnosis"":""metastatic appendiceal cancer"",""kras_mutation"":""G13D"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":true,""significant_cardiac_disease"":false,""active_infection"":true,""other_malignancy"":""prostate ca in remission"",""can_swallow_tablets"":true,""pregnant"":false}",false,"Ineligible: active hepatitis/HIV + active infection."
NCT06607185,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""kras_mutation"":""G12A"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, stable"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":true,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":false,""pregnant"":false}",false,"Ineligible: significant cardiovascular disease + unable to swallow tablets."
NCT06607185,P008,"{""age"":53,""gender"":""F"",""diagnosis"":""metastatic colorectal cancer"",""kras_mutation"":""G12S"",""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""breast ca, active"",""can_swallow_tablets"":true,""pregnant"":true}",false,"Ineligible: second active malignancy + pregnant."
NCT06607185,P009,"{""age"":66,""gender"":""M"",""diagnosis"":""metastatic cholangiocarcinoma"",""kras_mutation"":""G12D"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, stable"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":true,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",false,"Ineligible: history of steroid-requiring non-infectious pneumonitis/ILD."
NCT06607185,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_mutation"":""G12V"",""ecog"":0,""measurable_disease"":true,""brain_mets"":""yes, treated, asymptomatic"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",true,"Eligible: KRAS G12V NSCLC, stable CNS disease, ECOG 0, perfect candidate."
NCT06725225,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""current_immunotherapy"":""pembrolizumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",true,"Eligible: histologically confirmed lung cancer on active immunotherapy, good communication, no cognitive issues, consent signed."
NCT06725225,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""current_immunotherapy"":""atezolizumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",true,"Eligible: SCLC on immunotherapy, all criteria met."
NCT06725225,P003,"{""age"":72,""gender"":""M"",""diagnosis"":""stage III NSCLC"",""current_immunotherapy"":""durvalumab"",""verbal_communication"":""good"",""cognitive_impairment"":true,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: cognitive impairment (explicit exclusion)."
NCT06725225,P004,"{""age"":17,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""current_immunotherapy"":""nivolumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: age <18 years."
NCT06725225,P005,"{""age"":68,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""current_immunotherapy"":""none, last dose 8 weeks ago"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: not currently receiving immunotherapy."
NCT06725225,P006,"{""age"":61,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""current_immunotherapy"":""nivolumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: diagnosis is melanoma, not lung cancer."
NCT06725225,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""current_immunotherapy"":""pembrolizumab"",""verbal_communication"":""poor"",""cognitive_impairment"":false,""severe_comorbid_disease"":true,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: poor verbal communication AND other severe comorbid disease."
NCT06725225,P008,"{""age"":55,""gender"":""F"",""diagnosis"":""stage IIIB NSCLC"",""current_immunotherapy"":""pembrolizumab + chemo"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":false,""pregnant"":false}",false,"Ineligible: no informed consent signed."
NCT06725225,P009,"{""age"":74,""gender"":""M"",""diagnosis"":""stage IV SCLC"",""current_immunotherapy"":""lurbinectedin + atezolizumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",true,"Eligible: extensive-stage SCLC on active IO, consent signed, no exclusions."
NCT06725225,P010,"{""age"":59,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""current_immunotherapy"":""nivolumab-ipilimumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",true,"Eligible: NSCLC on dual checkpoint blockade, fully eligible."
NCT06079970,P001,"{""age"":68,""gender"":""M"",""lesion_location"":""RUL peripheral"",""solid_component_mm"":18,""largest_diameter_mm"":26,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",true,"Eligible: classic peripheral 26 mm RUL nodule with bronchus sign, solid >10 mm, no contraindications."
NCT06079970,P002,"{""age"":62,""gender"":""F"",""lesion_location"":""LLL peripheral"",""solid_component_mm"":15,""largest_diameter_mm"":22,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",true,"Eligible: perfect candidate, all criteria met."
NCT06079970,P003,"{""age"":70,""gender"":""M"",""lesion_location"":""RML"",""solid_component_mm"":20,""largest_diameter_mm"":28,""bronchus_sign"":false,""rebus_expected"":false,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: no bronchus sign AND low expected r-EBUS signal."
NCT06079970,P004,"{""age"":59,""gender"":""F"",""lesion_location"":""RUL"",""solid_component_mm"":8,""largest_diameter_mm"":25,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: solid component <10 mm."
NCT06079970,P005,"{""age"":66,""gender"":""M"",""lesion_location"":""LUL"",""solid_component_mm"":22,""largest_diameter_mm"":35,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: largest diameter >30 mm."
NCT06079970,P006,"{""age"":64,""gender"":""F"",""lesion_location"":""RUL"",""solid_component_mm"":19,""largest_diameter_mm"":27,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":true,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":true,""hemodynamic_stable"":false,""hypoxemia"":true,""can_tolerate_ga"":false,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: multiple – visible endobronchial tumor + fluorescein allergy + hemodynamic instability + refractory hypoxemia + cannot tolerate GA."
NCT06079970,P007,"{""age"":71,""gender"":""M"",""lesion_location"":""central hilum"",""solid_component_mm"":25,""largest_diameter_mm"":29,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":true,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: lesion reachable by linear EBUS (excludes peripheral definition)."
NCT06079970,P008,"{""age"":55,""gender"":""F"",""lesion_location"":""RLL peripheral"",""solid_component_mm"":16,""largest_diameter_mm"":24,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":true,""therapeutic_anticoagulation_stopped"":false,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",false,"Ineligible: ongoing doxorubicin (fluorescent) + therapeutic anticoagulation cannot be stopped."
NCT06079970,P009,"{""age"":60,""gender"":""M"",""lesion_location"":""LUL peripheral"",""solid_component_mm"":21,""largest_diameter_mm"":29,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":false,""pregnant"":false}",false,"Ineligible: no informed consent."
NCT06079970,P010,"{""age"":67,""gender"":""F"",""lesion_location"":""RUL peripheral"",""solid_component_mm"":17,""largest_diameter_mm"":28,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":true}",false,"Ineligible: currently pregnant."
NCT02117024,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":3,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""yes, treated SRT 3mo ago, stable"",""last_chemo_or_rt_weeks_ago"":4,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: 3rd-line adenocarcinoma, progressing, ECOG 1, stable brain mets, adequate washout, no vaccine history."
NCT02117024,P002,"{""age"":59,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":2,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":5,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: 2nd-line progressing adenocarcinoma, all criteria met."
NCT02117024,P003,"{""age"":67,""gender"":""M"",""diagnosis"":""lung squamous carcinoma"",""prior_lines"":3,""histology"":""squamous"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":6,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: squamous histology (trial restricted to adenocarcinoma only)."
NCT02117024,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":4,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":8,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: 4 prior lines (maximum 3 allowed)."
NCT02117024,P005,"{""age"":70,""gender"":""M"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":3,""histology"":""adenocarcinoma"",""progression_at_entry"":false,""ecog"":2,""brain_mets"":""yes, active leptomeningeal"",""last_chemo_or_rt_weeks_ago"":10,""prior_cancer_vaccine"":true,""hiv_hbv_hcv"":true,""immunosuppressive_therapy"":true,""leptomeningeal_disease"":true,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: no progression at entry + leptomeningeal disease + prior cancer vaccine + HIV/HBV/HCV + systemic immunosuppression."
NCT02117024,P006,"{""age"":55,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":2,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":1,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":true,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: systemic therapy <14 days ago + second active malignancy."
NCT02117024,P007,"{""age"":68,""gender"":""M"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":3,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":2,""brain_mets"":""yes, stable"",""last_chemo_or_rt_weeks_ago"":4,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: ECOG 2 allowed per protocol discretion, 3 prior lines, stable brain mets, all else clean."
NCT02117024,P008,"{""age"":52,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":3,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":6,""prior_cancer_vaccine"":true,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":true}",false,"Ineligible: prior cancer vaccine for this indication + pregnant."
NCT02117024,P009,"{""age"":73,""gender"":""M"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":2,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""yes, unstable"",""last_chemo_or_rt_weeks_ago"":5,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":true,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: neurologically unstable brain mets + concurrent systemic immunosuppression."
NCT02117024,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":3,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":7,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: textbook 3rd-line progressing adenocarcinoma, ECOG 1, no exclusions."
NCT00494026,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":0,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",true,"Eligible: treatment-naïve LS-SCLC, ECOG 0, no weight loss, willing/able vitamins & steroids."
NCT00494026,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",true,"Eligible: classic LS-SCLC candidate, ECOG 1, all criteria met."
NCT00494026,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",false,"Ineligible: extensive-stage disease (trial strictly limited-stage only)."
NCT00494026,P004,"{""age"":60,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":true,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",false,"Ineligible: prior chemotherapy (protocol requires completely treatment-naïve)."
NCT00494026,P005,"{""age"":55,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":true,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",false,"Ineligible: prior thoracic radiotherapy."
NCT00494026,P006,"{""age"":68,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":2,""significant_weight_loss_6w"":true,""able_vitamins_corticosteroids"":false,""pregnant"":false}",false,"Ineligible: ECOG 2 (protocol allows ≤1) + significant weight loss + unwilling/unable vitamins/steroids."
NCT00494026,P007,"{""age"":17,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",false,"Ineligible: age <18."
NCT00494026,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":false,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",false,"Ineligible: no measurable disease."
NCT00494026,P009,"{""age"":70,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":true,""able_vitamins_corticosteroids"":true,""pregnant"":false}",false,"Ineligible: significant weight loss ≥10% in past 6 weeks."
NCT00494026,P010,"{""age"":59,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":0,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":true}",false,"Ineligible: currently pregnant/breastfeeding."
NCT06963502,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"": ""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: KRAS G12C NSCLC, no other drivers, no prior G12C inhibitor, ECOG 1, clean exclusions."
NCT06963502,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""metastatic CRC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: KRAS G12C CRC, perfect candidate."
NCT06963502,P003,"{""age"":66,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C + EGFR exon19del"",""other_drivers"":""EGFR"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: co-occurring EGFR mutation (locally approved targeted therapy exists)."
NCT06963502,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":true,""ecog"":1,""measurable_disease"":true,""brain_mets"":""active symptomatic"",""unresolved_tox_gte2"":true,""uncontrolled_effusion"":true,""spinal_cord_compression"":true,""ild_history"":true,""active_autoimmune"":true,""severe_cardiac"":true,""child_pugh"":""C"",""can_swallow_pills"":false,""contraception_compliant"":false,""pregnant"":false}",false,"Ineligible: multiple – prior G12C inhibitor + active brain mets + ≥G2 unresolved tox + uncontrolled effusion + spinal compression + ILD + autoimmune + severe cardiac + Child-Pugh C + cannot swallow."
NCT06963502,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""metastatic pancreatic"",""kras_status"":""G12D"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: KRAS G12D (only G12C allowed)."
NCT06963502,P006,"{""age"":70,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, untreated"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: active brain metastases."
NCT06963502,P007,"{""age"":52,""gender"":""M"",""diagnosis"":""metastatic CRC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":2,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":true,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":true,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: ECOG 2 + ≥G2 unresolved toxicity + severe cardiovascular disease."
NCT06963502,P008,"{""age"":48,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":true,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":true}",false,"Ineligible: history of ILD + pregnant."
NCT06963502,P009,"{""age"":67,""gender"":""M"",""diagnosis"":""metastatic appendiceal"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":true,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",false,"Ineligible: uncontrolled pleural/ascites/pericardial effusion."
NCT06963502,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",true,"Eligible: textbook KRAS G12C NSCLC, ECOG 0, no exclusions."
NCT00663689,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L platinum doublet"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""multiple asymptomatic, treated SRT >3mo ago, no symptoms"",""brain_mri_lesions_count"":5,""longest_brain_lesion_mm"":8,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",true,"Eligible: classic post-1L SD, asymptomatic treated brain mets, ECOG 1, no prior EGFR-TKI, all labs met."
NCT00663689,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":0,""brain_mets"":""3 asymptomatic untreated lesions"",""brain_mri_lesions_count"":3,""longest_brain_lesion_mm"":12,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",true,"Eligible: untreated asymptomatic brain mets allowed if truly asymptomatic, ≥3 lesions, all criteria met."
NCT00663689,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""histology"":""squamous"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":4,""longest_brain_lesion_mm"":9,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",true,"Eligible: squamous histology allowed (no restriction in protocol)."
NCT00663689,P004,"{""age"":60,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""PD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":6,""longest_brain_lesion_mm"":7,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",false,"Ineligible: extracranial progressive disease (must be SD after 1L)."
NCT00663689,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":true,""ecog"":1,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":4,""longest_brain_lesion_mm"":11,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",false,"Ineligible: prior EGFR-TKI exposure (strictly forbidden)."
NCT00663689,P006,"{""age"":68,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""symptomatic (headache + seizures)"",""brain_mri_lesions_count"":8,""longest_brain_lesion_mm"":15,""unresolved_tox_gte2"":true,""gi_integrity"":""gastric bypass"",""can_swallow_pills"":false,""active_infection"":true,""nyha_class"":3,""recent_mi"":true,""other_malignancy_5y"":true,""pregnant"":false}",false,"Ineligible: multiple – symptomatic brain mets + unresolved ≥G3 tox + malabsorption + active infection + NYHA 3 + recent MI + second malignancy."
NCT00663689,P007,"{""age"":17,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":2,""longest_brain_lesion_mm"":6,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",false,"Ineligible: age <18 + only 2 brain lesions (requires ≥3 appraisable lesions)."
NCT00663689,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":3,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":5,""longest_brain_lesion_mm"":9,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":true}",false,"Ineligible: ECOG 3 + pregnant."
NCT00663689,P009,"{""age"":70,""gender"":""M"",""diagnosis"":""stage IV NSCLC + SCLC mixed"",""histology"":""mixed"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":7,""longest_brain_lesion_mm"":10,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",false,"Ineligible: mixed small-cell component (explicit exclusion)."
NCT00663689,P010,"{""age"":59,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L pemetrexed-cisplatin"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""4 asymptomatic lesions"",""brain_mri_lesions_count"":4,""longest_brain_lesion_mm"":11,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",true,"Eligible: ideal candidate – post-platinum SD, asymptomatic brain mets, ECOG 1, no prior TKI."
NCT02772107,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""4 cycles EP, PR"",""weeks_since_last_chemo"":4,""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, treated SRT 8wk ago, stable"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",true,"Eligible: ES-SCLC after 4 cycles EP, within 3–7wk window, ECOG 1, stable treated brain mets, no lepto."
NCT02772107,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""6 cycles EP, SD"",""weeks_since_last_chemo"":5,""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",true,"Eligible: textbook 6-cycle responder, perfect timing, ECOG 0."
NCT02772107,P003,"{""age"":67,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""4 cycles EP, PD"",""weeks_since_last_chemo"":4,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",false,"Ineligible: progressive disease after 1L (must have response or at least SD/CR/PR)."
NCT02772107,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""6 cycles EP, PR"",""weeks_since_last_chemo"":9,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""yes"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",false,"Ineligible: >7 weeks since last chemo + leptomeningeal involvement."
NCT02772107,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":""4 cycles EP + concurrent RT, CR"",""weeks_since_last_chemo"":5,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",false,"Ineligible: limited-stage disease (trial is extensive-stage only)."
NCT02772107,P006,"{""age"":70,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""6 cycles EP, PR"",""weeks_since_last_chemo"":2,""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, active"",""leptomeningeal"":""no"",""hiv_status"":""positive on HAART"",""uncontrolled_illness"":true,""pregnant"":false}",false,"Ineligible: <3 weeks since chemo + HIV on HAART + uncontrolled illness."
NCT02772107,P007,"{""age"":52,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""4 cycles EP, PR"",""weeks_since_last_chemo"":6,""ecog"":2,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":true}",false,"Ineligible: ECOG 2 + pregnant."
NCT02772107,P008,"{""age"":66,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""6 cycles EP, PR"",""weeks_since_last_chemo"":5,""ecog"":1,""measurable_disease"":false,""brain_mets"":""yes, stable"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",false,"Ineligible: no measurable disease (brain mets can count, but protocol explicitly requires measurable disease which includes them – borderline, but safest call is ineligible without extracranial measurable)."
NCT02772107,P009,"{""age"":63,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""5 cycles EP, PR"",""weeks_since_last_chemo"":4,""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, stable"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",true,"Eligible: 4–6 cycles completed (5 is allowed), within window, stable brain mets OK."
NCT02772107,P010,"{""age"":59,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""6 cycles EP, CR"",""weeks_since_last_chemo"":7,""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",true,"Eligible: complete responder at upper limit of timing window (7 weeks exactly), ECOG 0, ideal candidate."
NCT03313544,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""planned_treatment"":""nivolumab monotherapy"",""baseline_lvef_percent"":58,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",true,"Eligible: standard nivolumab candidate, normal LVEF, no cardiac history."
NCT03313544,P002,"{""age"":61,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""planned_treatment"":""nivolumab 2nd-line"",""baseline_lvef_percent"":62,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",true,"Eligible: NSCLC on nivolumab, clean cardiac history."
NCT03313544,P003,"{""age"":68,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""planned_treatment"":""nivolumab + ipilimumab"",""baseline_lvef_percent"":55,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",true,"Eligible: combo IO allowed (trial includes all patients selected for nivolumab ± ipi in routine care)."
NCT03313544,P004,"{""age"":59,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":48,""history_cardiomyopathy"":true,""history_arrhythmia"":true,""prior_cardiotoxicity"":true,""known_cad"":true,""recent_stroke"":true,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",false,"Ineligible: LVEF <50% + dilated cardiomyopathy + prior cardiotoxicity + known CAD + recent stroke."
NCT03313544,P005,"{""age"":17,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":60,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",false,"Ineligible: age <18 years."
NCT03313544,P006,"{""age"":72,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":52,""history_cardiomyopathy"":false,""history_arrhythmia"":true,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":true,""willing_to_participate"":true}",false,"Ineligible: permanent atrial fibrillation + adult under legal guardianship."
NCT03313544,P007,"{""age"":55,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":54,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":true,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":false}",false,"Ineligible: prior immune-related myocarditis + patient refuses participation."
NCT03313544,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":65,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":true,""under_guardianship"":false,""willing_to_participate"":true}",false,"Ineligible: currently pregnant."
NCT03313544,P009,"{""age"":70,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":51,""history_cardiomyopathy"":true,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",false,"Ineligible: hypertrophic cardiomyopathy (explicit exclusion)."
NCT03313544,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""planned_treatment"":""nivolumab monotherapy"",""baseline_lvef_percent"":60,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",true,"Eligible: perfect cardio-clean patient starting nivolumab."
NCT02349412,P001,"{""age"":68,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""weeks_since_informed_incurable"":4,""ecog"":1,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",true,"Eligible: classic advanced NSCLC, told incurable 4wk ago, ECOG 1, English-speaking, all care at site, eligible caregiver."
NCT02349412,P002,"{""age"":62,""gender"":""F"",""diagnosis"":""metastatic pancreatic adenocarcinoma"",""weeks_since_informed_incurable"":3,""ecog"":2,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":false}",true,"Eligible: no caregiver required for patient enrollment, pancreatic ca allowed, told <8wk ago."
NCT02349412,P003,"{""age"":70,""gender"":""M"",""diagnosis"":""stage IV SCLC"",""weeks_since_informed_incurable"":10,""ecog"":1,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",false,"Ineligible: informed of incurable disease >8 weeks ago (strict temporal criterion)."
NCT02349412,P004,"{""age"":65,""gender"":""F"",""diagnosis"":""metastatic esophageal squamous cell"",""weeks_since_informed_incurable"":5,""ecog"":0,""language"":""Spanish only, needs interpreter"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",false,"Ineligible: patient requires more than minimal interpreter assistance (protocol allows minimal help only)."
NCT02349412,P005,"{""age"":59,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""weeks_since_informed_incurable"":6,""ecog"":3,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",false,"Ineligible: ECOG 3 (max allowed 2)."
NCT02349412,P006,"{""age"":72,""gender"":""F"",""diagnosis"":""metastatic gastric adenocarcinoma"",""weeks_since_informed_incurable"":2,""ecog"":1,""language"":""English fluent"",""all_care_at_institution"":false,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",false,"Ineligible: plans some oncology care outside enrolling institution."
NCT02349412,P007,"{""age"":17,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""weeks_since_informed_incurable"":4,""ecog"":1,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",false,"Ineligible: age <18."
NCT02349412,P008,"{""age"":64,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""weeks_since_informed_incurable"":5,""ecog"":1,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":false}",false,"Ineligible: colorectal GI cancer explicitly excluded."
NCT02349412,P009,"{""age"":67,""gender"":""F"",""diagnosis"":""malignant pleural mesothelioma"",""weeks_since_informed_incurable"":7,""ecog"":2,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":false,""caregiver_english_fluent"":true}",true,"Eligible: mesothelioma allowed, caregiver sees patient only once weekly → still eligible because patient enrollment does not require caregiver registration."
NCT02349412,P010,"{""age"":61,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""weeks_since_informed_incurable"":1,""ecog"":0,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",true,"Eligible: ideal candidate – newly informed of incurable disease, ECOG 0, full caregiver support."
NCT07090499,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""metastatic urothelial carcinoma"",""prior_lines_advanced"":2,""part"":""Part 2"",""prior_camptothecin_adc"":false,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",true,"Eligible: bladder ca, ≤2 prior lines (Part 2), no prior topotecan/exatecan ADC, ECOG 1."
NCT07090499,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IV squamous NSCLC"",""prior_lines_advanced"":1,""part"":""Part 1"",""prior_camptothecin_adc"":false,""ecog"":0,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",true,"Eligible: lung cancer, Part 1 (no line limit), clean history."
NCT07090499,P003,"{""age"":67,""gender"":""M"",""diagnosis"":""recurrent head & neck SCC"",""prior_lines_advanced"":3,""part"":""Part 2"",""prior_camptothecin_adc"":false,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",false,"Ineligible: 3 prior lines in advanced setting (Part 2 max = 2)."
NCT07090499,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""metastatic pancreatic adenocarcinoma"",""prior_lines_advanced"":2,""part"":""Part 2"",""prior_camptothecin_adc"":true,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":true,""severe_pulmonary_disease"":true,""tissue_consent"":true}",false,"Ineligible: prior sacituzumab govitecan (camptothecin payload) + active intestinal obstruction + severe ILD."
NCT07090499,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""metastatic SCLC"",""prior_lines_advanced"":1,""part"":""Part 1"",""prior_camptothecin_adc"":false,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",false,"Ineligible: small cell lung cancer not included (only NSCLC allowed in lung category)."
NCT07090499,P006,"{""age"":70,""gender"":""F"",""diagnosis"":""metastatic esophageal adenocarcinoma"",""prior_lines_advanced"":1,""part"":""Part 2"",""prior_camptothecin_adc"":false,""ecog"":2,""measurable_disease"":true,""resolved_prior_tox"":false,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":false}",false,"Ineligible: ECOG 2 + unresolved ≥Grade 2 prior toxicity + refuses tissue submission."
NCT07090499,P007,"{""age"":59,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""prior_lines_advanced"":0,""part"":""Part 1"",""prior_camptothecin_adc"":false,""ecog"":0,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",true,"Eligible: treatment-naïve advanced NSCLC in dose-escalation (Part 1 allows any number of prior lines)."
NCT07090499,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""metastatic gallbladder carcinoma"",""prior_lines_advanced"":2,""part"":""Part 2"",""prior_camptothecin_adc"":false,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",false,"Ineligible: gallbladder not in allowed list (only esophageal, gastric, hepatic, biliary, pancreatic for non-lung GI)."
NCT07090499,P009,"{""age"":66,""gender"":""M"",""diagnosis"":""metastatic pancreatic adenocarcinoma"",""prior_lines_advanced"":2,""part"":""Part 2"",""prior_camptothecin_adc"":false,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",true,"Eligible: pancreatic ca, exactly 2 prior lines, perfect Part 2 candidate."
NCT07090499,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""recurrent HNSCC"",""prior_lines_advanced"":1,""part"":""Part 1"",""prior_camptothecin_adc"":true,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",false,"Ineligible: prior trastuzumab deruxtecan (camptothecin-class payload)."
NCT01075399,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""locally advanced HNSCC"",""tumor_size_cm"":4.5,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""definitive chemoradiotherapy"",""bilirubin_xuln"":1.2,""ast_alt_xuln"":1.8,""serum_creat_xuln"":1.4,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: classic LA-HNSCC ≥3cm, tissue available, FDG-PET timed correctly, planned CRT, labs OK."
NCT01075399,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IIIB NSCLC adenocarcinoma"",""tumor_size_cm"":5.2,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""concurrent chemoradiation"",""bilirubin_xuln"":0.9,""ast_alt_xuln"":2.1,""serum_creat_xuln"":1.1,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: NSCLC ≥3cm, all criteria cleanly met."
NCT01075399,P003,"{""age"":66,""gender"":""M"",""diagnosis"":""locally advanced rectal adenocarcinoma"",""tumor_size_cm"":2.8,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""neoadjuvant chemoradiation"",""bilirubin_xuln"":1.0,""ast_alt_xuln"":2.3,""serum_creat_xuln"":1.5,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",false,"Ineligible: primary tumor <3 cm."
NCT01075399,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""stage IV cervical squamous carcinoma"",""tumor_size_cm"":4.1,""tumor_tissue_available"":false,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""palliative chemotherapy"",""bilirubin_xuln"":1.3,""ast_alt_xuln"":2.4,""serum_creat_xuln"":1.8,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",false,"Ineligible: no archived tumor tissue available for HIF1α/CA-IX IHC."
NCT01075399,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""locally advanced pancreatic adenocarcinoma"",""tumor_size_cm"":3.8,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":false,""planned_treatment"":""FOLFIRINOX → chemoradiation"",""bilirubin_xuln"":3.1,""ast_alt_xuln"":4.2,""serum_creat_xuln"":1.2,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",false,"Ineligible: elevated bilirubin/AST (liver obstruction) + FDG-PET not within 14d window."
NCT01075399,P006,"{""age"":70,""gender"":""F"",""diagnosis"":""HCC"",""tumor_size_cm"":6.0,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""TACE + sorafenib"",""bilirubin_xuln"":1.4,""ast_alt_xuln"":2.2,""serum_creat_xuln"":1.6,""pregnant"":false,""recent_radioactive_study"":true,""can_comply"":false}",false,"Ineligible: hepatocellular carcinoma not allowed (only liver metastases implicitly via other primaries) + recent Y-90 radioembolization + compliance concerns."
NCT01075399,P007,"{""age"":17,""gender"":""M"",""diagnosis"":""locally advanced HNSCC"",""tumor_size_cm"":4.2,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""chemoradiation"",""bilirubin_xuln"":0.8,""ast_alt_xuln"":1.5,""serum_creat_xuln"":1.0,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",false,"Ineligible: age <18."
NCT01075399,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""stage III cervical cancer"",""tumor_size_cm"":5.5,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""cisplatin + RT"",""bilirubin_xuln"":1.1,""ast_alt_xuln"":1.9,""serum_creat_xuln"":1.3,""pregnant"":true,""recent_radioactive_study"":false,""can_comply"":true}",false,"Ineligible: currently pregnant."
NCT01075399,P009,"{""age"":59,""gender"":""M"",""diagnosis"":""locally advanced NSCLC"",""tumor_size_cm"":3.9,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""no anticancer therapy planned"",""bilirubin_xuln"":1.0,""ast_alt_xuln"":2.0,""serum_creat_xuln"":1.5,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",false,"Ineligible: no planned chemotherapy, radiation, or chemoradiotherapy after imaging."
NCT01075399,P010,"{""age"":67,""gender"":""F"",""diagnosis"":""locally advanced HNSCC"",""tumor_size_cm"":4.8,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""induction TPF → concurrent CRT"",""bilirubin_xuln"":0.9,""ast_alt_xuln"":1.7,""serum_creat_xuln"":1.2,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: ideal candidate – large HNSCC, tissue + timing + treatment plan all perfect."
NCT04964960,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""NSCLC adenocarcinoma"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":3,""max_lesion_size_cm"":2.1,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":15,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":21,""minor_surgery_days_ago"":5,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":8,""consent_capacity"":true}",true,"Eligible: NSCLC with asymptomatic brain mets, no driver mutations, lesions <3cm and <10 total, all exclusion criteria avoided."
NCT04964960,P002,"{""age"":45,""gender"":""F"",""diagnosis"":""NSCLC squamous cell"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":7,""max_lesion_size_cm"":2.8,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":12,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":30,""minor_surgery_days_ago"":7,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":7,""consent_capacity"":true}",true,"Eligible: Meets all criteria - asymptomatic brain mets, appropriate lesion characteristics, no exclusions."
NCT04964960,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""NSCLC adenocarcinoma"",""brain_metastases"":true,""brain_met_symptoms"":true,""num_brain_lesions"":4,""max_lesion_size_cm"":2.5,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":20,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":25,""minor_surgery_days_ago"":10,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":6,""consent_capacity"":true}",false,"Ineligible: New neurological symptoms from brain metastases."
NCT04964960,P004,"{""age"":67,""gender"":""F"",""diagnosis"":""NSCLC with EGFR mutation"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":5,""max_lesion_size_cm"":2.2,""oncogenic_mutations"":true,""optic_nerve_proximity_mm"":18,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":20,""minor_surgery_days_ago"":8,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":9,""consent_capacity"":true}",false,"Ineligible: Presence of oncogenic driver mutation (EGFR)."
NCT04964960,P005,"{""age"":71,""gender"":""M"",""diagnosis"":""NSCLC large cell"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":12,""max_lesion_size_cm"":1.8,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":25,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":18,""minor_surgery_days_ago"":6,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":5,""consent_capacity"":true}",false,"Ineligible: Too many brain lesions (12, exceeds limit of <10)."
NCT04964960,P006,"{""age"":52,""gender"":""F"",""diagnosis"":""NSCLC adenocarcinoma"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":2,""max_lesion_size_cm"":3.5,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":8,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":22,""minor_surgery_days_ago"":9,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":7,""consent_capacity"":true}",false,"Ineligible: Lesion too large (3.5cm > 3cm limit) and too close to optic nerve (8mm < 10mm limit)."
NCT04964960,P007,"{""age"":63,""gender"":""M"",""diagnosis"":""NSCLC squamous"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":6,""max_lesion_size_cm"":2.4,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":15,""leptomeningeal_involvement"":true,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":19,""minor_surgery_days_ago"":11,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":4,""consent_capacity"":true}",false,"Ineligible: Leptomeningeal involvement present."
NCT04964960,P008,"{""age"":48,""gender"":""F"",""diagnosis"":""NSCLC adenocarcinoma"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":4,""max_lesion_size_cm"":2.0,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":20,""leptomeningeal_involvement"":false,""midline_shift"":true,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":16,""minor_surgery_days_ago"":12,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":6,""consent_capacity"":true}",false,"Ineligible: Midline shift present on imaging."
NCT04964960,P009,"{""age"":59,""gender"":""M"",""diagnosis"":""NSCLC large cell"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":3,""max_lesion_size_cm"":2.2,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":22,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":5,""minor_surgery_days_ago"":15,""mab_allergy"":true,""cardiovascular_disease"":true,""intercurrent_illness"":true,""psychiatric_issues"":false,""organ_function_adequate"":false,""life_expectancy_months"":2,""consent_capacity"":true}",false,"Ineligible: Multiple exclusions - recent major surgery, mAb allergy, cardiovascular disease, uncontrolled illness, poor organ function, short life expectancy."
NCT04964960,P010,"{""age"":65,""gender"":""F"",""diagnosis"":""NSCLC adenocarcinoma"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":8,""max_lesion_size_cm"":2.7,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":25,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":false,""major_surgery_days_ago"":28,""minor_surgery_days_ago"":20,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":true,""organ_function_adequate"":true,""life_expectancy_months"":5,""consent_capacity"":false}",false,"Ineligible: Cannot complete neurocognitive testing, psychiatric issues limit compliance, questionable consent capacity."
NCT01951469,P001,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IV NSCLC with EGFR exon 19 deletion"",""brain_metastases"":true,""num_brain_lesions"":4,""largest_brain_lesion_mm"":12,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":0,""life_expectancy_weeks"":24,""hgb_g_dl"":11.2,""anc_x10e9"":2.1,""platelets_x10e9"":150,""bilirubin_xuln"":1.1,""ast_alt_xuln"":1.8,""crcl_ml_min"":75,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",true,"Eligible: Stage IV NSCLC with EGFR mutation, multiple brain mets, no prior CNS/EGFR therapy, good PS and organ function."
NCT01951469,P002,"{""age"":42,""gender"":""M"",""diagnosis"":""stage IV NSCLC with EGFR L858R mutation"",""brain_metastases"":true,""num_brain_lesions"":2,""largest_brain_lesion_mm"":8,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":1,""life_expectancy_weeks"":20,""hgb_g_dl"":10.5,""anc_x10e9"":1.8,""platelets_x10e9"":120,""bilirubin_xuln"":1.3,""ast_alt_xuln"":2.1,""crcl_ml_min"":68,""liver_metastases"":true,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",true,"Eligible: EGFR mutant NSCLC with 1-2 brain lesions >5mm, adequate organ function despite liver mets, meets all criteria."
NCT01951469,P003,"{""age"":72,""gender"":""F"",""diagnosis"":""stage IV NSCLC with EGFR exon 21 mutation"",""brain_metastases"":true,""num_brain_lesions"":3,""largest_brain_lesion_mm"":15,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":1,""life_expectancy_weeks"":16,""hgb_g_dl"":11.8,""anc_x10e9"":2.3,""platelets_x10e9"":180,""bilirubin_xuln"":1.0,""ast_alt_xuln"":1.5,""crcl_ml_min"":55,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",false,"Ineligible: Age 72 exceeds maximum age limit of 75."
NCT01951469,P004,"{""age"":35,""gender"":""M"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":5,""largest_brain_lesion_mm"":10,""prior_brain_rt"":true,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":0,""life_expectancy_weeks"":28,""hgb_g_dl"":12.1,""anc_x10e9"":2.5,""platelets_x10e9"":200,""bilirubin_xuln"":0.9,""ast_alt_xuln"":1.2,""crcl_ml_min"":85,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",false,"Ineligible: Prior brain irradiation received (exclusion criterion #1)."
NCT01951469,P005,"{""age"":61,""gender"":""F"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":4,""largest_brain_lesion_mm"":12,""prior_brain_rt"":false,""prior_egfr_tki"":true,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":1,""life_expectancy_weeks"":18,""hgb_g_dl"":10.8,""anc_x10e9"":1.9,""platelets_x10e9"":130,""bilirubin_xuln"":1.4,""ast_alt_xuln"":2.0,""crcl_ml_min"":70,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",false,"Ineligible: Prior EGFR TKI therapy received (exclusion criterion #3)."
NCT01951469,P006,"{""age"":47,""gender"":""M"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":2,""largest_brain_lesion_mm"":4,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":0,""life_expectancy_weeks"":22,""hgb_g_dl"":11.5,""anc_x10e9"":2.2,""platelets_x10e9"":160,""bilirubin_xuln"":1.1,""ast_alt_xuln"":1.6,""crcl_ml_min"":78,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",false,"Ineligible: Largest brain lesion 4mm (must be >5mm per inclusion criterion #3)."
NCT01951469,P007,"{""age"":55,""gender"":""F"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":3,""largest_brain_lesion_mm"":9,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":true,""ecog_ps"":1,""life_expectancy_weeks"":14,""hgb_g_dl"":10.2,""anc_x10e9"":1.7,""platelets_x10e9"":110,""bilirubin_xuln"":1.6,""ast_alt_xuln"":2.4,""crcl_ml_min"":65,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":false,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",false,"Ineligible: Meningeal metastases present and intracranial pressure uncontrolled."
NCT01951469,P008,"{""age"":63,""gender"":""M"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":4,""largest_brain_lesion_mm"":11,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":2,""life_expectancy_weeks"":20,""hgb_g_dl"":9.8,""anc_x10e9"":1.4,""platelets_x10e9"":95,""bilirubin_xuln"":1.7,""ast_alt_xuln"":3.0,""crcl_ml_min"":55,""liver_metastases"":true,""interstitial_pneumonia"":true,""effusions_controlled"":false,""cardiac_stable"":false,""ophthalmic_issues"":true,""gi_absorption_ok"":false,""icp_controlled"":true,""concurrent_meds_disallowed"":true,""contraception_used"":false,""oral_meds_ability"":false}",false,"Ineligible: Multiple violations - ECOG 2, low blood counts, elevated LFTs, interstitial pneumonia, uncontrolled effusions, cardiac issues, ophthalmic problems, GI issues, taking phenytoin, no contraception."
NCT01951469,P009,"{""age"":59,""gender"":""F"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":6,""largest_brain_lesion_mm"":14,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":0,""life_expectancy_weeks"":10,""hgb_g_dl"":11.0,""anc_x10e9"":1.6,""platelets_x10e9"":105,""bilirubin_xuln"":1.2,""ast_alt_xuln"":1.9,""crcl_ml_min"":62,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",false,"Ineligible: Life expectancy 10 weeks < required 12 weeks."
NCT01951469,P010,"{""age"":44,""gender"":""M"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":3,""largest_brain_lesion_mm"":7,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":1,""life_expectancy_weeks"":16,""hgb_g_dl"":10.1,""anc_x10e9"":1.6,""platelets_x10e9"":102,""bilirubin_xuln"":1.0,""ast_alt_xuln"":1.4,""crcl_ml_min"":58,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",false,"Ineligible: Platelets 102 < minimum 100 and creatinine clearance 58 < required 60 ml/min."
NCT00094003,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""colorectal cancer with liver metastases"",""primary_cancer"":""colorectal"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":6,""ecog_ps"":1,""prior_chemo_weeks_ago"":6,""prior_radiation_weeks_ago"":7,""prior_surgery_weeks_ago"":4,""prior_investigational_drug_weeks_ago"":35,""anc"":1800,""hgb_g_dl"":10.2,""platelets"":125000,""serum_creat_xuln"":1.2,""bilirubin_xuln"":1.3,""ast_alt_xuln"":2.5,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":9.8,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",true,"Eligible: Liver mets from colorectal primary, adequate washout periods, meets all lab criteria including amylase/lipase, no exclusions."
NCT00094003,P002,"{""age"":55,""gender"":""F"",""diagnosis"":""breast cancer with liver metastases"",""primary_cancer"":""breast"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":5,""ecog_ps"":0,""prior_chemo_weeks_ago"":5,""prior_radiation_weeks_ago"":6,""prior_surgery_weeks_ago"":5,""prior_investigational_drug_weeks_ago"":40,""anc"":2200,""hgb_g_dl"":11.5,""platelets"":150000,""serum_creat_xuln"":1.0,""bilirubin_xuln"":1.1,""ast_alt_xuln"":2.0,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.2,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",true,"Eligible: Ideal candidate - breast cancer liver mets, excellent performance status, all labs within range, no exclusion criteria."
NCT00094003,P003,"{""age"":48,""gender"":""M"",""diagnosis"":""pancreatic cancer with liver metastases"",""primary_cancer"":""pancreatic"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":4,""ecog_ps"":1,""prior_chemo_weeks_ago"":8,""prior_radiation_weeks_ago"":9,""prior_surgery_weeks_ago"":6,""prior_investigational_drug_weeks_ago"":45,""anc"":1600,""hgb_g_dl"":9.5,""platelets"":110000,""serum_creat_xuln"":1.3,""bilirubin_xuln"":2.8,""ast_alt_xuln"":4.5,""amylase_lipase_normal"":false,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.5,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":true,""nyha_class"":2,""intercurrent_illness_controlled"":false,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",false,"Ineligible: History of pancreatic disease, elevated bilirubin and AST/ALT, abnormal amylase/lipase, uncontrolled intercurrent illness."
NCT00094003,P004,"{""age"":67,""gender"":""F"",""diagnosis"":""lung adenocarcinoma with liver metastases"",""primary_cancer"":""lung"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":true,""life_expectancy_months"":5,""ecog_ps"":1,""prior_chemo_weeks_ago"":7,""prior_radiation_weeks_ago"":8,""prior_surgery_weeks_ago"":7,""prior_investigational_drug_weeks_ago"":50,""anc"":1900,""hgb_g_dl"":10.8,""platelets"":130000,""serum_creat_xuln"":1.1,""bilirubin_xuln"":1.4,""ast_alt_xuln"":2.8,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":9.9,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",false,"Ineligible: Brain metastases present (exclusion criterion)."
NCT00094003,P005,"{""age"":59,""gender"":""M"",""diagnosis"":""gastric cancer with liver metastases"",""primary_cancer"":""gastric"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":4,""ecog_ps"":1,""prior_chemo_weeks_ago"":3,""prior_radiation_weeks_ago"":10,""prior_surgery_weeks_ago"":8,""prior_investigational_drug_weeks_ago"":55,""anc"":1700,""hgb_g_dl"":9.2,""platelets"":105000,""serum_creat_xuln"":1.4,""bilirubin_xuln"":1.2,""ast_alt_xuln"":2.2,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.1,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",false,"Ineligible: Chemotherapy washout only 3 weeks (requires 4 weeks)."
NCT00094003,P006,"{""age"":71,""gender"":""F"",""diagnosis"":""hepatocellular carcinoma"",""primary_cancer"":""liver"",""liver_metastases"":false,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":6,""ecog_ps"":1,""prior_chemo_weeks_ago"":9,""prior_radiation_weeks_ago"":11,""prior_surgery_weeks_ago"":9,""prior_investigational_drug_weeks_ago"":60,""anc"":2000,""hgb_g_dl"":10.5,""platelets"":120000,""serum_creat_xuln"":1.2,""bilirubin_xuln"":1.6,""ast_alt_xuln"":3.2,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.3,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":true,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",false,"Ineligible: Primary liver cancer (HCC) - study is for metastatic disease to liver only."
NCT00094003,P007,"{""age"":45,""gender"":""M"",""diagnosis"":""melanoma with liver metastases"",""primary_cancer"":""melanoma"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":5,""ecog_ps"":0,""prior_chemo_weeks_ago"":6,""prior_radiation_weeks_ago"":12,""prior_surgery_weeks_ago"":10,""prior_investigational_drug_weeks_ago"":32,""anc"":1400,""hgb_g_dl"":8.8,""platelets"":95000,""serum_creat_xuln"":1.6,""bilirubin_xuln"":1.7,""ast_alt_xuln"":3.5,""amylase_lipase_normal"":true,""pt_ptt_normal"":false,""serum_calcium_mg_dl"":11.5,""ecg_normal"":false,""afebrile"":false,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":true,""anticoagulation_therapy"":true}",false,"Ineligible: Multiple violations - low ANC/HGB/platelets, elevated creatinine, abnormal PT/PTT, high calcium, abnormal ECG, febrile, egg yolk allergy, on anticoagulation."
NCT00094003,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""renal cell carcinoma with liver metastases"",""primary_cancer"":""renal"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":7,""ecog_ps"":2,""prior_chemo_weeks_ago"":8,""prior_radiation_weeks_ago"":15,""prior_surgery_weeks_ago"":11,""prior_investigational_drug_weeks_ago"":42,""anc"":2100,""hgb_g_dl"":11.2,""platelets"":140000,""serum_creat_xuln"":1.3,""bilirubin_xuln"":1.2,""ast_alt_xuln"":2.1,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.0,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":true,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",false,"Ineligible: ECOG PS 2 (max allowed is 1) and prior radiation to >25% of bone marrow."
NCT00094003,P009,"{""age"":52,""gender"":""M"",""diagnosis"":""neuroendocrine tumor with liver metastases"",""primary_cancer"":""neuroendocrine"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":8,""ecog_ps"":1,""prior_chemo_weeks_ago"":10,""prior_radiation_weeks_ago"":13,""prior_surgery_weeks_ago"":12,""prior_investigational_drug_weeks_ago"":38,""anc"":2300,""hgb_g_dl"":12.1,""platelets"":160000,""serum_creat_xuln"":1.1,""bilirubin_xuln"":1.0,""ast_alt_xuln"":1.8,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":9.7,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":false,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",false,"Ineligible: Significant emotional/psychiatric problems making compliance uncertain."
NCT00094003,P010,"{""age"":58,""gender"":""F"",""diagnosis"":""ovarian cancer with liver metastases"",""primary_cancer"":""ovarian"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":5,""ecog_ps"":1,""prior_chemo_weeks_ago"":7,""prior_radiation_weeks_ago"":14,""prior_surgery_weeks_ago"":2,""prior_investigational_drug_weeks_ago"":44,""anc"":1950,""hgb_g_dl"":10.9,""platelets"":135000,""serum_creat_xuln"":1.2,""bilirubin_xuln"":1.3,""ast_alt_xuln"":2.4,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.2,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":true,""contraception_used"":false,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",false,"Ineligible: Currently pregnant and major surgery only 2 weeks ago (requires 3 weeks washout)."
NCT03699956,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""extensive stage small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",true,"Eligible: SCLC with 3 prior lines including platinum and checkpoint inhibitor, no CNS mets, meets all inclusion/exclusion criteria."
NCT03699956,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":2,""prior_platinum"":true,""prior_checkpoint_inhibitor"":false,""checkpoint_contraindicated"":true,""measurable_disease"":true,""ecog_ps"":0,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",true,"Eligible: SCLC with 2 prior lines, checkpoint inhibitor contraindicated (allowed per criteria), all other requirements met."
NCT03699956,P003,"{""age"":72,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":1,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",false,"Ineligible: Only 1 prior line of therapy (requires ≥2 prior lines)."
NCT03699956,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":false,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",false,"Ineligible: No prior platinum treatment (required per inclusion criterion #2)."
NCT03699956,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":true,""cns_symptoms"":true,""steroid_dose_increasing"":true,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",false,"Ineligible: Symptomatic CNS metastases with increasing steroid dose (exclusion criterion #1)."
NCT03699956,P006,"{""age"":54,""gender"":""F"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":true,""current_breast_cancer"":true,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",false,"Ineligible: Presence of another primary malignancy (active breast cancer, excludes only cervical CIS and basal skin cancer)."
NCT03699956,P007,"{""age"":59,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":true,""current_topotecan"":true,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",false,"Ineligible: Currently receiving antineoplastic treatment for SCLC (exclusion criterion #3, only steroids allowed)."
NCT03699956,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":true,""uncontrolled_diabetes"":true,""uncontrolled_hypertension"":true,""active_hepatitis_b"":true,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":false}",false,"Ineligible: Multiple significant comorbidities (uncontrolled diabetes, hypertension, Hepatitis B) and compliance limitations."
NCT03699956,P009,"{""age"":57,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":true,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",false,"Ineligible: History of allergic reaction to platinum-based regimen (exclusion criterion #5)."
NCT03699956,P010,"{""age"":69,""gender"":""F"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":2,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":true,""elevated_lfts"":true,""pleural_effusion"":true,""symptomatic_effusion"":true,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",false,"Ineligible: ECOG PS 2 (max allowed 1), abnormal LFTs suggesting contraindication, and symptomatic pleural effusion."
NCT00046787,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":4,""chemo_side_effects_resolved"":true,""prior_chest_rt"":true,""chest_rt_weeks_ago"":5,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":15,""ct_scan_type"":""spiral"",""brain_metastases"":true,""cns_involvement_history"":true,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: Recurrent SCLC with 1 prior chemo line, adequate washout periods, small target lesion, controlled CNS disease, no SVC syndrome."
NCT00046787,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":6,""chemo_side_effects_resolved"":true,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":18,""ct_scan_type"":""conventional"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: Classic recurrent SCLC case - one prior chemo, adequate washout, small measurable lesion, no exclusions."
NCT00046787,P003,"{""age"":67,""gender"":""M"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":2,""chemo_weeks_ago"":5,""chemo_side_effects_resolved"":true,""prior_chest_rt"":true,""chest_rt_weeks_ago"":4,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":12,""ct_scan_type"":""spiral"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",false,"Ineligible: Two prior lines of chemotherapy (maximum one prior treatment allowed)."
NCT00046787,P004,"{""age"":54,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":2,""chemo_side_effects_resolved"":false,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":16,""ct_scan_type"":""conventional"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",false,"Ineligible: Chemotherapy only 2 weeks ago (requires 3 weeks) and side effects not resolved."
NCT00046787,P005,"{""age"":71,""gender"":""M"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":5,""chemo_side_effects_resolved"":true,""prior_chest_rt"":true,""chest_rt_weeks_ago"":2,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":false,""target_tumor_size_mm"":14,""ct_scan_type"":""spiral"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",false,"Ineligible: Chest radiotherapy only 2 weeks ago (requires 3 weeks) and radiation side effects not resolved."
NCT00046787,P006,"{""age"":49,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":4,""chemo_side_effects_resolved"":true,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":true,""head_rt_days_ago"":7,""rt_side_effects_resolved"":false,""target_tumor_size_mm"":13,""ct_scan_type"":""spiral"",""brain_metastases"":true,""cns_involvement_history"":true,""cns_disease_controlled"":false,""superior_vena_cava_syndrome"":false}",false,"Ineligible: Head irradiation only 7 days ago (requires 10 days), radiation side effects not resolved, and CNS disease uncontrolled."
NCT00046787,P007,"{""age"":63,""gender"":""M"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":5,""chemo_side_effects_resolved"":true,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":25,""ct_scan_type"":""conventional"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",false,"Ineligible: Target tumor 25mm (exceeds 20mm maximum for conventional CT)."
NCT00046787,P008,"{""age"":66,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":4,""chemo_side_effects_resolved"":true,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":12,""ct_scan_type"":""spiral"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":true}",false,"Ineligible: Superior vena cava syndrome present (sole exclusion criterion)."
NCT00046787,P009,"{""age"":59,""gender"":""M"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":false,""prior_lines_therapy"":0,""chemo_weeks_ago"":null,""chemo_side_effects_resolved"":true,""prior_chest_rt"":true,""chest_rt_weeks_ago"":6,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":11,""ct_scan_type"":""spiral"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",false,"Ineligible: No prior chemotherapy (one prior chemotherapy treatment required)."
NCT00046787,P010,"{""age"":55,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":4,""chemo_side_effects_resolved"":true,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":true,""head_rt_days_ago"":12,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":9,""ct_scan_type"":""spiral"",""brain_metastases"":true,""cns_involvement_history"":true,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: Meets all criteria - one prior chemo, adequate head RT washout, small spiral CT lesion, controlled CNS disease."
NCT02606149,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_proven"":true,""time_since_diag_weeks"":4,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",true,"Eligible: All inclusion criteria met (Stage IV lung cancer, recent diagnosis, no prior systemic therapy, eligible age, consent/social security OK)."
NCT02606149,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""stage IV SCLC"",""histology_proven"":true,""time_since_diag_weeks"":7,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""mild CHF"",""consent_given"":true,""systemic_therapy_indicated"":true}",true,"Eligible: All key criteria met. The trial specifies 'lung cancer' which includes SCLC. Mild CHF is not a contraindication if the investigator deems it compatible."
NCT02606149,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""stage IV lung squamous carcinoma"",""histology_proven"":true,""time_since_diag_weeks"":10,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""well-controlled diabetes"",""consent_given"":true,""systemic_therapy_indicated"":true}",false,"Ineligible: Diagnosis was made 10 weeks ago, which exceeds the 'diagnosed during the last 8 weeks' inclusion window."
NCT02606149,P004,"{""age"":68,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology_proven"":true,""time_since_diag_weeks"":3,""prior_systemic_therapy"":true,""social_security"":true,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",false,"Ineligible: Patient received prior systemic therapy (chemotherapy) for their metastatic disease."
NCT02606149,P005,"{""age"":45,""gender"":""M"",""diagnosis"":""stage IV colorectal cancer"",""histology_proven"":true,""time_since_diag_weeks"":5,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",false,"Ineligible: Diagnosis is colorectal cancer, not stage IV lung cancer."
NCT02606149,P006,"{""age"":80,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology_proven"":false,""time_since_diag_weeks"":6,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",false,"Ineligible: Diagnosis is not histologically proven (e.g., diagnosed by imaging/cytology only), which is a hard inclusion criterion."
NCT02606149,P007,"{""age"":32,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""histology_proven"":true,""time_since_diag_weeks"":1,""prior_systemic_therapy"":false,""social_security"":false,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",false,"Ineligible: Patient is not affiliated with a social security scheme, a clear exclusion criterion."
NCT02606149,P008,"{""age"":60,""gender"":""F"",""diagnosis"":""stage IV adenocarcinoma lung"",""histology_proven"":true,""time_since_diag_weeks"":2,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""severe, rapidly progressing COPD"",""consent_given"":true,""systemic_therapy_indicated"":true}",false,"Ineligible: Severe comorbidity (COPD) may be deemed 'not compatible with the inclusion' by the investigator."
NCT02606149,P009,"{""age"":17,""gender"":""M"",""diagnosis"":""stage IV lung cancer"",""histology_proven"":true,""time_since_diag_weeks"":4,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",false,"Ineligible: Patient is 17 years old, which is below the minimum age of 18 years."
NCT02606149,P010,"{""age"":50,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology_proven"":true,""time_since_diag_weeks"":6,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""controlled hypertension"",""consent_given"":false,""systemic_therapy_indicated"":true}",false,"Ineligible: Patient has not given non-objection (consent_given: false) or is unable to give it."
NCT06838208,P001,"{""age"":68,""gender"":""M"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":0,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""stable treated"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",true,"Eligible: Meets all key criteria—ES-SCLC, PS 0, no prior therapy, measurable lesion, no major contraindications (ICI/autoimmune/recent drugs)."
NCT06838208,P002,"{""age"":75,""gender"":""F"",""diagnosis"":""ES-SCLC"",""histology_proven"":false,""prior_systemic_therapy_sclc"":false,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",false,"Ineligible: Diagnosis is not histologically or cytologically confirmed."
NCT06838208,P003,"{""age"":60,""gender"":""M"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":true,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",false,"Ineligible: Received prior systemic therapy (carboplatin + etoposide) for ES-SCLC."
NCT06838208,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":2,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",false,"Ineligible: ECOG Performance Status is 2, exceeding the maximum allowed PS 1."
NCT06838208,P005,"{""age"":70,""gender"":""M"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""untreated symptomatic"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",false,"Ineligible: Has untreated, symptomatic brain metastasis, which is an exclusion."
NCT06838208,P006,"{""age"":50,""gender"":""F"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":0,""measurable_chest_lesion"":false,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",false,"Ineligible: Lacks a measurable chest lesion suitable for the specified irradiation dose."
NCT06838208,P007,"{""age"":62,""gender"":""M"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":true,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",false,"Ineligible: History of prior anti-PD-1 therapy, which is an exclusion criterion."
NCT06838208,P008,"{""age"":45,""gender"":""F"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":0,""measurable_chest_lesion"":true,""organ_function_adequate"":false,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":true}",false,"Ineligible: Received oral antibiotics for a respiratory infection 10 days prior to screening, violating the 2-week washout period."
NCT06838208,P009,"{""age"":72,""gender"":""M"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":true,""recent_systemic_steroid"":true,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",false,"Ineligible: History of active rheumatoid arthritis (autoimmune disease) requiring systemic steroid treatment 10 days ago (violates <14 day rule)."
NCT06838208,P010,"{""age"":58,""gender"":""F"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":true,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":true,""recent_antibiotics"":false}",false,"Ineligible: History of interstitial lung disease (ILD) and received a live shingles vaccine 3 weeks prior (violates 4-week washout)."
NCT03778814,P001,"{""age"":60,""gender"":""M"",""diagnosis"":""advanced NSCLC"",""biopsy_obtainable"":true,""life_expectancy_weeks"":15,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":25,""killing_percent"":22,""prior_gene_therapy"":false,""tumor_size_cm"":12,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",true,"Eligible: Meets all critical criteria. Advanced NSCLC with obtainable biopsy, Child-Pugh <7, life expectancy >12wk, and T-cell product meets both 20% thresholds."
NCT03778814,P002,"{""age"":55,""gender"":""F"",""diagnosis"":""advanced ovarian cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":20,""child_pugh_score"":5,""organ_function_adequate"":true,""tcr_exp_percent"":15,""killing_percent"":25,""prior_gene_therapy"":false,""tumor_size_cm"":8,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",false,"Ineligible: T-cell product fails to meet the minimum 20% targeted TCR expression requirement."
NCT03778814,P003,"{""age"":70,""gender"":""M"",""diagnosis"":""metastatic prostate cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":18,""child_pugh_score"":7,""organ_function_adequate"":true,""tcr_exp_percent"":30,""killing_percent"":35,""prior_gene_therapy"":false,""tumor_size_cm"":10,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",false,"Ineligible: Child-Pugh-Turcotte score is 7, which is not <7 (indicates inadequate liver function)."
NCT03778814,P004,"{""age"":65,""gender"":""F"",""diagnosis"":""advanced SCLC"",""biopsy_obtainable"":false,""life_expectancy_weeks"":16,""child_pugh_score"":5,""organ_function_adequate"":true,""tcr_exp_percent"":28,""killing_percent"":20,""prior_gene_therapy"":false,""tumor_size_cm"":6,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",false,"Ineligible: Biopsy is not safely obtainable for establishing tumor organoids/TILs, violating a key requirement."
NCT03778814,P005,"{""age"":42,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":10,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":40,""killing_percent"":50,""prior_gene_therapy"":false,""tumor_size_cm"":15,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",false,"Ineligible: Estimated life expectancy is only 10 weeks, which is less than the required >12 weeks."
NCT03778814,P006,"{""age"":50,""gender"":""M"",""diagnosis"":""advanced lung squamous cell carcinoma"",""biopsy_obtainable"":true,""life_expectancy_weeks"":14,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":33,""killing_percent"":18,""prior_gene_therapy"":false,""tumor_size_cm"":14,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",false,"Ineligible: T-cell product fails to meet the minimum 20% tumor cell killing requirement."
NCT03778814,P007,"{""age"":68,""gender"":""F"",""diagnosis"":""advanced cervical cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":13,""child_pugh_score"":5,""organ_function_adequate"":true,""tcr_exp_percent"":30,""killing_percent"":25,""prior_gene_therapy"":false,""tumor_size_cm"":26,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",false,"Ineligible: Tumor size is 26 cm, which exceeds the maximum allowed size of 25 cm."
NCT03778814,P008,"{""age"":53,""gender"":""M"",""diagnosis"":""advanced mesothelioma"",""biopsy_obtainable"":true,""life_expectancy_weeks"":15,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":35,""killing_percent"":30,""prior_gene_therapy"":true,""tumor_size_cm"":9,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",false,"Ineligible: Patient previously accepted gene therapy for an unrelated condition."
NCT03778814,P009,"{""age"":40,""gender"":""F"",""diagnosis"":""advanced renal cell carcinoma"",""biopsy_obtainable"":true,""life_expectancy_weeks"":18,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":22,""killing_percent"":22,""prior_gene_therapy"":false,""tumor_size_cm"":7,""active_infection"":true,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":true,""high_dose_steroids"":false}",false,"Ineligible: Has active infectious disease (pneumonia) and is currently pregnant/lactating, violating two exclusion criteria."
NCT03778814,P010,"{""age"":61,""gender"":""M"",""diagnosis"":""advanced NSCLC"",""biopsy_obtainable"":true,""life_expectancy_weeks"":14,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":28,""killing_percent"":25,""prior_gene_therapy"":false,""tumor_size_cm"":11,""active_infection"":false,""hiv_status"":""positive"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":true}",false,"Ineligible: Known HIV positivity and is currently on high-dose systemic steroids for colitis (≥0.5 mg/kg/day prednisone equivalent)."
NCT03613753,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + cisplatin"",""time_since_flt_days"":45,""life_expectancy_months"":4,""ecog_ps"":1,""neutrophils_g_per_l"":2.1,""platelets_g_per_l"":150,""hemoglobin_g_per_l"":100,""ast_alt_xuln"":1.5,""bilirubin_xuln"":1.0,""creatinine_umol_per_l"":90,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",true,"Eligible: All inclusion criteria met, including relapsed SCLC, correct first-line regimen, sufficient washout, good labs, and PS 1."
NCT03613753,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + carboplatin"",""time_since_flt_days"":60,""life_expectancy_months"":5,""ecog_ps"":0,""neutrophils_g_per_l"":1.8,""platelets_g_per_l"":120,""hemoglobin_g_per_l"":95,""ast_alt_xuln"":1.8,""bilirubin_xuln"":1.1,""creatinine_umol_per_l"":100,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",false,"Ineligible: Age is 72 years, which is above the maximum allowed age of 70 years."
NCT03613753,P003,"{""age"":60,""gender"":""M"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""doxorubicin + cyclophosphamide"",""time_since_flt_days"":35,""life_expectancy_months"":3,""ecog_ps"":1,""neutrophils_g_per_l"":2.5,""platelets_g_per_l"":180,""hemoglobin_g_per_l"":110,""ast_alt_xuln"":1.1,""bilirubin_xuln"":0.9,""creatinine_umol_per_l"":85,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",false,"Ineligible: First-line chemotherapy was not Etoposide + Cisplatin/Carboplatin as required by the protocol."
NCT03613753,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + cisplatin"",""time_since_flt_days"":25,""life_expectancy_months"":6,""ecog_ps"":1,""neutrophils_g_per_l"":2.0,""platelets_g_per_l"":140,""hemoglobin_g_per_l"":105,""ast_alt_xuln"":1.3,""bilirubin_xuln"":1.0,""creatinine_umol_per_l"":95,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",false,"Ineligible: Only 25 days since first-line therapy completion; minimum washout is 30 days."
NCT03613753,P005,"{""age"":68,""gender"":""M"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + carboplatin"",""time_since_flt_days"":40,""life_expectancy_months"":2,""ecog_ps"":1,""neutrophils_g_per_l"":2.2,""platelets_g_per_l"":160,""hemoglobin_g_per_l"":102,""ast_alt_xuln"":1.6,""bilirubin_xuln"":1.2,""creatinine_umol_per_l"":105,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",false,"Ineligible: Expected life time is 2 months, which is less than the required minimum of 3 months."
NCT03613753,P006,"{""age"":58,""gender"":""F"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + cisplatin"",""time_since_flt_days"":50,""life_expectancy_months"":4,""ecog_ps"":2,""neutrophils_g_per_l"":1.9,""platelets_g_per_l"":130,""hemoglobin_g_per_l"":98,""ast_alt_xuln"":1.4,""bilirubin_xuln"":0.9,""creatinine_umol_per_l"":88,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",false,"Ineligible: ECOG PS is 2 due to comorbid conditions (uncontrolled heart failure), which is explicitly excluded."
NCT03613753,P007,"{""age"":45,""gender"":""M"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + carboplatin"",""time_since_flt_days"":70,""life_expectancy_months"":4,""ecog_ps"":1,""neutrophils_g_per_l"":1.4,""platelets_g_per_l"":75,""hemoglobin_g_per_l"":90,""ast_alt_xuln"":1.0,""bilirubin_xuln"":0.8,""creatinine_umol_per_l"":80,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",false,"Ineligible: Inadequate organ function: Neutrophils (1.4) are <1.5 and Platelets (75) are <80."
NCT03613753,P008,"{""age"":62,""gender"":""F"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + cisplatin"",""time_since_flt_days"":42,""life_expectancy_months"":5,""ecog_ps"":1,""neutrophils_g_per_l"":2.8,""platelets_g_per_l"":170,""hemoglobin_g_per_l"":115,""ast_alt_xuln"":3.0,""bilirubin_xuln"":1.5,""creatinine_umol_per_l"":110,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",false,"Ineligible: Inadequate organ function: AST/ALT (3.0 x ULN) > 2.0 x ULN and Bilirubin (1.5 x ULN) > 1.25 x ULN."
NCT03613753,P009,"{""age"":69,""gender"":""M"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + carboplatin"",""time_since_flt_days"":55,""life_expectancy_months"":4,""ecog_ps"":1,""neutrophils_g_per_l"":2.3,""platelets_g_per_l"":145,""hemoglobin_g_per_l"":108,""ast_alt_xuln"":1.2,""bilirubin_xuln"":0.9,""creatinine_umol_per_l"":92,""measurable_disease"":true,""concomitant_malignancy"":true,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",false,"Ineligible: Concomitant other malignant disease (active prostate adenocarcinoma) is an exclusion."
NCT03613753,P010,"{""age"":50,""gender"":""F"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + cisplatin"",""time_since_flt_days"":38,""life_expectancy_months"":4,""ecog_ps"":2,""ps_cause"":""bulky disease"",""neutrophils_g_per_l"":2.0,""platelets_g_per_l"":155,""hemoglobin_g_per_l"":110,""ast_alt_xuln"":1.1,""bilirubin_xuln"":0.8,""creatinine_umol_per_l"":95,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",true,"Eligible: PS 2 is acceptable because it's due to bulky disease (investigator discretion implied), and all other criteria are met (correct FLC, washout, labs OK)."
NCT05369312,P001,"{""age"":60,""gender"":""M"",""phase"":""dose escalation"",""diagnosis"":""metastatic colorectal cancer"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""KRAS G12C"",""pregnant_or_lactating"":false}",true,"Eligible (DEsc): CRC, PS 1, failed standard therapy, has evaluable lesion, age/organ function/washout/exclusions all OK. Mutation status is irrelevant for escalation."
NCT05369312,P002,"{""age"":55,""gender"":""F"",""phase"":""dose expansion"",""diagnosis"":""locally advanced NSCLC"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":0,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""NF1 LOF"",""pregnant_or_lactating"":false}",true,"Eligible (DExp): NSCLC is a specific target tumor, PS 0, measurable disease, and confirmed NF1 LOF mutation."
NCT05369312,P003,"{""age"":70,""gender"":""M"",""phase"":""dose expansion"",""diagnosis"":""metastatic pancreatic cancer"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""Wild Type (no targetable mutation) "",""pregnant_or_lactating"":false}",false,"Ineligible (DExp): In the dose expansion phase, a patient must have one of the required targetable mutations, which is missing here."
NCT05369312,P004,"{""age"":76,""gender"":""F"",""phase"":""dose escalation"",""diagnosis"":""metastatic ovarian cancer"",""histology_confirmed"":true,""prior_therapy_status"":""no standard exists"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""N/A"",""pregnant_or_lactating"":false}",false,"Ineligible: Age is 76 years, exceeding the maximum allowed age of 75 years."
NCT05369312,P005,"{""age"":50,""gender"":""M"",""phase"":""dose expansion"",""diagnosis"":""locally advanced NSCLC"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":true,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""KRAS G12V"",""pregnant_or_lactating"":false}",false,"Ineligible: Patient previously received a SHP2 inhibitor, which is a key exclusion."
NCT05369312,P006,"{""age"":63,""gender"":""F"",""phase"":""dose escalation"",""diagnosis"":""metastatic breast cancer"",""histology_confirmed"":true,""prior_therapy_status"":""refused standard"",""ecog_ps"":1,""evaluable_lesion"":false,""measurable_lesion"":false,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""N/A"",""pregnant_or_lactating"":false}",false,"Ineligible (DEsc): Patient is in the dose escalation phase but lacks an evaluable lesion."
NCT05369312,P007,"{""age"":48,""gender"":""M"",""phase"":""dose expansion"",""diagnosis"":""metastatic NSCLC"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":0,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""symptomatic untreated"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""BRAF Class-3"",""pregnant_or_lactating"":false}",false,"Ineligible (DExp): Has unstable/symptomatic CNS metastasis, which is a major exclusion."
NCT05369312,P008,"{""age"":35,""gender"":""F"",""phase"":""dose escalation"",""diagnosis"":""locally advanced gastric cancer"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":true,""washout_adequate"":true,""mutation_status"":""N/A"",""pregnant_or_lactating"":true}",false,"Ineligible: Has active autoimmune disease (Lupus) and is pregnant/lactating, violating two exclusion criteria."
NCT05369312,P009,"{""age"":68,""gender"":""M"",""phase"":""dose expansion"",""diagnosis"":""metastatic colorectal cancer"",""histology_confirmed"":true,""prior_therapy_status"":""intolerable to standard"",""ecog_ps"":0,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":false,""mutation_status"":""RTK rearrangement"",""pregnant_or_lactating"":false}",false,"Ineligible (DExp): Washout of prior strong CYP3A inhibitor medication was inadequate, violating a washout exclusion criterion."
NCT05369312,P010,"{""age"":61,""gender"":""F"",""phase"":""dose expansion"",""diagnosis"":""metastatic pancreatic cancer"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""KRAS G12D"",""pregnant_or_lactating"":false}",true,"Eligible (DExp): Meets all DE criteria; Pancreatic cancer is a specific target, PS 1, measurable, and confirmed KRAS G12D mutation."
NCT02805530,P001,"{""age"":60,""gender"":""M"",""diagnosis"":""NSCLC adenocarcinoma"",""pathology_confirmed"":true,""ecog_ps"":0,""clinical_stage"":""IV"",""mets_sites_count"":2,""synchronous_mets_days"":15,""candidate_pt_chemo"":true,""life_expectancy_weeks"":30,""leukocytes_k_per_mm3"":5.0,""platelets_k_per_mm3"":180,""hemoglobin_g_per_dl"":12.0,""creatinine_mg_per_dl"":1.0,""total_bilirubin_xuln"":1.0,""transaminases_xuln"":1.5,""alp_xuln"":2.0,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",true,"Eligible: All criteria met. Oligometastatic (2 sites), synchronous, PS 0, good labs, and no prior treatment."
NCT02805530,P002,"{""age"":55,""gender"":""F"",""diagnosis"":""NSCLC squamous cell carcinoma"",""pathology_confirmed"":true,""ecog_ps"":1,""clinical_stage"":""IV"",""mets_sites_count"":5,""synchronous_mets_days"":25,""candidate_pt_chemo"":true,""life_expectancy_weeks"":26,""leukocytes_k_per_mm3"":4.5,""platelets_k_per_mm3"":150,""hemoglobin_g_per_dl"":11.0,""creatinine_mg_per_dl"":1.2,""total_bilirubin_xuln"":1.2,""transaminases_xuln"":2.0,""alp_xuln"":3.5,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",true,"Eligible: Meets maximum limits for metastases (5 sites) and transaminases (2.0 x ULN) but remains within protocol limits."
NCT02805530,P003,"{""age"":68,""gender"":""M"",""diagnosis"":""NSCLC large cell carcinoma"",""pathology_confirmed"":true,""ecog_ps"":1,""clinical_stage"":""IV"",""mets_sites_count"":7,""synchronous_mets_days"":10,""candidate_pt_chemo"":true,""life_expectancy_weeks"":35,""leukocytes_k_per_mm3"":6.0,""platelets_k_per_mm3"":200,""hemoglobin_g_per_dl"":13.0,""creatinine_mg_per_dl"":1.4,""total_bilirubin_xuln"":1.1,""transaminases_xuln"":1.8,""alp_xuln"":1.5,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Patient has 7 metastatic sites, which exceeds the oligometastatic limit of 5 sites."
NCT02805530,P004,"{""age"":45,""gender"":""F"",""diagnosis"":""NSCLC adenocarcinoma"",""pathology_confirmed"":true,""ecog_ps"":0,""clinical_stage"":""IV"",""mets_sites_count"":3,""synchronous_mets_days"":60,""candidate_pt_chemo"":true,""life_expectancy_weeks"":40,""leukocytes_k_per_mm3"":4.0,""platelets_k_per_mm3"":160,""hemoglobin_g_per_dl"":11.5,""creatinine_mg_per_dl"":0.8,""total_bilirubin_xuln"":0.9,""transaminases_xuln"":1.0,""alp_xuln"":1.2,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Metastases were identified 60 days (2 months) after diagnosis, violating the synchronous (≤1 month) definition."
NCT02805530,P005,"{""age"":70,""gender"":""M"",""diagnosis"":""NSCLC adenocarcinoma"",""pathology_confirmed"":true,""ecog_ps"":1,""clinical_stage"":""IV"",""mets_sites_count"":4,""synchronous_mets_days"":18,""candidate_pt_chemo"":true,""life_expectancy_weeks"":28,""leukocytes_k_per_mm3"":5.5,""platelets_k_per_mm3"":190,""hemoglobin_g_per_dl"":12.5,""creatinine_mg_per_dl"":1.1,""total_bilirubin_xuln"":1.5,""transaminases_xuln"":2.5,""alp_xuln"":4.8,""malignant_effusion"":true,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Patient has a malignant pleural effusion, which is an exclusion criterion."
NCT02805530,P006,"{""age"":63,""gender"":""F"",""diagnosis"":""NSCLC squamous cell carcinoma"",""pathology_confirmed"":true,""ecog_ps"":0,""clinical_stage"":""IV"",""mets_sites_count"":2,""synchronous_mets_days"":12,""candidate_pt_chemo"":true,""life_expectancy_weeks"":25,""leukocytes_k_per_mm3"":3.2,""platelets_k_per_mm3"":110,""hemoglobin_g_per_dl"":10.5,""creatinine_mg_per_dl"":1.5,""total_bilirubin_xuln"":1.0,""transaminases_xuln"":1.3,""alp_xuln"":1.9,""malignant_effusion"":false,""prior_treatment"":true,""prior_treatment_type"":""TKI"",""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Patient previously received a tyrosine kinase inhibitor (TKI) for their cancer."
NCT02805530,P007,"{""age"":75,""gender"":""M"",""diagnosis"":""NSCLC adenocarcinoma"",""pathology_confirmed"":true,""ecog_ps"":0,""clinical_stage"":""IV"",""mets_sites_count"":3,""synchronous_mets_days"":5,""candidate_pt_chemo"":false,""life_expectancy_weeks"":30,""leukocytes_k_per_mm3"":5.1,""platelets_k_per_mm3"":185,""hemoglobin_g_per_dl"":12.0,""creatinine_mg_per_dl"":1.0,""total_bilirubin_xuln"":1.0,""transaminases_xuln"":1.5,""alp_xuln"":2.0,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Patient is not a candidate for platinum-based chemotherapy due to severe pre-existing neuropathy."
NCT02805530,P008,"{""age"":58,""gender"":""F"",""diagnosis"":""NSCLC large cell carcinoma"",""pathology_confirmed"":true,""ecog_ps"":2,""clinical_stage"":""IV"",""mets_sites_count"":1,""synchronous_mets_days"":20,""candidate_pt_chemo"":true,""life_expectancy_weeks"":24,""leukocytes_k_per_mm3"":3.0,""platelets_k_per_mm3"":105,""hemoglobin_g_per_dl"":10.0,""creatinine_mg_per_dl"":1.3,""total_bilirubin_xuln"":1.5,""transaminases_xuln"":2.5,""alp_xuln"":4.0,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",false,"Ineligible: ECOG Performance Status is 2, which exceeds the maximum allowed PS 1."
NCT02805530,P009,"{""age"":35,""gender"":""F"",""diagnosis"":""NSCLC adenocarcinoma"",""pathology_confirmed"":true,""ecog_ps"":1,""clinical_stage"":""IV"",""mets_sites_count"":2,""synchronous_mets_days"":15,""candidate_pt_chemo"":true,""life_expectancy_weeks"":28,""leukocytes_k_per_mm3"":5.0,""platelets_k_per_mm3"":180,""hemoglobin_g_per_dl"":12.0,""creatinine_mg_per_dl"":1.0,""total_bilirubin_xuln"":1.0,""transaminases_xuln"":1.5,""alp_xuln"":2.0,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":true}",false,"Ineligible: Patient is currently pregnant or lactating."
NCT02805530,P010,"{""age"":61,""gender"":""M"",""diagnosis"":""NSCLC squamous cell carcinoma"",""pathology_confirmed"":true,""ecog_ps"":0,""clinical_stage"":""IV"",""mets_sites_count"":1,""synchronous_mets_days"":8,""candidate_pt_chemo"":true,""life_expectancy_weeks"":24,""leukocytes_k_per_mm3"":3.1,""platelets_k_per_mm3"":101,""hemoglobin_g_per_dl"":10.1,""creatinine_mg_per_dl"":1.4,""total_bilirubin_xuln"":1.4,""transaminases_xuln"":2.4,""alp_xuln"":4.9,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",true,"Eligible: A minimum criteria case: single metastasis, labs close to the minimum but still adequate, and life expectancy exactly 24 weeks."
NCT02669719,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":5.2,""neutrophil_g_per_l"":2.0,""plt_g_per_l"":150,""hb_g_per_dl"":10.5,""total_bilirubin_xuln"":1.1,""ast_alt_xuln"":1.5,""crcl_ml_min"":80,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",true,"Eligible: Ideal candidate – non-squamous, EGFR WT/ALK-, treatment naive, PS 1, all labs and washout criteria met."
NCT02669719,P002,"{""age"":70,""gender"":""F"",""diagnosis"":""stage IV NSCLC large cell carcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":0,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":4.5,""neutrophil_g_per_l"":1.8,""plt_g_per_l"":110,""hb_g_per_dl"":9.5,""total_bilirubin_xuln"":1.4,""ast_alt_xuln"":4.0,""crcl_ml_min"":55,""liver_mets"":true,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",true,"Eligible: AST/ALT are elevated but acceptable (4.0 x ULN) because the patient has known liver metastases."
NCT02669719,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""stage IV NSCLC squamous cell carcinoma"",""histology_type"":""squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":6.0,""neutrophil_g_per_l"":2.5,""plt_g_per_l"":180,""hb_g_per_dl"":12.0,""total_bilirubin_xuln"":1.0,""ast_alt_xuln"":1.2,""crcl_ml_min"":90,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Diagnosis is **squamous cell carcinoma**, but the trial requires **non-squamous** NSCLC."
NCT02669719,P004,"{""age"":45,""gender"":""F"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""L858R mutation"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":0,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":5.5,""neutrophil_g_per_l"":2.2,""plt_g_per_l"":160,""hb_g_per_dl"":11.0,""total_bilirubin_xuln"":0.9,""ast_alt_xuln"":1.0,""crcl_ml_min"":100,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Patient has an **EGFR mutation**, but the trial requires **wild-type EGFR**."
NCT02669719,P005,"{""age"":60,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":false,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":5.0,""neutrophil_g_per_l"":2.1,""plt_g_per_l"":155,""hb_g_per_dl"":10.8,""total_bilirubin_xuln"":1.2,""ast_alt_xuln"":1.6,""crcl_ml_min"":75,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Patient received prior systemic treatment for the currently diagnosed NSCLC, violating the treatment naive criterion."
NCT02669719,P006,"{""age"":72,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":2,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":4.8,""neutrophil_g_per_l"":2.0,""plt_g_per_l"":130,""hb_g_per_dl"":10.0,""total_bilirubin_xuln"":1.0,""ast_alt_xuln"":1.5,""crcl_ml_min"":60,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",false,"Ineligible: ECOG Performance Status is 2, exceeding the maximum allowed PS 1."
NCT02669719,P007,"{""age"":55,""gender"":""F"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":4.0,""neutrophil_g_per_l"":1.5,""plt_g_per_l"":100,""hb_g_per_dl"":9.0,""total_bilirubin_xuln"":1.5,""ast_alt_xuln"":3.0,""crcl_ml_min"":44,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Creatinine clearance is $44 \text{ mL/min}$, which is less than the required minimum of $45 \text{ mL/min}$."
NCT02669719,P008,"{""age"":68,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":5.8,""neutrophil_g_per_l"":2.3,""plt_g_per_l"":170,""hb_g_per_dl"":12.5,""total_bilirubin_xuln"":1.0,""ast_alt_xuln"":1.8,""crcl_ml_min"":85,""liver_mets"":false,""active_cns_mets"":true,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Patient has active, untreated CNS metastases, which is an exclusion criterion."
NCT02669719,P009,"{""age"":62,""gender"":""F"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":5.1,""neutrophil_g_per_l"":2.0,""plt_g_per_l"":140,""hb_g_per_dl"":11.0,""total_bilirubin_xuln"":1.0,""ast_alt_xuln"":1.5,""crcl_ml_min"":70,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":false,""prior_ici_washout_days"":15,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Received an experimental monoclonal antibody (Immunotherapy) 15 days prior, violating the 4-week (28 day) washout period."
NCT02669719,P010,"{""age"":40,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":0,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":4.9,""neutrophil_g_per_l"":2.4,""plt_g_per_l"":165,""hb_g_per_dl"":11.8,""total_bilirubin_xuln"":1.0,""ast_alt_xuln"":1.4,""crcl_ml_min"":95,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":true,""infection_status"":""Hep B positive"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Known chronic Hepatitis B infection and requires long-term chronic steroid therapy, both of which are exclusions."
NCT02318277,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":2,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":25,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",true,"Eligible: Failed prior therapy, sufficient washout (21 days), no prior ICI/IDO, no CNS mets, and no autoimmune history."
NCT02318277,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""advanced NSCLC"",""histology_confirmed"":true,""prior_treatment_regimens"":1,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":true,""tumor_type_ici_approved"":true,""days_since_last_anticancer"":28,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",true,"Eligible: Prior ICI is permitted since NSCLC is an approved tumor type for PD-1 pathway agents, and all washout periods are adequate."
NCT02318277,P003,"{""age"":70,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""histology_confirmed"":true,""prior_treatment_regimens"":3,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":true,""tumor_type_ici_approved"":false,""days_since_last_anticancer"":30,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Prior treatment with ICI (anti-CTLA-4) is explicitly excluded for melanoma in this trial (due to the study design/agents used)."
NCT02318277,P004,"{""age"":50,""gender"":""F"",""diagnosis"":""metastatic pancreatic cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":1,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":15,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Received anti-cancer medication (chemotherapy) 15 days ago, violating the 21-day washout period."
NCT02318277,P005,"{""age"":62,""gender"":""M"",""diagnosis"":""advanced head and neck cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":2,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":22,""investigational_washout_ok"":false,""inv_drug_washout_days"":20,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Participated in another study with an investigational drug 20 days prior, violating the 28-day minimum washout."
NCT02318277,P006,"{""age"":45,""gender"":""F"",""diagnosis"":""metastatic ovarian cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":1,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":25,""investigational_washout_ok"":true,""autoimmune_disease"":true,""autoimmune_status"":""inactive vitiligo"",""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Has an inactive autoimmune process (vitiligo). Both active and inactive autoimmune diseases are exclusions."
NCT02318277,P007,"{""age"":68,""gender"":""M"",""diagnosis"":""metastatic bladder cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":1,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":23,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":true,""cns_mets_status"":""untreated and symptomatic"",""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Patient has untreated, symptomatic CNS metastases."
NCT02318277,P008,"{""age"":55,""gender"":""F"",""diagnosis"":""advanced cervical cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":2,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":24,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":true,""ild_status"":""mild ILD"",""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Has evidence of interstitial lung disease (ILD), which is an exclusion."
NCT02318277,P009,"{""age"":40,""gender"":""M"",""diagnosis"":""metastatic sarcoma"",""histology_confirmed"":true,""prior_treatment_regimens"":2,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":28,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":true,""rad_date_weeks"":1,""rad_toxicity_recovered"":true,""pregnant_or_lactating"":false}",false,"Ineligible: Received radiotherapy 1 week prior, violating the 2-week minimum washout period for prior radiation."
NCT02318277,P010,"{""age"":67,""gender"":""F"",""diagnosis"":""metastatic renal cell carcinoma"",""histology_confirmed"":true,""prior_treatment_regimens"":1,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":22,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":true}",false,"Ineligible: Patient is currently pregnant or breastfeeding."
NCT00910676,P001,"{""age"":65,""gender"":""M"",""cancer_type"":""metastatic colorectal cancer"",""prior_chemo_failure"":""Irinotecan failure"",""planned_egfr_inhibitor"":""Cetuximab"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",true,"Eligible: Metastatic CRC patient, failed Irinotecan, planned Cetuximab, no pre-existing skin toxicity, and no contraindication to local steroids/study drugs."
NCT00910676,P002,"{""age"":70,""gender"":""F"",""cancer_type"":""metastatic NSCLC"",""prior_chemo_failure"":""Two prior chemo regimens failure"",""planned_egfr_inhibitor"":""Erlotinib"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",true,"Eligible: Metastatic NSCLC, failed >1 chemo regimen, planned Erlotinib, and meets all other safety/toxicity criteria."
NCT00910676,P003,"{""age"":58,""gender"":""M"",""cancer_type"":""metastatic colorectal cancer"",""prior_chemo_failure"":""5FU-based chemo failure, no prior Irinotecan"",""planned_egfr_inhibitor"":""Cetuximab"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",false,"Ineligible: CRC patient receiving Cetuximab must have failed an Irinotecan-containing chemotherapy regimen."
NCT00910676,P004,"{""age"":62,""gender"":""F"",""cancer_type"":""metastatic NSCLC"",""prior_chemo_failure"":""One prior chemo regimen failure"",""planned_egfr_inhibitor"":""Erlotinib"",""pre_existing_cutaneous_toxicity"":true,""cutaneous_toxicity_type"":""Grade 2 rash"",""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",false,"Ineligible: Has pre-existing cutaneous toxicity (Grade 2 rash), violating the inclusion criterion of 'No pre-existing cutaneous toxicity'."
NCT00910676,P005,"{""age"":50,""gender"":""M"",""cancer_type"":""metastatic CRC"",""prior_chemo_failure"":""Irinotecan failure"",""planned_egfr_inhibitor"":""Cetuximab"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":true,""contraindication_reason"":""severe skin atrophy"",""severe_hypersensitivity"":false}",false,"Ineligible: Has a contraindication to local corticotherapy (Diprosone cream) due to severe skin atrophy."
NCT00910676,P006,"{""age"":45,""gender"":""F"",""cancer_type"":""metastatic NSCLC"",""prior_chemo_failure"":""One prior chemo regimen failure"",""planned_egfr_inhibitor"":""Erlotinib"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":true,""hypersensitivity_to"":""Cetuximab"",""betamethasone_allergy"":false}",false,"Ineligible: History of severe (Grade III/IV) hypersensitivity reaction to Cetuximab, a study-related drug."
NCT00910676,P007,"{""age"":75,""gender"":""M"",""cancer_type"":""metastatic CRC"",""prior_chemo_failure"":""Irinotecan failure"",""planned_egfr_inhibitor"":""Cetuximab"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false,""betamethasone_allergy"":true}",false,"Ineligible: Known allergy to Betamethasone (the active ingredient in Diprosone cream)."
NCT00910676,P008,"{""age"":68,""gender"":""F"",""cancer_type"":""metastatic NSCLC"",""prior_chemo_failure"":""One prior chemo regimen failure"",""planned_egfr_inhibitor"":""Gefitinib"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",false,"Ineligible: The trial is specific to Cetuximab or Erlotinib; the planned EGFR inhibitor is Gefitinib."
NCT00910676,P009,"{""age"":60,""gender"":""M"",""cancer_type"":""metastatic CRC"",""prior_chemo_failure"":""Irinotecan failure"",""planned_egfr_inhibitor"":""Cetuximab"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":true,""hypersensitivity_to"":""Irinotecan"",""betamethasone_allergy"":false}",false,"Ineligible: History of severe hypersensitivity (Grade IV anaphylaxis) to Irinotecan."
NCT00910676,P010,"{""age"":55,""gender"":""F"",""cancer_type"":""metastatic CRC"",""prior_chemo_failure"":""Irinotecan failure"",""planned_egfr_inhibitor"":""Cetuximab + Irinotecan"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",true,"Eligible: Meets all criteria. CRC post-Irinotecan failure, planned Cetuximab (with Irinotecan re-challenge is acceptable), no contraindications."
NCT03871205,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":120,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",true,"Eligible: Meets all inclusion criteria: confirmed lung cancer, failed both chemo and targeted therapy, good PS, and no infectious or other major exclusions."
NCT03871205,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""SCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":100,""life_expectancy_days"":100,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Age is 72 years, exceeding the maximum allowed age of 70 years."
NCT03871205,P003,"{""age"":60,""gender"":""M"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":false,""karnofsky_ps"":90,""life_expectancy_days"":150,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Patient has only failed chemotherapy but not targeted therapy, violating the requirement to have failed both."
NCT03871205,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":70,""life_expectancy_days"":95,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Karnofsky Performance Status is 70, which is equivalent to ECOG PS 2, exceeding the maximum allowed KPS 90-100 (ECOG 0-1)."
NCT03871205,P005,"{""age"":45,""gender"":""M"",""diagnosis"":""SCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":100,""life_expectancy_days"":80,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Life expectancy is estimated at 80 days, which is less than the required minimum of 90 days."
NCT03871205,P006,"{""age"":68,""gender"":""F"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":110,""organ_function_adequate"":true,""active_infection"":true,""infection_type"":""active Hepatitis C"",""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Has an actively infectious condition (Active Hepatitis C), which is an exclusion."
NCT03871205,P007,"{""age"":50,""gender"":""M"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":140,""organ_function_adequate"":false,""inadequate_function_reason"":""severe renal impairment"",""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",false,"Ineligible: Inadequate organ function (severe renal impairment) is present."
NCT03871205,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""SCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":130,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":true,""immunodeficiency_type"":""Common Variable Immunodeficiency"",""investigational_agent"":false,""pregnant_or_lactating"":false}",false,"Ineligible: History of primary immunodeficiency (Common Variable Immunodeficiency)."
NCT03871205,P009,"{""age"":58,""gender"":""M"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":115,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":true,""investigational_agent_type"":""within 30 days"",""pregnant_or_lactating"":false}",false,"Ineligible: Currently receiving or recently received another investigational agent."
NCT03871205,P010,"{""age"":66,""gender"":""F"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":95,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":true}",false,"Ineligible: Patient is pregnant or breastfeeding."
NCT04311710,P001,"{""age"":65,""gender"":""M"",""trial_part"":""Part 1, Arms A/B"",""diagnosis"":""Metastatic Melanoma"",""histology_confirmed"":true,""prior_treatment_melanoma"":""Untreated"",""ecog_ps"":0,""karnofsky_ps_percent"":100,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_exclusions_apply"":false}",true,"Eligible (Melanoma): Meets the specific inclusion for Melanoma (untreated Stage IV) and general criteria (PS 0, no drug allergy)."
NCT04311710,P002,"{""age"":55,""gender"":""F"",""trial_part"":""Part 2, Arm B"",""diagnosis"":""Metastatic RCC"",""histology_confirmed"":true,""prior_treatment_rcc"":""Previously treated"",""ecog_ps"":1,""karnofsky_ps_percent"":80,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_exclusions_apply"":false}",true,"Eligible (RCC): Meets RCC criteria (Metastatic, PS 0-1, KPS 80%), and no general exclusions apply."
NCT04311710,P003,"{""age"":70,""gender"":""M"",""trial_part"":""Part 2, Arm A"",""diagnosis"":""Recurrent NSCLC"",""histology_confirmed"":true,""prior_treatment_nsclc"":""Failed chemo"",""ecog_ps"":1,""karnofsky_ps_percent"":90,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_molecular_status"":""EGFR wild type, ALK negative""}",true,"Eligible (NSCLC): Confirmed recurrent NSCLC, PS 1, and no sensitive EGFR/ALK alterations present."
NCT04311710,P004,"{""age"":60,""gender"":""F"",""trial_part"":""Part 1, Arms A/B"",""diagnosis"":""Metastatic Melanoma"",""histology_confirmed"":true,""prior_treatment_melanoma"":""Failed prior anti-PD-1"",""ecog_ps"":0,""karnofsky_ps_percent"":100,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_exclusions_apply"":false}",false,"Ineligible (Melanoma): Melanoma must be **previously untreated** (first-line) but this patient has failed prior anti-PD-1 therapy."
NCT04311710,P005,"{""age"":58,""gender"":""M"",""trial_part"":""Part 2, Arm A"",""diagnosis"":""Stage IV NSCLC"",""histology_confirmed"":true,""prior_treatment_nsclc"":""Treatment naive"",""ecog_ps"":1,""karnofsky_ps_percent"":90,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_molecular_status"":""EGFR L858R mutation"",""sensitive_to_tki"":true}",false,"Ineligible (NSCLC): Has an **EGFR mutation** (L858R) that is sensitive to available targeted inhibitor therapy (TKI)."
NCT04311710,P006,"{""age"":63,""gender"":""F"",""trial_part"":""Part 1, Arm A"",""diagnosis"":""Advanced HCC"",""histology_confirmed"":true,""ecog_ps"":0,""karnofsky_ps_percent"":100,""study_drug_allergy"":false,""hcc_hepatic_encephalopathy"":true,""hcc_portal_hypertension"":false,""nsclc_exclusions_apply"":false}",false,"Ineligible (HCC): History of hepatic encephalopathy, which is a specific exclusion for the HCC arm."
NCT04311710,P007,"{""age"":45,""gender"":""M"",""trial_part"":""Part 2, Arm B"",""diagnosis"":""Metastatic RCC"",""histology_confirmed"":true,""prior_treatment_rcc"":""Previously treated"",""ecog_ps"":2,""karnofsky_ps_percent"":60,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_exclusions_apply"":false}",false,"Ineligible (RCC): ECOG Performance Status is 2, which exceeds the maximum allowed PS 1 (KPS must be $\geq 70\%$). "
NCT04311710,P008,"{""age"":50,""gender"":""F"",""trial_part"":""Part 1, Arm A"",""diagnosis"":""Metastatic Urothelial Carcinoma"",""histology_confirmed"":true,""ecog_ps"":0,""karnofsky_ps_percent"":100,""study_drug_allergy"":true,""allergy_drug"":""Nivolumab"",""hcc_exclusions_apply"":false,""nsclc_exclusions_apply"":false}",false,"Ineligible: History of allergy/hypersensitivity to one of the study drug components (Nivolumab)."
NCT04311710,P009,"{""age"":75,""gender"":""M"",""trial_part"":""Part 1, Arm A"",""diagnosis"":""Advanced HCC"",""histology_confirmed"":true,""ecog_ps"":1,""karnofsky_ps_percent"":90,""study_drug_allergy"":false,""hcc_hepatic_encephalopathy"":false,""hcc_portal_hypertension"":false,""nsclc_exclusions_apply"":false,""hbv_hdv_coinfection"":true}",false,"Ineligible (HCC): Active coinfection with Hepatitis D Virus (HDV) in a participant with HBV is an exclusion."
NCT04311710,P010,"{""age"":61,""gender"":""F"",""trial_part"":""Part 2, Arm A"",""diagnosis"":""Stage IV NSCLC"",""histology_confirmed"":true,""prior_treatment_nsclc"":""Failed chemo"",""ecog_ps"":0,""karnofsky_ps_percent"":100,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_molecular_status"":""EGFR wild type, ALK positive but TKI resistant""}",true,"Eligible (NSCLC): Although ALK-positive, the molecular status specifies it is TKI-resistant, meaning it is **not sensitive to available targeted inhibitor therapy**, thus making the patient eligible."
NCT07006727,P001,"{""age"": 60, ""diagnosis"": ""SCLC"", ""dll3_positive"": true, ""prior_lines"": 1, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 85, ""QTcF_msec"": 420, ""ANC_g_per_l"": 1.5, ""platelets_g_per_l"": 150, ""hemoglobin_g_per_dl"": 11.0, ""cns_mets"": ""stable, asymptomatic"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",True,"Eligible (SCLC, DE): Meets all general criteria, is DLL3 positive, and has good organ function. 1 prior line is acceptable."
NCT07006727,P002,"{""age"": 70, ""diagnosis"": ""SCLC"", ""dll3_positive"": true, ""prior_lines"": 2, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 90, ""QTcF_msec"": 440, ""ANC_g_per_l"": 1.8, ""platelets_g_per_l"": 65, ""hemoglobin_g_per_dl"": 10.5, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",False,"Ineligible: Platelet count is $65 \\times 10^9/\\text{L}$, which is below the minimum required $75 \\times 10^9/\\text{L}$."
NCT07006727,P003,"{""age"": 55, ""diagnosis"": ""SCLC"", ""dll3_positive"": true, ""prior_lines"": 1, ""prior_dll3_therapy"": true, ""eGFR_ml_min"": 75, ""QTcF_msec"": 480, ""ANC_g_per_l"": 2.0, ""platelets_g_per_l"": 120, ""hemoglobin_g_per_dl"": 9.5, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",False,"Ineligible: QTcF is 480 msec, which is $\\geq 470 \\text{ msec}$."
NCT07006727,P004,"{""age"": 45, ""diagnosis"": ""LCNEC of the lung"", ""dll3_positive"": true, ""prior_lines"": 1, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 95, ""QTcF_msec"": 450, ""ANC_g_per_l"": 1.9, ""platelets_g_per_l"": 180, ""hemoglobin_g_per_dl"": 12.0, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",True,"Eligible (LCNEC, DE): LCNEC is an inclusion only for Dose Escalation, and all criteria are met."
NCT07006727,P005,"{""age"": 63, ""diagnosis"": ""LCNEC of the lung"", ""dll3_positive"": true, ""prior_lines"": 3, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 80, ""QTcF_msec"": 430, ""ANC_g_per_l"": 1.4, ""platelets_g_per_l"": 100, ""hemoglobin_g_per_dl"": 9.2, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""uptake seen"", ""phase"": ""Dose Expansion""}",False,"Ineligible: LCNEC is not included in the Dose Expansion phase. Also, prior lines (3) exceed the maximum (2) for the Dose Expansion phase, and ANC (1.4) is below $1.0 \\times 10^9/\\text{L}$."
NCT07006727,P006,"{""age"": 68, ""diagnosis"": ""NEPC (treatment-emergent)"", ""dll3_positive"": true, ""prior_lines"": 2, ""prior_dll3_therapy"": false, ""prior_rlt"": ""Lu-177-PSMA RLT"", ""eGFR_ml_min"": 70, ""QTcF_msec"": 465, ""ANC_g_per_l"": 1.2, ""platelets_g_per_l"": 80, ""hemoglobin_g_per_dl"": 9.0, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""uptake seen"", ""phase"": ""Dose Expansion""}",True,"Eligible (NEPC, DExp): NEPC is a target for DExp, 2 prior lines, prior Lu-177-PSMA RLT is allowed, and meets all organ/imaging criteria."
NCT07006727,P007,"{""age"": 75, ""diagnosis"": ""GEP-NEC"", ""dll3_positive"": true, ""prior_lines"": 1, ""prior_dll3_therapy"": false, ""prior_rlt"": ""Y-90 RLT"", ""eGFR_ml_min"": 80, ""QTcF_msec"": 445, ""ANC_g_per_l"": 1.7, ""platelets_g_per_l"": 110, ""hemoglobin_g_per_dl"": 10.0, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""uptake seen"", ""phase"": ""Dose Expansion""}",False,"Ineligible: Prior RLT (Y-90) is an exclusion criterion, as only Lu-177-PSMA RLT for NEPC is allowed."
NCT07006727,P008,"{""age"": 50, ""diagnosis"": ""GEP-NEC"", ""dll3_positive"": true, ""prior_lines"": 2, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 65, ""QTcF_msec"": 450, ""ANC_g_per_l"": 1.5, ""platelets_g_per_l"": 105, ""hemoglobin_g_per_dl"": 10.0, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""uptake seen"", ""phase"": ""Dose Expansion""}",True,"Eligible (GEP-NEC, DExp): Meets all DExp criteria, including 2 prior lines (max allowed) and positive imaging/measurable lesion."
NCT07006727,P009,"{""age"": 62, ""diagnosis"": ""SCLC"", ""dll3_positive"": false, ""prior_lines"": 1, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 90, ""QTcF_msec"": 435, ""ANC_g_per_l"": 1.6, ""platelets_g_per_l"": 130, ""hemoglobin_g_per_dl"": 11.5, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",False,"Ineligible: Tumor is DLL3 negative, which is a required biomarker for inclusion."
NCT07006727,P010,"{""age"": 40, ""diagnosis"": ""SCLC"", ""dll3_positive"": true, ""prior_lines"": 2, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 98, ""QTcF_msec"": 410, ""ANC_g_per_l"": 1.9, ""platelets_g_per_l"": 160, ""hemoglobin_g_per_dl"": 12.5, ""cns_mets"": ""symptomatic metastases"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",False,"Ineligible: Patient has symptomatic CNS metastases, which is an exclusion criterion."
NCT04306900,P001,"{""age"":60,""gender"":""M"",""diagnosis"":""Metastatic Colorectal Cancer"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":0,""life_expectancy_weeks"":15,""prior_investigational_washout_days"":35,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",true,"Eligible: Meets all core criteria (PS 0, metastatic, adequate life expectancy), and no exclusionary factors present (washout > 28 days)."
NCT04306900,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""Unresectable Head and Neck SCC"",""histology_confirmed"":true,""metastatic"":false,""unresectable"":true,""ecog_ps"":1,""life_expectancy_weeks"":13,""prior_investigational_washout_days"":20,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",false,"Ineligible: Received an investigational agent 20 days prior, violating the 28-day washout period."
NCT04306900,P003,"{""age"":55,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":2,""life_expectancy_weeks"":16,""prior_investigational_washout_days"":30,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",false,"Ineligible: ECOG Performance Status is 2, exceeding the maximum allowed PS 1."
NCT04306900,P004,"{""age"":68,""gender"":""F"",""diagnosis"":""Metastatic Breast Cancer"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":1,""life_expectancy_weeks"":10,""prior_investigational_washout_days"":40,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",false,"Ineligible: Life expectancy is only 10 weeks, which is less than the required minimum of > 12 weeks."
NCT04306900,P005,"{""age"":45,""gender"":""M"",""diagnosis"":""Metastatic Renal Cell Carcinoma"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":0,""life_expectancy_weeks"":20,""prior_investigational_washout_days"":45,""steroid_immunosuppressive_use"":true,""steroid_details"":""prednisone 20 mg/day for chronic back pain"",""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",false,"Ineligible: Receiving high-dose systemic steroid therapy (Prednisone $20 \text{ mg/day}$) which is an exclusion."
NCT04306900,P006,"{""age"":62,""gender"":""F"",""diagnosis"":""Metastatic Ovarian Cancer"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":1,""life_expectancy_weeks"":14,""prior_investigational_washout_days"":32,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":true,""autoimmune_details"":""severe, active rheumatoid arthritis requiring ongoing treatment"",""hypersensitivity_history"":false,""other_active_malignancy"":false}",false,"Ineligible: History of severe autoimmune disease (active rheumatoid arthritis)."
NCT04306900,P007,"{""age"":50,""gender"":""M"",""diagnosis"":""Metastatic Pancreatic Cancer"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":1,""life_expectancy_weeks"":18,""prior_investigational_washout_days"":38,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":true,""hypersensitivity_details"":""Grade 4 anaphylaxis to Rituximab (monoclonal antibody)"",""other_active_malignancy"":false}",false,"Ineligible: History of severe hypersensitivity reaction (Grade 4 anaphylaxis) to a monoclonal antibody (Rituximab)."
NCT04306900,P008,"{""age"":70,""gender"":""F"",""diagnosis"":""Metastatic NSCLC"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":0,""life_expectancy_weeks"":17,""prior_investigational_washout_days"":30,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":true,""other_malignancy_details"":""recently diagnosed prostate cancer requiring active hormone therapy"",""uncontrolled_illness"":false}",false,"Ineligible: Has another active malignancy (prostate cancer) requiring ongoing treatment (hormone therapy)."
NCT04306900,P009,"{""age"":40,""gender"":""M"",""diagnosis"":""Metastatic Sarcoma"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":0,""life_expectancy_weeks"":25,""prior_investigational_washout_days"":30,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false,""uncontrolled_illness"":true,""illness_details"":""uncontrolled diabetes and active sepsis"",""brain_mets"":""stable, asymptomatic""}",false,"Ineligible: Has an uncontrolled intercurrent illness (uncontrolled diabetes and active sepsis)."
NCT04306900,P010,"{""age"":58,""gender"":""F"",""diagnosis"":""Metastatic Urothelial Carcinoma"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":1,""life_expectancy_weeks"":19,""prior_investigational_washout_days"":29,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",true,"Eligible: Meets all inclusion criteria. The 29-day washout for the investigational agent is acceptable ($\geq 28$ days)."
NCT01487499,P001,"{""age"":65,""gender"":""M"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":true,""response_to_soc"":""Responder"",""disseminated_disease"":false,""cns_mets_only"":false,""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",true,"Eligible (Consolidation): Limited stage SCLC, responder to SOC, no disseminated disease, and fit for bronchoscopy."
NCT01487499,P002,"{""age"":70,""gender"":""F"",""cancer_type"":""Disseminated SCLC"",""disease_status"":""Recurrent disseminated"",""prior_soc_completed"":true,""response_to_soc"":""N/A"",""disseminated_disease"":true,""cns_mets_only"":false,""central_obstruction_symptoms"":true,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",true,"Eligible (Recurrent Disseminated): Recurrent disseminated disease after SOC, with symptoms of central tumor obstruction, and fit for bronchoscopy."
NCT01487499,P003,"{""age"":58,""gender"":""M"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Recurrent limited stage"",""prior_soc_completed"":true,""response_to_soc"":""N/A"",""disseminated_disease"":false,""mediastinal_hilar_recurrence"":true,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",true,"Eligible (Recurrent Limited Stage): Recurrent limited stage with mediastinal/hilar recurrence, and no prior intratumoral cisplatin."
NCT01487499,P004,"{""age"":62,""gender"":""F"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":true,""response_to_soc"":""Non-Responder (Progression) to SOC"",""disseminated_disease"":false,""cns_mets_only"":false,""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",false,"Ineligible (Consolidation): Required to be a **responder** to the standard of care treatment."
NCT01487499,P005,"{""age"":75,""gender"":""M"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":true,""response_to_soc"":""Responder"",""disseminated_disease"":true,""dissemination_site"":""Bone/Liver"",""cns_mets_only"":false,""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",false,"Ineligible (Consolidation): Has evidence of disseminated disease (Bone/Liver), other than CNS metastasis."
NCT01487499,P006,"{""age"":60,""gender"":""F"",""cancer_type"":""Disseminated SCLC"",""disease_status"":""Recurrent disseminated"",""prior_soc_completed"":true,""response_to_soc"":""N/A"",""disseminated_disease"":true,""cns_mets_only"":false,""central_obstruction_symptoms"":false,""bronchoscopy_risk"":false}",false,"Ineligible (Recurrent Disseminated): Recurrent disseminated SCLC must have **symptoms related to central tumor obstruction**; patient is asymptomatic."
NCT01487499,P007,"{""age"":68,""gender"":""M"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Recurrent limited stage"",""prior_soc_completed"":true,""response_to_soc"":""N/A"",""disseminated_disease"":false,""mediastinal_hilar_recurrence"":true,""previous_intratumoral_cisplatin"":true,""bronchoscopy_risk"":false}",false,"Ineligible (Recurrent Limited Stage): Patient was previously treated with intratumoral cisplatin for this recurrence site."
NCT01487499,P008,"{""age"":50,""gender"":""F"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":true,""response_to_soc"":""Responder"",""disseminated_disease"":false,""cns_mets_only"":true,""cns_mets_status"":""treated and stable"",""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",true,"Eligible (Consolidation): Disseminated disease is restricted to CNS metastasis, which is allowed for this cohort, and meets all other criteria."
NCT01487499,P009,"{""age"":55,""gender"":""M"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":false,""prior_treatment_details"":""Only received chemotherapy, refused radiation"",""response_to_soc"":""Responder"",""disseminated_disease"":false,""cns_mets_only"":false,""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",false,"Ineligible: Did not complete the **standard systemic chemotherapy and radiation therapy** for limited stage SCLC."
NCT01487499,P010,"{""age"":72,""gender"":""F"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":true,""response_to_soc"":""Responder"",""disseminated_disease"":false,""cns_mets_only"":false,""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":true,""bronchoscopy_risk_details"":""Severe COPD/high risk of respiratory failure"",""english_speaking"":true}",false,"Ineligible: Patient is at risk undergoing a bronchoscopy due to severe COPD."
NCT05450692,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":15,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",true,"Eligible: Meets all core requirements (WT, prior ICI/Platinum, PS 1) and all strict ICI toxicity and prior ATR inhibitor exclusions are met."
NCT05450692,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""Locally Advanced NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":2,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":0,""life_expectancy_weeks"":18,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",false,"Ineligible: Received 2 prior lines of anti-PD-(L)1 therapy. Maximum allowed is one line."
NCT05450692,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":false,""molecular_status"":""EGFR L858R mutation"",""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":14,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",false,"Ineligible: Does not have EGFR/ALK wild-type status (has an EGFR mutation)."
NCT05450692,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":2,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":16,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",false,"Ineligible: Received 2 prior lines of platinum-based chemotherapy in the metastatic setting. Maximum allowed is one line."
NCT05450692,P005,"{""age"":60,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":2,""life_expectancy_weeks"":13,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",false,"Ineligible: ECOG Performance Status is 2, exceeding the maximum allowed PS 1."
NCT05450692,P006,"{""age"":68,""gender"":""F"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":15,""prior_ici_discontinued_ae"":true,""discontinuation_reason"":""Grade 2 pneumonitis"",""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",false,"Ineligible: Prior ICI therapy was permanently discontinued due to a toxicity (Grade 2 pneumonitis)."
NCT05450692,P007,"{""age"":50,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":0,""life_expectancy_weeks"":18,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":false,""unresolved_ae"":""Persistent Grade 3 neuropathy"",""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",false,"Ineligible: Persistent toxicity (Grade > 2 neuropathy) caused by previous anticancer therapy."
NCT05450692,P008,"{""age"":62,""gender"":""F"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":12,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":true,""imae_type"":""Grade 3 Colitis"",""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",false,"Ineligible: Experienced a Grade $\\geq 3$ immune-mediated adverse event (Colitis) while receiving prior anti-PD-(L)1 therapy."
NCT05450692,P009,"{""age"":45,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":0,""life_expectancy_weeks"":20,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":true,""prior_atr_inhibitor_name"":""Atemonistat"",""autoimmune_disorder"":false}",false,"Ineligible: Has received a prior ATR inhibitor (Atemonistat)."
NCT05450692,P010,"{""age"":70,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":14,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":true,""autoimmune_status"":""active Sjogren's syndrome"",""weight_kg"":80}",false,"Ineligible: Has an active or prior documented autoimmune or inflammatory disorder (active Sjogren's syndrome)."
NCT01064466,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",true,"Eligible: Meets all core inclusion criteria for SCLC (biopsy confirmed, measurable, adequate PS/organ function) and has none of the listed exclusions."
NCT01064466,P002,"{""age"":70,""gender"":""F"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":true,""tx_details"":""receiving concurrent radiation therapy for bone mets"",""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",false,"Ineligible: Receiving other anti-cancer therapies (concurrent radiation therapy) which cannot be stopped currently."
NCT01064466,P003,"{""age"":22,""gender"":""M"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",false,"Ineligible: Age is 22 years old, which is below the minimum required age of 24 years old."
NCT01064466,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Inadequate"",""organ_function_details"":""Severe renal impairment"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",false,"Ineligible: Does not have adequate organ function (severe renal impairment)."
NCT01064466,P005,"{""age"":45,""gender"":""M"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":true,""pneumonectomy_details"":""right lung removed 5 years ago"",""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",false,"Ineligible: History of pneumonectomy."
NCT01064466,P006,"{""age"":68,""gender"":""F"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":true,""illness_details"":""active, uncontrolled septic infection"",""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",false,"Ineligible: Has other serious intercurrent illness or infectious diseases (active, uncontrolled septic infection)."
NCT01064466,P007,"{""age"":60,""gender"":""M"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":true,""other_cancer"":""Squamous Cell Carcinoma of the skin (untreated)"",""bleed_tendency"":false,""allergy_to_drugs"":false}",false,"Ineligible: Has more than one different kind of cancer at the same time (SCLC and untreated Squamous Cell Carcinoma of the skin)."
NCT01064466,P008,"{""age"":50,""gender"":""F"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":true,""bleed_details"":""Active Grade 3 GI bleed"",""allergy_to_drugs"":false}",false,"Ineligible: Has a serious clot or bleed tendency (Active Grade 3 GI bleed)."
NCT01064466,P009,"{""age"":58,""gender"":""M"",""diagnosis"":""SCLC"",""biopsy_confirmed"":false,""biopsy_details"":""Clinical diagnosis only, biopsy unsuccessful"",""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",false,"Ineligible: Lacks a confirmed lung tissue biopsy diagnosis of SCLC."
NCT01064466,P010,"{""age"":63,""gender"":""F"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":true,""allergy_details"":""Severe allergy to cisplatin"",""pregnant_or_breastfeeding"":true}",false,"Ineligible: Patient is pregnant/breastfeeding (Exclusion 3/4). Also has a serious allergy to drugs (Exclusion 7)."
NCT00375245,P001,"{""age"":55,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""ecog_ps"":1,""life_expectancy_weeks"":15,""washout_weeks"":5,""anc"":2000,""platelets"":120000,""creatinine_clearance_ml_min"":80,""ast_alt_x_uln"":1.5,""triglycerides_mg_dl"":250,""cns_mets"":""stable, asymptomatic"",""concurrent_meds"":[],""gi_malabsorption"":false}",true,"Eligible: Meets all PS, life expectancy, washout, and organ function criteria. CNS mets are stable and no prohibited drugs or GI issues."
NCT00375245,P002,"{""age"":68,""gender"":""F"",""diagnosis"":""Metastatic Breast Cancer"",""ecog_ps"":2,""life_expectancy_weeks"":13,""washout_weeks"":3,""anc"":1800,""platelets"":110000,""creatinine_clearance_ml_min"":75,""ast_alt_x_uln"":1.8,""triglycerides_mg_dl"":300,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":false}",false,"Ineligible: Prior chemotherapy washout period is 3 weeks, which is less than the required minimum of 4 weeks."
NCT00375245,P003,"{""age"":70,""gender"":""M"",""diagnosis"":""Multiple Myeloma (Phase IB)"",""ecog_ps"":1,""life_expectancy_weeks"":20,""washout_weeks"":4,""anc"":1100,""platelets"":60000,""creatinine_clearance_ml_min"":90,""ast_alt_x_uln"":2.0,""triglycerides_mg_dl"":400,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":false}",true,"Eligible (Hematologic): Meets hematologic specific criteria: ANC $\\geq 1,000$, PLT $\\geq 50,000$, and all other criteria."
NCT00375245,P004,"{""age"":60,""gender"":""F"",""diagnosis"":""Metastatic Colon Cancer"",""ecog_ps"":1,""life_expectancy_weeks"":16,""washout_weeks"":5,""anc"":1400,""platelets"":105000,""creatinine_clearance_ml_min"":85,""ast_alt_x_uln"":1.2,""triglycerides_mg_dl"":280,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":false}",false,"Ineligible: Absolute Neutrophil Count (ANC) is 1,400/$\mu\text{L}$, below the minimum required 1,500/$\mu\text{L}$ for solid tumor patients."
NCT00375245,P005,"{""age"":45,""gender"":""M"",""diagnosis"":""Metastatic Melanoma"",""ecog_ps"":0,""life_expectancy_weeks"":18,""washout_weeks"":4,""anc"":2500,""platelets"":150000,""creatinine_clearance_ml_min"":55,""ast_alt_x_uln"":1.0,""triglycerides_mg_dl"":350,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":false}",false,"Ineligible: Creatinine clearance is $55 \text{ mL/min}$, which is below the minimum required $60 \text{ mL/min}$."
NCT00375245,P006,"{""age"":50,""gender"":""F"",""diagnosis"":""Metastatic Ovarian Cancer"",""ecog_ps"":1,""life_expectancy_weeks"":14,""washout_weeks"":6,""anc"":2200,""platelets"":130000,""creatinine_clearance_ml_min"":70,""ast_alt_x_uln"":2.2,""triglycerides_mg_dl"":550,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":false}",false,"Ineligible: Serum triglycerides are $550 \text{ mg/dL}$, exceeding the maximum allowed $500 \text{ mg/dL}$."
NCT00375245,P007,"{""age"":62,""gender"":""M"",""diagnosis"":""Metastatic Prostate Cancer"",""ecog_ps"":2,""life_expectancy_weeks"":12,""washout_weeks"":7,""anc"":2000,""platelets"":115000,""creatinine_clearance_ml_min"":70,""ast_alt_x_uln"":1.5,""triglycerides_mg_dl"":200,""cns_mets"":""uncontrolled and symptomatic"",""concurrent_meds"":[],""gi_malabsorption"":false}",false,"Ineligible: Has uncontrolled brain metastases."
NCT00375245,P008,"{""age"":58,""gender"":""F"",""diagnosis"":""Metastatic Urothelial Carcinoma"",""ecog_ps"":1,""life_expectancy_weeks"":17,""washout_weeks"":4,""anc"":1900,""platelets"":125000,""creatinine_clearance_ml_min"":80,""ast_alt_x_uln"":1.0,""triglycerides_mg_dl"":300,""cns_mets"":""none"",""concurrent_meds"":[""Ketoconazole""],""gi_malabsorption"":false}",false,"Ineligible: Concurrent use of Ketoconazole is an explicit exclusion."
NCT00375245,P009,"{""age"":66,""gender"":""M"",""diagnosis"":""Metastatic Gastric Cancer"",""ecog_ps"":1,""life_expectancy_weeks"":15,""washout_weeks"":5,""anc"":2100,""platelets"":140000,""creatinine_clearance_ml_min"":75,""ast_alt_x_uln"":1.8,""triglycerides_mg_dl"":450,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":true,""gi_issue"":""partial small bowel obstruction"",""immuno_deficient"":false}",false,"Ineligible: Has a gastrointestinal malabsorption issue (partial small bowel obstruction) which interferes with oral medication absorption."
NCT00375245,P010,"{""age"":52,""gender"":""F"",""diagnosis"":""Metastatic Endometrial Cancer"",""ecog_ps"":0,""life_expectancy_weeks"":19,""washout_weeks"":4,""anc"":2000,""platelets"":135000,""creatinine_clearance_ml_min"":70,""ast_alt_x_uln"":1.1,""triglycerides_mg_dl"":290,""cns_mets"":""none"",""concurrent_meds"":[""Diltiazem""],""gi_malabsorption"":false}",false,"Ineligible: Concurrent use of Diltiazem is prohibited (due to the grapefruit juice component of the study)."
NCT00475657,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":15,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":5,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",true,"Eligible: Meets all requirements for first-line extended-stage SCLC (PS 1, treatment-naïve, measurable disease, adequate organ function, and no specific exclusions)."
NCT00475657,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":true,""tx_details"":""Received 2 cycles of Carboplatin/Etoposide"",""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":14,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":0,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",false,"Ineligible: Has received previous systemic chemotherapy (Carboplatin/Etoposide) for SCLC. The trial requires treatment-naïve status."
NCT00475657,P003,"{""age"":55,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":3,""life_expectancy_weeks"":12,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":8,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",false,"Ineligible: ECOG Performance Status is 3, exceeding the maximum allowed PS 2."
NCT00475657,P004,"{""age"":60,""gender"":""F"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":16,""adequate_organ_function"":false,""organ_details"":""Severe Renal Failure"",""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":5,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",false,"Ineligible: Has severe renal failure, which is an explicit exclusion."
NCT00475657,P005,"{""age"":50,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":18,""adequate_organ_function"":true,""discontinue_nsaids"":false,""nsaids_details"":""Unable to stop daily Aspirin for cardiac history"",""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":2,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",false,"Ineligible: Unable to discontinue administration of NSAID agents (daily Aspirin)."
NCT00475657,P006,"{""age"":75,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":2,""life_expectancy_weeks"":13,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":true,""fluid_details"":""Large pleural effusion requiring drainage"",""weight_loss_6wks_percent"":5,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",false,"Ineligible: Has clinically relevant fluid accumulation in the third space (large pleural effusion)."
NCT00475657,P007,"{""age"":58,""gender"":""F"",""diagnosis"":""Mixed SCLC/NSCLC"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":17,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":3,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",false,"Ineligible: Mixed histologic diagnosis of SCLC and NSCLC is an exclusion criterion."
NCT00475657,P008,"{""age"":68,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":15,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":12,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",false,"Ineligible: Significant weight loss (12%) within 6 weeks prior to trial inclusion (threshold is $\geq 10\%$)."
NCT00475657,P009,"{""age"":62,""gender"":""F"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":0,""life_expectancy_weeks"":16,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":false,""cannot_take_details"":""Inability to take Folic Acid supplements"",""third_space_fluid"":false,""weight_loss_6wks_percent"":1,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",false,"Ineligible: Inability or unwillingness to take folic acid and vitamin B12 supplements, which are required co-medications for Pemetrexed."
NCT00475657,P010,"{""age"":45,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":19,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":3,""cns_mets_status"":""Treated and Stable, requires 5 mg daily dexamethasone"",""prior_pemetrexed_trial"":false}",true,"Eligible: Treated and stable CNS metastases are allowed, and the required steroid dose (5 mg Dexamethasone/equivalent) is low enough not to be considered 'concurrent corticoid therapy' required for the CNS mets exclusion."
NCT01944137,P001,"{""age"":55,""diagnosis"":""Stage II Breast Cancer"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for neoadjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",true,"Eligible: Meets all criteria—newly diagnosed Stage II Breast Cancer, scheduled for neoadjuvant chemotherapy, and no prior cycles of the current regimen."
NCT01944137,P002,"{""age"":60,""diagnosis"":""Stage IV Colorectal Cancer"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for palliative chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",false,"Ineligible: Stage IV (metastatic) disease is excluded. Only Stage I-III is allowed."
NCT01944137,P003,"{""age"":72,""diagnosis"":""Stage III NSCLC"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for adjuvant chemo"",""prior_chemo_cycles"":1,""english_speaking"":true}",false,"Ineligible: Has already received 1 cycle of chemotherapy for the current regimen (Exclusion: already received $\geq 1$ cycle)."
NCT01944137,P004,"{""age"":45,""diagnosis"":""Stage I Colorectal Cancer"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for neoadjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":false}",false,"Ineligible: Unable to respond to questions in English."
NCT01944137,P005,"{""age"":68,""diagnosis"":""Stage II Prostate Cancer"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for adjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",false,"Ineligible: Prostate cancer is not one of the eligible tumor types (only CRC, NSCLC, or Breast Cancer)."
NCT01944137,P006,"{""age"":50,""diagnosis"":""Stage I Breast Cancer"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for neoadjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",true,"Eligible: Meets all criteria. Stage I Breast Cancer is an allowed type and stage."
NCT01944137,P007,"{""age"":35,""diagnosis"":""Stage II NSCLC"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for adjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",true,"Eligible: Meets all criteria. Stage II NSCLC is an allowed type and stage."
NCT01944137,P008,"{""age"":78,""diagnosis"":""Stage III Colorectal Cancer"",""newly_diagnosed"":true,""chemo_status"":""Completed 3 cycles of chemo 6 months ago"",""prior_chemo_cycles"":3,""english_speaking"":true}",false,"Ineligible: Although the patient is newly diagnosed (within the trial context of having a cancer directed therapy) they have already completed 3 cycles of chemotherapy for the current regimen."
NCT01944137,P009,"{""age"":25,""diagnosis"":""Stage II Breast Cancer"",""newly_diagnosed"":false,""chemo_status"":""Scheduled for neoadjuvant chemo (recurrence) "",""prior_chemo_cycles"":0,""english_speaking"":true}",false,"Ineligible: Not a newly diagnosed case of Stage I-III cancer. The chemotherapy is for a recurrence, not the initial therapy setting."
NCT01944137,P010,"{""age"":63,""diagnosis"":""Stage III NSCLC"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for adjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",true,"Eligible: Meets all criteria. Stage III NSCLC, scheduled for adjuvant chemo, and no prior cycles."
NCT03501056,P001,"{""age"":65,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":15,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",true,"Eligible: Meets age, disease (MUC1+ advanced lung cancer), measurable disease, washout, survival, and exclusion criteria (no CNS mets, normal coag, no autoimmune/HIV)."
NCT03501056,P002,"{""age"":70,""diagnosis"":""Advanced SCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":false,""washout_details"":""Received last dose of chemo 3 weeks ago"",""expected_survival_weeks"":13,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",false,"Ineligible: Did not complete the required $\\geq 4$ weeks washout from prior anti-tumor drugs (chemotherapy)."
NCT03501056,P003,"{""age"":76,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":16,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",false,"Ineligible: Age is 76 years, which is above the maximum allowed age of 75 years."
NCT03501056,P004,"{""age"":55,""diagnosis"":""Advanced Lung Adenocarcinoma"",""muc1_positive"":false,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":14,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",false,"Ineligible: The tumor is MUC1 negative, but MUC1 positive status is required for inclusion."
NCT03501056,P005,"{""age"":60,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":false,""surgery_details"":""Major surgery 8 weeks ago"",""expected_survival_weeks"":18,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",false,"Ineligible: Major surgical treatment time is 8 weeks ago, which is less than the required $\\geq 3$ months (12 weeks) washout."
NCT03501056,P006,"{""age"":58,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":16,""autoimmune_hiv_history"":true,""hiv_status"":""HIV positive, receiving combination antiretroviral therapy"",""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",false,"Ineligible: Patient is positive for HIV antibody (an exclusion)."
NCT03501056,P007,"{""age"":62,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":12,""autoimmune_hiv_history"":false,""coagulation_normal"":false,""coag_details"":""INR 2.5"",""cns_mets"":false,""ascites_level"":""None""}",false,"Ineligible: Coagulant function abnormality (INR $2.5$), violating the $\\text{INR} < 2$ limit."
NCT03501056,P008,"{""age"":50,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":15,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":true,""cns_mets_details"":""Multiple brain metastases"",""ascites_level"":""None""}",false,"Ineligible: Has brain or dura mater metastases."
NCT03501056,P009,"{""age"":68,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":13,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""Moderate"",""other_cancer"":false}",false,"Ineligible: Presence of medium or above (moderate) ascites."
NCT03501056,P010,"{""age"":40,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":20,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",true,"Eligible: Meets all requirements (young, MUC1+, adequate washouts, no critical exclusions)."
NCT00759824,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":80,""polynuclear_cells"":2500,""platelets"":150000,""bilirubin_mg_dl"":1.0,""transaminases_x_normal"":1.5,""creatinine_mg_dl"":1.0,""lvef_percent"":60,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",true,"Eligible: Refractory SCLC to Platinum/Etoposide. No prior ACV components. Meets all PS, hematologic, organ function, and cardiac criteria."
NCT00759824,P002,"{""age"":70,""gender"":""F"",""diagnosis"":""SCLC"",""refractory_status"":""Secondary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":true,""prior_acv_details"":""Received Vincristine (Vinca-Alkaloid) in a prior regimen"",""karnofsky_ps"":70,""polynuclear_cells"":2200,""platelets"":120000,""bilirubin_mg_dl"":0.8,""transaminases_x_normal"":1.1,""creatinine_mg_dl"":1.2,""lvef_percent"":55,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",false,"Ineligible: Was previously treated with a Vinca-Alkaloid derivative (Vindesine component is prohibited if used previously)."
NCT00759824,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":50,""polynuclear_cells"":2300,""platelets"":130000,""bilirubin_mg_dl"":1.1,""transaminases_x_normal"":1.6,""creatinine_mg_dl"":1.3,""lvef_percent"":65,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",false,"Ineligible: Karnofsky Performance Status is 50, which is below the minimum required 60."
NCT00759824,P004,"{""age"":62,""gender"":""F"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":70,""polynuclear_cells"":1800,""platelets"":110000,""bilirubin_mg_dl"":0.9,""transaminases_x_normal"":1.0,""creatinine_mg_dl"":1.0,""lvef_percent"":58,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",false,"Ineligible: Polynuclear cells are 1,800/$\text{mm}^3$, below the minimum required 2,000/$\text{mm}^3$."
NCT00759824,P005,"{""age"":50,""gender"":""M"",""diagnosis"":""SCLC"",""refractory_status"":""Secondary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":80,""polynuclear_cells"":2400,""platelets"":140000,""bilirubin_mg_dl"":1.8,""transaminases_x_normal"":1.4,""creatinine_mg_dl"":1.1,""lvef_percent"":62,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",false,"Ineligible: Serum bilirubin is $1.8 \text{ mg/dL}$, exceeding the maximum allowed $1.5 \text{ mg/dL}$."
NCT00759824,P006,"{""age"":75,""gender"":""F"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":60,""polynuclear_cells"":2100,""platelets"":105000,""bilirubin_mg_dl"":1.0,""transaminases_x_normal"":2.5,""creatinine_mg_dl"":1.4,""lvef_percent"":45,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",false,"Ineligible: Left Ventricular Ejection Fraction (LVEF) is 45%, below the minimum required 50%."
NCT00759824,P007,"{""age"":45,""gender"":""M"",""diagnosis"":""SCLC"",""refractory_status"":""Secondary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":80,""polynuclear_cells"":2800,""platelets"":160000,""bilirubin_mg_dl"":1.2,""transaminases_x_normal"":1.8,""creatinine_mg_dl"":1.0,""lvef_percent"":60,""recent_mi"":false,""active_epilepsy"":true,""epilepsy_status"":""Active epilepsy treated with Carbamazepine"",""prohibited_meds"":true}",false,"Ineligible: Active epilepsy needing specific treatment AND concomitant treatment with Carbamazepine, which is a prohibited medication."
NCT00759824,P008,"{""age"":60,""gender"":""F"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":true,""prior_acv_details"":""Received Cyclophosphamide in a prior regimen"",""karnofsky_ps"":70,""polynuclear_cells"":2200,""platelets"":120000,""bilirubin_mg_dl"":1.0,""transaminases_x_normal"":1.5,""creatinine_mg_dl"":1.0,""lvef_percent"":55,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",false,"Ineligible: Patient was previously treated with Cyclophosphamide, which is an explicit exclusion."
NCT00759824,P009,"{""age"":68,""gender"":""M"",""diagnosis"":""SCLC"",""refractory_status"":""Recurrence 4 months after end of treatment"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":80,""polynuclear_cells"":3000,""platelets"":180000,""bilirubin_mg_dl"":0.9,""transaminases_x_normal"":0.8,""creatinine_mg_dl"":0.9,""lvef_percent"":65,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",false,"Ineligible: Disease recurrence occurred 4 months after treatment, classifying the patient as 'sensitive' and not 'refractory' (refractory requires recurrence $< 3$ months)."
NCT00759824,P010,"{""age"":52,""gender"":""F"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":90,""polynuclear_cells"":3200,""platelets"":150000,""bilirubin_mg_dl"":0.7,""transaminases_x_normal"":0.9,""creatinine_mg_dl"":0.8,""lvef_percent"":60,""recent_mi"":true,""mi_time"":""2 months prior"",""active_epilepsy"":false,""prohibited_meds"":false}",false,"Ineligible: Suffered a recent myocardial infarction (2 months prior), which is within the 3-month exclusion period."
NCT00621361,P001,"{""age"":65,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":1,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",true,"Eligible: Meets disease and stage requirements (Extensive-Stage SCLC where EP is standard), is treatment-naïve for advanced disease, and has a WHO PS of 1 with no exclusions."
NCT00621361,P002,"{""age"":72,""diagnosis"":""Extensive-Stage NSCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":2,""brain_mets_status"":""treated and stable"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",true,"Eligible: Meets disease, stage, and PS criteria. Treated and stable CNS metastases are not explicitly excluded, only untreated/unstable are excluded."
NCT00621361,P003,"{""age"":55,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":true,""tx_details"":""Received 2 cycles of Carboplatin/Etoposide 3 months ago"",""prior_radiotherapy"":false,""who_ps"":1,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",false,"Ineligible: Has received prior chemotherapy for advanced lung cancer."
NCT00621361,P004,"{""age"":68,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":true,""radiation_details"":""Completed palliative radiotherapy 1 week ago (within measurable field) "",""who_ps"":2,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",false,"Ineligible: Prior radiotherapy was completed only 1 week ago, violating the required $\\geq 2$ week washout period."
NCT00621361,P005,"{""age"":60,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":3,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",false,"Ineligible: WHO Performance Status is 3, exceeding the maximum allowed PS 2."
NCT00621361,P006,"{""age"":70,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":1,""brain_mets_status"":""untreated and symptomatic brain mets"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",false,"Ineligible: Has untreated unstable brain metastases."
NCT00621361,P007,"{""age"":50,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":0,""brain_mets_status"":""none"",""bone_marrow_reserve"":""inadequate"",""bone_marrow_details"":""Platelets < 50,000/mm^3"",""lab_values"":""inappropriate""}",false,"Ineligible: Has inadequate bone marrow reserve (inappropriate lab test values)."
NCT00621361,P008,"{""age"":58,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":true,""radiation_details"":""Completed prophylactic cranial irradiation (PCI) 3 weeks ago (outside measurable field) "",""who_ps"":1,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",true,"Eligible: Prior radiotherapy (PCI) was outside the measurable field and completed 3 weeks ago ($\\geq 2$ weeks washout)."
NCT00621361,P009,"{""age"":45,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":0,""brain_mets_status"":""meningeal metastases"",""brain_mets_details"":""untreated and symptomatic"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",false,"Ineligible: Has untreated unstable meningeal metastases."
NCT00621361,P010,"{""age"":75,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":1,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",true,"Eligible: Meets all criteria. Advanced age is not an exclusion criterion for this trial."
NCT06749691,P001,"{""age"":65,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":1,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":15,""infection_status"":""none"",""oral_absorption_issues"":false}",true,"Eligible: Meets age, stage, and measurable disease criteria. Failed first-line, no prior VEGF/VEGFR inhibitors, and no infection or absorption issues."
NCT06749691,P002,"{""age"":70,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":3,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":13,""infection_status"":""none"",""oral_absorption_issues"":false}",false,"Ineligible: Has failed 3 prior lines of treatment. The trial is for patients who have failed first-line or second-line treatment (maximum 2 prior lines)."
NCT06749691,P003,"{""age"":58,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":2,""prior_vegf_tx"":true,""vegf_drug"":""Anlotinib"",""measurable_lesion"":true,""expected_survival_weeks"":14,""infection_status"":""none"",""oral_absorption_issues"":false}",false,"Ineligible: Has previously received systemic treatment targeting VEGF/VEGFR (Anlotinib)."
NCT06749691,P004,"{""age"":76,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":1,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":16,""infection_status"":""none"",""oral_absorption_issues"":false}",false,"Ineligible: Age is 76 years, exceeding the maximum allowed age of 75 years."
NCT06749691,P005,"{""age"":50,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":2,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":11,""infection_status"":""none"",""oral_absorption_issues"":false}",false,"Ineligible: Expected survival period is 11 weeks, which is below the minimum required 12 weeks."
NCT06749691,P006,"{""age"":62,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":1,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":15,""infection_status"":""Active Severe Infection (CTCAE 3)"",""antibiotics_2wks"":true,""oral_absorption_issues"":false}",false,"Ineligible: Active or uncontrolled severe infection (CTCAE $\\geq 2$) AND received antibiotic treatment within 2 weeks prior to enrollment."
NCT06749691,P007,"{""age"":45,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":2,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":18,""infection_status"":""none"",""oral_absorption_issues"":true,""absorption_details"":""Intestinal obstruction"",""antibiotics_2wks"":false}",false,"Ineligible: Has intestinal obstruction, a factor that affects the absorption of oral medication (Apatinib)."
NCT06749691,P008,"{""age"":68,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":1,""prior_vegf_tx"":false,""measurable_lesion"":false,""measurable_details"":""only non-measurable bone lesions"",""expected_survival_weeks"":12,""infection_status"":""none"",""oral_absorption_issues"":false}",false,"Ineligible: Does not have at least one measurable lesion according to RECIST V1.1."
NCT06749691,P009,"{""age"":55,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":2,""prior_vegf_tx"":true,""vegf_drug"":""Ranibizumab (for diabetic retinopathy) 6 months ago"",""measurable_lesion"":true,""expected_survival_weeks"":17,""infection_status"":""none"",""oral_absorption_issues"":false}",false,"Ineligible: Has previously received systemic treatment targeting VEGF (Ranibizumab), regardless of the indication."
NCT06749691,P010,"{""age"":40,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":1,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":20,""infection_status"":""Active mild infection (CTCAE 1) but no antibiotics in 2 weeks"",""oral_absorption_issues"":false}",true,"Eligible: Meets all criteria. While there is an infection, it is mild (CTCAE 1) and does not meet the $\\geq 2$ severity exclusion."
NCT01588821,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""Metastatic Renal Cell Carcinoma"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":28,""prior_tki_washout_days"":15,""radiation_washout_days"":60,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",true,"Eligible: Solid tumor (non-Breast/Prostate), has bony mets, and meets all washout requirements (chemo $> 21$ days, TKI $> 14$ days, radiation $> 14$ days/bone)."
NCT01588821,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""Metastatic Breast Cancer"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":30,""prior_tki_washout_days"":20,""radiation_washout_days"":40,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",false,"Ineligible: Primary tumor is Breast Cancer, which is explicitly excluded."
NCT01588821,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":18,""prior_tki_washout_days"":20,""radiation_washout_days"":35,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",false,"Ineligible: Cytotoxic chemotherapy washout is 18 days, which is less than the required minimum of 3 weeks (21 days)."
NCT01588821,P004,"{""age"":60,""gender"":""F"",""diagnosis"":""Metastatic Ovarian Cancer"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":25,""prior_tki_washout_days"":10,""prior_tki_half_life"":2,""radiation_washout_days"":60,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",false,"Ineligible: Small molecule kinase inhibitor washout is 10 days. This is less than the required 14 days and less than $5 \times$ half-lives ($5 \times 2 = 10$ days, so it is exactly 5 half-lives, but the rule is 14 days $\text{OR } 5 \times$ half-lives. Assuming the standard interpretation of the minimum of the two: 14 days is the minimum if the half-life is short, 10 days is the minimum if the half-life is long. Since 10 days is $\text{NOT} \geq 14$ days, and is the $5 \times$ half-lives limit, this is a borderline failure. Let's use 14 days as the strict minimum for TKI washout)."
NCT01588821,P005,"{""age"":70,""gender"":""M"",""diagnosis"":""Metastatic Colon Cancer"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":28,""prior_tki_washout_days"":20,""radiation_washout_days"":10,""radiation_site"":""bone metastasis"",""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",false,"Ineligible: Radiation to bone metastasis was 10 days ago, violating the required $\\geq 14$ day washout."
NCT01588821,P006,"{""age"":45,""gender"":""F"",""diagnosis"":""Metastatic Thyroid Cancer"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":25,""prior_tki_washout_days"":30,""radiation_washout_days"":100,""prior_toxicities_resolved"":false,""unresolved_toxicity"":""CTCAE Grade 3 Peripheral Neuropathy"",""active_brain_mets"":false,""primary_brain_tumor"":false}",false,"Ineligible: Has not recovered from toxicities due to prior therapies (unresolved Grade 3 Neuropathy)."
NCT01588821,P007,"{""age"":62,""gender"":""M"",""diagnosis"":""Metastatic Lung Adenocarcinoma"",""bony_metastases"":false,""bony_metastases_status"":""none"",""refractory_status"":true,""prior_chemo_washout_days"":25,""prior_tki_washout_days"":20,""radiation_washout_days"":50,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",false,"Ineligible: Does not have bony metastases, which is a required inclusion criterion."
NCT01588821,P008,"{""age"":68,""gender"":""F"",""diagnosis"":""Metastatic Small Intestine Cancer"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":25,""prior_tki_washout_days"":20,""radiation_washout_days"":80,""radiation_site"":""GI Tract"",""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",false,"Ineligible: Radiation to the GI tract was 80 days ago, which is less than the required minimum of 3 months (approx 90-91 days) washout."
NCT01588821,P009,"{""age"":50,""gender"":""M"",""diagnosis"":""Metastatic Melanoma"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":28,""prior_tki_washout_days"":20,""radiation_washout_days"":50,""prior_toxicities_resolved"":true,""active_brain_mets"":true,""active_brain_mets_details"":""Symptomatic and requires steroids"",""primary_brain_tumor"":false}",false,"Ineligible: Has active brain metastases."
NCT01588821,P010,"{""age"":55,""gender"":""F"",""diagnosis"":""Metastatic Sarcoma"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":22,""prior_tki_washout_days"":15,""radiation_washout_days"":30,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",true,"Eligible: Meets all disease and treatment washout criteria. Sarcoma is a solid tumor (non-Breast/Prostate) and has bony mets."
NCT03361228,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":3,""prior_targeted_therapy_weeks_ago"":4,""prior_mab_weeks_ago"":6,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":1}",true,"Eligible: Phase 2 CRC with measurable disease, adequate washout periods, resolved toxicities, no exclusion criteria."
NCT03361228,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""advanced NSCLC"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":0,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":4,""prior_targeted_therapy_weeks_ago"":5,""prior_mab_weeks_ago"":8,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",true,"Eligible: Phase 2 NSCLC with excellent performance status, all washout periods met, no prior IDO1/arginase inhibitors."
NCT03346728,P003,"{""age"":45,""gender"":""M"",""diagnosis"":""metastatic pancreatic cancer"",""phase_eligible"":""phase_1"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":1,""prior_targeted_therapy_weeks_ago"":6,""prior_mab_weeks_ago"":10,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",false,"Ineligible: Chemotherapy only 1 week ago (requires 2-week washout)."
NCT03361228,P004,"{""age"":67,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":false,""prior_chemo_weeks_ago"":5,""prior_targeted_therapy_weeks_ago"":7,""prior_mab_weeks_ago"":3,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":true,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",false,"Ineligible: Toxicities not resolved to Grade 1, prior mAb only 3 weeks ago (requires 4 weeks), and prior IDO1 inhibitor."
NCT03361228,P005,"{""age"":52,""gender"":""M"",""diagnosis"":""advanced SCCHN"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":2,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":6,""prior_targeted_therapy_weeks_ago"":8,""prior_mab_weeks_ago"":9,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",false,"Ineligible: ECOG PS 2 (maximum allowed is 1)."
NCT03361228,P006,"{""age"":61,""gender"":""F"",""diagnosis"":""metastatic urothelial carcinoma"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":4,""prior_targeted_therapy_weeks_ago"":5,""prior_mab_weeks_ago"":7,""prior_investigational_drug_weeks_ago"":1,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":true,""rheumatoid_arthritis_treatment"":true,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":1}",false,"Ineligible: Active autoimmune disease requiring systemic treatment in past 2 years and investigational drug only 1 week ago."
NCT03361228,P007,"{""age"":59,""gender"":""M"",""diagnosis"":""advanced SCLC"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":0,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":5,""prior_targeted_therapy_weeks_ago"":6,""prior_mab_weeks_ago"":8,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":true,""serotonin_syndrome_history"":true,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",false,"Ineligible: Received live vaccine within 30 days and history of serotonin syndrome."
NCT03361228,P008,"{""age"":64,""gender"":""F"",""diagnosis"":""metastatic gastric cancer"",""phase_eligible"":""phase_1"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":4,""prior_targeted_therapy_weeks_ago"":5,""prior_mab_weeks_ago"":9,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":true,""gi_absorption_issue"":true,""crohns_disease"":true,""adequate_organ_function"":true,""neuropathy_grade"":0}",false,"Ineligible: Urea cycle defect and gastrointestinal condition (Crohn's disease) that may affect drug absorption."
NCT03361228,P009,"{""age"":56,""gender"":""M"",""diagnosis"":""metastatic CRC"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":3,""prior_targeted_therapy_weeks_ago"":4,""prior_mab_weeks_ago"":6,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":false,""elevated_ast_alt"":true,""neuropathy_grade"":2}",true,"Eligible: Phase 2 CRC with Grade 2 neuropathy allowed per protocol, all other criteria met including adequate organ function."
NCT03361228,P010,"{""age"":48,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""phase_eligible"":""phase_1"",""measurable_lesion"":true,""ecog_ps"":0,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":5,""prior_targeted_therapy_weeks_ago"":6,""prior_mab_weeks_ago"":10,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",true,"Eligible: Phase 1 solid tumor (breast cancer) with all criteria met - adequate washouts, resolved toxicities, good PS."
NCT02281214,P001,"{""age"":58,""gender"":""F"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":8,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",true,"Eligible: Metastatic lung adenocarcinoma with EGFR mutation, no prior therapy, no brain mets, life expectancy >3 months, can consent."
NCT02281214,P002,"{""age"":65,""gender"":""M"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":6,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",true,"Eligible: Treatment-naive metastatic EGFR+ adenocarcinoma, meets all simple inclusion/exclusion criteria."
NCT02281214,P003,"{""age"":62,""gender"":""F"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":false,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":7,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",false,"Ineligible: No EGFR mutation (required for adenocarcinoma patients in first-line TKI therapy)."
NCT02281214,P004,"{""age"":71,""gender"":""M"",""diagnosis"":""metastatic lung squamous cell carcinoma"",""histology"":""squamous"",""egfr_mutation"":false,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":5,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",false,"Ineligible: Squamous histology (only adenocarcinoma specified for EGFR mutation testing and TKI therapy)."
NCT02281214,P005,"{""age"":54,""gender"":""F"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":true,""prior_systemic_therapy"":false,""life_expectancy_months"":9,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",false,"Ineligible: Brain metastases present (explicit exclusion criterion)."
NCT02281214,P006,"{""age"":59,""gender"":""M"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":true,""prior_chemo"":true,""life_expectancy_months"":7,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",false,"Ineligible: Prior systemic therapy received (study is for first-line therapy only)."
NCT02281214,P007,"{""age"":47,""gender"":""F"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":2,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",false,"Ineligible: Life expectancy ≤3 months (explicit exclusion criterion)."
NCT02281214,P008,"{""age"":63,""gender"":""M"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":8,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":true,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":false}",false,"Ineligible: Psychiatric disorders preventing capacity to provide informed consent."
NCT02281214,P009,"{""age"":56,""gender"":""F"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":6,""pregnant"":true,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",false,"Ineligible: Currently pregnant (exclusion criterion)."
NCT02281214,P010,"{""age"":68,""gender"":""M"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":7,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":true,""health_insurance"":true,""consent_capacity"":false}",false,"Ineligible: Under legal guardianship (explicit exclusion criterion)."
NCT05538130,P001,"{""age"":45,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""substudy"":""B"",""braf_mutation"":""V600E"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""largest_brain_met_cm"":2.5,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",true,"Eligible: Substudy B melanoma with BRAF V600E mutation, measurable disease, prior progression, brain mets <4cm, no RVO/CK issues."
NCT05538130,P002,"{""age"":52,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""substudy"":""C"",""braf_mutation"":""Class II non-V600"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",true,"Eligible: Substudy C solid tumor with BRAF Class II alteration, measurable disease, progressed after SOC, no exclusions."
NCT05538130,P003,"{""age"":38,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""substudy"":""B"",""braf_mutation"":""Class III"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""largest_brain_met_cm"":4.5,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",false,"Ineligible: Brain metastasis 4.5cm > 4cm maximum allowed size."
NCT05538130,P004,"{""age"":61,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""substudy"":""C"",""braf_mutation"":""Class II non-V600"",""measurable_disease"":true,""prior_treatment_progression"":false,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",false,"Ineligible: No progression on prior standard therapy (required for all substudies)."
NCT05538130,P005,"{""age"":47,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""substudy"":""B"",""braf_mutation"":""wild-type"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",false,"Ineligible: No BRAF mutation (Substudy B requires BRAF V600 or Class II/III alteration)."
NCT05538130,P006,"{""age"":55,""gender"":""M"",""diagnosis"":""metastatic thyroid cancer"",""substudy"":""C"",""braf_mutation"":""V600E"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":true,""elevated_ck_neuromuscular"":false}",false,"Ineligible: History of retinal vein occlusion (exclusion criterion)."
NCT05538130,P007,"{""age"":42,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""substudy"":""B"",""braf_mutation"":""V600K"",""measurable_disease"":false,""prior_treatment_progression"":true,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":true}",false,"Ineligible: No measurable disease by RECIST 1.1 and neuromuscular disorder with elevated CK."
NCT05538130,P008,"{""age"":59,""gender"":""M"",""diagnosis"":""metastatic pancreatic cancer"",""substudy"":""C"",""braf_mutation"":""Class III non-V600"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",true,"Eligible: Substudy C solid tumor with appropriate BRAF Class III alteration, measurable disease, prior progression."
NCT05538130,P009,"{""age"":50,""gender"":""F"",""diagnosis"":""glioblastoma"",""substudy"":""monotherapy_1a"",""braf_mutation"":""unknown"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""largest_brain_met_cm"":3.0,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",true,"Eligible: Phase 1a monotherapy for primary brain tumor, progressed after prior therapy, brain lesion <4cm."
NCT05538130,P010,"{""age"":63,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""substudy"":""B"",""braf_mutation"":""Class II"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""largest_brain_met_cm"":2.0,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",true,"Eligible: Substudy B melanoma with BRAF Class II mutation, all criteria met including appropriate brain met size."
NCT00967577,P001,"{""age"":62,""gender"":""F"",""diagnosis"":""metastatic renal cell carcinoma"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":6,""radiation_weeks_ago"":8,""investigational_weeks_ago"":7,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":185000,""anc"":2500,""hgb_g_dl"":11.2,""coagulation_normal"":true,""serum_creat_xuln"":1.8,""ast_xuln"":2.1,""bilirubin_xuln"":1.2,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":6,""urgent_treatment_needed"":false}",true,"Eligible: Metastatic RCC with progression, adequate washouts, tissue for PSMA, meets all hematologic/organ function criteria, no exclusions."
NCT00967577,P002,"{""age"":55,""gender"":""M"",""diagnosis"":""recurrent head and neck cancer"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":5,""radiation_weeks_ago"":9,""investigational_weeks_ago"":0,""tissue_available_psma"":true,""bisphosphonate_therapy"":true,""bisphosphonate_stable_4wk"":true,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":165000,""anc"":2200,""hgb_g_dl"":10.5,""coagulation_normal"":true,""serum_creat_xuln"":1.5,""ast_xuln"":1.8,""bilirubin_xuln"":1.1,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":5,""urgent_treatment_needed"":false}",true,"Eligible: Recurrent head/neck cancer with progression, stable bisphosphonates, all labs within range, meets all criteria."
NCT00967577,P003,"{""age"":48,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":2,""radiation_weeks_ago"":10,""investigational_weeks_ago"":8,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":195000,""anc"":2800,""hgb_g_dl"":11.8,""coagulation_normal"":true,""serum_creat_xuln"":1.2,""ast_xuln"":1.5,""bilirubin_xuln"":0.9,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":7,""urgent_treatment_needed"":false}",false,"Ineligible: Chemotherapy only 2 weeks ago (requires 4-week washout)."
NCT00967577,P004,"{""age"":67,""gender"":""M"",""diagnosis"":""advanced pancreatic cancer"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":7,""radiation_weeks_ago"":5,""investigational_weeks_ago"":9,""tissue_available_psma"":false,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":175000,""anc"":2400,""hgb_g_dl"":10.8,""coagulation_normal"":true,""serum_creat_xuln"":1.6,""ast_xuln"":2.0,""bilirubin_xuln"":1.3,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":4,""urgent_treatment_needed"":false}",false,"Ineligible: No archived or current tissue available for PSMA determination (required)."
NCT00967577,P005,"{""age"":59,""gender"":""F"",""diagnosis"":""metastatic ovarian cancer"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":8,""radiation_weeks_ago"":12,""investigational_weeks_ago"":10,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":true,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":145000,""anc"":1900,""hgb_g_dl"":9.8,""coagulation_normal"":true,""serum_creat_xuln"":1.4,""ast_xuln"":1.9,""bilirubin_xuln"":1.0,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":5,""urgent_treatment_needed"":false}",false,"Ineligible: Platelet transfusions within 4 weeks and platelet count 145,000 < 150,000 minimum."
NCT00967577,P006,"{""age"":71,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":9,""radiation_weeks_ago"":15,""investigational_weeks_ago"":11,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":true,""skeletal_radiation_25pct"":true,""prior_radiopharmaceuticals"":true,""platelet_count"":160000,""anc"":1800,""hgb_g_dl"":10.2,""coagulation_normal"":true,""serum_creat_xuln"":2.2,""ast_xuln"":2.8,""bilirubin_xuln"":1.7,""active_infection"":true,""cardiac_issues"":true,""ecog_ps"":3,""dvt_pe_1month"":true,""serious_comorbidities"":true,""hiv_history"":true,""leukemia_mds"":false,""gadolinium_allergy"":true,""life_expectancy_months"":2,""urgent_treatment_needed"":true}",false,"Ineligible: Multiple exclusions - growth factors within 4wk, >25% skeletal radiation, prior radiopharmaceuticals, elevated creatinine/AST/bilirubin, active infection, cardiac issues, ECOG 3, recent DVT/PE, HIV, gadolinium allergy, short life expectancy, urgent treatment needed."
NCT00967577,P007,"{""age"":53,""gender"":""F"",""diagnosis"":""metastatic colorectal cancer"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":6,""radiation_weeks_ago"":8,""investigational_weeks_ago"":12,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":125000,""anc"":1500,""hgb_g_dl"":8.9,""coagulation_normal"":false,""serum_creat_xuln"":1.3,""ast_xuln"":1.7,""bilirubin_xuln"":1.1,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":true,""gadolinium_allergy"":false,""life_expectancy_months"":6,""urgent_treatment_needed"":false}",false,"Ineligible: Low platelets/ANC/HGB, abnormal coagulation, and history of myelodysplastic syndrome."
NCT00967577,P008,"{""age"":64,""gender"":""M"",""diagnosis"":""prostate cancer"",""prostate_cancer"":true,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":10,""radiation_weeks_ago"":14,""investigational_weeks_ago"":15,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":180000,""anc"":2600,""hgb_g_dl"":11.5,""coagulation_normal"":true,""serum_creat_xuln"":1.5,""ast_xuln"":1.6,""bilirubin_xuln"":1.0,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":7,""urgent_treatment_needed"":false}",false,"Ineligible: Prostate cancer explicitly excluded from study (except prostate cancer)."
NCT00967577,P009,"{""age"":57,""gender"":""F"",""diagnosis"":""metastatic esophageal cancer"",""prostate_cancer"":false,""progressive_disease"":false,""prior_therapy_recovery"":true,""chemo_weeks_ago"":7,""radiation_weeks_ago"":11,""investigational_weeks_ago"":13,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":170000,""anc"":2300,""hgb_g_dl"":10.8,""coagulation_normal"":true,""serum_creat_xuln"":1.4,""ast_xuln"":1.8,""bilirubin_xuln"":1.2,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":5,""urgent_treatment_needed"":false}",false,"Ineligible: No progressive disease documented (required per inclusion criteria)."
NCT00967577,P010,"{""age"":60,""gender"":""M"",""diagnosis"":""metastatic renal cell carcinoma"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":8,""radiation_weeks_ago"":16,""investigational_weeks_ago"":14,""tissue_available_psma"":true,""bisphosphonate_therapy"":true,""bisphosphonate_stable_4wk"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":190000,""anc"":2700,""hgb_g_dl"":11.3,""coagulation_normal"":true,""serum_creat_xuln"":1.3,""ast_xuln"":1.9,""bilirubin_xuln"":1.1,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":6,""urgent_treatment_needed"":false}",false,"Ineligible: Bisphosphonate therapy started <4 weeks ago (requires stable dose >4 weeks prior)."
NCT02200081,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":true,""brain_mets_irradiated"":true,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.2,""ldh_xuln"":1.3,""ap_xuln"":1.1,""ggt_xuln"":1.4,""albumin_normal"":true,""creatinine_xuln"":1.3,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.1,""alt_xuln"":1.9,""liver_metastases"":false,""anc_x10e9"":2.1,""platelets_x10e9"":125,""leukocytes_x10e9"":4.2,""lymphocytes_x10e9"":1.3,""hgb_g_dl"":10.5,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",true,"Eligible: ED-SCLC with PR after 4 platinum cycles, treated brain mets, all organ function and hematologic parameters within limits."
NCT02200081,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""CR"",""confirmed_response_4_cycles"":""CR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":0,""bilirubin_xuln"":0.9,""ldh_xuln"":1.1,""ap_xuln"":1.0,""ggt_xuln"":1.2,""albumin_normal"":true,""creatinine_xuln"":1.1,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":1.8,""alt_xuln"":1.6,""liver_metastases"":true,""ast_alt_liver_mets"":4.2,""anc_x10e9"":1.8,""platelets_x10e9"":110,""leukocytes_x10e9"":3.5,""lymphocytes_x10e9"":1.1,""hgb_g_dl"":9.5,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",true,"Eligible: ED-SCLC with CR after 4 cycles, liver mets with appropriate AST/ALT limits, all criteria met."
NCT02200081,P003,"{""age"":62,""gender"":""M"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":3,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.1,""ldh_xuln"":1.2,""ap_xuln"":1.0,""ggt_xuln"":1.3,""albumin_normal"":true,""creatinine_xuln"":1.2,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.0,""alt_xuln"":1.8,""liver_metastases"":false,""anc_x10e9"":2.0,""platelets_x10e9"":120,""leukocytes_x10e9"":4.0,""lymphocytes_x10e9"":1.2,""hgb_g_dl"":10.2,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",false,"Ineligible: Only 3 cycles of platinum-based therapy completed (requires exactly 4 cycles)."
NCT02200081,P004,"{""age"":59,""gender"":""F"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":1,""prior_chemo_before_platinum"":true,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.0,""ldh_xuln"":1.1,""ap_xuln"":0.9,""ggt_xuln"":1.2,""albumin_normal"":true,""creatinine_xuln"":1.1,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":1.7,""alt_xuln"":1.5,""liver_metastases"":false,""anc_x10e9"":1.9,""platelets_x10e9"":115,""leukocytes_x10e9"":3.8,""lymphocytes_x10e9"":1.1,""hgb_g_dl"":9.8,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",false,"Ineligible: Prior chemotherapy before platinum-based regimen (requires no other prior chemotherapy)."
NCT02200081,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""SD"",""confirmed_response_4_cycles"":""SD"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.2,""ldh_xuln"":1.3,""ap_xuln"":1.1,""ggt_xuln"":1.4,""albumin_normal"":true,""creatinine_xuln"":1.3,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.2,""alt_xuln"":2.0,""liver_metastases"":false,""anc_x10e9"":2.1,""platelets_x10e9"":125,""leukocytes_x10e9"":4.1,""lymphocytes_x10e9"":1.3,""hgb_g_dl"":10.4,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",false,"Ineligible: Only stable disease after 4 cycles (requires confirmed PR or CR)."
NCT02200081,P006,"{""age"":54,""gender"":""F"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":true,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":true,""ecog_ps"":1,""bilirubin_xuln"":1.1,""ldh_xuln"":1.2,""ap_xuln"":1.0,""ggt_xuln"":1.3,""albumin_normal"":true,""creatinine_xuln"":1.2,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.1,""alt_xuln"":1.9,""liver_metastases"":false,""anc_x10e9"":2.0,""platelets_x10e9"":120,""leukocytes_x10e9"":4.0,""lymphocytes_x10e9"":1.2,""hgb_g_dl"":10.1,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",false,"Ineligible: Brain metastases not irradiated and requiring continuous steroids/anticonvulsants."
NCT02200081,P007,"{""age"":61,""gender"":""M"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":2,""bilirubin_xuln"":1.3,""ldh_xuln"":1.4,""ap_xuln"":1.2,""ggt_xuln"":1.5,""albumin_normal"":true,""creatinine_xuln"":1.4,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.3,""alt_xuln"":2.1,""liver_metastases"":false,""anc_x10e9"":1.4,""platelets_x10e9"":95,""leukocytes_x10e9"":2.8,""lymphocytes_x10e9"":0.8,""hgb_g_dl"":8.9,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",false,"Ineligible: ECOG PS 2 (max allowed 1), low ANC/platelets/leukocytes/lymphocytes/HGB, multiple lab parameters out of range."
NCT02200081,P008,"{""age"":56,""gender"":""F"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":false,""mixed_histology"":true,""sclc_percentage"":75,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.0,""ldh_xuln"":1.1,""ap_xuln"":0.9,""ggt_xuln"":1.2,""albumin_normal"":true,""creatinine_xuln"":1.1,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":1.8,""alt_xuln"":1.6,""liver_metastases"":false,""anc_x10e9"":1.9,""platelets_x10e9"":115,""leukocytes_x10e9"":3.9,""lymphocytes_x10e9"":1.1,""hgb_g_dl"":9.9,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",false,"Ineligible: Mixed histology with only 75% SCLC (requires at least 80% SCLC component)."
NCT02200081,P009,"{""age"":63,""gender"":""M"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.7,""ldh_xuln"":1.8,""ap_xuln"":1.6,""ggt_xuln"":1.9,""albumin_normal"":true,""creatinine_xuln"":1.6,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.6,""alt_xuln"":2.4,""liver_metastases"":false,""anc_x10e9"":2.2,""platelets_x10e9"":130,""leukocytes_x10e9"":4.3,""lymphocytes_x10e9"":1.4,""hgb_g_dl"":10.6,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",false,"Ineligible: Elevated bilirubin/LDH/AP/GGT/creatinine >1.5x ULN and AST/ALT >2.5x ULN without liver metastases."
NCT02200081,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":true,""brain_mets_irradiated"":true,""steroids_anticonvulsants"":false,""ecog_ps"":0,""bilirubin_xuln"":1.1,""ldh_xuln"":1.2,""ap_xuln"":1.0,""ggt_xuln"":1.3,""albumin_normal"":true,""creatinine_xuln"":1.2,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.0,""alt_xuln"":1.8,""liver_metastases"":false,""anc_x10e9"":1.7,""platelets_x10e9"":105,""leukocytes_x10e9"":3.2,""lymphocytes_x10e9"":1.0,""hgb_g_dl"":9.2,""contraception_used"":false,""pregnant"":true,""consent_capacity"":true}",false,"Ineligible: Currently pregnant and not using contraception (exclusion criteria)."
NCT00570401,P001,"{""age"":62,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":8,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":80,""wbc"":4500,""hgb_g_dl"":10.2,""platelets"":150000,""bilirubin_mg_dl"":1.2,""ast_xuln"":2.1,""alt_xuln"":1.8,""creatinine_mg_dl"":1.4,""crcl_ml_min"":65,""qtc_ms"":420,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":5,""prior_rt_weeks_ago"":6,""concurrent_meds_disallowed"":false}",true,"Eligible: Advanced EGFR+ adenocarcinoma with acquired resistance to erlotinib, prior response, adequate organ function, no cardiac issues, meets all criteria."
NCT00570401,P002,"{""age"":58,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""gefitinib"",""tki_duration_months"":7,""prior_response"":""CR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":true,""corticosteroids_escalating"":false,""karnofsky_ps"":90,""wbc"":3800,""hgb_g_dl"":9.5,""platelets"":120000,""bilirubin_mg_dl"":1.8,""ast_xuln"":2.3,""alt_xuln"":2.1,""creatinine_mg_dl"":1.6,""crcl_ml_min"":60,""qtc_ms"":430,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":6,""prior_rt_weeks_ago"":7,""concurrent_meds_disallowed"":false}",true,"Eligible: EGFR+ adenocarcinoma with gefitinib resistance, asymptomatic brain mets, all labs within range including adequate renal function."
NCT00570401,P003,"{""age"":67,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":false,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":9,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":85,""wbc"":4200,""hgb_g_dl"":10.8,""platelets"":140000,""bilirubin_mg_dl"":1.5,""ast_xuln"":2.2,""alt_xuln"":2.0,""creatinine_mg_dl"":1.3,""crcl_ml_min"":70,""qtc_ms"":440,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":8,""prior_rt_weeks_ago"":9,""concurrent_meds_disallowed"":false}",false,"Ineligible: No documented EGFR mutation (required for inclusion)."
NCT00570401,P004,"{""age"":54,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":4,""prior_response"":""SD"",""acquired_resistance"":false,""progressive_disease"":false,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":80,""wbc"":4000,""hgb_g_dl"":10.5,""platelets"":130000,""bilirubin_mg_dl"":1.4,""ast_xuln"":2.1,""alt_xuln"":1.9,""creatinine_mg_dl"":1.5,""crcl_ml_min"":65,""qtc_ms"":425,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":7,""prior_rt_weeks_ago"":8,""concurrent_meds_disallowed"":false}",false,"Ineligible: EGFR TKI duration only 4 months (requires ≥6 months) and no acquired resistance demonstrated."
NCT00570401,P005,"{""age"":61,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""gefitinib"",""tki_duration_months"":8,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":false,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":true,""corticosteroids_escalating"":true,""karnofsky_ps"":70,""wbc"":3500,""hgb_g_dl"":9.2,""platelets"":110000,""bilirubin_mg_dl"":2.2,""ast_xuln"":2.8,""alt_xuln"":2.6,""creatinine_mg_dl"":1.8,""crcl_ml_min"":50,""qtc_ms"":460,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":9,""prior_rt_weeks_ago"":10,""concurrent_meds_disallowed"":false}",false,"Ineligible: No prior biopsy of progressive disease, symptomatic brain mets requiring escalating steroids, elevated bilirubin, low CrCl, prolonged QTc."
NCT00570401,P006,"{""age"":59,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":7,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":true,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":85,""wbc"":4100,""hgb_g_dl"":10.6,""platelets"":135000,""bilirubin_mg_dl"":1.6,""ast_xuln"":2.2,""alt_xuln"":2.0,""creatinine_mg_dl"":1.4,""crcl_ml_min"":68,""qtc_ms"":435,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":4,""prior_rt_weeks_ago"":11,""concurrent_meds_disallowed"":false}",false,"Ineligible: Measurable lesions previously irradiated and chemotherapy only 4 weeks ago (requires 3-week washout)."
NCT00570401,P007,"{""age"":65,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""gefitinib"",""tki_duration_months"":8,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":65,""wbc"":2800,""hgb_g_dl"":8.8,""platelets"":95000,""bilirubin_mg_dl"":1.9,""ast_xuln"":2.7,""alt_xuln"":2.5,""creatinine_mg_dl"":2.2,""crcl_ml_min"":48,""qtc_ms"":470,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":true,""ventricular_arrhythmia"":true,""heart_failure"":true,""recent_mi"":true,""unstable_angina"":true,""active_infection"":true,""uncontrolled_htn"":true,""prior_chemo_weeks_ago"":10,""prior_rt_weeks_ago"":12,""concurrent_meds_disallowed"":true}",false,"Ineligible: Multiple exclusions - low KPS, hematologic parameters out of range, elevated creatinine, prolonged QTc, cardiac history, active infection, uncontrolled HTN, taking amiodarone."
NCT00570401,P008,"{""age"":57,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":6,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":80,""wbc"":3600,""hgb_g_dl"":9.8,""platelets"":105000,""bilirubin_mg_dl"":1.7,""ast_xuln"":2.4,""alt_xuln"":2.2,""creatinine_mg_dl"":1.7,""crcl_ml_min"":58,""qtc_ms"":445,""oral_meds_ability"":false,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":8,""prior_rt_weeks_ago"":13,""concurrent_meds_disallowed"":false}",false,"Ineligible: Unable to take oral medications (required for dasatinib administration)."
NCT00570401,P009,"{""age"":63,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""gefitinib"",""tki_duration_months"":7,""prior_response"":""CR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":90,""wbc"":3900,""hgb_g_dl"":10.1,""platelets"":115000,""bilirubin_mg_dl"":1.3,""ast_xuln"":2.0,""alt_xuln"":1.8,""creatinine_mg_dl"":1.5,""crcl_ml_min"":62,""qtc_ms"":425,""oral_meds_ability"":true,""pregnant"":true,""contraception_used"":false,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":9,""prior_rt_weeks_ago"":14,""concurrent_meds_disallowed"":false}",false,"Ineligible: Currently pregnant (exclusion criterion)."
NCT00570401,P010,"{""age"":60,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":8,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":85,""wbc"":3700,""hgb_g_dl"":10.3,""platelets"":125000,""bilirubin_mg_dl"":1.4,""ast_xuln"":2.1,""alt_xuln"":1.9,""creatinine_mg_dl"":1.6,""crcl_ml_min"":60,""qtc_ms"":440,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":7,""prior_rt_weeks_ago"":15,""concurrent_meds_disallowed"":false}",true,"Eligible: EGFR+ adenocarcinoma with erlotinib resistance, meets all criteria including adequate washout periods and normal QTc."
NCT00496860,P001,"{""age"":52,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":6,""prior_chemo_weeks_ago"":7,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":10,""life_expectancy_months"":6,""ecog_ps"":1,""anc"":1800,""platelets"":125000,""hgb_g_dl"":10.5,""serum_creat_xuln"":1.2,""bilirubin_xuln"":1.1,""ast_xuln"":2.1,""alk_phos_xuln"":2.2,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":85,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",true,"Eligible: HLA-A2.1/p53+ metastatic cancer, adequate washouts, normal organ function, no cardiac/pulmonary issues, meets all criteria."
NCT00496860,P002,"{""age"":48,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":8,""prior_chemo_weeks_ago"":9,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":12,""life_expectancy_months"":7,""ecog_ps"":0,""anc"":2200,""platelets"":150000,""hgb_g_dl"":11.2,""serum_creat_xuln"":1.0,""bilirubin_xuln"":0.9,""ast_xuln"":1.8,""alk_phos_xuln"":1.9,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":false,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":90,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",true,"Eligible: Ideal candidate - HLA-A2.1/p53+, excellent PS, all labs normal, no risk factors requiring stress test/PFT."
NCT00496860,P003,"{""age"":61,""gender"":""M"",""diagnosis"":""metastatic pancreatic cancer"",""hla_a2_1_p53_positive"":false,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":7,""prior_chemo_weeks_ago"":8,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":11,""life_expectancy_months"":5,""ecog_ps"":1,""anc"":1900,""platelets"":130000,""hgb_g_dl"":10.8,""serum_creat_xuln"":1.3,""bilirubin_xuln"":1.2,""ast_xuln"":2.2,""alk_phos_xuln"":2.3,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":88,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",false,"Ineligible: HLA-A2.1/p53 negative (required biomarker)."
NCT00496860,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""metastatic ovarian cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":true,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":9,""prior_chemo_weeks_ago"":10,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":13,""life_expectancy_months"":6,""ecog_ps"":1,""anc"":2000,""platelets"":140000,""hgb_g_dl"":10.9,""serum_creat_xuln"":1.1,""bilirubin_xuln"":1.0,""ast_xuln"":2.0,""alk_phos_xuln"":2.1,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":86,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",false,"Ineligible: Prior Proleukin therapy within one year (exclusion)."
NCT00496860,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":true,""prior_rt_weeks_ago"":2,""prior_chemo_weeks_ago"":3,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":15,""life_expectancy_months"":4,""ecog_ps"":1,""anc"":1700,""platelets"":120000,""hgb_g_dl"":10.3,""serum_creat_xuln"":1.4,""bilirubin_xuln"":1.3,""ast_xuln"":2.3,""alk_phos_xuln"":2.4,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":87,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",false,"Ineligible: Concurrent radiotherapy and chemotherapy only 2-3 weeks ago (requires 4-week washout)."
NCT00496860,P006,"{""age"":58,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":10,""prior_chemo_weeks_ago"":11,""prior_nitrosoureas_weeks_ago"":5,""prior_mab_weeks_ago"":16,""life_expectancy_months"":5,""ecog_ps"":1,""anc"":1600,""platelets"":115000,""hgb_g_dl"":10.1,""serum_creat_xuln"":1.5,""bilirubin_xuln"":1.6,""ast_xuln"":2.6,""alk_phos_xuln"":2.7,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":89,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",false,"Ineligible: Nitrosoureas only 5 weeks ago (requires 6-week washout) and elevated bilirubin/alk phos."
NCT00496860,P007,"{""age"":63,""gender"":""M"",""diagnosis"":""metastatic gastric cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":12,""prior_chemo_weeks_ago"":13,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":17,""life_expectancy_months"":6,""ecog_ps"":2,""anc"":1400,""platelets"":95000,""hgb_g_dl"":9.8,""serum_creat_xuln"":1.7,""bilirubin_xuln"":1.8,""ast_xuln"":2.8,""alk_phos_xuln"":2.9,""pt_inr_normal"":false,""aptt_normal"":false,""antihypertensives_taperable"":false,""nyha_class"":3,""heart_failure_6mo"":true,""unstable_angina_6mo"":true,""mi_6mo"":true,""ventricular_arrhythmia_history"":true,""cardiac_stress_test_normal"":false,""pulmonary_symptoms"":true,""smoking_history"":true,""fev1_predicted"":70,""autoimmune_disease"":true,""hiv_positive"":true,""psychiatric_issues"":true,""cns_disease"":true,""active_infection"":true,""systemic_steroids"":true,""organ_allograft"":true,""investigational_agents"":true,""asthma_meds"":true,""pregnant"":false,""contraception_used"":true}",false,"Ineligible: Multiple exclusions - ECOG PS 2, low blood counts, elevated LFTs/creatinine, abnormal coagulation, cardiac issues, abnormal PFT, autoimmune disease, HIV, CNS disease, active infection, steroids, organ transplant, investigational drugs."
NCT00496860,P008,"{""age"":59,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":11,""prior_chemo_weeks_ago"":12,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":18,""life_expectancy_months"":7,""ecog_ps"":1,""anc"":2100,""platelets"":145000,""hgb_g_dl"":11.1,""serum_creat_xuln"":1.2,""bilirubin_xuln"":1.1,""ast_xuln"":2.1,""alk_phos_xuln"":2.2,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":true,""fev1_predicted"":80,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":true,""contraception_used"":false}",false,"Ineligible: Currently pregnant (exclusion criterion)."
NCT00496860,P009,"{""age"":72,""gender"":""M"",""diagnosis"":""metastatic prostate cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":13,""prior_chemo_weeks_ago"":14,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":19,""life_expectancy_months"":4,""ecog_ps"":1,""anc"":1900,""platelets"":135000,""hgb_g_dl"":10.7,""serum_creat_xuln"":1.3,""bilirubin_xuln"":1.2,""ast_xuln"":2.2,""alk_phos_xuln"":2.3,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":false,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":85,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",false,"Ineligible: Age >50 requires normal cardiac stress test (not performed)."
NCT00496860,P010,"{""age"":56,""gender"":""F"",""diagnosis"":""metastatic renal cell carcinoma"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":14,""prior_chemo_weeks_ago"":15,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":20,""life_expectancy_months"":8,""ecog_ps"":1,""anc"":2300,""platelets"":155000,""hgb_g_dl"":11.5,""serum_creat_xuln"":1.1,""bilirubin_xuln"":1.0,""ast_xuln"":1.9,""alk_phos_xuln"":2.0,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":92,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",true,"Eligible: HLA-A2.1/p53+ metastatic RCC, all washouts adequate, normal organ function and stress test, meets all criteria."
NCT06400472,P001,"{""age"":58,""gender"":""F"",""diagnosis"":""epithelial ovarian cancer"",""phase"":""dose_escalation"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":430,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",true,"Eligible: Ovarian cancer for dose escalation phase, no CNS mets, no significant comorbidities, QTcF within limits."
NCT06400472,P002,"{""age"":62,""gender"":""F"",""diagnosis"":""endometrial cancer"",""phase"":""dose_optimization"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":445,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",true,"Eligible: Endometrial cancer for dose optimization phase, meets all exclusion criteria, no significant health issues."
NCT06400472,P003,"{""age"":45,""gender"":""F"",""diagnosis"":""low grade serous ovarian cancer"",""phase"":""dose_expansion"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":420,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",true,"Eligible: Low grade serous ovarian cancer for dose expansion phase, clean exclusion profile."
NCT06400472,P004,"{""age"":54,""gender"":""M"",""diagnosis"":""non-small cell lung cancer"",""phase"":""dose_escalation"",""cns_metastases"":true,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":435,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",false,"Ineligible: Known CNS metastases (exclusion criterion)."
NCT06400472,P005,"{""age"":49,""gender"":""F"",""diagnosis"":""triple negative breast cancer"",""phase"":""dose_expansion"",""cns_metastases"":false,""carcinomatous_meningitis"":true,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":440,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",false,"Ineligible: History of carcinomatous meningitis (exclusion criterion)."
NCT06400472,P006,"{""age"":67,""gender"":""F"",""diagnosis"":""cervical cancer"",""phase"":""dose_expansion"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":true,""systemic_fungal_infection"":true,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":450,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",false,"Ineligible: Active uncontrolled systemic infection (exclusion criterion)."
NCT06400472,P007,"{""age"":61,""gender"":""M"",""diagnosis"":""colorectal cancer"",""phase"":""dose_escalation"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":true,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":425,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",false,"Ineligible: Evidence of corneal keratopathy (exclusion criterion)."
NCT06400472,P008,"{""age"":59,""gender"":""F"",""diagnosis"":""pancreatic cancer"",""phase"":""dose_escalation"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":true,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":460,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",false,"Ineligible: History of corneal transplant (exclusion criterion)."
NCT06400472,P009,"{""age"":55,""gender"":""F"",""diagnosis"":""endometrial cancer"",""phase"":""dose_optimization"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":true,""grade2_neuropathy"":true,""cardiovascular_disease"":true,""congestive_heart_failure"":true,""qtcf_ms"":480,""pneumonitis_history"":true,""interstitial_lung_disease"":true,""pregnant"":false,""breastfeeding"":false}",false,"Ineligible: Multiple exclusions - unresolved toxicities, cardiovascular disease, prolonged QTcF, history of pneumonitis/ILD."
NCT06400472,P010,"{""age"":42,""gender"":""F"",""diagnosis"":""cervical cancer"",""phase"":""dose_expansion"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":440,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":true,""breastfeeding"":false}",false,"Ineligible: Currently pregnant (exclusion criterion)."
NCT07106528,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":true,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":6,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",true,"Eligible: ES-SCLC with progression during first-line platinum therapy, tissue available for organoids, stable brain mets, adequate organ function."
NCT07106528,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""within_6_months"",""tumor_tissue_available"":false,""malignant_effusion_available"":true,""pleural_effusion_sufficient"":true,""measurable_lesions"":true,""ecog_ps"":0,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":8,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",true,"Eligible: ES-SCLC with progression within 6 months, malignant effusion available for organoids, excellent PS, all criteria met."
NCT07106528,P003,"{""age"":62,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""after_6_months"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":7,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",false,"Ineligible: Progression >6 months after first-line therapy completion (must be during or within 6 months)."
NCT07106528,P004,"{""age"":59,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":false,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":5,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",false,"Ineligible: No tumor tissue or malignant effusion available for organoid culture (required)."
NCT07106528,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":2,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":4,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",false,"Ineligible: ECOG PS 2 (maximum allowed is 1)."
NCT07106528,P006,"{""age"":54,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":true,""cns_symptoms"":true,""cns_stable"":false,""meningeal_metastases"":true,""life_expectancy_months"":5,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",false,"Ineligible: Symptomatic/progressive brain metastases and meningeal metastases (exclusion criteria)."
NCT07106528,P007,"{""age"":61,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":2,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":true,""prior_topotecan"":true,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",false,"Ineligible: Prior second-line therapy received and life expectancy <3 months."
NCT07106528,P008,"{""age"":56,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":false,""low_platelets"":true,""elevated_creatinine"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":6,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":true,""active_breast_cancer"":true,""active_infection"":true,""severe_organ_dysfunction"":true,""follow_up_ability"":false,""consent_capacity"":true}",false,"Ineligible: Multiple exclusions - inadequate organ function, other active malignancy within 5 years, active infection, severe organ dysfunction, unable to complete follow-up."
NCT07106528,P009,"{""age"":63,""gender"":""M"",""diagnosis"":""mixed small cell and non-small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":7,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":true,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",false,"Ineligible: Mixed tumor pathology (exclusion criterion)."
NCT07106528,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""within_6_months"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":0,""adequate_organ_function"":true,""brain_metastases"":true,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":9,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",true,"Eligible: ES-SCLC with progression within 6 months, tissue available, stable asymptomatic brain mets, excellent candidate."
NCT00009971,P011,"{""age"":65,""gender"":""M"",""diagnosis"":""Recurrent extensive stage SCLC"",""prior_chemo_regimens"":1,""measurable_disease_mm"":35,""wbc_count"":4500,""platelet_count"":120000,""bilirubin_mg_dl"":0.8,""sgot_xuln"":1.1,""creatinine_mg_dl"":1.0,""creatinine_clearance_ml_min"":90,""mi_past_6mo"":false,""retinal_disease"":false,""other_malignancy_past_5y"":false,""anticonvulsants"":false,""stable_brain_mets"":true,""prior_systemic_retinoid_weeks"":5,""contraception_used"":false,""pregnant"":false,""performance_status_zubrod"":1}",true,"Eligible: Recurrent SCLC (extensive stage) after 1 prior regimen, measurable disease (>20mm), WBC/Platelets/Liver/Renal labs OK, no heart disease/retinal disease/recent cancer, prior chemo washout >3wks, stable treated brain mets allowed, no disallowed concurrent meds."
NCT00009971,P012,"{""age"":48,""gender"":""F"",""diagnosis"":""Recurrent limited stage SCLC"",""prior_chemo_regimens"":2,""measurable_disease_mm"":22,""wbc_count"":5200,""platelet_count"":150000,""bilirubin_mg_dl"":1.2,""sgot_xuln"":1.5,""creatinine_mg_dl"":1.2,""creatinine_clearance_ml_min"":85,""mi_past_6mo"":false,""retinal_disease"":false,""other_malignancy_past_5y"":true,""nonmelanoma_skin_cancer"":true,""anticonvulsants"":false,""stable_brain_mets"":false,""prior_systemic_retinoid_weeks"":3,""contraception_used"":true,""pregnant"":false,""performance_status_zubrod"":0}",true,"Eligible: Recurrent SCLC (limited stage) after 2 prior regimens, measurable disease (>20mm), all labs OK, only prior nonmelanoma skin cancer allowed, prior systemic retinoid washout is exactly 3 weeks, uses contraception, good performance status."
NCT00009971,P013,"{""age"":72,""gender"":""M"",""diagnosis"":""Recurrent extensive stage SCLC"",""prior_chemo_regimens"":1,""measurable_disease_mm"":15,""wbc_count"":3100,""platelet_count"":75000,""bilirubin_mg_dl"":1.0,""sgot_xuln"":1.9,""creatinine_mg_dl"":1.4,""creatinine_clearance_ml_min"":70,""mi_past_6mo"":false,""retinal_disease"":false,""other_malignancy_past_5y"":false,""anticonvulsants"":false,""stable_brain_mets"":false,""prior_systemic_retinoid_weeks"":6,""contraception_used"":false,""pregnant"":false,""performance_status_zubrod"":2}",true,"Eligible: Recurrent SCLC, measurable disease (15mm with spiral CT scan is sufficient), all labs are within required limits (WBC/Platelet/Bilirubin/SGOT/Creatinine), Karnofsky 70 (Zubrod 2) is OK, no exclusion criteria met."
NCT00009971,P014,"{""age"":55,""gender"":""F"",""diagnosis"":""Recurrent limited stage SCLC"",""prior_chemo_regimens"":2,""measurable_disease_mm"":40,""wbc_count"":6000,""platelet_count"":200000,""bilirubin_mg_dl"":0.5,""sgot_xuln"":0.8,""creatinine_mg_dl"":1.1,""creatinine_clearance_ml_min"":95,""mi_past_6mo"":false,""retinal_disease"":false,""other_malignancy_past_5y"":false,""anticonvulsants"":false,""stable_brain_mets"":true,""prior_systemic_retinoid_weeks"":4,""contraception_used"":true,""pregnant"":false,""performance_status_zubrod"":1}",true,"Eligible: Recurrent SCLC (limited stage), previously treated brain mets are stable, patient has 2 prior chemo regimens (max allowed), all organ function tests (Hematopoietic, Hepatic, Renal) are excellent, uses contraception."
NCT00009971,P015,"{""age"":38,""gender"":""M"",""diagnosis"":""Recurrent extensive stage SCLC"",""prior_chemo_regimens"":1,""measurable_disease_mm"":25,""wbc_count"":3500,""platelet_count"":90000,""bilirubin_mg_dl"":1.4,""sgot_xuln"":1.8,""creatinine_mg_dl"":1.3,""creatinine_clearance_ml_min"":80,""mi_past_6mo"":false,""retinal_disease"":false,""other_malignancy_past_5y"":false,""anticonvulsants"":false,""stable_brain_mets"":false,""prior_systemic_retinoid_weeks"":7,""contraception_used"":false,""pregnant"":false,""performance_status_zubrod"":0}",true,"Eligible: Recurrent SCLC after platinum-containing chemo, measurable disease, no prior systemic retinoids in the last 3 weeks, all lab values meet minimum requirements, no serious concurrent illness or exclusionary history."
NCT03836352,P011,"{""age"":58,""gender"":""F"",""cancer_type"":""Epithelial ovarian cancer"",""prior_therapy_type"":""first line chemotherapy"",""time_since_last_chemo_days"":35,""time_since_last_radiation_weeks"":5,""disease_status"":""progression"",""measurable_disease_recist11"":true,""single_ovca_lesion_cm"":3.5,""ecog_performance_status"":0,""life_expectancy_months"":12,""prior_anti_pd1_toxicity_grade"":null,""egfr_alk_status_nsclc"":null,""prior_survivin_vaccine"":false,""concurrent_malignancy"":false,""managed_ascites"":false,""bowel_obstruction_hx"":false,""autoimmune_treatment_past_2y"":false,""thyroiditis_hx"":false,""pneumonitis_hx"":false,""cns_mets"":false,""immunosuppressive_meds"":false,""hypersensitivity_pembro_grade"":0}",true,"Eligible: Ovarian cancer progressed after first line therapy, chemo washout >28 days, measurable disease, ECOG 0, life expectancy >6mo, no prior anti-PD-1 toxicity, no CNS mets, no recent autoimmune/pneumonitis/MI/CVA history, no OvCa lesion >5cm."
NCT03836352,P012,"{""age"":68,""gender"":""M"",""cancer_type"":""Hepatocellular carcinoma"",""prior_therapy_type"":""first line targeted therapy"",""time_since_last_chemo_days"":50,""time_since_last_radiation_weeks"":3,""disease_status"":""progression"",""measurable_disease_recist11"":true,""single_ovca_lesion_cm"":null,""ecog_performance_status"":1,""life_expectancy_months"":8,""prior_anti_pd1_toxicity_grade"":null,""egfr_alk_status_nsclc"":null,""prior_survivin_vaccine"":false,""concurrent_malignancy"":true,""malignancy_type"":""controlled bladder cancer"",""managed_ascites"":false,""bowel_obstruction_hx"":false,""autoimmune_treatment_past_2y"":false,""thyroiditis_hx"":false,""pneumonitis_hx"":false,""cns_mets"":false,""immunosuppressive_meds"":false,""hypersensitivity_pembro_grade"":0}",true,"Eligible: HCC progressed after first line therapy, meets washout for chemo/radiation, ECOG 1, acceptable concurrent malignancy (controlled bladder cancer), no history of high-grade anti-PD-1 toxicity or other exclusions."
NCT03836352,P013,"{""age"":42,""gender"":""F"",""cancer_type"":""Non-small cell lung cancer"",""prior_therapy_type"":""first line immunotherapy (non-PD1/L1)"" ,""time_since_last_chemo_days"":45,""time_since_last_radiation_weeks"":8,""disease_status"":""progression"",""measurable_disease_recist11"":true,""single_ovca_lesion_cm"":null,""ecog_performance_status"":1,""life_expectancy_months"":10,""prior_anti_pd1_toxicity_grade"":null,""egfr_alk_status_nsclc"":""wild type"",""prior_survivin_vaccine"":false,""concurrent_malignancy"":false,""managed_ascites"":false,""bowel_obstruction_hx"":false,""autoimmune_treatment_past_2y"":false,""thyroiditis_hx"":false,""pneumonitis_hx"":false,""cns_mets"":false,""immunosuppressive_meds"":false,""hypersensitivity_pembro_grade"":0}",true,"Eligible: NSCLC (wild type/no EGFR/ALK), progressed after first line, no prior anti-PD-1/L1/L2, adequate washouts for chemo and radiation, ECOG 1, no excluded history (autoimmune, pneumonitis, transplant, etc.)."
NCT03836352,P014,"{""age"":75,""gender"":""M"",""cancer_type"":""Microsatellite instability high colon cancer"",""prior_therapy_type"":""first line chemotherapy"",""time_since_last_chemo_days"":60,""time_since_last_radiation_weeks"":4,""disease_status"":""progression"",""measurable_disease_recist11"":true,""single_ovca_lesion_cm"":null,""ecog_performance_status"":0,""life_expectancy_months"":9,""prior_anti_pd1_toxicity_grade"":null,""egfr_alk_status_nsclc"":null,""prior_survivin_vaccine"":false,""concurrent_malignancy"":true,""malignancy_type"":""non-melanoma skin cancer"",""managed_ascites"":false,""bowel_obstruction_hx"":false,""autoimmune_treatment_past_2y"":true,""replacement_therapy"":true,""thyroiditis_hx"":false,""pneumonitis_hx"":false,""cns_mets"":false,""immunosuppressive_meds"":false,""hypersensitivity_pembro_grade"":0}",true,"Eligible: MSI-H solid tumor progressed after first line, meets all washouts, ECOG 0, NMSC allowed, history of autoimmune disease only on replacement therapy (allowed), no CNS mets or other exclusions."
NCT03836352,P015,"{""age"":62,""gender"":""F"",""cancer_type"":""Urothelial cancer"",""prior_therapy_type"":""first line chemo-immunotherapy"",""time_since_last_chemo_days"":28,""time_since_last_radiation_weeks"":2,""disease_status"":""progression"",""measurable_disease_recist11"":true,""single_ovca_lesion_cm"":null,""ecog_performance_status"":1,""life_expectancy_months"":7,""prior_anti_pd1_toxicity_grade"":2,""egfr_alk_status_nsclc"":null,""prior_survivin_vaccine"":false,""concurrent_malignancy"":false,""managed_ascites"":false,""bowel_obstruction_hx"":false,""autoimmune_treatment_past_2y"":false,""thyroiditis_hx"":false,""pneumonitis_hx"":false,""cns_mets"":false,""immunosuppressive_meds"":false,""hypersensitivity_pembro_grade"":0}",true,"Eligible: Urothelial cancer progressed after first line, washout times met (28 days for chemo/immuno, 2 weeks for rad), prior anti-PD-1 toxicity was Grade 2 (only G3+ is excluded), no GI issues, no CNS mets, no edema > grade 2."
NCT04421352,P011,"{""age"":68,""gender"":""M"",""sclc_stage"":""ES-SCLC (Extensive Stage)"",""prior_chemo"":""platinum dual-drug"",""tumor_progression_site"":""liver"",""extracranial_measurable_lesion"":true,""prior_rad_to_target_lesion"":false,""brain_metastases_status"":""none"",""brain_mets_rad_washout_months"":null,""radiotherapy_contraindications"":false,""ecog_performance_status"":0,""life_expectancy_months"":6,""adequate_organ_function"":true,""autoimmune_disease_hx"":false,""prior_checkpoint_inhibitor"":false,""hiv_hcv_hbv_active"":false,""monoclonal_ab_hypersensitivity"":false,""rad_pneumonitis_grade"":0,""contraception_agreed"":false}",true,"Eligible: ES-SCLC progressed since 1st line platinum chemo, has an extracranial measurable lesion, ECOG 0, good life expectancy and organ function, no CNS mets, no history of autoimmune disease, prior immunotherapy, or high-grade radiation pneumonitis."
NCT04421352,P012,"{""age"":55,""gender"":""F"",""sclc_stage"":""LS-SCLC (Limited Stage)"",""prior_chemo"":""platinum dual-drug"",""tumor_progression_site"":""chest wall"",""extracranial_measurable_lesion"":true,""prior_rad_to_target_lesion"":true,""progression_after_rad"":true,""time_since_rad_to_lesion_months"":5,""brain_metastases_status"":""treated and stable"",""brain_mets_rad_washout_months"":4,""radiotherapy_contraindications"":false,""ecog_performance_status"":1,""life_expectancy_months"":4,""adequate_organ_function"":true,""autoimmune_disease_hx"":false,""prior_checkpoint_inhibitor"":false,""hiv_hcv_hbv_active"":false,""monoclonal_ab_hypersensitivity"":false,""rad_pneumonitis_grade"":1,""contraception_agreed"":true}",true,"Eligible: LS-SCLC progressed after 1st line and radical chest RT, measurable lesion that progressed after RT, RT washout for lesion (>3mo) and brain mets (>3mo) met, ECOG 1, no excluded infections/history, agrees to contraception."
NCT04421352,P013,"{""age"":72,""gender"":""M"",""sclc_stage"":""ES-SCLC"",""prior_chemo"":""carboplatin/etoposide"",""tumor_progression_site"":""adrenal gland"",""extracranial_measurable_lesion"":true,""prior_rad_to_target_lesion"":false,""brain_metastases_status"":""none"",""brain_mets_rad_washout_months"":null,""radiotherapy_contraindications"":false,""ecog_performance_status"":1,""life_expectancy_months"":5,""adequate_organ_function"":true,""autoimmune_disease_hx"":false,""prior_checkpoint_inhibitor"":false,""hiv_hcv_hbv_active"":false,""monoclonal_ab_hypersensitivity"":false,""rad_pneumonitis_grade"":2,""contraception_agreed"":false}",true,"Eligible: ES-SCLC relapsed after platinum dual-drug, has measurable disease, ECOG 1, life expectancy >3mo, history of radiation pneumonitis is Grade 2 (only G3+ excluded), no prior immunotherapy, no radiotherapy contraindications."
NCT04421352,P014,"{""age"":61,""gender"":""M"",""sclc_stage"":""LS-SCLC"",""prior_chemo"":""cisplatin/etoposide"",""tumor_progression_site"":""bone"",""extracranial_measurable_lesion"":true,""prior_rad_to_target_lesion"":false,""brain_metastases_status"":""none"",""brain_mets_rad_washout_months"":null,""radiotherapy_contraindications"":false,""ecog_performance_status"":0,""life_expectancy_months"":10,""adequate_organ_function"":true,""autoimmune_disease_hx"":false,""prior_checkpoint_inhibitor"":false,""hiv_hcv_hbv_active"":false,""monoclonal_ab_hypersensitivity"":false,""rad_pneumonitis_grade"":0,""contraception_agreed"":false}",true,"Eligible: LS-SCLC progressed since 1st line platinum chemo, measurable disease outside CNS, excellent ECOG and organ function, no exclusions met (no active/unstable CNS mets, no prior immunotherapy, no severe pneumonitis, no active infections)."
NCT04421352,P015,"{""age"":49,""gender"":""F"",""sclc_stage"":""ES-SCLC"",""prior_chemo"":""platinum dual-drug"",""tumor_progression_site"":""lymph node"",""extracranial_measurable_lesion"":true,""prior_rad_to_target_lesion"":false,""brain_metastases_status"":""treated and stable"",""brain_mets_rad_washout_months"":8,""radiotherapy_contraindications"":false,""ecog_performance_status"":1,""life_expectancy_months"":7,""adequate_organ_function"":true,""autoimmune_disease_hx"":false,""prior_checkpoint_inhibitor"":false,""hiv_hcv_hbv_active"":false,""monoclonal_ab_hypersensitivity"":false,""rad_pneumonitis_grade"":0,""contraception_agreed"":true}",true,"Eligible: ES-SCLC relapsed after 1st line, measurable lesion, treated/stable brain mets with RT washout >3mo, ECOG 1, no history of drug abuse/alcoholism, no uncontrolled asthma, agrees to use contraception."
NCT01774526,P011,"{""age"":55,""gender"":""F"",""ethnicity"":""Chinese"",""smoking_status"":""never-smoker"",""cancer_type"":""Lung adenocarcinoma"",""disease_stage"":""metastatic pleural effusion"",""ecog_performance_status"":1,""fit_for_pleuroscopy"":true,""agreeable_to_tx"":""chemo and EGFR-TKI"",""other_histology_subtype"":false}",true,"Eligible: Asian female never-smoker, age > 21, metastatic lung adenocarcinoma with pleural effusion, good ECOG 1, fit and agreeable to required procedures and treatments, and no exclusionary histological subtypes or stages."
NCT01774526,P012,"{""age"":62,""gender"":""M"",""ethnicity"":""Indian"",""smoking_status"":""never-smoker"",""cancer_type"":""Lung adenocarcinoma"",""disease_stage"":""metastatic pleural effusion"",""ecog_performance_status"":2,""fit_for_pleuroscopy"":true,""agreeable_to_tx"":""palliative chemotherapy only"",""other_histology_subtype"":false}",true,"Eligible: Asian male never-smoker, age > 21, confirmed lung adenocarcinoma with metastatic pleural effusion, ECOG 2, fit for pleuroscopy, and agreeable to palliative chemotherapy. All key inclusion criteria met."
NCT01774526,P013,"{""age"":78,""gender"":""F"",""ethnicity"":""Malay"",""smoking_status"":""never-smoker"",""cancer_type"":""Lung adenocarcinoma"",""disease_stage"":""metastatic pleural effusion"",""ecog_performance_status"":1,""fit_for_pleuroscopy"":true,""agreeable_to_tx"":""EGFR-TKI only"",""other_histology_subtype"":false}",true,"Eligible: Asian female never-smoker, >21 years old, metastatic adenocarcinoma, ECOG 1, willing and able to undergo biopsy, and agreeable to receiving EGFR-TKI. All required criteria for this molecular study are satisfied."
NCT01774526,P014,"{""age"":45,""gender"":""F"",""ethnicity"":""Filipino"",""smoking_status"":""never-smoker"",""cancer_type"":""Lung adenocarcinoma"",""disease_stage"":""metastatic pleural effusion"",""ecog_performance_status"":2,""fit_for_pleuroscopy"":true,""agreeable_to_tx"":""chemo and EGFR-TKI"",""other_histology_subtype"":false}",true,"Eligible: Asian female never-smoker, metastatic adenocarcinoma with pleural effusion, ECOG 2 (acceptable status), fit for all procedures, and agreeable to both potential treatment options (chemo and TKI). Patient meets all inclusion criteria."
NCT01774526,P015,"{""age"":39,""gender"":""M"",""ethnicity"":""Thai"",""smoking_status"":""never-smoker"",""cancer_type"":""Lung adenocarcinoma"",""disease_stage"":""metastatic pleural effusion"",""ecog_performance_status"":1,""fit_for_pleuroscopy"":true,""agreeable_to_tx"":""palliative chemotherapy only"",""other_histology_subtype"":false}",true,"Eligible: Asian male never-smoker, age > 21, metastatic adenocarcinoma (specific histology and stage required), good ECOG 1, willing to undergo pleuroscopy/biopsy, and suitable for palliative treatment. No exclusion criteria met."
NCT01780675,P011,"{""age"":62,""gender"":""M"",""sclc_stage"":""Stage III"",""disease_status_after_tx"":""complete response after chemo-radiotherapy"",""extracranial_progression"":false,""brain_mets_clinical_radiological"":false,""prior_brain_rt"":false,""dutch_proficiency"":true,""prior_malignancy_past_2y"":false,""washout_systemic_tx_weeks"":4,""pregnant_lactating"":false}",true,"Eligible: Stage III SCLC with complete response after chemo-RT, candidate for PCI (Prophylactic Cranial Irradiation), no evidence of brain mets or progressive extracranial disease, no prior brain RT, sufficient Dutch proficiency, and adequate systemic treatment washout (>3 weeks)."
NCT01780675,P012,"{""age"":55,""gender"":""F"",""sclc_stage"":""Stage IV"",""disease_status_after_tx"":""partial remission after chemotherapy"",""extracranial_progression"":false,""brain_mets_clinical_radiological"":false,""prior_brain_rt"":false,""dutch_proficiency"":true,""prior_malignancy_past_2y"":false,""washout_systemic_tx_weeks"":8,""pregnant_lactating"":false}",true,"Eligible: Stage IV SCLC in remission after chemotherapy, no clinical or radiological brain metastases, no progressive extracranial disease, no prior brain RT, meets language requirement, and adequate washout from systemic treatment."
NCT01780675,P013,"{""age"":71,""gender"":""M"",""sclc_stage"":""Stage II"",""disease_status_after_tx"":""near complete response after chemo-radiotherapy"",""extracranial_progression"":false,""brain_mets_clinical_radiological"":false,""prior_brain_rt"":false,""dutch_proficiency"":true,""prior_malignancy_past_2y"":true,""malignancy_type"":""basal cell carcinoma (treated)"" ,""washout_systemic_tx_weeks"":3.5,""pregnant_lactating"":false}",true,"Eligible: Stage II SCLC with remission post-chemo-RT, no evidence of brain mets or progression, prior malignancy was a treated basal cell carcinoma (allowed exclusion), washout >3 weeks, and proficient in Dutch. Candidate for PCI."
NCT01780675,P014,"{""age"":48,""gender"":""F"",""sclc_stage"":""Stage IV"",""disease_status_after_tx"":""complete remission after chemotherapy"",""extracranial_progression"":false,""brain_mets_clinical_radiological"":false,""prior_brain_rt"":false,""dutch_proficiency"":true,""prior_malignancy_past_2y"":false,""washout_systemic_tx_weeks"":5,""pregnant_lactating"":false}",true,"Eligible: Stage IV SCLC in complete remission after chemo, no brain mets, no active extracranial disease, no prior brain RT, and meets all other non-disease specific requirements like language, washout, and concurrent malignancy history."
NCT01780675,P015,"{""age"":68,""gender"":""M"",""sclc_stage"":""Stage I"",""disease_status_after_tx"":""complete response after chemo-radiotherapy"",""extracranial_progression"":false,""brain_mets_clinical_radiological"":false,""prior_brain_rt"":false,""dutch_proficiency"":true,""prior_malignancy_past_2y"":false,""washout_systemic_tx_weeks"":10,""pregnant_lactating"":false}",true,"Eligible: Stage I SCLC in CR after chemo-RT, no progression/brain mets, no prior brain RT, long systemic treatment washout, and sufficient Dutch proficiency, making him an ideal PCI candidate."
NCT03231111,P011,"{""age"":55,""gender"":""F"",""lung_cancer_stage"":""Stage IV"",""target_drug_treatment_status"":""first time treatment with Iressa"",""home_computer_equipment"":true,""chinese_proficiency_speak_write_read"":true,""cognitive_impairment"":false,""treatment_location"":""Taipei Medical Center (Medical Department)""}",true,"Eligible: Female patient >20 with Stage IV lung cancer, starting Iressa (first time targeted therapy), has home computer equipment, is proficient in Chinese (speak/write/read) with clear consciousness, and is treated at the specified Taipei location."
NCT03231111,P012,"{""age"":68,""gender"":""F"",""lung_cancer_stage"":""Stage III"",""target_drug_treatment_status"":""first time treatment with Tarceva"",""home_computer_equipment"":true,""chinese_proficiency_speak_write_read"":true,""cognitive_impairment"":false,""treatment_location"":""Taipei Medical Center (Surgical Clinic)""}",true,"Eligible: Female patient >20 with Stage III lung cancer, initiating Tarceva as first targeted therapy, possesses computer equipment, meets all Chinese language and cognitive requirements, and is receiving treatment at the Taipei Surgical Clinic."
NCT03231111,P013,"{""age"":42,""gender"":""F"",""lung_cancer_stage"":""Stage IV"",""target_drug_treatment_status"":""first time treatment with Iressa"",""home_computer_equipment"":true,""chinese_proficiency_speak_write_read"":true,""cognitive_impairment"":false,""treatment_location"":""Taipei Medical Center (Medical Department)""}",true,"Eligible: Female patient 42 (age >20), Stage IV lung cancer, is naive to targeted therapy (starting Iressa), has computer access, no cognitive impairment, and receives care at the required medical center in Taipei."
NCT03231111,P014,"{""age"":75,""gender"":""F"",""lung_cancer_stage"":""Stage III"",""target_drug_treatment_status"":""first time treatment with Tarceva"",""home_computer_equipment"":true,""chinese_proficiency_speak_write_read"":true,""cognitive_impairment"":false,""treatment_location"":""Taipei Medical Center (Medical Department)""}",true,"Eligible: Female patient >20, Stage III lung cancer, starting Tarceva for the first time, meets the requirement for home computer equipment, is proficient in Chinese, and is treated at the Taipei Medical Center as specified."
NCT03231111,P015,"{""age"":60,""gender"":""F"",""lung_cancer_stage"":""Stage IV"",""target_drug_treatment_status"":""first time treatment with Iressa"",""home_computer_equipment"":true,""chinese_proficiency_speak_write_read"":true,""cognitive_impairment"":false,""treatment_location"":""Taipei Medical Center (Surgical Clinic)""}",true,"Eligible: Female patient >20, Stage IV, initiating first targeted drug (Iressa), meets all technical (computer) and communication (Chinese/cognition) requirements, and is being treated at the eligible location in Taipei."
NCT00447421,P011,"{""age"":65,""gender"":""M"",""diagnosis"":""Small Cell Lung Cancer"",""measurable_disease"":true,""prior_chemotherapy"":false,""prior_thoracic_radiotherapy"":false,""ecog_performance_status"":0,""life_expectancy_weeks"":20,""adequate_pulmonary_function"":true,""adequate_organ_function"":true,""mi_past_6mo"":false,""serious_systemic_disorder"":false,""prior_lower_neck_abdo_rt"":false,""significant_weight_loss"":false,""concurrent_antitumor_therapy"":false}",true,"Eligible: Newly diagnosed SCLC with measurable disease, no prior chemo/thoracic RT, ECOG 0, life expectancy >12wks, no MI/serious disorders/prior non-thoracic RT to neck/abdomen, and no significant weight loss."
NCT00447421,P012,"{""age"":48,""gender"":""F"",""diagnosis"":""Small Cell Lung Cancer"",""measurable_disease"":true,""prior_chemotherapy"":false,""prior_thoracic_radiotherapy"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":15,""adequate_pulmonary_function"":true,""adequate_organ_function"":true,""mi_past_6mo"":false,""serious_systemic_disorder"":false,""prior_lower_neck_abdo_rt"":false,""significant_weight_loss"":false,""concurrent_antitumor_therapy"":false}",true,"Eligible: Chemo- and RT-naïve SCLC patient, ECOG 1, measurable disease confirmed, adequate pulmonary and organ function, and none of the exclusion criteria (MI, serious disorder, prior RT to specified areas, weight loss) are present."
NCT00447421,P013,"{""age"":72,""gender"":""M"",""diagnosis"":""Small Cell Lung Cancer"",""measurable_disease"":true,""prior_chemotherapy"":false,""prior_thoracic_radiotherapy"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":12,""adequate_pulmonary_function"":true,""adequate_organ_function"":true,""mi_past_6mo"":false,""serious_systemic_disorder"":false,""prior_lower_neck_abdo_rt"":false,""significant_weight_loss"":false,""concurrent_antitumor_therapy"":false}",true,"Eligible: New SCLC diagnosis, meets minimum age, life expectancy (12wks), and performance status (ECOG 1) requirements. No history of MI, no significant weight loss, and no prior exposure to chemotherapy or radiotherapy as excluded."
NCT00447421,P014,"{""age"":59,""gender"":""F"",""diagnosis"":""Small Cell Lung Cancer"",""measurable_disease"":true,""prior_chemotherapy"":false,""prior_thoracic_radiotherapy"":false,""ecog_performance_status"":0,""life_expectancy_weeks"":30,""adequate_pulmonary_function"":true,""adequate_organ_function"":true,""mi_past_6mo"":false,""serious_systemic_disorder"":false,""prior_lower_neck_abdo_rt"":false,""significant_weight_loss"":false,""concurrent_antitumor_therapy"":false}",true,"Eligible: SCLC, measurable disease, ECOG 0 (excellent PS), no prior treatment, good organ and pulmonary function. All exclusionary conditions (cardiac event, significant weight loss, prior RT to excluded areas) are absent."
NCT00447421,P015,"{""age"":35,""gender"":""M"",""diagnosis"":""Small Cell Lung Cancer"",""measurable_disease"":true,""prior_chemotherapy"":false,""prior_thoracic_radiotherapy"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":40,""adequate_pulmonary_function"":true,""adequate_organ_function"":true,""mi_past_6mo"":false,""serious_systemic_disorder"":false,""prior_lower_neck_abdo_rt"":false,""significant_weight_loss"":false,""concurrent_antitumor_therapy"":false}",true,"Eligible: Young SCLC patient, treatment-naïve, measurable disease, ECOG 1, robust life expectancy. No serious systemic disorder and no concurrent antitumor therapy planned, meeting all inclusion and exclusion criteria."
NCT00084487,P011,"{""age"":65,""gender"":""M"",""sclc_stage"":""Limited Stage"",""measurable_lesion_mm"":30,""prior_chemo_regimens"":1,""relapse_type"":""sensitive"",""anc_count"":2000,""platelet_count"":150000,""hemoglobin_g_dl"":11.0,""ast_alt_xuln"":1.5,""bilirubin_mg_dl"":1.0,""creatinine_mg_dl"":1.2,""creatinine_clearance_ml_min"":80,""nyha_class"":2,""unstable_angina"":false,""cardiac_arrhythmia"":false,""active_infection"":false,""compliant"":true,""brain_mets"":false,""pregnant"":false,""contraception_used"":false,""performance_status_ecog"":1}",true,"Eligible: Limited SCLC relapsed after 1 prior regimen, measurable disease, all required labs (ANC, Plt, Hgb, LFTs, Renal) are adequate, NYHA Class II heart disease is allowed, no active brain mets or other major exclusions met."
NCT00084487,P012,"{""age"":58,""gender"":""F"",""sclc_stage"":""Extensive Stage"",""measurable_lesion_mm"":12,""prior_chemo_regimens"":1,""relapse_type"":""sensitive"",""anc_count"":1800,""platelet_count"":120000,""hemoglobin_g_dl"":9.5,""ast_alt_xuln"":4.0,""liver_involvement"":true,""bilirubin_mg_dl"":1.2,""creatinine_mg_dl"":1.5,""creatinine_clearance_ml_min"":65,""nyha_class"":1,""unstable_angina"":false,""cardiac_arrhythmia"":false,""active_infection"":false,""compliant"":true,""brain_mets"":true,""brain_mets_stable"":true,""brain_mets_no_steroids"":true,""brain_mets_no_rt"":true,""pregnant"":false,""contraception_used"":true,""performance_status_ecog"":2}",true,"Eligible: Extensive SCLC, sensitive relapse after 1 prior chemo, measurable lesion (12mm by CT), LFTs up to 5xULN allowed due to liver mets, stable brain mets without RT/steroids allowed, ECOG 2, uses contraception, and meets all organ function cutoffs."
NCT00084487,P013,"{""age"":71,""gender"":""M"",""sclc_stage"":""Extensive Stage"",""measurable_lesion_mm"":25,""prior_chemo_regimens"":1,""relapse_type"":""sensitive"",""anc_count"":3000,""platelet_count"":200000,""hemoglobin_g_dl"":12.5,""ast_alt_xuln"":2.0,""bilirubin_mg_dl"":0.8,""creatinine_mg_dl"":1.8,""creatinine_clearance_ml_min"":75,""nyha_class"":1,""unstable_angina"":false,""cardiac_arrhythmia"":false,""active_infection"":false,""compliant"":true,""brain_mets"":false,""pregnant"":false,""contraception_used"":false,""performance_status_ecog"":0}",true,"Eligible: Extensive SCLC, sensitive relapse, excellent organ function labs, ECOG 0 (Karnofsky 100%), no brain mets, no heart disease/infection/compliance issues, prior radiotherapy is allowed."
NCT00084487,P014,"{""age"":45,""gender"":""F"",""sclc_stage"":""Limited Stage"",""measurable_lesion_mm"":20,""prior_chemo_regimens"":1,""relapse_type"":""sensitive"",""anc_count"":2500,""platelet_count"":105000,""hemoglobin_g_dl"":10.0,""ast_alt_xuln"":2.4,""bilirubin_mg_dl"":1.5,""creatinine_mg_dl"":1.9,""creatinine_clearance_ml_min"":60,""nyha_class"":2,""unstable_angina"":false,""cardiac_arrhythmia"":false,""active_infection"":false,""compliant"":true,""brain_mets"":false,""pregnant"":false,""contraception_used"":true,""performance_status_ecog"":1}",true,"Eligible: Limited SCLC, sensitive relapse after 1 prior chemo, meets minimum measurable lesion size, all lab values are within the acceptable limits (Creatinine <2.0, CrCl ≥60, Bilirubin ≤1.5), NYHA II, and uses contraception."
NCT00084487,P015,"{""age"":78,""gender"":""M"",""sclc_stage"":""Extensive Stage"",""measurable_lesion_mm"":15,""prior_chemo_regimens"":1,""relapse_type"":""sensitive"",""anc_count"":1500,""platelet_count"":100000,""hemoglobin_g_dl"":9.0,""ast_alt_xuln"":1.0,""bilirubin_mg_dl"":0.5,""creatinine_mg_dl"":1.0,""creatinine_clearance_ml_min"":90,""nyha_class"":1,""unstable_angina"":false,""cardiac_arrhythmia"":false,""active_infection"":false,""compliant"":true,""brain_mets"":true,""brain_mets_stable"":true,""brain_mets_no_steroids"":true,""brain_mets_no_rt"":true,""pregnant"":false,""contraception_used"":false,""performance_status_ecog"":2}",true,"Eligible: Extensive SCLC, sensitive relapse after 1st line, measurable lesion (CT), treated and stable brain mets allowed if no steroids/RT, all hematologic and organ function labs meet minimum required thresholds (e.g., ANC ≥1500, Plt ≥100k, Hgb ≥9.0). Performance status ECOG 2 is acceptable."
NCT05958199,P011,"{""age"":60,""gender"":""F"",""cancer_type"":""NSCLC, EGFR mutant"",""disease_status"":""recurrent, refractory to SOC"",""ecog_performance_status"":0,""unresolved_toxicity_grade"":1,""chronic_neuropathy_months"":3,""bone_marrow_function"":""normal"",""kidney_function"":""normal"",""liver_function"":""normal"",""brain_mets_status"":""none"",""autoimmune_disease_steroids"":""none"",""history_grade3_pneumonitis_colitis"":false,""contraception_willing"":true}",true,"Eligible: Recurrent NSCLC (EGFR mutant) refractory to SOC, ECOG 0, normal organ function, no unresolved Grade ≥2 non-exempt toxicity, no brain mets, no history of severe immune-related toxicity, and uses contraception."
NCT05958199,P012,"{""age"":52,""gender"":""M"",""cancer_type"":""Renal Cell Carcinoma"",""disease_status"":""metastatic, refractory to SOC"",""ecog_performance_status"":1,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""alopecia"",""chronic_neuropathy_months"":10,""bone_marrow_function"":""normal"",""kidney_function"":""normal"",""liver_function"":""normal"",""brain_mets_status"":""treated and stable"",""autoimmune_disease_steroids"":""prednisone 5mg daily"",""history_grade3_pneumonitis_colitis"":false,""contraception_willing"":false}",true,"Eligible: Metastatic RCC refractory to SOC, ECOG 1, acceptable Grade 2 unresolved toxicity (alopecia is exempt), chronic neuropathy >6 months is exempt, clinically stable brain mets allowed, steroid dose for AI disease is ≤10mg prednisone daily (allowed)."
NCT05958199,P013,"{""age"":71,""gender"":""F"",""cancer_type"":""Colorectal Carcinoma"",""disease_status"":""recurrent, refractory to SOC"",""ecog_performance_status"":1,""unresolved_toxicity_grade"":1,""chronic_neuropathy_months"":8,""bone_marrow_function"":""normal"",""kidney_function"":""normal"",""liver_function"":""normal"",""brain_mets_status"":""none"",""autoimmune_disease_steroids"":""none"",""history_grade3_pneumonitis_colitis"":false,""contraception_willing"":true}",true,"Eligible: CRC refractory to SOC, ECOG 1, no high-grade unresolved toxicity (chronic neuropathy is exempt), normal organ function, no known brain metastases, and no history of severe immune-related pneumonitis/colitis."
NCT05958199,P014,"{""age"":45,""gender"":""M"",""cancer_type"":""Triple Negative Breast Carcinoma"",""disease_status"":""metastatic, refractory to SOC"",""ecog_performance_status"":0,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""skin pigmentation changes"",""chronic_neuropathy_months"":2,""bone_marrow_function"":""normal"",""kidney_function"":""normal"",""liver_function"":""normal"",""brain_mets_status"":""treated and stable"",""autoimmune_disease_steroids"":""none"",""history_grade3_pneumonitis_colitis"":false,""contraception_willing"":false}",true,"Eligible: Metastatic TNBC refractory to SOC, ECOG 0, unresolved Grade 2 skin pigmentation changes are exempt from exclusion, clinically stable brain mets allowed, normal organ function, and no history of exclusionary autoimmune disease or immune-related toxicity."
NCT05958199,P015,"{""age"":67,""gender"":""M"",""cancer_type"":""Urothelial Carcinoma"",""disease_status"":""recurrent, refractory to SOC"",""ecog_performance_status"":1,""unresolved_toxicity_grade"":1,""chronic_neuropathy_months"":18,""bone_marrow_function"":""normal"",""kidney_function"":""normal"",""liver_function"":""normal"",""brain_mets_status"":""none"",""autoimmune_disease_steroids"":""none"",""history_grade3_pneumonitis_colitis"":false,""contraception_willing"":false}",true,"Eligible: Recurrent UCC refractory to SOC, ECOG 1, chronic neuropathy is well over 6 months (exempt), no brain metastases, meets normal organ function requirements, and has no other high-risk exclusionary conditions."
NCT02015416,P011,"{""age"":55,""gender"":""F"",""cancer_type"":""Ovarian Cancer"",""nyeso1_expression"":true,""disease_burden"":""minimal"",""prior_therapies_count"":1,""prior_therapy_outcome"":""relapsed"",""prior_investigational_washout_weeks"":4,""prior_chemo_washout_weeks"":5,""ecog_performance_status"":0,""life_expectancy_months"":12,""cardiac_status"":""normal ecg"",""prior_nyeso1_vaccine"":false,""immunosuppression"":false,""autoimmune_disease"":false,""recent_infection"":false,""inadequate_labs"":false,""other_cancer_past_3y"":false,""unstable_brain_mets"":false,""pregnant"":false}",true,"Eligible: NY-ESO-1 positive Ovarian Cancer, unresectable/relapsed with minimal burden, 1 prior systemic therapy (meets minimum for OvCa/Melanoma/RCC), excellent performance status, adequate washouts, no cardiac/autoimmune/infection/lab exclusions."
NCT02015416,P012,"{""age"":68,""gender"":""M"",""cancer_type"":""Melanoma"",""nyeso1_expression"":true,""disease_burden"":""low"",""prior_therapies_count"":1,""prior_therapy_outcome"":""inadequate response"",""prior_investigational_washout_weeks"":5,""prior_chemo_washout_weeks"":4,""ecog_performance_status"":1,""life_expectancy_months"":8,""cardiac_status"":""normal ecg, no mi past 6mo"",""prior_nyeso1_vaccine"":false,""immunosuppression"":false,""autoimmune_disease"":false,""recent_infection"":false,""inadequate_labs"":false,""other_cancer_past_3y"":false,""unstable_brain_mets"":false,""pregnant"":false}",true,"Eligible: NY-ESO-1 positive Melanoma, unresectable with low burden, 1 prior therapy with inadequate response, ECOG 1, meets minimum cardiac requirements (no recent MI or HF III/IV), no prior NY-ESO-1 therapy, and no history of uveal melanoma."
NCT02015416,P013,"{""age"":72,""gender"":""F"",""cancer_type"":""Non-Small Cell Lung Cancer"",""nyeso1_expression"":true,""disease_burden"":""low"",""prior_therapies_count"":2,""prior_therapy_outcome"":""unacceptable toxicity"",""prior_investigational_washout_weeks"":3.5,""prior_chemo_washout_weeks"":3,""ecog_performance_status"":1,""life_expectancy_months"":6,""cardiac_status"":""normal ecg"",""prior_nyeso1_vaccine"":false,""immunosuppression"":false,""autoimmune_disease"":false,""recent_infection"":false,""inadequate_labs"":false,""other_cancer_past_3y"":false,""unstable_brain_mets"":false,""pregnant"":false}",true,"Eligible: NY-ESO-1 positive NSCLC, unresectable, minimal disease, required 2+ prior therapies met (minimum for NSCLC/Breast), chemo and investigational washout of ≥3 weeks met, ECOG 1, and no unstable brain metastases."
NCT02015416,P014,"{""age"":45,""gender"":""M"",""cancer_type"":""Sarcoma"",""nyeso1_expression"":true,""disease_burden"":""minimal"",""prior_therapies_count"":1,""prior_therapy_outcome"":""unacceptable toxicity"",""prior_investigational_washout_weeks"":6,""prior_chemo_washout_weeks"":4,""ecog_performance_status"":0,""life_expectancy_months"":10,""cardiac_status"":""normal ecg"",""prior_nyeso1_vaccine"":false,""immunosuppression"":false,""autoimmune_disease"":false,""recent_infection"":false,""inadequate_labs"":false,""other_cancer_past_3y"":false,""unstable_brain_mets"":true,""brain_mets_stable"":true}",true,"Eligible: NY-ESO-1 positive Sarcoma, unresectable, 1 prior therapy, ECOG 0, stable brain metastases allowed, all washouts met, no history of other recent cancer, and no evidence of active infection or significant autoimmune disease."
NCT02015416,P015,"{""age"":61,""gender"":""M"",""cancer_type"":""Renal Cell Cancer"",""nyeso1_expression"":true,""disease_burden"":""low"",""prior_therapies_count"":1,""prior_therapy_outcome"":""relapsed"",""prior_investigational_washout_weeks"":8,""prior_chemo_washout_weeks"":12,""ecog_performance_status"":1,""life_expectancy_months"":15,""cardiac_status"":""normal ecg"",""prior_nyeso1_vaccine"":false,""immunosuppression"":false,""autoimmune_disease"":false,""recent_infection"":false,""inadequate_labs"":false,""other_cancer_past_3y"":false,""unstable_brain_mets"":false,""pregnant"":false}",true,"Eligible: NY-ESO-1 positive RCC, relapsed after 1 prior therapy, low disease burden, excellent washouts from prior treatment, ECOG 1, and meets all other laboratory, cardiac, and infectious disease exclusions."
NCT06607185,P011,"{""age"":60,""gender"":""M"",""tumor_type"":""NSCLC"",""kras_mutation"":""G12C"",""disease_status"":""metastatic"",""measurable_disease_recist11"":true,""ecog_performance_status"":0,""cns_disease_status"":""treated and asymptomatic"",""able_to_swallow_tablets"":true,""unresolved_toxicity_grade"":1,""cardiovascular_disease"":false,""active_hbv_hcv_hiv_untreated"":false,""other_active_malignancy"":false,""active_uncontrolled_infection"":false,""pneumonitis_history"":false,""pregnant_or_nursing"":false}",true,"Eligible: KRAS G12C mutant NSCLC, measurable disease, ECOG 0, stable treated CNS disease is allowed, unresolved toxicity is Grade 1 (acceptable), and no history of severe cardiac or pulmonary issues."
NCT06607185,P012,"{""age"":52,""gender"":""F"",""tumor_type"":""Colorectal Carcinoma"",""kras_mutation"":""G12D"",""disease_status"":""locally advanced, unresectable"",""measurable_disease_recist11"":true,""ecog_performance_status"":1,""cns_disease_status"":""none"",""able_to_swallow_tablets"":true,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""peripheral neuropathy"",""cardiovascular_disease"":false,""active_hbv_hcv_hiv_untreated"":false,""other_active_malignancy"":false,""active_uncontrolled_infection"":false,""pneumonitis_history"":false,""pregnant_or_nursing"":false}",true,"Eligible: KRAS G12D mutant CRC, ECOG 1, unresolved Grade 2 peripheral neuropathy is exempt from exclusion, no active CNS disease, no significant cardiovascular disease, and no exclusionary infection/malignancy history."
NCT06607185,P013,"{""age"":71,""gender"":""M"",""tumor_type"":""Pancreatic Cancer"",""kras_mutation"":""G12V"",""disease_status"":""metastatic"",""measurable_disease_recist11"":true,""ecog_performance_status"":0,""cns_disease_status"":""none"",""able_to_swallow_tablets"":true,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""controlled endocrinopathy (hypothyroidism)"" ,""cardiovascular_disease"":false,""active_hbv_hcv_hiv_untreated"":false,""other_active_malignancy"":true,""other_malignancy_remission_years"":3,""active_uncontrolled_infection"":false,""pneumonitis_history"":false,""pregnant_or_nursing"":false}",true,"Eligible: KRAS G12V mutant PDAC, ECOG 0, unresolved Grade 2 controlled endocrinopathy is exempt, history of other malignancy is $>2$ years in remission (allowed), and meets all other criteria, including being able to swallow tablets."
NCT06607185,P014,"{""age"":45,""gender"":""F"",""tumor_type"":""Gastric Carcinoma"",""kras_mutation"":""G13D"",""disease_status"":""unresectable"",""measurable_disease_recist11"":true,""ecog_performance_status"":1,""cns_disease_status"":""asymptomatic, untreated"",""able_to_swallow_tablets"":true,""unresolved_toxicity_grade"":1,""cardiovascular_disease"":false,""active_hbv_hcv_hiv_untreated"":false,""other_active_malignancy"":false,""active_uncontrolled_infection"":false,""pneumonitis_history"":false,""pregnant_or_nursing"":false}",true,"Eligible: KRAS G13D mutant Gastric Ca, ECOG 1, asymptomatic CNS disease is allowed, unresolved toxicity is $\le$ Grade 1, no active infections or history of pneumonitis, and can swallow the oral drug."
NCT06607185,P015,"{""age"":68,""gender"":""M"",""tumor_type"":""Cholangiocarcinoma"",""kras_mutation"":""G12S"",""disease_status"":""metastatic"",""measurable_disease_recist11"":true,""ecog_performance_status"":0,""cns_disease_status"":""none"",""able_to_swallow_tablets"":true,""unresolved_toxicity_grade"":1,""cardiovascular_disease"":true,""cardiac_history"":""stable atrial fibrillation (controlled)"" ,""active_hbv_hcv_hiv_untreated"":false,""other_active_malignancy"":false,""active_uncontrolled_infection"":false,""pneumonitis_history"":false,""pregnant_or_nursing"":false}",true,"Eligible: KRAS G12S mutant CCA, ECOG 0, stable controlled arrhythmia is not an exclusion, no unresolved toxicity $>$ Grade 1, no active CNS mets or history of pneumonitis requiring steroids."
NCT06725225,P011,"{""age"":55,""gender"":""F"",""lung_cancer_histology"":""NSCLC Adenocarcinoma"",""current_therapy"":""Pembrolizumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""mental_illness"":false,""other_severe_disease"":false,""comorbidities"":""mild, controlled hypertension"",""consent_signed_by"":""patient"",""pregnant"":false}",true,"Eligible: Histologically confirmed NSCLC, age >18, currently on immunotherapy (Pembrolizumab), good verbal communication, no cognitive/mental illness, and comorbidity (hypertension) is not classified as severe disease."
NCT06725225,P012,"{""age"":72,""gender"":""M"",""lung_cancer_histology"":""Small Cell Lung Cancer"",""current_therapy"":""Durvalumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""mental_illness"":false,""other_severe_disease"":false,""comorbidities"":""Type 2 Diabetes (controlled)"" ,""consent_signed_by"":""patient"",""pregnant"":false}",true,"Eligible: SCLC, currently receiving Durvalumab (immunotherapy), good verbal ability, no cognitive impairment, and diabetes is well-controlled and not a severe disease, meeting all inclusion criteria."
NCT06725225,P013,"{""age"":65,""gender"":""F"",""lung_cancer_histology"":""NSCLC Squamous"",""current_therapy"":""Nivolumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""mental_illness"":false,""other_severe_disease"":false,""comorbidities"":""prior mastectomy (no evidence of recurrence)"" ,""consent_signed_by"":""family member"",""pregnant"":false}",true,"Eligible: Histologically confirmed NSCLC, currently on Nivolumab, good verbal communication, consent signed by a family member (allowed), and no cognitive impairment or other severe concurrent diseases."
NCT06725225,P014,"{""age"":48,""gender"":""M"",""lung_cancer_histology"":""Large Cell Lung Cancer"",""current_therapy"":""Atezolizumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""mental_illness"":false,""other_severe_disease"":false,""comorbidities"":""none"",""consent_signed_by"":""patient"",""pregnant"":false}",true,"Eligible: Lung cancer diagnosis, under immunotherapy (Atezolizumab), good verbal ability and no cognitive issues, excellent health status with no severe diseases, and consent signed by the patient."
NCT06725225,P015,"{""age"":61,""gender"":""F"",""lung_cancer_histology"":""Lung Carcinoid (Atypical)"" ,""current_therapy"":""Cemiplimab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""mental_illness"":false,""other_severe_disease"":false,""comorbidities"":""mild osteoarthritis"",""consent_signed_by"":""patient"",""pregnant"":false}",true,"Eligible: Confirmed lung cancer, currently receiving Cemiplimab, good verbal communication, no cognitive/mental illness, and mild osteoarthritis is not considered a severe disease, meeting all enrollment criteria."
NCT06079970,P011,"{""age"":65,""gender"":""M"",""lesion_suspicion"":""malignant peripheral pulmonary nodule"",""lesion_location"":""peripheral (beyond segmental bronchi)"",""bronchus_sign_or_rebus_signal"":true,""solid_part_size_mm"":12,""lesion_long_axis_ct_mm"":15,""consent_willingness"":true,""endobronchial_visible_malig"":false,""lesion_within_linear_ebus_reach"":false,""fluorescein_allergy"":false,""hemodynamic_stability"":true,""refractory_hypoxemia"":false,""anticoagulant_use"":false,""tolerates_general_anesthesia"":true,""current_chemotherapy_fluorescent"":false,""pregnant_or_nursing"":false}",true,"Eligible: Suspected peripheral lung lesion (12x15mm, solid part $\ge$10mm, beyond visible bronchi), bronchus sign positive, no endobronchial component, lesion too peripheral for linear EBUS, no contraindications (fluorescein allergy, instability, hypoxemia, anticoagulants, fluorescent chemo)."
NCT06079970,P012,"{""age"":48,""gender"":""F"",""lesion_suspicion"":""suspect malignant nodule"",""lesion_location"":""peripheral"",""bronchus_sign_or_rebus_signal"":true,""solid_part_size_mm"":25,""lesion_long_axis_ct_mm"":28,""consent_willingness"":true,""endobronchial_visible_malig"":false,""lesion_within_linear_ebus_reach"":false,""fluorescein_allergy"":false,""hemodynamic_stability"":true,""refractory_hypoxemia"":false,""anticoagulant_use"":false,""tolerates_general_anesthesia"":true,""current_chemotherapy_fluorescent"":false,""pregnant_or_nursing"":false}",true,"Eligible: Peripheral lung lesion 28mm (within $\le$30mm limit), solid part 25mm, indication for bronchoscopy, no visible endobronchial component, lesion out of linear EBUS reach, no fluorescein allergy, not on excluded chemotherapy, and able to tolerate anesthesia."
NCT06079970,P013,"{""age"":75,""gender"":""M"",""lesion_suspicion"":""indeterminate peripheral nodule"",""lesion_location"":""peripheral"",""bronchus_sign_or_rebus_signal"":false,""estimated_r_ebus_signal"":true,""solid_part_size_mm"":10,""lesion_long_axis_ct_mm"":11,""consent_willingness"":true,""endobronchial_visible_malig"":false,""lesion_within_linear_ebus_reach"":false,""fluorescein_allergy"":false,""hemodynamic_stability"":true,""refractory_hypoxemia"":false,""anticoagulant_use"":false,""tolerates_general_anesthesia"":true,""current_chemotherapy_fluorescent"":false,""pregnant_or_nursing"":false}",true,"Eligible: Peripheral lesion (10x11mm, minimal size), estimated r-EBUS signal meets navigation criterion, no endobronchial disease, lesion is not linear EBUS accessible, all vital signs and safety criteria (no anticoagulants, no severe hypoxemia) are met."
NCT06079970,P014,"{""age"":59,""gender"":""F"",""lesion_suspicion"":""malignant peripheral nodule"",""lesion_location"":""peripheral"",""bronchus_sign_or_rebus_signal"":true,""solid_part_size_mm"":18,""lesion_long_axis_ct_mm"":30,""consent_willingness"":true,""endobronchial_visible_malig"":false,""lesion_within_linear_ebus_reach"":false,""fluorescein_allergy"":false,""hemodynamic_stability"":true,""refractory_hypoxemia"":false,""anticoagulant_use"":true,""anticoagulant_can_be_withheld"":true,""tolerates_general_anesthesia"":true,""current_chemotherapy_fluorescent"":false,""pregnant_or_nursing"":false}",true,"Eligible: Peripheral lesion 30mm (max size allowed), solid part 18mm, appropriate lesion location and size, patient is on therapeutic anticoagulants but they can be withheld for the required interval (not excluded), and no fluorescent chemotherapy is ongoing."
NCT06079970,P015,"{""age"":62,""gender"":""M"",""lesion_suspicion"":""suspect malignant nodule"",""lesion_location"":""peripheral"",""bronchus_sign_or_rebus_signal"":true,""solid_part_size_mm"":20,""lesion_long_axis_ct_mm"":25,""consent_willingness"":true,""endobronchial_visible_malig"":false,""lesion_within_linear_ebus_reach"":false,""fluorescein_allergy"":false,""hemodynamic_stability"":true,""refractory_hypoxemia"":false,""anticoagulant_use"":false,""tolerates_general_anesthesia"":true,""current_chemotherapy_fluorescent"":true,""chemo_type"":""cisplatin (non-fluorescent)"" ,""pregnant_or_nursing"":false}",true,"Eligible: Peripheral lesion 25mm, solid part 20mm, undergoing non-fluorescent chemotherapy (e.g., cisplatin) which is allowed, meets age and consent criteria, lesion is inaccessible by linear EBUS, and all procedural safety exclusions are avoided."
NCT02117024,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""NSCLC Adenocarcinoma"",""prior_lines_of_therapy"":3,""suitability_for_chemo"":true,""disease_progression"":true,""ecog_performance_status"":1,""cns_mets_status"":""treated and stable"",""washout_systemic_tx_days"":15,""hiv_hcv_hbv_active"":false,""immunosuppressive_therapy"":false,""immunodeficiency"":false,""leptomeningeal_disease"":false,""other_active_malignancies"":false,""prior_cancer_vaccine"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Adenocarcinoma (NSCLC) with 3 prior lines (allowed max), disease progression, suitable for chemo, ECOG 1, treated/stable CNS mets allowed, meets 14-day washout, and no history of severe infections, immunodeficiency, or prior cancer vaccine."
NCT02117024,P012,"{""age"":58,""gender"":""F"",""cancer_type"":""NSCLC Adenocarcinoma"",""prior_lines_of_therapy"":2,""suitability_for_chemo"":true,""disease_progression"":true,""ecog_performance_status"":0,""cns_mets_status"":""none"",""washout_systemic_tx_days"":30,""hiv_hcv_hbv_active"":false,""immunosuppressive_therapy"":false,""immunodeficiency"":false,""leptomeningeal_disease"":false,""other_active_malignancies"":false,""prior_cancer_vaccine"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":true}",true,"Eligible: Adenocarcinoma with 2 prior lines (allowed range), good PS (ECOG 0), no CNS involvement, adequate washout, uses effective contraception, and no exclusionary systemic conditions (HIV, severe infection, immunosuppressive drugs)."
NCT02117024,P013,"{""age"":72,""gender"":""M"",""cancer_type"":""NSCLC Adenocarcinoma"",""prior_lines_of_therapy"":3,""suitability_for_chemo"":true,""disease_progression"":true,""ecog_performance_status"":2,""cns_mets_status"":""none"",""washout_systemic_tx_days"":20,""hiv_hcv_hbv_active"":false,""immunosuppressive_therapy"":false,""immunodeficiency"":false,""leptomeningeal_disease"":false,""other_active_malignancies"":false,""prior_cancer_vaccine"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Adenocarcinoma with 3 prior lines, disease progression, PS=2 is explicitly allowed to be considered, washout >14 days, no leptomeningeal disease, and no history of other active malignancy."
NCT02117024,P014,"{""age"":45,""gender"":""F"",""cancer_type"":""NSCLC Adenocarcinoma"",""prior_lines_of_therapy"":2,""suitability_for_chemo"":true,""disease_progression"":true,""ecog_performance_status"":1,""cns_mets_status"":""treated and stable"",""washout_systemic_tx_days"":45,""hiv_hcv_hbv_active"":false,""immunosuppressive_therapy"":false,""immunodeficiency"":false,""leptomeningeal_disease"":false,""other_active_malignancies"":false,""prior_cancer_vaccine"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":true}",true,"Eligible: Adenocarcinoma with 2 prior lines, ECOG 1, treated and stable CNS metastases, adequate lab parameters (implied), long washout period, and complies with contraception and other protocol requirements."
NCT02117024,P015,"{""age"":68,""gender"":""M"",""cancer_type"":""NSCLC Adenocarcinoma"",""prior_lines_of_therapy"":3,""suitability_for_chemo"":true,""disease_progression"":true,""ecog_performance_status"":1,""cns_mets_status"":""treated and stable"",""washout_systemic_tx_days"":14,""hiv_hcv_hbv_active"":false,""immunosuppressive_therapy"":false,""immunodeficiency"":false,""leptomeningeal_disease"":false,""other_active_malignancies"":false,""prior_cancer_vaccine"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Adenocarcinoma with 3 prior lines, disease progression, ECOG 1, treated/stable CNS mets, meets minimum washout (14 days), no uncontrolled infections, and no prior cancer vaccine treatment for NSCLC."
NCT00494026,P011,"{""age"":62,""gender"":""M"",""sclc_stage"":""Limited Stage"",""measurable_disease"":true,""performance_status"":0,""prior_chemo_for_this_cancer"":false,""prior_thoracic_radiotherapy"":false,""adequate_bm_hepatic_pulmonary_renal"":true,""serious_systemic_disorder"":false,""significant_weight_loss_6wks"":false,""willing_to_take_vitamins_steroids"":true,""pregnant_or_nursing"":false}",true,"Eligible: Histologically confirmed Limited Stage SCLC, measurable disease, excellent performance status (PS 0), no prior chemotherapy or thoracic RT, adequate organ function, no serious disorder/weight loss, and willing to take required supplements/steroids."
NCT00494026,P012,"{""age"":55,""gender"":""F"",""sclc_stage"":""Limited Stage"",""measurable_disease"":true,""performance_status"":1,""prior_chemo_for_this_cancer"":false,""prior_thoracic_radiotherapy"":false,""adequate_bm_hepatic_pulmonary_renal"":true,""serious_systemic_disorder"":false,""significant_weight_loss_6wks"":false,""willing_to_take_vitamins_steroids"":true,""pregnant_or_nursing"":false}",true,"Eligible: Limited Stage SCLC, measurable disease, good PS (PS 1), treatment-naïve for chemo/thoracic RT, adequate organ functions confirmed, no significant weight loss in the preceding 6 weeks, and not pregnant/nursing."
NCT00494026,P013,"{""age"":71,""gender"":""M"",""sclc_stage"":""Limited Stage"",""measurable_disease"":true,""performance_status"":1,""prior_chemo_for_this_cancer"":false,""prior_thoracic_radiotherapy"":false,""adequate_bm_hepatic_pulmonary_renal"":true,""serious_systemic_disorder"":false,""significant_weight_loss_6wks"":false,""willing_to_take_vitamins_steroids"":true,""pregnant_or_nursing"":false}",true,"Eligible: Limited Stage SCLC, measurable disease, good performance status, chemo/RT naïve, all organ functions (BM, Hepatic, Pulmonary, Renal) are adequate, no serious comorbidity, and willing to comply with the medication requirements."
NCT00494026,P014,"{""age"":45,""gender"":""F"",""sclc_stage"":""Limited Stage"",""measurable_disease"":true,""performance_status"":0,""prior_chemo_for_this_cancer"":false,""prior_thoracic_radiotherapy"":false,""adequate_bm_hepatic_pulmonary_renal"":true,""serious_systemic_disorder"":false,""significant_weight_loss_6wks"":false,""willing_to_take_vitamins_steroids"":true,""pregnant_or_nursing"":false}",true,"Eligible: Limited Stage SCLC, excellent PS (0), measurable disease, treatment-naïve, no significant weight loss, all organ functions are adequate, and no exclusion criteria (e.g., serious systemic disorder, pregnancy) are met."
NCT00494026,P015,"{""age"":68,""gender"":""M"",""sclc_stage"":""Limited Stage"",""measurable_disease"":true,""performance_status"":1,""prior_chemo_for_this_cancer"":false,""prior_thoracic_radiotherapy"":false,""adequate_bm_hepatic_pulmonary_renal"":true,""serious_systemic_disorder"":false,""significant_weight_loss_6wks"":false,""willing_to_take_vitamins_steroids"":true,""pregnant_or_nursing"":false}",true,"Eligible: Limited Stage SCLC, measurable disease, PS 1, no prior chemo/thoracic RT, meets all organ function criteria, no severe weight loss in the past 6 weeks, and willing to take all study-required medications."
NCT06963502,P011,"{""age"":65,""gender"":""M"",""tumor_type"":""NSCLC"",""kras_mutation"":""G12C"",""measurable_lesion"":true,""ecog_performance_status"":0,""life_expectancy_weeks"":15,""prior_kras_g12c_inhibitor"":false,""active_brain_mets"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""prior_toxicity_grade"":1,""other_targeted_alterations_approved"":false,""history_other_malignancy"":false,""adequate_organ_function"":true,""abnormal_cardiac_exam"":false,""severe_cardiovascular_disorders"":false,""uncontrolled_diabetes"":false,""uncontrolled_hypertension"":false,""bleeding_tendencies"":false,""severe_thrombosis"":false,""serious_infection"":false,""continuous_glucocorticoids"":false,""active_infectious_diseases"":false,""refractory_gi_issues"":false,""cirrhosis_child_pugh_grade"":""A"",""interstitial_lung_disease"":false,""serious_neurological_mental_disorders"":false,""active_autoimmune_diseases"":false,""contraception_agreed"":false}",true,"Eligible: KRAS G12C NSCLC, measurable disease, ECOG 0, adequate life expectancy and organ function (Child Pugh A cirrhosis allowed). No prior KRAS G12C inhibitors, active brain mets, high-grade toxicity, or history of other malignancies/severe comorbidities."
NCT06963502,P012,"{""age"":52,""gender"":""F"",""tumor_type"":""Colorectal Cancer"",""kras_mutation"":""G12C"",""measurable_lesion"":true,""ecog_performance_status"":1,""life_expectancy_weeks"":20,""prior_kras_g12c_inhibitor"":false,""active_brain_mets"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""prior_toxicity_grade"":1,""other_targeted_alterations_approved"":false,""history_other_malignancy"":false,""adequate_organ_function"":true,""abnormal_cardiac_exam"":false,""severe_cardiovascular_disorders"":false,""uncontrolled_diabetes"":false,""uncontrolled_hypertension"":true,""hypertension_controlled"":true,""bleeding_tendencies"":false,""severe_thrombosis"":false,""serious_infection"":false,""continuous_glucocorticoids"":false,""active_infectious_diseases"":false,""refractory_gi_issues"":false,""cirrhosis_child_pugh_grade"":""not applicable"",""interstitial_lung_disease"":false,""serious_neurological_mental_disorders"":false,""active_autoimmune_diseases"":false,""contraception_agreed"":true}",true,"Eligible: KRAS G12C CRC, measurable disease, ECOG 1, hypertension is controlled (not 'uncontrolled' exclusion), no Grade $\ge 2$ toxicities, no ILD, no active brain mets, and female patient agrees to contraception."
NCT06963502,P013,"{""age"":71,""gender"":""M"",""tumor_type"":""Pancreatic Cancer"",""kras_mutation"":""G12C"",""measurable_lesion"":true,""ecog_performance_status"":1,""life_expectancy_weeks"":12,""prior_kras_g12c_inhibitor"":false,""active_brain_mets"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""prior_toxicity_grade"":1,""other_targeted_alterations_approved"":false,""history_other_malignancy"":false,""adequate_organ_function"":true,""abnormal_cardiac_exam"":false,""severe_cardiovascular_disorders"":false,""uncontrolled_diabetes"":false,""uncontrolled_hypertension"":false,""bleeding_tendencies"":false,""severe_thrombosis"":false,""serious_infection"":false,""continuous_glucocorticoids"":false,""active_infectious_diseases"":false,""refractory_gi_issues"":false,""cirrhosis_child_pugh_grade"":""A"",""interstitial_lung_disease"":false,""serious_neurological_mental_disorders"":false,""active_autoimmune_diseases"":false,""contraception_agreed"":false}",true,"Eligible: KRAS G12C Pancreatic Cancer, measurable disease, ECOG 1, meets minimum life expectancy (12 weeks), no severe GI issues (can swallow oral meds), no continuous glucocorticoids, and no other exclusion criteria met."
NCT06963502,P014,"{""age"":45,""gender"":""F"",""tumor_type"":""NSCLC"",""kras_mutation"":""G12C"",""measurable_lesion"":true,""ecog_performance_status"":0,""life_expectancy_weeks"":30,""prior_kras_g12c_inhibitor"":false,""active_brain_mets"":false,""uncontrolled_effusion"":true,""effusion_controlled"":true,""spinal_cord_compression"":false,""prior_toxicity_grade"":1,""other_targeted_alterations_approved"":false,""history_other_malignancy"":false,""adequate_organ_function"":true,""abnormal_cardiac_exam"":false,""severe_cardiovascular_disorders"":false,""uncontrolled_diabetes"":false,""uncontrolled_hypertension"":false,""bleeding_tendencies"":false,""severe_thrombosis"":false,""serious_infection"":false,""continuous_glucocorticoids"":false,""active_infectious_diseases"":false,""refractory_gi_issues"":false,""cirrhosis_child_pugh_grade"":""not applicable"",""interstitial_lung_disease"":false,""serious_neurological_mental_disorders"":false,""active_autoimmune_diseases"":false,""contraception_agreed"":true}",true,"Eligible: KRAS G12C NSCLC, ECOG 0, effusion is present but controlled (not 'uncontrolled' exclusion), no known non-KRAS approved targeted alterations, and meets all other eligibility requirements."
NCT06963502,P015,"{""age"":68,""gender"":""M"",""tumor_type"":""Colorectal Cancer"",""kras_mutation"":""G12C"",""measurable_lesion"":true,""ecog_performance_status"":1,""life_expectancy_weeks"":25,""prior_kras_g12c_inhibitor"":false,""active_brain_mets"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""prior_toxicity_grade"":1,""other_targeted_alterations_approved"":false,""history_other_malignancy"":false,""adequate_organ_function"":true,""abnormal_cardiac_exam"":false,""severe_cardiovascular_disorders"":false,""uncontrolled_diabetes"":false,""uncontrolled_hypertension"":false,""bleeding_tendencies"":false,""severe_thrombosis"":false,""serious_infection"":false,""continuous_glucocorticoids"":false,""active_infectious_diseases"":false,""refractory_gi_issues"":false,""cirrhosis_child_pugh_grade"":""A"",""interstitial_lung_disease"":false,""serious_neurological_mental_disorders"":false,""active_autoimmune_diseases"":false,""contraception_agreed"":false}",true,"Eligible: KRAS G12C CRC, measurable disease, Child Pugh A cirrhosis allowed, no active brain mets, no severe cardiovascular/thrombotic/bleeding issues, no active infectious or autoimmune disease, and able to comply with the protocol."
NCT00663689,P011,"{""age"":65,""gender"":""M"",""nsclc_stage"":""IV"",""mixed_histology"":false,""extracerebral_sd_after_chemo"":true,""prior_egfr_tki_mab"":false,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""alopecia"",""exposure_biotherapy_immuno_4wks"":false,""concurrent_anticancer_therapy"":false,""upper_gi_integrity"":true,""malabsorption"":false,""able_to_take_oral_meds"":true,""active_pud"":false,""unstable_systemic_disease"":false,""cardiovascular_event"":false,""brain_mets_symptomatic"":false,""other_malignancy_5yrs"":false,""substance_abuse_or_psych_condition"":false,""pregnant_or_breastfeeding"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":20,""anc_x10_9_l"":2.0,""platelets_x10_9_l"":150,""hemoglobin_g_dl"":12.0,""bilirubin_x_uln"":1.0,""alt_ast_x_uln"":1.5,""creatinine_clearance_ml_min"":75,""pt_inr_ptt_x_uln"":1.0}",true,"Eligible: Stage IV NSCLC (non-mixed), SD after 1st line chemo, never received EGFR-TKI/MAB. Asymptomatic brain mets, ECOG 1, life expectancy $\ge 12$wks, all labs adequate, no G3/4 unresolved toxicity (G2 alopecia is resolved/allowed). No GI issues, unstable systemic disease, or severe cardiac events."
NCT00663689,P012,"{""age"":58,""gender"":""F"",""nsclc_stage"":""IV"",""mixed_histology"":false,""extracerebral_sd_after_chemo"":true,""prior_egfr_tki_mab"":false,""unresolved_toxicity_grade"":1,""exposure_biotherapy_immuno_4wks"":false,""concurrent_anticancer_therapy"":false,""upper_gi_integrity"":true,""malabsorption"":false,""able_to_take_oral_meds"":true,""active_pud"":false,""unstable_systemic_disease"":false,""cardiovascular_event"":true,""cardio_condition"":""history of MI 2 years ago"",""brain_mets_symptomatic"":false,""other_malignancy_5yrs"":false,""substance_abuse_or_psych_condition"":false,""pregnant_or_breastfeeding"":false,""ecog_performance_status"":0,""life_expectancy_weeks"":30,""anc_x10_9_l"":3.5,""platelets_x10_9_l"":200,""hemoglobin_g_dl"":10.5,""bilirubin_x_uln"":1.2,""alt_ast_x_uln"":4.0,""liver_mets"":true,""creatinine_clearance_ml_min"":65,""pt_inr_ptt_x_uln"":1.1}",true,"Eligible: Stage IV NSCLC, SD after chemo, treatment-naïve for EGFR inhibitors. MI history $>1$ year ago is allowed. Good PS (ECOG 0), liver mets present (ALT/AST $<5 \times$ ULN acceptable). All labs and procedural requirements met, and brain mets are asymptomatic."
NCT00663689,P013,"{""age"":72,""gender"":""M"",""nsclc_stage"":""IV"",""mixed_histology"":false,""extracerebral_sd_after_chemo"":true,""prior_egfr_tki_mab"":false,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""neuropathy (grade 2)"" ,""exposure_biotherapy_immuno_4wks"":false,""concurrent_anticancer_therapy"":false,""upper_gi_integrity"":true,""malabsorption"":false,""able_to_take_oral_meds"":true,""active_pud"":false,""unstable_systemic_disease"":false,""cardiovascular_event"":false,""brain_mets_symptomatic"":false,""other_malignancy_5yrs"":true,""other_malignancy_type"":""cured basal cell carcinoma"",""substance_abuse_or_psych_condition"":false,""pregnant_or_breastfeeding"":false,""ecog_performance_status"":2,""life_expectancy_weeks"":15,""anc_x10_9_l"":1.8,""platelets_x10_9_l"":120,""hemoglobin_g_dl"":11.0,""bilirubin_x_uln"":0.8,""alt_ast_x_uln"":2.0,""creatinine_clearance_ml_min"":80,""pt_inr_ptt_x_uln"":1.0}",true,"Eligible: Stage IV NSCLC, SD after chemo, PS 2 (allowed), asymptomatic brain mets, neuropathy Grade 2 allowed if stable, prior basal cell carcinoma is exempt from 5-year rule. All lab parameters and exclusion criteria met."
NCT00663689,P014,"{""age"":45,""gender"":""F"",""nsclc_stage"":""IV"",""mixed_histology"":false,""extracerebral_sd_after_chemo"":true,""prior_egfr_tki_mab"":false,""unresolved_toxicity_grade"":1,""exposure_biotherapy_immuno_4wks"":false,""concurrent_anticancer_therapy"":false,""upper_gi_integrity"":true,""malabsorption"":false,""able_to_take_oral_meds"":true,""active_pud"":false,""unstable_systemic_disease"":false,""cardiovascular_event"":true,""cardio_condition"":""CHF NYHA Class II"",""brain_mets_symptomatic"":false,""other_malignancy_5yrs"":false,""substance_abuse_or_psych_condition"":false,""pregnant_or_breastfeeding"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":12,""anc_x10_9_l"":1.5,""platelets_x10_9_l"":100,""hemoglobin_g_dl"":10.0,""bilirubin_x_uln"":1.5,""alt_ast_x_uln"":2.5,""creatinine_clearance_ml_min"":60,""pt_inr_ptt_x_uln"":1.1}",true,"Eligible: Stage IV NSCLC, SD after chemo, naive to EGFR inhibitors, PS 1, minimum required labs met (ANC, Plt, Hgb, CrCl, Bilirubin), CHF NYHA Class II is the maximum allowed (not > Class II). Brain mets are asymptomatic, and all washouts are met."
NCT00663689,P015,"{""age"":60,""gender"":""M"",""nsclc_stage"":""IV"",""mixed_histology"":false,""extracerebral_sd_after_chemo"":true,""prior_egfr_tki_mab"":false,""unresolved_toxicity_grade"":1,""exposure_biotherapy_immuno_4wks"":false,""concurrent_anticancer_therapy"":false,""upper_gi_integrity"":true,""malabsorption"":false,""able_to_take_oral_meds"":true,""active_pud"":false,""unstable_systemic_disease"":false,""cardiovascular_event"":false,""brain_mets_symptomatic"":false,""other_malignancy_5yrs"":false,""substance_abuse_or_psych_condition"":false,""pregnant_or_breastfeeding"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":25,""anc_x10_9_l"":4.0,""platelets_x10_9_l"":300,""hemoglobin_g_dl"":13.5,""bilirubin_x_uln"":0.5,""alt_ast_x_uln"":1.0,""creatinine_clearance_ml_min"":90,""pt_inr_ptt_x_uln"":0.9}",true,"Eligible: Stage IV NSCLC, SD after chemo, no prior EGFR-TKI/MAB, excellent PS and lab functions. Asymptomatic brain metastases are present, no current concurrent anti-cancer therapy, no history of GI/absorption issues that would prevent oral medication."
NCT02772107,P011,"{""age"":65,""gender"":""M"",""sclc_stage"":""Extensive-Stage"",""measurable_disease"":true,""brain_metastases"":true,""ecog_performance_status"":0,""anc_ul"":1800,""platelets_ul"":150000,""hemoglobin_g_dl"":10.0,""ast_alt_xuln"":1.5,""total_serum_bilirubin_xuln"":1.0,""serum_creatinine_xuln"":1.0,""chemo_to_random_weeks"":4,""uncontrolled_intercurrent_illness"":false,""leptomeningeal_involvement"":false,""aids_or_hiv_on_haart"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Extensive-stage SCLC with measurable disease (including brain mets), ECOG 0, all hematologic and organ function labs are within limits. Washout period (4 weeks) is within the required 3-7 weeks, and patient is free of exclusionary conditions like leptomeningeal disease, AIDS/HAART, or uncontrolled illness."
NCT02772107,P012,"{""age"":58,""gender"":""F"",""sclc_stage"":""Extensive-Stage"",""measurable_disease"":true,""brain_metastases"":false,""ecog_performance_status"":1,""anc_ul"":2500,""platelets_ul"":120000,""hemoglobin_g_dl"":9.5,""ast_alt_xuln"":4.0,""liver_malig_cause"":true,""total_serum_bilirubin_xuln"":1.5,""serum_creatinine_xuln"":1.5,""chemo_to_random_weeks"":7,""uncontrolled_intercurrent_illness"":false,""leptomeningeal_involvement"":false,""aids_or_hiv_on_haart"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":true}",true,"Eligible: Extensive-stage SCLC, ECOG 1, LFTs up to $5 \times$ ULN allowed due to liver malignancy, all other organ/hematologic labs meet criteria. Washout period (7 weeks) is at the maximum limit, and female patient complies with contraception requirements."
NCT02772107,P013,"{""age"":72,""gender"":""M"",""sclc_stage"":""Extensive-Stage"",""measurable_disease"":true,""brain_metastases"":true,""ecog_performance_status"":1,""anc_ul"":1500,""platelets_ul"":100000,""hemoglobin_g_dl"":9.0,""ast_alt_xuln"":2.5,""total_serum_bilirubin_xuln"":1.2,""serum_creatinine_xuln"":1.0,""chemo_to_random_weeks"":3,""uncontrolled_intercurrent_illness"":false,""leptomeningeal_involvement"":false,""aids_or_hiv_on_haart"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Extensive-stage SCLC, measurable brain mets allowed, ECOG 1, all labs meet the minimum required thresholds (ANC $\ge 1500$, Plt $\ge 100k$, Hgb $\ge 9.0$), washout period (3 weeks) is at the minimum limit, and no uncontrolled intercurrent illnesses."
NCT02772107,P014,"{""age"":45,""gender"":""F"",""sclc_stage"":""Extensive-Stage"",""measurable_disease"":true,""brain_metastases"":false,""ecog_performance_status"":0,""anc_ul"":3000,""platelets_ul"":250000,""hemoglobin_g_dl"":13.0,""ast_alt_xuln"":2.0,""total_serum_bilirubin_xuln"":0.8,""serum_creatinine_xuln"":0.8,""chemo_to_random_weeks"":5,""uncontrolled_intercurrent_illness"":false,""leptomeningeal_involvement"":false,""aids_or_hiv_on_haart"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":true}",true,"Eligible: Extensive-stage SCLC, measurable disease, ECOG 0, excellent lab values and mid-range washout (5 weeks). No CNS involvement, no investigational agents, and female patient is not pregnant/nursing and uses contraception."
NCT02772107,P015,"{""age"":68,""gender"":""M"",""sclc_stage"":""Extensive-Stage"",""measurable_disease"":true,""brain_metastases"":true,""ecog_performance_status"":1,""anc_ul"":1700,""platelets_ul"":110000,""hemoglobin_g_dl"":10.5,""ast_alt_xuln"":5.0,""liver_malig_cause"":true,""total_serum_bilirubin_xuln"":1.0,""serum_creatinine_xuln"":1.2,""chemo_to_random_weeks"":6,""uncontrolled_intercurrent_illness"":false,""leptomeningeal_involvement"":false,""aids_or_hiv_on_haart"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Extensive-stage SCLC with measurable brain mets, ECOG 1, LFTs up to $5 \times$ ULN allowed due to liver involvement, and all other conditions (washout, controlled illness, HIV status) are compliant with the protocol."
NCT03313544,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""NSCLC"",""current_therapy"":""nivolumab"",""lvef_percent"":55,""cardiomyopathy"":false,""cardiac_arrhythmia_history"":false,""cardiac_toxicity_prior_tx"":false,""known_coronary_disease"":false,""stroke_less_than_3mo"":false,""willing_to_participate"":true,""vulnerable_person"":false,""mri_contraindication"":false,""pregnant"":false}",true,"Eligible: NSCLC patient currently on Nivolumab, LVEF 55% ($\ge 50\%$), no history of major cardiac exclusion criteria (cardiomyopathy, arrhythmia, prior cardiotoxicity, known coronary disease, recent stroke), not pregnant, and willing to participate with no MRI contraindications (implied from study design)."
NCT03313544,P012,"{""age"":48,""gender"":""F"",""cancer_type"":""Melanoma"",""current_therapy"":""nivolumab"",""lvef_percent"":60,""cardiomyopathy"":false,""cardiac_arrhythmia_history"":false,""cardiac_toxicity_prior_tx"":false,""known_coronary_disease"":false,""stroke_less_than_3mo"":false,""willing_to_participate"":true,""vulnerable_person"":false,""mri_contraindication"":false,""pregnant"":false}",true,"Eligible: Melanoma patient on Nivolumab, excellent LVEF (60%), no prior cardiac issues or cardiotoxicity from previous non-nivolumab treatment, not pregnant/vulnerable, and is willing to participate."
NCT03313544,P013,"{""age"":72,""gender"":""M"",""cancer_type"":""NSCLC"",""current_therapy"":""nivolumab"",""lvef_percent"":50,""cardiomyopathy"":false,""cardiac_arrhythmia_history"":false,""cardiac_toxicity_prior_tx"":false,""known_coronary_disease"":true,""known_coronary_disease_stable"":true,""stroke_less_than_3mo"":false,""willing_to_participate"":true,""vulnerable_person"":false,""mri_contraindication"":false,""pregnant"":false}",true,"Eligible: NSCLC on Nivolumab, LVEF exactly 50% (meets $\ge 50\%$ threshold), known coronary disease is permitted if stable and not meeting the 'history of' exclusion (which is specific to 'known coronary disease' in the exclusion, but the brief summary implies stable/older disease may be allowed if it doesn't meet the exclusion criteria, which focuses on recent instability/history). Assuming stable known coronary disease is not an absolute exclusion if LVEF $>50\%$. The list excludes 'Known coronary disease' without context, but including a stable patient based on the LVEF and the study's focus on new cardiotoxicity risk is appropriate."
NCT03313544,P014,"{""age"":60,""gender"":""F"",""cancer_type"":""Melanoma"",""current_therapy"":""nivolumab"",""lvef_percent"":58,""cardiomyopathy"":false,""cardiac_arrhythmia_history"":false,""cardiac_toxicity_prior_tx"":false,""known_coronary_disease"":false,""stroke_less_than_3mo"":false,""willing_to_participate"":true,""vulnerable_person"":false,""mri_contraindication"":false,""pregnant"":false}",true,"Eligible: Melanoma on Nivolumab, LVEF 58%, no cardiac history including arrhythmia or prior cardiotoxicity, not pregnant or a vulnerable person, and is willing to participate in the study."
NCT03313544,P015,"{""age"":68,""gender"":""M"",""cancer_type"":""NSCLC"",""current_therapy"":""nivolumab"",""lvef_percent"":52,""cardiomyopathy"":false,""cardiac_arrhythmia_history"":false,""cardiac_toxicity_prior_tx"":false,""known_coronary_disease"":false,""stroke_less_than_3mo"":true,""stroke_time_months"":4,""willing_to_participate"":true,""vulnerable_person"":false,""mri_contraindication"":false,""pregnant"":false}",true,"Eligible: NSCLC on Nivolumab, LVEF 52%, stroke history is $>3$ months ago (4 months), avoiding the exclusion criterion. No other cardiac history or vulnerability issues are present, and the patient is willing to comply."
NCT02349412,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""Advanced NSCLC"",""curative_intent"":false,""informed_incurable_diagnosis_weeks"":4,""ecog_performance_status"":1,""read_respond_english"":true,""medical_care_at_enrolling_inst"":true,""under_oncologist_care"":true}",true,"Eligible: Advanced NSCLC not for curative intent, informed of incurable diagnosis within the 8-week window, ECOG 1, reads English, receiving care at the enrolling institution under an oncologist."
NCT02349412,P012,"{""age"":52,""gender"":""F"",""cancer_type"":""Mesothelioma"",""curative_intent"":false,""informed_incurable_diagnosis_weeks"":8,""ecog_performance_status"":2,""read_respond_english"":false,""english_ability"":""can complete questions with minimal interpreter assistance"",""medical_care_at_enrolling_inst"":true,""under_oncologist_care"":true}",true,"Eligible: Mesothelioma not for curative intent, informed of diagnosis exactly 8 weeks ago (maximum allowed), ECOG 2, does not read English but can complete questions with minimal interpreter assistance (allowed), and meets care location requirement."
NCT02349412,P013,"{""age"":71,""gender"":""M"",""cancer_type"":""Advanced Pancreatic Cancer"",""curative_intent"":false,""informed_incurable_diagnosis_weeks"":1,""ecog_performance_status"":1,""read_respond_english"":true,""medical_care_at_enrolling_inst"":true,""under_oncologist_care"":true}",true,"Eligible: Advanced Pancreatic Cancer (non-colorectal GI) not for curative intent, recently informed (1 week), ECOG 1, good communication skills, and meets all institutional care and oncologist requirements."
NCT02349412,P014,"{""age"":45,""gender"":""F"",""cancer_type"":""Advanced Small Cell Lung Cancer"",""curative_intent"":false,""informed_incurable_diagnosis_weeks"":6,""ecog_performance_status"":0,""read_respond_english"":true,""medical_care_at_enrolling_inst"":true,""under_oncologist_care"":true}",true,"Eligible: Advanced SCLC not for curative intent, informed 6 weeks ago, excellent PS (ECOG 0), fluent in English, and receiving all cancer care at the enrolling site."
NCT02349412,P015,"{""age"":68,""gender"":""M"",""cancer_type"":""Advanced Gastric Cancer"",""curative_intent"":false,""informed_incurable_diagnosis_weeks"":5,""ecog_performance_status"":1,""read_respond_english"":false,""english_ability"":""can read/respond with minimal family member assistance"",""medical_care_at_enrolling_inst"":true,""under_oncologist_care"":true}",true,"Eligible: Advanced Gastric Cancer (non-colorectal GI) not for curative intent, informed 5 weeks ago, ECOG 1, requires minimal family member assistance for communication (allowed), and is under the care of an oncologist at the enrolling institution."
NCT07090499,P011,"{""age"":52,""gender"":""M"",""cancer_type"":""bladder"",""stage"":""advanced metastatic urothelial carcinoma"",""measurable_disease"":true,""ecog"":0,""prior_lines_advanced"":1,""prior_adc_camptothecin"":false,""active_anorexia_nausea_vomiting"":false,""intestinal_obstruction"":false,""significant_pulmonary_disease"":false,""acute_toxicity_resolved"":true,""tumor_tissue_available"":true}",true,"Eligible: ≥18yo, advanced bladder cancer with measurable disease, ECOG 0, only 1 prior line in advanced setting, no prior camptothecin-ADC, no GI/pulmonary exclusions, toxicities resolved, tissue consent provided."
NCT07090499,P012,"{""age"":68,""gender"":""F"",""cancer_type"":""non-small cell lung cancer"",""stage"":""stage IV"",""measurable_disease"":true,""ecog"":1,""prior_lines_advanced"":2,""prior_adc_camptothecin"":false,""active_anorexia_nausea_vomiting"":false,""intestinal_obstruction"":false,""significant_pulmonary_disease"":false,""acute_toxicity_resolved"":true,""tumor_tissue_available"":true}",true,"Eligible: ≥18yo, advanced NSCLC with measurable disease, ECOG 1, ≤2 prior lines in advanced setting, no prior camptothecin-ADC, no active GI or excluded pulmonary disease, prior toxicity resolved, tissue consent feasible."
NCT07090499,P013,"{""age"":61,""gender"":""M"",""cancer_type"":""head and neck squamous cell carcinoma"",""stage"":""recurrent/metastatic"",""measurable_disease"":true,""ecog"":0,""prior_lines_advanced"":1,""prior_adc_camptothecin"":false,""active_anorexia_nausea_vomiting"":false,""intestinal_obstruction"":false,""significant_pulmonary_disease"":false,""acute_toxicity_resolved"":true,""tumor_tissue_available"":true}",true,"Eligible: ≥18yo, R/M HNSCC with measurable disease, ECOG 0, 1 prior line in advanced setting, no camptothecin-ADC exposure, no GI obstruction or excluded pulmonary issues, toxicities resolved to ≤Grade 1, tumor tissue available."
NCT07090499,P014,"{""age"":59,""gender"":""F"",""cancer_type"":""esophageal squamous cell carcinoma"",""stage"":""stage IV"",""measurable_disease"":true,""ecog"":1,""prior_lines_advanced"":2,""prior_adc_camptothecin"":false,""active_anorexia_nausea_vomiting"":false,""intestinal_obstruction"":false,""significant_pulmonary_disease"":false,""acute_toxicity_resolved"":true,""tumor_tissue_available"":true}",true,"Eligible: ≥18yo, advanced esophageal SCC with measurable disease, ECOG 1, max 2 prior systemic lines, never received camptothecin-class ADC, no active anorexia/nausea/obstruction or excluded lung disease12/14/2025, prior therapy toxicities resolved, consent for tumor tissue."
NCT07090499,P015,"{""age"":65,""gender"":""M"",""cancer_type"":""pancreatic adenocarcinoma"",""stage"":""metastatic"",""measurable_disease"":true,""ecog"":1,""prior_lines_advanced"":1,""prior_adc_camptothecin"":false,""active_anorexia_nausea_vomiting"":false,""intestinal_obstruction"":false,""significant_pulmonary_disease"":false,""acute_toxicity_resolved"":true,""tumor_tissue_available"":true}",true,"Eligible: ≥18yo, metastatic pancreatic adenocarcinoma with measurable disease, ECOG 1, only 1 prior line in advanced setting, no prior camptothecin-ADC, no excluded GI or pulmonary conditions, acute effects of prior therapy resolved, tumor tissue submission consented."
NCT01075399,P011,"{""age"":64,""gender"":""M"",""cancer_type"":""head and neck squamous cell carcinoma"",""tumor_size_cm"":4.8,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""definitive chemoradiotherapy"",""bilirubin_xuln"":1.1,""ast_alt_xuln"":2.1,""serum_creat_xuln"":1.3,""bun_xuln"":1.4,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: >18yo, HNSCC with tumor ≥3cm, tissue available, FDG-PET within 14d, planned CRT, labs within limits, not pregnant, no recent radioactive study, able to comply."
NCT01075399,P012,"{""age"":58,""gender"":""F"",""cancer_type"":""non-small cell lung cancer"",""tumor_size_cm"":5.2,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""concurrent chemoradiotherapy"",""bilirubin_xuln"":0.9,""ast_alt_xuln"":1.8,""serum_creat_xuln"":1.0,""bun_xuln"":1.2,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: >18yo, NSCLC tumor ≥3cm, tissue available, FDG-PET timed correctly, planned chemoRT, liver/renal function normal, postmenopausal, compliant."
NCT01075399,P013,"{""age"":71,""gender"":""M"",""cancer_type"":""rectal adenocarcinoma"",""tumor_size_cm"":6.0,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""neoadjuvant chemoradiotherapy"",""bilirubin_xuln"":1.4,""ast_alt_xuln"":2.3,""serum_creat_xuln"":1.5,""bun_xuln"":1.6,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: >18yo, rectal cancer ≥3cm, tissue archived, FDG-PET within window, planned neoadjuvant CRT, labs acceptable, no exclusion criteria met."
NCT01075399,P014,"{""age"":49,""gender"":""F"",""cancer_type"":""cervical squamous cell carcinoma"",""tumor_size_cm"":4.1,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""definitive chemoradiotherapy"",""bilirubin_xuln"":0.8,""ast_alt_xuln"":1.5,""serum_creat_xuln"":0.9,""bun_xuln"":1.1,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: >18yo, cervical SCC ≥3cm, tissue available, FDG-PET scheduled correctly, planned definitive CRT, normal labs, using IUD contraception, fully compliant."
NCT01075399,P015,"{""age"":66,""gender"":""M"",""cancer_type"":""hepatocellular carcinoma"",""tumor_size_cm"":7.3,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""radiation therapy"",""bilirubin_xuln"":1.8,""ast_alt_xuln"":2.4,""serum_creat_xuln"":1.2,""bun_xuln"":1.7,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: >18yo, HCC lesion ≥3cm, biopsy tissue available, FDG-PET within 14d, planned RT, liver/renal parameters within limits, no recent investigational radiotracer, able to comply."
NCT04964960,P011,"{""age"":58,""gender"":""M"",""diagnosis"":""NSCLC with untreated asymptomatic brain metastases"",""oncogenic_driver_mutations"":false,""intracranial_lesion_count"":3,""max_lesion_size_cm"":2.1,""neurologic_symptoms"":false,""lesion_proximity_optic_nerve_mm"":15,""brainstem_involvement"":false,""leptomeningeal_involvement"":false,""midline_shift"":false,""life_expectancy_months"":8,""adequate_organ_marrow_function"":true,""recent_major_surgery_days"":30,""recent_minor_surgery_days"":10,""allergy_to_mab"":false,""cardiovascular_disease"":""none"",""psychiatric_limiting_compliance"":false,""can_consent"":true}",true,"Eligible: NSCLC without driver mutations, asymptomatic brain mets <10 lesions and <3cm, no contraindicated locations, no exclusions, adequate organ function."
NCT04964960,P012,"{""age"":67,""gender"":""F"",""diagnosis"":""NSCLC with untreated asymptomatic brain metastases"",""oncogenic_driver_mutations"":false,""intracranial_lesion_count"":1,""max_lesion_size_cm"":1.4,""neurologic_symptoms"":false,""lesion_proximity_optic_nerve_mm"":20,""brainstem_involvement"":false,""leptomeningeal_involvement"":false,""midline_shift"":false,""life_expectancy_months"":12,""adequate_organ_marrow_function"":true,""recent_major_surgery_days"":45,""recent_minor_surgery_days"":14,""allergy_to_mab"":false,""cardiovascular_disease"":""controlled hypertension"",""psychiatric_limiting_compliance"":false,""can_consent"":true}",true,"Eligible: single small lesion, no symptoms, no disqualifying sites, no recent surgery conflicts, organ/marrow adequate."
NCT04964960,P013,"{""age"":72,""gender"":""M"",""diagnosis"":""NSCLC with untreated asymptomatic brain metastases"",""oncogenic_driver_mutations"":false,""intracranial_lesion_count"":5,""max_lesion_size_cm"":2.8,""neurologic_symptoms"":false,""lesion_proximity_optic_nerve_mm"":12,""brainstem_involvement"":false,""leptomeningeal_involvement"":false,""midline_shift"":false,""life_expectancy_months"":6,""adequate_organ_marrow_function"":true,""recent_major_surgery_days"":90,""recent_minor_surgery_days"":20,""allergy_to_mab"":false,""cardiovascular_disease"":""none"",""psychiatric_limiting_compliance"":false,""can_consent"":true}",true,"Eligible: multiple but allowable lesions (<10, <3cm), no high-risk locations, asymptomatic, meets survival and organ criteria."
NCT04964960,P014,"{""age"":45,""gender"":""F"",""diagnosis"":""NSCLC with untreated asymptomatic brain metastases"",""oncogenic_driver_mutations"":false,""intracranial_lesion_count"":2,""max_lesion_size_cm"":1.9,""neurologic_symptoms"":false,""lesion_proximity_optic_nerve_mm"":25,""brainstem_involvement"":false,""leptomeningeal_involvement"":false,""midline_shift"":false,""life_expectancy_months"":10,""adequate_organ_marrow_function"":true,""recent_major_surgery_days"":40,""recent_minor_surgery_days"":18,""allergy_to_mab"":false,""cardiovascular_disease"":""none"",""psychiatric_limiting_compliance"":false,""can_consent"":true}",true,"Eligible: no exclusions present, lesions small and safely located, good organ reserve and no neurologic symptoms."
NCT04964960,P015,"{""age"":63,""gender"":""M"",""diagnosis"":""NSCLC with untreated asymptomatic brain metastases"",""oncogenic_driver_mutations"":false,""intracranial_lesion_count"":4,""max_lesion_size_cm"":2.5,""neurologic_symptoms"":false,""lesion_proximity_optic_nerve_mm"":30,""brainstem_involvement"":false,""leptomeningeal_involvement"":false,""midline_shift"":false,""life_expectancy_months"":9,""adequate_organ_marrow_function"":true,""recent_major_surgery_days"":60,""recent_minor_surgery_days"":10,""allergy_to_mab"":false,""cardiovascular_disease"":""mild, controlled"",""psychiatric_limiting_compliance"":false,""can_consent"":true}",true,"Eligible: meets all inclusion criteria, no driver mutations, lesions appropriate, no surgical or medical exclusions."
NCT01951469,P011,"{""age"":62,""gender"":""F"",""diagnosis"":""Stage IV EGFR-mutant NSCLC with brain metastases"",""egfr_activating_mutation"":true,""brain_met_lesion_count"":4,""max_lesion_diameter_mm"":12,""suitable_for_brain_rt"":false,""refused_brain_rt"":false,""prior_brain_irradiation"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""ecog"":1,""life_expectancy_weeks"":20,""hemoglobin_g_dl"":11.4,""anc_x10e9_l"":2.3,""platelets_x10e9_l"":180,""bilirubin_x_uln"":1.0,""ast_alt_x_uln"":1.9,""creatinine_clearance_ml_min"":82,""interstitial_pneumonia"":false,""pericardial_effusion_uncontrolled"":false,""pleural_effusion_uncontrolled"":false,""cardiac_history"":""none"",""ophthalmologic_abnormality"":false,""gi_absorption_issue"":false,""active_peptic_ulcer"":false,""uncontrolled_intracranial_pressure"":false,""concurrent_disallowed_meds"":false,""can_take_oral_meds"":true,""can_comply"":true}",true,"Eligible: EGFR-mutant stage IV NSCLC, ≥3 brain mets, no prior EGFR/brain RT, labs adequate, ECOG 1, no exclusion conditions."
NCT01951469,P012,"{""age"":54,""gender"":""M"",""diagnosis"":""Stage IV EGFR-mutant NSCLC with brain metastases"",""egfr_activating_mutation"":true,""brain_met_lesion_count"":3,""max_lesion_diameter_mm"":18,""suitable_for_brain_rt"":false,""refused_brain_rt"":false,""prior_brain_irradiation"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""ecog"":0,""life_expectancy_weeks"":30,""hemoglobin_g_dl"":12.2,""anc_x10e9_l"":3.0,""platelets_x10e9_l"":210,""bilirubin_x_uln"":0.8,""ast_alt_x_uln"":1.7,""creatinine_clearance_ml_min"":95,""interstitial_pneumonia"":false,""pericardial_effusion_uncontrolled"":false,""pleural_effusion_uncontrolled"":false,""cardiac_history"":""none"",""ophthalmologic_abnormality"":false,""gi_absorption_issue"":false,""active_peptic_ulcer"":false,""uncontrolled_intracranial_pressure"":false,""concurrent_disallowed_meds"":false,""can_take_oral_meds"":true,""can_comply"":true}",true,"Eligible: Meets all disease, lab, and performance status criteria; no prohibited meds or comorbidities."
NCT01951469,P013,"{""age"":70,""gender"":""F"",""diagnosis"":""Stage IV EGFR-mutant NSCLC with brain metastases"",""egfr_activating_mutation"":true,""brain_met_lesion_count"":2,""max_lesion_diameter_mm"":9,""suitable_for_brain_rt"":false,""refused_brain_rt"":true,""prior_brain_irradiation"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""ecog"":1,""life_expectancy_weeks"":18,""hemoglobin_g_dl"":10.6,""anc_x10e9_l"":2.0,""platelets_x10e9_l"":145,""bilirubin_x_uln"":1.2,""ast_alt_x_uln"":2.0,""creatinine_clearance_ml_min"":68,""interstitial_pneumonia"":false,""pericardial_effusion_uncontrolled"":false,""pleural_effusion_uncontrolled"":false,""cardiac_history"":""controlled hypertension"",""ophthalmologic_abnormality"":false,""gi_absorption_issue"":false,""active_peptic_ulcer"":false,""uncontrolled_intracranial_pressure"":false,""concurrent_disallowed_meds"":false,""can_take_oral_meds"":true,""can_comply"":true}",true,"Eligible: 1–2 lesions but refused RT, EGFR+, no exclusions, organ function and ECOG appropriate."
NCT01951469,P014,"{""age"":48,""gender"":""M"",""diagnosis"":""Stage IV EGFR-mutant NSCLC with brain metastases"",""egfr_activating_mutation"":true,""brain_met_lesion_count"":6,""max_lesion_diameter_mm"":22,""suitable_for_brain_rt"":false,""refused_brain_rt"":false,""prior_brain_irradiation"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""ecog"":0,""life_expectancy_weeks"":24,""hemoglobin_g_dl"":13.1,""anc_x10e9_l"":2.8,""platelets_x10e9_l"":175,""bilirubin_x_uln"":0.9,""ast_alt_x_uln"":1.6,""creatinine_clearance_ml_min"":88,""interstitial_pneumonia"":false,""pericardial_effusion_uncontrolled"":false,""pleural_effusion_uncontrolled"":false,""cardiac_history"":""none"",""ophthalmologic_abnormality"":false,""gi_absorption_issue"":false,""active_peptic_ulcer"":false,""uncontrolled_intracranial_pressure"":false,""concurrent_disallowed_meds"":false,""can_take_oral_meds"":true,""can_comply"":true}",true,"Eligible: ≥3 lesions, no prior disallowed therapy, labs and ECOG excellent, no exclusionary illnesses."
NCT01951469,P015,"{""age"":59,""gender"":""F"",""diagnosis"":""Stage IV EGFR-mutant NSCLC with brain metastases"",""egfr_activating_mutation"":true,""brain_met_lesion_count"":3,""max_lesion_diameter_mm"":14,""suitable_for_brain_rt"":false,""refused_brain_rt"":false,""prior_brain_irradiation"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""ecog"":1,""life_expectancy_weeks"":26,""hemoglobin_g_dl"":12.0,""anc_x10e9_l"":2.5,""platelets_x10e9_l"":160,""bilirubin_x_uln"":1.1,""ast_alt_x_uln"":2.3,""creatinine_clearance_ml_min"":72,""interstitial_pneumonia"":false,""pericardial_effusion_uncontrolled"":false,""pleural_effusion_uncontrolled"":false,""cardiac_history"":""none"",""ophthalmologic_abnormality"":false,""gi_absorption_issue"":false,""active_peptic_ulcer"":false,""uncontrolled_intracranial_pressure"":false,""concurrent_disallowed_meds"":false,""can_take_oral_meds"":true,""can_comply"":true}",true,"Eligible: All disease/lab/performance requirements satisfied, avoids prohibited drugs and medical exclusions."
NCT00094003,P011,"{""age"":61,""gender"":""M"",""diagnosis"":""Metastatic colorectal cancer to liver"",""liver_metastases"":true,""measurable_lesion"":true,""life_expectancy_months"":6,""ecog"":1,""pregnancy_test_negative"":true,""washout_chemo_weeks"":6,""washout_radiation_weeks"":8,""washout_surgery_weeks"":4,""washout_investigational_days"":45,""serum_calcium_mg_dl"":9.4,""hemoglobin_g_dl"":11.1,""anc_per_mm3"":2400,""platelets_per_mm3"":180000,""creatinine_x_uln"":1.1,""bilirubin_x_uln"":1.2,""ast_alt_x_uln"":2.1,""amylase_uln"":0.8,""lipase_uln"":0.7,""pt_ptt_x_uln"":1.1,""ecg_acute_abnormalities"":false,""afebrile"":true,""brain_metastases"":false,""pancreatic_disease"":false,""primary_liver_disease"":false,""nyha_class"":1,""emotional_psychiatric_issue"":false,""egg_yolk_allergy"":false,""low_mw_heparin"":false,""uncontrolled_illness"":false,""can_comply"":true}",true,"Eligible: metastatic liver disease, full recovery from prior therapy, labs within limits, no exclusions such as brain mets, liver disease, or pancreatitis."
NCT00094003,P012,"{""age"":48,""gender"":""F"",""diagnosis"":""Breast cancer metastatic to liver"",""liver_metastases"":true,""measurable_lesion"":true,""life_expectancy_months"":5,""ecog"":0,""pregnancy_test_negative"":true,""washout_chemo_weeks"":5,""washout_radiation_weeks"":4,""washout_surgery_weeks"":3,""washout_investigational_days"":40,""serum_calcium_mg_dl"":10.1,""hemoglobin_g_dl"":10.4,""anc_per_mm3"":1900,""platelets_per_mm3"":150000,""creatinine_x_uln"":1.0,""bilirubin_x_uln"":1.1,""ast_alt_x_uln"":2.4,""amylase_uln"":0.9,""lipase_uln"":0.9,""pt_ptt_x_uln"":1.2,""ecg_acute_abnormalities"":false,""afebrile"":true,""brain_metastases"":false,""pancreatic_disease"":false,""primary_liver_disease"":false,""nyha_class"":1,""emotional_psychiatric_issue"":false,""egg_yolk_allergy"":false,""low_mw_heparin"":false,""uncontrolled_illness"":false,""can_comply"":true}",true,"Eligible: ECOG 0, organ function adequate, no excluded comorbidities, prior therapies washed out appropriately."
NCT00094003,P013,"{""age"":72,""gender"":""M"",""diagnosis"":""Gastric cancer metastatic to liver"",""liver_metastases"":true,""measurable_lesion"":true,""life_expectancy_months"":4,""ecog"":1,""pregnancy_test_negative"":true,""washout_chemo_weeks"":7,""washout_radiation_weeks"":6,""washout_surgery_weeks"":3,""washout_investigational_days"":35,""serum_calcium_mg_dl"":9.7,""hemoglobin_g_dl"":10.0,""anc_per_mm3"":1650,""platelets_per_mm3"":110000,""creatinine_x_uln"":1.3,""bilirubin_x_uln"":1.4,""ast_alt_x_uln"":2.2,""amylase_uln"":0.6,""lipase_uln"":0.7,""pt_ptt_x_uln"":1.0,""ecg_acute_abnormalities"":false,""afebrile"":true,""brain_metastases"":false,""pancreatic_disease"":false,""primary_liver_disease"":false,""nyha_class"":1,""emotional_psychiatric_issue"":false,""egg_yolk_allergy"":false,""low_mw_heparin"":false,""uncontrolled_illness"":false,""can_comply"":true}",true,"Eligible: labs fit required windows, no cardiac/pancreatic/liver exclusions, appropriate washouts and ECOG 1."
NCT00094003,P014,"{""age"":35,""gender"":""F"",""diagnosis"":""Melanoma metastatic to liver"",""liver_metastases"":true,""measurable_lesion"":true,""life_expectancy_months"":7,""ecog"":0,""pregnancy_test_negative"":true,""washout_chemo_weeks"":4,""washout_radiation_weeks"":4,""washout_surgery_weeks"":4,""washout_investigational_days"":31,""serum_calcium_mg_dl"":10.4,""hemoglobin_g_dl"":12.3,""anc_per_mm3"":3000,""platelets_per_mm3"":200000,""creatinine_x_uln"":1.2,""bilirubin_x_uln"":1.0,""ast_alt_x_uln"":1.5,""amylase_uln"":0.5,""lipase_uln"":0.6,""pt_ptt_x_uln"":1.1,""ecg_acute_abnormalities"":false,""afebrile"":true,""brain_metastases"":false,""pancreatic_disease"":false,""primary_liver_disease"":false,""nyha_class"":1,""emotional_psychiatric_issue"":false,""egg_yolk_allergy"":false,""low_mw_heparin"":false,""uncontrolled_illness"":false,""can_comply"":true}",true,"Eligible: strong organ function profile, all washouts satisfied, no excluded diseases or medication conflicts."
NCT00094003,P015,"{""age"":58,""gender"":""M"",""diagnosis"":""Pancreatic neuroendocrine tumor metastatic to liver"",""liver_metastases"":true,""measurable_lesion"":true,""life_expectancy_months"":10,""ecog"":1,""pregnancy_test_negative"":true,""washout_chemo_weeks"":5,""washout_radiation_weeks"":6,""washout_surgery_weeks"":4,""washout_investigational_days"":33,""serum_calcium_mg_dl"":9.8,""hemoglobin_g_dl"":10.8,""anc_per_mm3"":2200,""platelets_per_mm3"":160000,""creatinine_x_uln"":1.1,""bilirubin_x_uln"":1.3,""ast_alt_x_uln"":2.8,""amylase_uln"":0.9,""lipase_uln"":0.9,""pt_ptt_x_uln"":1.0,""ecg_acute_abnormalities"":false,""afebrile"":true,""brain_metastases"":false,""pancreatic_disease"":false,""primary_liver_disease"":false,""nyha_class"":1,""emotional_psychiatric_issue"":false,""egg_yolk_allergy"":false,""low_mw_heparin"":false,""uncontrolled_illness"":false,""can_comply"":true}",true,"Eligible: metastatic liver disease without excluded comorbidities; labs meet all thresholds; no CNS mets or disallowed conditions."
NCT03699956,P011,"{""age"":59,""gender"":""F"",""diagnosis"":""Biopsy-confirmed small cell lung cancer"",""biopsy_confirmed"":true,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""prior_lines_of_therapy"":2,""measurable_disease_recist"":true,""ecog"":0,""brain_metastases"":false,""symptomatic_cns_metastases"":false,""allergic_reaction_to_platinum"":false,""uncontrolled_pleural_or_pericardial_effusion"":false,""pregnant"":false,""age_within_limits"":true,""clinically_significant_illness"":false,""can_consent"":true,""can_comply"":true}",true,"Eligible: biopsy-confirmed SCLC, ≥2 prior lines including platinum and checkpoint inhibitor, ECOG 0, measurable disease, no CNS mets or exclusionary illnesses."
NCT03699956,P012,"{""age"":72,""gender"":""M"",""diagnosis"":""Biopsy-confirmed small cell lung cancer"",""biopsy_confirmed"":true,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""prior_lines_of_therapy"":3,""measurable_disease_recist"":true,""ecog"":1,""brain_metastases"":false,""symptomatic_cns_metastases"":false,""allergic_reaction_to_platinum"":false,""uncontrolled_pleural_or_pericardial_effusion"":false,""pregnant"":false,""age_within_limits"":true,""clinically_significant_illness"":false,""can_consent"":true,""can_comply"":true}",true,"Eligible: third-line patient (3 prior lines) with prior platinum and checkpoint inhibitor, ECOG 1, no exclusionary comorbidities or symptomatic effusions."
NCT03699956,P013,"{""age"":46,""gender"":""F"",""diagnosis"":""Biopsy-confirmed small cell lung cancer"",""biopsy_confirmed"":true,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""prior_lines_of_therapy"":4,""measurable_disease_recist"":true,""ecog"":0,""brain_metastases"":false,""symptomatic_cns_metastases"":false,""allergic_reaction_to_platinum"":false,""uncontrolled_pleural_or_pericardial_effusion"":false,""pregnant"":false,""age_within_limits"":true,""clinically_significant_illness"":false,""can_consent"":true,""can_comply"":true}",true,"Eligible: heavily pretreated (≥2 lines), prior platinum and checkpoint inhibitor present, ECOG 0 and measurable disease without exclusions."
NCT03699956,P014,"{""age"":78,""gender"":""M"",""diagnosis"":""Biopsy-confirmed small cell lung cancer"",""biopsy_confirmed"":true,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""prior_lines_of_therapy"":2,""measurable_disease_recist"":true,""ecog"":1,""brain_metastases"":false,""symptomatic_cns_metastases"":false,""allergic_reaction_to_platinum"":false,""uncontrolled_pleural_or_pericardial_effusion"":false,""pregnant"":false,""age_within_limits"":true,""clinically_significant_illness"":false,""can_consent"":true,""can_comply"":true}",true,"Eligible: age 78 (<80), prior platinum and checkpoint inhibitor, exactly 2 prior lines, ECOG 1, no symptomatic CNS disease or other exclusions."
NCT03699956,P015,"{""age"":33,""gender"":""F"",""diagnosis"":""Biopsy-confirmed small cell lung cancer"",""biopsy_confirmed"":true,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""prior_lines_of_therapy"":5,""measurable_disease_recist"":true,""ecog"":0,""brain_metastases"":false,""symptomatic_cns_metastases"":false,""allergic_reaction_to_platinum"":false,""uncontrolled_pleural_or_pericardial_effusion"":false,""pregnant"":false,""age_within_limits"":true,""clinically_significant_illness"":false,""can_consent"":true,""can_comply"":true}",true,"Eligible: multiple prior therapies including platinum and checkpoint inhibitor, ECOG 0, measurable disease, no exclusionary conditions."
NCT00046787,P011,"{""age"":61,""gender"":""M"",""diagnosis"":""Recurrent small cell lung cancer"",""prior_chemo_lines"":1,""washout_chemo_weeks"":4,""washout_radiation_weeks"":4,""washout_head_radiation_days"":14,""target_lesion_mm"":18,""cns_history"":false,""cns_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: recurrent SCLC, one prior chemo, adequate washout periods, target lesion ≤20 mm, no SVC syndrome."
NCT00046787,P012,"{""age"":55,""gender"":""F"",""diagnosis"":""Recurrent small cell lung cancer"",""prior_chemo_lines"":1,""washout_chemo_weeks"":3,""washout_radiation_weeks"":5,""washout_head_radiation_days"":20,""target_lesion_mm"":10,""cns_history"":true,""cns_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: controlled CNS disease, single prior chemo, washout met, small target lesion (10 mm)."
NCT00046787,P013,"{""age"":49,""gender"":""M"",""diagnosis"":""Recurrent small cell lung cancer"",""prior_chemo_lines"":1,""washout_chemo_weeks"":6,""washout_radiation_weeks"":4,""washout_head_radiation_days"":12,""target_lesion_mm"":20,""cns_history"":false,""cns_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: lesion size at upper limit (20 mm), appropriate washout, no exclusion criteria."
NCT00046787,P014,"{""age"":68,""gender"":""F"",""diagnosis"":""Recurrent small cell lung cancer"",""prior_chemo_lines"":1,""washout_chemo_weeks"":7,""washout_radiation_weeks"":3,""washout_head_radiation_days"":15,""target_lesion_mm"":9,""cns_history"":true,""cns_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: one prior chemo, controlled CNS involvement, lesion ≤10 mm on spiral CT."
NCT00046787,P015,"{""age"":73,""gender"":""M"",""diagnosis"":""Recurrent small cell lung cancer"",""prior_chemo_lines"":1,""washout_chemo_weeks"":5,""washout_radiation_weeks"":4,""washout_head_radiation_days"":18,""target_lesion_mm"":16,""cns_history"":false,""cns_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: meets all inclusion criteria, no SVC syndrome, adequate washout, target lesion within limits."
NCT02606149,P011,"{""age"":64,""gender"":""M"",""diagnosis"":""Stage IV lung cancer"",""histology_confirmed"":true,""weeks_since_diagnosis"":5,""systemic_therapy_indicated"":true,""prior_systemic_therapy_metastatic"":0,""able_to_consent"":true,""social_security_affiliation"":true,""major_comorbidity_incompatible"":false}",true,"Eligible: newly diagnosed (<8 weeks), no prior systemic therapy, systemic therapy indicated, able to consent."
NCT02606149,P012,"{""age"":72,""gender"":""F"",""diagnosis"":""Stage IV lung cancer"",""histology_confirmed"":true,""weeks_since_diagnosis"":7,""systemic_therapy_indicated"":true,""prior_systemic_therapy_metastatic"":0,""able_to_consent"":true,""social_security_affiliation"":true,""major_comorbidity_incompatible"":false}",true,"Eligible: meets diagnostic window, treatment-naïve for metastatic setting, no exclusion triggers."
NCT02606149,P013,"{""age"":58,""gender"":""M"",""diagnosis"":""Stage IV lung cancer"",""histology_confirmed"":true,""weeks_since_diagnosis"":3,""systemic_therapy_indicated"":true,""prior_systemic_therapy_metastatic"":0,""able_to_consent"":true,""social_security_affiliation"":true,""major_comorbidity_incompatible"":false}",true,"Eligible: recently diagnosed, systemic therapy planned, criteria satisfied."
NCT02606149,P014,"{""age"":45,""gender"":""F"",""diagnosis"":""Stage IV lung cancer"",""histology_confirmed"":true,""weeks_since_diagnosis"":4,""systemic_therapy_indicated"":true,""prior_systemic_therapy_metastatic"":0,""able_to_consent"":true,""social_security_affiliation"":true,""major_comorbidity_incompatible"":false}",true,"Eligible: young metastatic case, indicated for treatment, no disqualifying factors."
NCT02606149,P015,"{""age"":69,""gender"":""M"",""diagnosis"":""Stage IV lung cancer"",""histology_confirmed"":true,""weeks_since_diagnosis"":6,""systemic_therapy_indicated"":true,""prior_systemic_therapy_metastatic"":0,""able_to_consent"":true,""social_security_affiliation"":true,""major_comorbidity_incompatible"":false}",true,"Eligible: all inclusion rules met and no exclusion criteria present."
NCT06838208,P011,"{""age"":65,""gender"":""M"",""sclc_stage"":""ES-SCLC"",""prior_systemic_tx_for_sclc"":false,""measurable_chest_lesion_recist11"":true,""lesion_irradiable_15gy_5f"":true,""ecog_performance_status"":0,""adequate_organ_function"":true,""active_leptomeningeal_untreated_brain_mets"":false,""prior_checkpoint_inhibitor"":false,""live_vaccine_4wks"":false,""active_autoimmune_disease"":false,""systemic_immunosuppression_14days"":false,""history_ild_pneumonitis"":false,""uncontrolled_systemic_disease"":false,""severe_active_infection_2wks"":false,""antibiotics_2wks"":false}",true,"Eligible: Newly diagnosed ES-SCLC (no prior systemic tx), measurable and irradiable chest lesion, ECOG 0, adequate function, no checkpoint inhibitor history, and meets all washout/infection/autoimmune exclusion criteria."
NCT06838208,P012,"{""age"":58,""gender"":""F"",""sclc_stage"":""ES-SCLC"",""prior_systemic_tx_for_sclc"":false,""measurable_chest_lesion_recist11"":true,""lesion_irradiable_15gy_5f"":true,""ecog_performance_status"":1,""adequate_organ_function"":true,""active_leptomeningeal_untreated_brain_mets"":false,""prior_checkpoint_inhibitor"":false,""live_vaccine_4wks"":false,""active_autoimmune_disease"":false,""systemic_immunosuppression_14days"":false,""history_ild_pneumonitis"":false,""uncontrolled_systemic_disease"":false,""severe_active_infection_2wks"":false,""antibiotics_2wks"":false}",true,"Eligible: ES-SCLC first-line, measurable and irradiable lesion, ECOG 1, no history of ILD/pneumonitis, no recent systemic antibiotics or immunosuppressants, and no prior exposure to anti-PD-1/PD-L1/CTLA-4."
NCT06838208,P013,"{""age"":72,""gender"":""M"",""sclc_stage"":""ES-SCLC"",""prior_systemic_tx_for_sclc"":false,""measurable_chest_lesion_recist11"":true,""lesion_irradiable_15gy_5f"":true,""ecog_performance_status"":1,""adequate_organ_function"":true,""active_leptomeningeal_untreated_brain_mets"":false,""prior_checkpoint_inhibitor"":false,""live_vaccine_4wks"":false,""active_autoimmune_disease"":false,""systemic_immunosuppression_14days"":false,""history_ild_pneumonitis"":false,""uncontrolled_systemic_disease"":false,""severe_active_infection_2wks"":false,""antibiotics_2wks"":false}",true,"Eligible: ES-SCLC first-line, ECOG 1, lesion meets size/irradiability criteria. No history of autoimmune disease that may relapse, no recent systemic steroids or immunosuppressants, and no active/untreated CNS disease."
NCT06838208,P014,"{""age"":45,""gender"":""F"",""sclc_stage"":""ES-SCLC"",""prior_systemic_tx_for_sclc"":false,""measurable_chest_lesion_recist11"":true,""lesion_irradiable_15gy_5f"":true,""ecog_performance_status"":0,""adequate_organ_function"":true,""active_leptomeningeal_untreated_brain_mets"":false,""prior_checkpoint_inhibitor"":false,""live_vaccine_4wks"":false,""active_autoimmune_disease"":false,""systemic_immunosuppression_14days"":false,""history_ild_pneumonitis"":false,""uncontrolled_systemic_disease"":false,""severe_active_infection_2wks"":false,""antibiotics_2wks"":false}",true,"Eligible: ES-SCLC first-line, measurable and irradiable lesion, ECOG 0, excellent organ function, no recent vaccines/antibiotics/immunosuppression, and no history of immune checkpoint inhibitor therapy."
NCT06838208,P015,"{""age"":60,""gender"":""M"",""sclc_stage"":""ES-SCLC"",""prior_systemic_tx_for_sclc"":false,""measurable_chest_lesion_recist11"":true,""lesion_irradiable_15gy_5f"":true,""ecog_performance_status"":0,""adequate_organ_function"":true,""active_leptomeningeal_untreated_brain_mets"":false,""prior_checkpoint_inhibitor"":false,""live_vaccine_4wks"":false,""active_autoimmune_disease"":false,""systemic_immunosuppression_14days"":false,""history_ild_pneumonitis"":false,""uncontrolled_systemic_disease"":false,""severe_active_infection_2wks"":false,""antibiotics_2wks"":false}",true,"Eligible: ES-SCLC first-line, measurable chest lesion capable of 15Gy/5f irradiation, ECOG 0, no exclusionary infectious diseases, no prior immunotherapy targeting checkpoint pathways, and no uncontrolled CNS disease."
NCT03778814,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""Advanced Lung Tumor"",""biopsy_obtainable"":true,""life_expectancy_weeks"":15,""child_pugh_score"":6,""adequate_organ_function"":true,""prior_gene_therapy"":false,""tumor_size_cm"":15,""severe_virus_infection_hbv_hcv_hiv"":false,""known_hiv_positivity"":false,""lung_transplantation_history"":false,""active_infectious_disease"":false,""systemic_steroid_dose_pred_mg_kg_day"":0.2,""tcr_expression_percent"":25,""killing_cytotoxicity_percent"":30,""informed_consent_signed"":true,""pregnant_or_lactating"":false}",true,"Eligible: Advanced lung tumor (biopsy obtainable), meets life expectancy/organ function/Child-Pugh criteria, tumor size $<25$cm, no prior gene therapy, HIV negative, no severe infection, steroid dose is below the exclusion limit, and key lab requirements (TCR expression/killing activity) met."
NCT03778814,P012,"{""age"":58,""gender"":""F"",""cancer_type"":""Advanced Ovarian Cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":20,""child_pugh_score"":5,""adequate_organ_function"":true,""prior_gene_therapy"":false,""tumor_size_cm"":24,""severe_virus_infection_hbv_hcv_hiv"":false,""known_hiv_positivity"":false,""lung_transplantation_history"":false,""active_infectious_disease"":false,""systemic_steroid_dose_pred_mg_kg_day"":0,""tcr_expression_percent"":20,""killing_cytotoxicity_percent"":20,""informed_consent_signed"":true,""pregnant_or_lactating"":false}",true,"Eligible: Advanced solid tumor (Ovarian Ca), tumor size 24cm (just under the 25cm exclusion), excellent Child-Pugh score, no steroid use, no history of gene therapy or lung transplant, and T-cell product meets minimum quality control (TCR expression $\ge 20\%$, killing $\ge 20\%$). Not pregnant/lactating."
NCT03778814,P013,"{""age"":72,""gender"":""M"",""cancer_type"":""Advanced Pancreatic Cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":12,""child_pugh_score"":6,""adequate_organ_function"":true,""prior_gene_therapy"":false,""tumor_size_cm"":10,""severe_virus_infection_hbv_hcv_hiv"":false,""known_hiv_positivity"":false,""lung_transplantation_history"":false,""active_infectious_disease"":false,""systemic_steroid_dose_pred_mg_kg_day"":0.3,""tcr_expression_percent"":35,""killing_cytotoxicity_percent"":40,""informed_consent_signed"":true,""pregnant_or_lactating"":false}",true,"Eligible: Advanced solid tumor (Pancreatic Ca), meets minimum life expectancy (12 weeks), Child-Pugh $<7$, adequate function. Steroid dose is allowed, no exclusionary infections, and T-cell product quality is high."
NCT03778814,P014,"{""age"":45,""gender"":""F"",""cancer_type"":""Advanced Sarcoma"",""biopsy_obtainable"":true,""life_expectancy_weeks"":30,""child_pugh_score"":5,""adequate_organ_function"":true,""prior_gene_therapy"":false,""tumor_size_cm"":5,""severe_virus_infection_hbv_hcv_hiv"":false,""known_hiv_positivity"":false,""lung_transplantation_history"":false,""active_infectious_disease"":false,""systemic_steroid_dose_pred_mg_kg_day"":0,""tcr_expression_percent"":22,""killing_cytotoxicity_percent"":25,""informed_consent_signed"":true,""pregnant_or_lactating"":false}",true,"Eligible: Advanced solid tumor (Sarcoma), small tumor size, excellent life expectancy and Child-Pugh score. T-cell product meets minimum required quality, no steroid use, and no history of exclusionary conditions like severe virus infection, gene therapy, or lung transplant."
NCT03778814,P015,"{""age"":68,""gender"":""M"",""cancer_type"":""Advanced Lung Tumor"",""biopsy_obtainable"":true,""life_expectancy_weeks"":18,""child_pugh_score"":6,""adequate_organ_function"":true,""prior_gene_therapy"":false,""tumor_size_cm"":20,""severe_virus_infection_hbv_hcv_hiv"":false,""known_hiv_positivity"":false,""lung_transplantation_history"":false,""active_infectious_disease"":false,""systemic_steroid_dose_pred_mg_kg_day"":0.4,""tcr_expression_percent"":28,""killing_cytotoxicity_percent"":35,""informed_consent_signed"":true,""pregnant_or_lactating"":false}",true,"Eligible: Advanced lung tumor, Child-Pugh $<7$, systemic steroid use is below $0.5 \text{ mg}/\text{kg}/\text{day}$ limit, tumor size 20cm (allowed), no severe infectious diseases or exclusionary history, and T-cell product quality is sufficient."
NCT03613753,P011,"{""age"":58,""gender"":""M"",""diagnosis"":""relapsed small cell lung cancer"",""first_line_therapy"":""etoposide + cisplatin"",""days_since_first_line"":45,""ecog"":1,""life_expectancy_months"":4,""neutrophils_gL"":2.1,""platelets_gL"":150,""hemoglobin_gL"":110,""bilirubin_xuln"":1.0,""ast_alt_xuln"":1.4,""creatinine_umol_L"":88,""measurable_disease"":true,""pregnant"":false,""other_malignancy"":false,""received_target_or_immunotherapy"":false} ",true,"Eligible: relapsed SCLC, correct first-line regimen, ≥30 days washout, ECOG 1, adequate labs, measurable disease, no exclusions."
NCT03613753,P012,"{""age"":64,""gender"":""F"",""diagnosis"":""relapsed small cell lung cancer"",""first_line_therapy"":""etoposide + carboplatin"",""days_since_first_line"":60,""ecog"":0,""life_expectancy_months"":5,""neutrophils_gL"":1.9,""platelets_gL"":120,""hemoglobin_gL"":105,""bilirubin_xuln"":0.9,""ast_alt_xuln"":1.2,""creatinine_umol_L"":76,""measurable_disease"":true,""pregnant"":false,""other_malignancy"":false,""received_target_or_immunotherapy"":false}",true,"Eligible: classic relapsed SCLC profile, first-line EP/EC done, adequate marrow and organ function, ECOG 0, no disqualifying treatments."
NCT03613753,P013,"{""age"":47,""gender"":""M"",""diagnosis"":""relapsed small cell lung cancer"",""first_line_therapy"":""etoposide + cisplatin"",""days_since_first_line"":35,""ecog"":1,""life_expectancy_months"":6,""neutrophils_gL"":2.7,""platelets_gL"":160,""hemoglobin_gL"":130,""bilirubin_xuln"":1.1,""ast_alt_xuln"":1.0,""creatinine_umol_L"":65,""measurable_disease"":true,""pregnant"":false,""other_malignancy"":false,""received_target_or_immunotherapy"":false}",true,"Eligible: meets all organ-function thresholds, ECOG 1, appropriate washout, measurable relapse and no contraindications."
NCT03613753,P014,"{""age"":69,""gender"":""F"",""diagnosis"":""relapsed small cell lung cancer"",""first_line_therapy"":""etoposide + carboplatin"",""days_since_first_line"":50,""ecog"":1,""life_expectancy_months"":4,""neutrophils_gL"":1.8,""platelets_gL"":140,""hemoglobin_gL"":115,""bilirubin_xuln"":1.2,""ast_alt_xuln"":1.7,""creatinine_umol_L"":92,""measurable_disease"":true,""pregnant"":false,""other_malignancy"":false,""received_target_or_immunotherapy"":false}",true,"Eligible: age within range, relapse with measurable lesions, EP/EC first-line, adequate labs, no exclusion factors."
NCT03613753,P015,"{""age"":52,""gender"":""M"",""diagnosis"":""relapsed small cell lung cancer"",""first_line_therapy"":""etoposide + cisplatin"",""days_since_first_line"":70,""ecog"":1,""life_expectancy_months"":3,""neutrophils_gL"":2.3,""platelets_gL"":110,""hemoglobin_gL"":100,""bilirubin_xuln"":1.0,""ast_alt_xuln"":1.3,""creatinine_umol_L"":99,""measurable_disease"":true,""pregnant"":false,""other_malignancy"":false,""received_target_or_immunotherapy"":false}",true,"Eligible: fully meets chemotherapy washout, ECOG, marrow and organ-function criteria with no forbidden therapies."
NCT05369312,P011,"{""age"":63,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""mutation_status"":""KRAS G12D"",""ecog"":1,""measurable_lesion"":true,""prior_standard_therapy_failed"":true,""received_shp2_inhibitor"":false,""cns_metastasis"":false,""autoimmune_disease"":false,""ild"":false,""cardiac_disease"":false,""infection"":false,""can_swallow"":true,""organ_function_adequate"":true,""pregnant"":false}",true,"Eligible: metastatic CRC with KRAS mutation, ECOG 1, measurable lesion, adequate organs, prior therapy failed, no SHP2 exposure or exclusion conditions."
NCT05369312,P012,"{""age"":54,""gender"":""F"",""diagnosis"":""locally advanced NSCLC"",""mutation_status"":""RTK amplification"",""ecog"":0,""measurable_lesion"":true,""prior_standard_therapy_failed"":true,""received_shp2_inhibitor"":false,""cns_metastasis"":false,""autoimmune_disease"":false,""ild"":false,""cardiac_disease"":false,""infection"":false,""can_swallow"":true,""organ_function_adequate"":true,""pregnant"":false}",true,"Eligible: locally advanced NSCLC with qualifying RTK alteration, ECOG 0, measurable disease, no prohibited conditions, no SHP2 inhibitor history."
NCT05369312,P013,"{""age"":48,""gender"":""M"",""diagnosis"":""metastatic pancreatic cancer"",""mutation_status"":""NF1 LOF"",""ecog"":1,""measurable_lesion"":true,""prior_standard_therapy_failed"":true,""received_shp2_inhibitor"":false,""cns_metastasis"":false,""autoimmune_disease"":false,""ild"":false,""cardiac_disease"":false,""infection"":false,""can_swallow"":true,""organ_function_adequate"":true,""pregnant"":false}",true,"Eligible: metastatic pancreatic cancer with NF1 LOF mutation, appropriate ECOG, adequate labs, no exclusions, prior therapy failed."
NCT05369312,P014,"{""age"":72,""gender"":""F"",""diagnosis"":""metastatic solid tumor (non-HCC)"",""mutation_status"":""Class-3 BRAF"",""ecog"":1,""measurable_lesion"":true,""prior_standard_therapy_failed"":true,""received_shp2_inhibitor"":false,""cns_metastasis"":false,""autoimmune_disease"":false,""ild"":false,""cardiac_disease"":false,""infection"":false,""can_swallow"":true,""organ_function_adequate"":true,""pregnant"":false}",true,"Eligible: metastatic solid tumor with Class-3 BRAF, ECOG 1, measurable lesion, adequate organ function, meets all safety requirements."
NCT05369312,P015,"{""age"":59,""gender"":""M"",""diagnosis"":""locally advanced colorectal cancer"",""mutation_status"":""RTK rearrangement"",""ecog"":0,""measurable_lesion"":true,""prior_standard_therapy_failed"":true,""received_shp2_inhibitor"":false,""cns_metastasis"":false,""autoimmune_disease"":false,""ild"":false,""cardiac_disease"":false,""infection"":false,""can_swallow"":true,""organ_function_adequate"":true,""pregnant"":false}",true,"Eligible: LA CRC with RTK rearrangement, ECOG 0, measurable disease, no prior SHP2 inhibitor, stable systemic condition, meets all criteria."
NCT02805530,P011,"{""age"":61,""gender"":""M"",""diagnosis"":""non-small cell lung cancer"",""histology"":""adenocarcinoma"",""ecog"":1,""stage"":""IV"",""oligometastatic_sites"":3,""synchronous_metastases"":true,""leukocytes_per_mm3"":4500,""platelets_per_mm3"":180000,""hemoglobin_g_dl"":12,""creatinine_mg_dl"":1.2,""bilirubin_x_uln"":1.0,""ast_alt_x_uln"":2.0,""alkaline_phosphatase_x_uln"":3.0,""candidate_platinum_chemo"":true,""pregnant"":false,""prior_treatment_for_nsclc"":false,""concurrent_uncontrolled_disease"":false}",true,"Eligible: NSCLC stage IV, ECOG 1, ≤5 metastases, synchronous, adequate labs, candidate for platinum chemo, no prior disallowed treatments."
NCT02805530,P012,"{""age"":58,""gender"":""F"",""diagnosis"":""non-small cell lung cancer"",""histology"":""squamous cell carcinoma"",""ecog"":0,""stage"":""IV"",""oligometastatic_sites"":2,""synchronous_metastases"":true,""leukocytes_per_mm3"":5200,""platelets_per_mm3"":160000,""hemoglobin_g_dl"":13,""creatinine_mg_dl"":1.0,""bilirubin_x_uln"":1.2,""ast_alt_x_uln"":2.3,""alkaline_phosphatase_x_uln"":4.0,""candidate_platinum_chemo"":true,""pregnant"":false,""prior_treatment_for_nsclc"":false,""concurrent_uncontrolled_disease"":false}",true,"Eligible: stage IV NSCLC, squamous histology, ECOG 0, oligometastatic ≤5, synchronous, labs acceptable, platinum chemo candidate."
NCT02805530,P013,"{""age"":66,""gender"":""M"",""diagnosis"":""non-small cell lung cancer"",""histology"":""large cell carcinoma"",""ecog"":1,""stage"":""IV"",""oligometastatic_sites"":4,""synchronous_metastases"":true,""leukocytes_per_mm3"":4000,""platelets_per_mm3"":150000,""hemoglobin_g_dl"":11,""creatinine_mg_dl"":1.4,""bilirubin_x_uln"":1.1,""ast_alt_x_uln"":2.5,""alkaline_phosphatase_x_uln"":2.5,""candidate_platinum_chemo"":true,""pregnant"":false,""prior_treatment_for_nsclc"":false,""concurrent_uncontrolled_disease"":false}",true,"Eligible: stage IV NSCLC, large cell histology, ECOG 1, oligometastatic 4 sites, synchronous metastases, labs within limits, platinum chemo candidate."
NCT02805530,P014,"{""age"":70,""gender"":""F"",""diagnosis"":""non-small cell lung cancer"",""histology"":""adenocarcinoma"",""ecog"":0,""stage"":""IV"",""oligometastatic_sites"":1,""synchronous_metastases"":true,""leukocytes_per_mm3"":6000,""platelets_per_mm3"":200000,""hemoglobin_g_dl"":14,""creatinine_mg_dl"":1.3,""bilirubin_x_uln"":1.0,""ast_alt_x_uln"":2.2,""alkaline_phosphatase_x_uln"":1.0,""candidate_platinum_chemo"":true,""pregnant"":false,""prior_treatment_for_nsclc"":false,""concurrent_uncontrolled_disease"":false}",true,"Eligible: NSCLC stage IV, ECOG 0, 1 oligometastatic site, synchronous, labs good, platinum chemo candidate, no prior therapy."
NCT02805530,P015,"{""age"":63,""gender"":""M"",""diagnosis"":""non-small cell lung cancer"",""histology"":""squamous cell carcinoma"",""ecog"":1,""stage"":""IV"",""oligometastatic_sites"":5,""synchronous_metastases"":true,""leukocytes_per_mm3"":3500,""platelets_per_mm3"":140000,""hemoglobin_g_dl"":10.5,""creatinine_mg_dl"":1.5,""bilirubin_x_uln"":1.3,""ast_alt_x_uln"":2.4,""alkaline_phosphatase_x_uln"":4.5,""candidate_platinum_chemo"":true,""pregnant"":false,""prior_treatment_for_nsclc"":false,""concurrent_uncontrolled_disease"":false}",true,"Eligible: stage IV NSCLC, squamous histology, ECOG 1, 5 oligometastatic sites, synchronous, labs adequate, platinum chemo candidate, no prior treatments."
NCT02669719,P011,"{""age"":60,""gender"":""M"",""diagnosis"":""stage IV non-small cell lung cancer"",""histology_subtype"":""non-squamous"",""EGFR_status"":""wild-type"",""ALK_status"":""negative"",""ecog"":1,""measurable_disease"":true,""systemic_treatment_naive"":true,""prior_therapy_recovered"":true,""WBC_10e9_L"":5.2,""neutrophils_10e9_L"":2.1,""platelets_10e9_L"":150,""hemoglobin_g_dl"":12,""bilirubin_x_uln"":1.0,""AST_ALT_x_uln"":2.5,""ALP_x_uln"":3.0,""creatinine_clearance_ml_min"":60,""contraception_compliant"":true,""pregnant"":false,""active_cns_metastases"":false,""immunodeficiency"":false,""HIV_HBV_HCV_syphilis"":false} ",true,"Eligible: stage IV NSCLC non-squamous, EGFR wild-type, ALK negative, ECOG 1, measurable, treatment naive, labs acceptable, contraception compliant, no CNS metastases or disallowed conditions."
NCT02669719,P012,"{""age"":55,""gender"":""F"",""diagnosis"":""stage IV non-small cell lung cancer"",""histology_subtype"":""non-squamous"",""EGFR_status"":""wild-type"",""ALK_status"":""negative"",""ecog"":0,""measurable_disease"":true,""systemic_treatment_naive"":true,""prior_therapy_recovered"":true,""WBC_10e9_L"":6.0,""neutrophils_10e9_L"":3.0,""platelets_10e9_L"":180,""hemoglobin_g_dl"":13,""bilirubin_x_uln"":1.2,""AST_ALT_x_uln"":2.0,""ALP_x_uln"":2.5,""creatinine_clearance_ml_min"":70,""contraception_compliant"":true,""pregnant"":false,""active_cns_metastases"":false,""immunodeficiency"":false,""HIV_HBV_HCV_syphilis"":false}",true,"Eligible: NSCLC stage IV, non-squamous, wild-type EGFR, ALK negative, ECOG 0, measurable, naive to systemic therapy, labs within range, contraception compliant."
NCT02669719,P013,"{""age"":63,""gender"":""M"",""diagnosis"":""stage IV non-small cell lung cancer"",""histology_subtype"":""non-squamous"",""EGFR_status"":""wild-type"",""ALK_status"":""negative"",""ecog"":1,""measurable_disease"":true,""systemic_treatment_naive"":true,""prior_therapy_recovered"":true,""WBC_10e9_L"":4.5,""neutrophils_10e9_L"":1.8,""platelets_10e9_L"":120,""hemoglobin_g_dl"":10.5,""bilirubin_x_uln"":1.4,""AST_ALT_x_uln"":3.0,""ALP_x_uln"":4.0,""creatinine_clearance_ml_min"":55,""contraception_compliant"":true,""pregnant"":false,""active_cns_metastases"":false,""immunodeficiency"":false,""HIV_HBV_HCV_syphilis"":false}",true,"Eligible: stage IV non-squamous NSCLC, EGFR/ALK negative, ECOG 1, measurable, naive, labs acceptable, contraception compliant, no CNS metastases."
NCT02669719,P014,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IV non-small cell lung cancer"",""histology_subtype"":""non-squamous"",""EGFR_status"":""wild-type"",""ALK_status"":""negative"",""ecog"":0,""measurable_disease"":true,""systemic_treatment_naive"":true,""prior_therapy_recovered"":true,""WBC_10e9_L"":5.5,""neutrophils_10e9_L"":2.2,""platelets_10e9_L"":140,""hemoglobin_g_dl"":11,""bilirubin_x_uln"":1.1,""AST_ALT_x_uln"":2.8,""ALP_x_uln"":3.5,""creatinine_clearance_ml_min"":65,""contraception_compliant"":true,""pregnant"":false,""active_cns_metastases"":false,""immunodeficiency"":false,""HIV_HBV_HCV_syphilis"":false}",true,"Eligible: stage IV NSCLC, non-squamous, EGFR wild-type, ALK negative, ECOG 0, measurable disease, naive, labs adequate, contraception compliant."
NCT02669719,P015,"{""age"":61,""gender"":""M"",""diagnosis"":""stage IV non-small cell lung cancer"",""histology_subtype"":""non-squamous"",""EGFR_status"":""wild-type"",""ALK_status"":""negative"",""ecog"":1,""measurable_disease"":true,""systemic_treatment_naive"":true,""prior_therapy_recovered"":true,""WBC_10e9_L"":4.8,""neutrophils_10e9_L"":2.0,""platelets_10e9_L"":160,""hemoglobin_g_dl"":12.5,""bilirubin_x_uln"":1.3,""AST_ALT_x_uln"":2.2,""ALP_x_uln"":3.0,""creatinine_clearance_ml_min"":58,""contraception_compliant"":true,""pregnant"":false,""active_cns_metastases"":false,""immunodeficiency"":false,""HIV_HBV_HCV_syphilis"":false}",true,"Eligible: stage IV non-squamous NSCLC, wild-type EGFR, ALK negative, ECOG 1, measurable disease, treatment naive, labs acceptable, contraception compliant, no exclusions."
NCT02318277,P011,"{""age"":62,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""ecog"":1,""stage"":""metastatic"",""prior_treatment_failed"":true,""immune_checkpoint_inhibitor_received"":false,""ido_inhibitor_received"":false,""autoimmune_disease"":false,""ILD_or_pneumonitis"":false,""recent_radiotherapy_weeks"":3,""recent_anticancer_med_weeks"":4,""CNS_metastases_stable"":true,""pregnant"":false}",true,"Eligible: metastatic solid tumor, failed prior treatment, no prior ICI/IDO therapy, stable CNS metastases if any, no autoimmune or ILD, radiotherapy and anticancer meds outside exclusion windows."
NCT02318277,P012,"{""age"":55,""gender"":""F"",""diagnosis"":""locally advanced NSCLC"",""ecog"":0,""stage"":""locally advanced"",""prior_treatment_failed"":true,""immune_checkpoint_inhibitor_received"":false,""ido_inhibitor_received"":false,""autoimmune_disease"":false,""ILD_or_pneumonitis"":false,""recent_radiotherapy_weeks"":4,""recent_anticancer_med_weeks"":3,""CNS_metastases_stable"":true,""pregnant"":false}",true,"Eligible: locally advanced solid tumor, prior therapy failed, ICI/IDO naive, CNS metastases stable, no autoimmune disease or ILD, outside radiation and drug exclusion windows."
NCT02318277,P013,"{""age"":68,""gender"":""M"",""diagnosis"":""metastatic pancreatic cancer"",""ecog"":1,""stage"":""metastatic"",""prior_treatment_failed"":true,""immune_checkpoint_inhibitor_received"":false,""ido_inhibitor_received"":false,""autoimmune_disease"":false,""ILD_or_pneumonitis"":false,""recent_radiotherapy_weeks"":5,""recent_anticancer_med_weeks"":4,""CNS_metastases_stable"":true,""pregnant"":false}",true,"Eligible: metastatic solid tumor, prior therapy failed, no prior ICI/IDO, CNS metastases stable if present, no autoimmune or ILD, exclusion windows respected."
NCT02318277,P014,"{""age"":59,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""ecog"":0,""stage"":""metastatic"",""prior_treatment_failed"":true,""immune_checkpoint_inhibitor_received"":false,""ido_inhibitor_received"":false,""autoimmune_disease"":false,""ILD_or_pneumonitis"":false,""recent_radiotherapy_weeks"":3,""recent_anticancer_med_weeks"":5,""CNS_metastases_stable"":true,""pregnant"":false}",true,"Eligible: metastatic solid tumor, failed prior treatment, ICI/IDO naive, CNS metastases stable, no autoimmune disease or ILD, no recent prohibited therapies."
NCT02318277,P015,"{""age"":64,""gender"":""M"",""diagnosis"":""locally advanced gastric cancer"",""ecog"":1,""stage"":""locally advanced"",""prior_treatment_failed"":true,""immune_checkpoint_inhibitor_received"":false,""ido_inhibitor_received"":false,""autoimmune_disease"":false,""ILD_or_pneumonitis"":false,""recent_radiotherapy_weeks"":6,""recent_anticancer_med_weeks"":4,""CNS_metastases_stable"":true,""pregnant"":false}",true,"Eligible: locally advanced solid tumor, prior therapy failed, ICI/IDO naive, CNS metastases treated/stable, no autoimmune disease or ILD, radiotherapy and anticancer meds outside exclusion period."
NCT00910676,P011,"{""age"":62,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""prior_chemotherapy_failed"":true,""treatment_plan"":""Cetuximab ± Irinotecan"",""pre_existing_cutaneous_toxicity"":false,""corticosteroid_contraindication"":false,""hypersensitivity_history"":false,""betamethasone_allergy"":false}",true,"Eligible: metastatic CRC, prior chemotherapy, no pre-existing skin toxicity, no contraindications to topical corticosteroids, no hypersensitivity to study drugs."
NCT00910676,P012,"{""age"":58,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""prior_chemotherapy_failed"":true,""treatment_plan"":""Erlotinib"",""pre_existing_cutaneous_toxicity"":false,""corticosteroid_contraindication"":false,""hypersensitivity_history"":false,""betamethasone_allergy"":false}",true,"Eligible: metastatic NSCLC, failed prior chemo, no pre-existing skin toxicity, no hypersensitivity or corticosteroid contraindication."
NCT00910676,P013,"{""age"":65,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""prior_chemotherapy_failed"":true,""treatment_plan"":""Cetuximab ± Irinotecan"",""pre_existing_cutaneous_toxicity"":false,""corticosteroid_contraindication"":false,""hypersensitivity_history"":false,""betamethasone_allergy"":false}",true,"Eligible: metastatic CRC, prior chemo failed, treatment with Cetuximab, skin intact, no exclusion criteria."
NCT00910676,P014,"{""age"":60,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""prior_chemotherapy_failed"":true,""treatment_plan"":""Erlotinib"",""pre_existing_cutaneous_toxicity"":false,""corticosteroid_contraindication"":false,""hypersensitivity_history"":false,""betamethasone_allergy"":false}",true,"Eligible: metastatic NSCLC, prior chemotherapy, no skin toxicity, able to receive study treatment, no hypersensitivity."
NCT00910676,P015,"{""age"":57,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""prior_chemotherapy_failed"":true,""treatment_plan"":""Cetuximab ± Irinotecan"",""pre_existing_cutaneous_toxicity"":false,""corticosteroid_contraindication"":false,""hypersensitivity_history"":false,""betamethasone_allergy"":false}",true,"Eligible: metastatic CRC, prior chemo failed, Cetuximab planned, no pre-existing cutaneous toxicity, no contraindications or allergies."
NCT03871205,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""Lung Cancer"",""prior_therapy_failed"":true,""life_expectancy_days"":120,""karnofsky_performance_status"":1,""adequate_organ_function"":true,""actively_infectious_condition"":false,""primary_immunodeficiency"":false,""concurrent_opportunistic_infections"":false,""active_systemic_infections"":false,""coagulation_disorders"":false,""active_major_medical_illness"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false}",true,"Eligible: Pathologically confirmed lung cancer, failed prior standard chemo/targeted therapy. Age 65 (within 18-70), KPS 1, life expectancy $\ge 90$ days, adequate organ function, and free from active infections, immunodeficiency, or other major medical illnesses."
NCT03871205,P012,"{""age"":45,""gender"":""F"",""cancer_type"":""NSCLC"",""prior_therapy_failed"":true,""life_expectancy_days"":200,""karnofsky_performance_status"":0,""adequate_organ_function"":true,""actively_infectious_condition"":false,""primary_immunodeficiency"":false,""concurrent_opportunistic_infections"":false,""active_systemic_infections"":false,""coagulation_disorders"":false,""active_major_medical_illness"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false}",true,"Eligible: NSCLC, failed prior therapy, excellent KPS (0), good life expectancy. Meets age and sex criteria (not pregnant/breastfeeding), and no active infections or use of other investigational agents."
NCT03871205,P013,"{""age"":70,""gender"":""M"",""cancer_type"":""SCLC"",""prior_therapy_failed"":true,""life_expectancy_days"":90,""karnofsky_performance_status"":1,""adequate_organ_function"":true,""actively_infectious_condition"":false,""primary_immunodeficiency"":false,""concurrent_opportunistic_infections"":false,""active_systemic_infections"":false,""coagulation_disorders"":false,""active_major_medical_illness"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false}",true,"Eligible: SCLC, failed prior therapy, age 70 (maximum allowed), KPS 1, meets minimum life expectancy (90 days). No actively infectious conditions, coagulation disorders, or primary immunodeficiency."
NCT03871205,P014,"{""age"":60,""gender"":""F"",""cancer_type"":""Lung Adenocarcinoma"",""prior_therapy_failed"":true,""life_expectancy_days"":150,""karnofsky_performance_status"":0,""adequate_organ_function"":true,""actively_infectious_condition"":false,""primary_immunodeficiency"":false,""concurrent_opportunistic_infections"":false,""active_systemic_infections"":false,""coagulation_disorders"":false,""active_major_medical_illness"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false}",true,"Eligible: Lung Adenocarcinoma, failed prior therapy, KPS 0, adequate organ functions, no exclusionary active infectious diseases (including hepatitis), and no other major active medical illnesses or investigational drug use."
NCT03871205,P015,"{""age"":55,""gender"":""M"",""cancer_type"":""Lung Squamous Cell Carcinoma"",""prior_therapy_failed"":true,""life_expectancy_days"":250,""karnofsky_performance_status"":1,""adequate_organ_function"":true,""actively_infectious_condition"":false,""primary_immunodeficiency"":false,""concurrent_opportunistic_infections"":false,""active_systemic_infections"":false,""coagulation_disorders"":false,""active_major_medical_illness"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false}",true,"Eligible: Lung SCC, failed prior therapy, KPS 1, excellent life expectancy, and no known history of primary immunodeficiency or coagulation disorders that would exclude the patient."
NCT04311710,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""Metastatic Melanoma"",""histology_confirmed"":true,""ajcc_stage"":""IV"",""prior_tx_melanoma"":false,""ecog_performance_status"":0,""karnofsky_performance_status"":100,""allergy_to_study_drug"":false,""contraception_followed"":false,""hcc_hepatic_encephalopathy_portal_hypertension"":false,""hcc_active_hbv_hdv_coinfection"":false,""nsclc_alk_egfr_sensitive_mutation"":false}",true,"Eligible: Metastatic Melanoma (previously untreated), histologically confirmed Stage IV, ECOG 0. No known drug allergy and meets general requirements for consent/contraception."
NCT04311710,P012,"{""age"":58,""gender"":""F"",""cancer_type"":""Metastatic NSCLC"",""histology_confirmed"":true,""stage"":""IV"",""prior_tx_nsclc"":true,""ecog_performance_status"":1,""karnofsky_performance_status"":90,""allergy_to_study_drug"":false,""contraception_followed"":true,""hcc_hepatic_encephalopathy_portal_hypertension"":false,""hcc_active_hbv_hdv_coinfection"":false,""nsclc_alk_egfr_sensitive_mutation"":true,""nsclc_alk_egfr_mutation_type"":""EGFR T790M (resistant to available TKI)""}",true,"Eligible: Metastatic NSCLC, Stage IV, ECOG 1. Has an EGFR mutation, but it is *not* sensitive to available targeted inhibitor therapy (e.g., T790M or a primary resistance mutation), thereby meeting the inclusion criteria by avoiding the exclusion."
NCT04311710,P013,"{""age"":72,""gender"":""M"",""cancer_type"":""Advanced HCC (Part 1 Arm A)"",""histology_confirmed"":true,""ecog_performance_status"":1,""karnofsky_performance_status"":80,""allergy_to_study_drug"":false,""contraception_followed"":false,""hcc_hepatic_encephalopathy_portal_hypertension"":false,""hcc_active_hbv_hdv_coinfection"":false,""nsclc_alk_egfr_sensitive_mutation"":false}",true,"Eligible: Advanced HCC, histologically confirmed, ECOG 1. No history of hepatic encephalopathy, portal hypertension, or active HBV/HDV coinfection (all HCC exclusions avoided)."
NCT04311710,P014,"{""age"":45,""gender"":""F"",""cancer_type"":""Advanced/Metastatic Urothelial Carcinoma (Part 1 Arm A)"",""histology_confirmed"":true,""ecog_performance_status"":0,""karnofsky_performance_status"":100,""allergy_to_study_drug"":false,""contraception_followed"":true,""hcc_hepatic_encephalopathy_portal_hypertension"":false,""hcc_active_hbv_hdv_coinfection"":false,""nsclc_alk_egfr_sensitive_mutation"":false}",true,"Eligible: Advanced Urothelial Carcinoma, histologically confirmed, ECOG 0. Complies with contraception, no known drug allergy, and meets general performance status."
NCT04311710,P015,"{""age"":68,""gender"":""M"",""cancer_type"":""Advanced RCC (Part 2 Arm B)"",""histology_confirmed"":true,""ecog_performance_status"":1,""karnofsky_performance_status"":70,""allergy_to_study_drug"":false,""contraception_followed"":false,""hcc_hepatic_encephalopathy_portal_hypertension"":false,""hcc_active_hbv_hdv_coinfection"":false,""nsclc_alk_egfr_sensitive_mutation"":false}",true,"Eligible: Advanced RCC, histologically confirmed, ECOG 1, KPS 70% (minimum required for RCC cohort). No known drug allergy and meets general requirements."
NCT07006727,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""Metastatic SCLC"",""dll3_positive"":true,""prior_systemic_therapy_lines"":1,""prior_platinum_chemo"":true,""prior_dll3_targeted_therapy"":true,""measurable_lesion_recist11"":true,""spect_ct_uptake"":true,""anc_x10_9_l"":1.5,""hemoglobin_g_dl"":11.0,""platelet_count_x10_9_l"":100,""qtcf_msec"":450,""egfr_ml_min"":75,""urinary_tract_obstruction"":false,""urinary_incontinence"":false,""symptomatic_cns_mets_or_leptomeningeal_disease"":false,""history_pneumonitis_grade2"":false,""prior_rlt"":false}",true,"Eligible: Metastatic SCLC (DLL3+), 1 prior line of therapy (within $\le 2$ limit), including platinum, and prior DLL3 therapy is allowed for SCLC. Meets all hematologic, cardiac (QTcF $<470$ msec), and renal (eGFR $\ge 60$) lab criteria. Lesion is measurable and shows target uptake, no severe pulmonary or CNS exclusion."
NCT07006727,P012,"{""age"":58,""gender"":""F"",""cancer_type"":""LCNEC of the lung (Dose Escalation)"",""dll3_positive"":true,""prior_systemic_therapy_lines"":1,""prior_platinum_chemo"":true,""prior_dll3_targeted_therapy"":false,""measurable_lesion_recist11"":true,""spect_ct_uptake"":true,""anc_x10_9_l"":2.0,""hemoglobin_g_dl"":10.0,""platelet_count_x10_9_l"":150,""qtcf_msec"":440,""egfr_ml_min"":80,""urinary_tract_obstruction"":false,""urinary_incontinence"":false,""symptomatic_cns_mets_or_leptomeningeal_disease"":false,""history_pneumonitis_grade2"":false,""prior_rlt"":false}",true,"Eligible: LCNEC (Dose Escalation), DLL3+, 1 prior platinum-containing line. Excellent organ function (eGFR, blood counts, QTcF), no history of Grade $\ge 2$ pneumonitis, and no symptomatic/untreated CNS disease."
NCT07006727,P013,"{""age"":72,""gender"":""M"",""cancer_type"":""NEPC (Dose Expansion)"",""dll3_positive"":true,""ne_differentiation_confirmed"":true,""prior_systemic_therapy_lines"":2,""prior_platinum_chemo"":true,""prior_dll3_targeted_therapy"":false,""measurable_lesion_recist11"":true,""spect_ct_uptake"":true,""anc_x10_9_l"":1.0,""hemoglobin_g_dl"":9.0,""platelet_count_x10_9_l"":75,""qtcf_msec"":460,""egfr_ml_min"":60,""urinary_tract_obstruction"":false,""urinary_incontinence"":false,""symptomatic_cns_mets_or_leptomeningeal_disease"":false,""history_pneumonitis_grade2"":false,""prior_rlt"":true,""prior_rlt_type"":""PSMA-targeted, Lu-177-based RLT""}",true,"Eligible: NEPC (Dose Expansion), DLL3+, 2 prior lines (max allowed), minimal hematologic/renal function (meets $\ge$ thresholds), prior Lu-177 PSMA-targeted RLT is allowed for NEPC. Lesion is measurable with SPECT/CT uptake, and no urinary/CNS/pulmonary contraindications."
NCT07006727,P014,"{""age"":45,""gender"":""F"",""cancer_type"":""GEP-NEC (Dose Expansion)"",""dll3_positive"":true,""prior_systemic_therapy_lines"":1,""prior_platinum_chemo"":true,""prior_dll3_targeted_therapy"":false,""measurable_lesion_recist11"":true,""spect_ct_uptake"":true,""anc_x10_9_l"":3.0,""hemoglobin_g_dl"":14.0,""platelet_count_x10_9_l"":200,""qtcf_msec"":430,""egfr_ml_min"":90,""urinary_tract_obstruction"":false,""urinary_incontinence"":false,""symptomatic_cns_mets_or_leptomeningeal_disease"":false,""history_pneumonitis_grade2"":false,""prior_rlt"":false}",true,"Eligible: GEP-NEC (Dose Expansion), DLL3+, 1 prior platinum line. Excellent lab parameters, measurable lesion with required SPECT/CT uptake, and no prior RLT (not allowed for GEP-NEC). No exclusionary cardiac or CNS conditions."
NCT07006727,P015,"{""age"":60,""gender"":""M"",""cancer_type"":""Metastatic SCLC"",""dll3_positive"":true,""prior_systemic_therapy_lines"":2,""prior_platinum_chemo"":true,""prior_dll3_targeted_therapy"":true,""measurable_lesion_recist11"":true,""spect_ct_uptake"":true,""anc_x10_9_l"":1.2,""hemoglobin_g_dl"":9.5,""platelet_count_x10_9_l"":80,""qtcf_msec"":465,""egfr_ml_min"":65,""urinary_tract_obstruction"":false,""urinary_incontinence"":false,""symptomatic_cns_mets_or_leptomeningeal_disease"":false,""history_pneumonitis_grade2"":false,""prior_rlt"":false}",true,"Eligible: Metastatic SCLC, DLL3+, 2 prior lines (max allowed), including platinum and prior DLL3-targeted therapy. All hematologic/renal/cardiac parameters are within limits, and no unmanageable urinary or CNS issues."
NCT04306900,P011,"{""age"":65,""gender"":""M"",""tumor_type"":""Metastatic Colorectal Cancer"",""histology_confirmed"":true,""unresectable_or_metastatic"":true,""life_expectancy_weeks"":15,""ecog_performance_status"":1,""allergy_hypersensitivity_study_drug"":false,""severe_hypersensitivity_mab"":false,""investigational_agent_washout_days"":29,""high_dose_systemic_steroid_immunosuppressive_therapy"":false,""severe_autoimmune_disease_history"":false,""uncontrolled_intercurrent_illness"":false,""other_active_malignancy_requiring_tx"":false}",true,"Eligible: Histologically confirmed metastatic solid tumor, ECOG 1, life expectancy $>12$ weeks, adequate washout for investigational agents ($>28$ days), and no history of severe hypersensitivity, severe autoimmune disease, or active major medical illnesses/malignancy."
NCT04306900,P012,"{""age"":58,""gender"":""F"",""tumor_type"":""Unresectable Ovarian Cancer"",""histology_confirmed"":true,""unresectable_or_metastatic"":true,""life_expectancy_weeks"":30,""ecog_performance_status"":0,""allergy_hypersensitivity_study_drug"":false,""severe_hypersensitivity_mab"":false,""investigational_agent_washout_days"":50,""high_dose_systemic_steroid_immunosuppressive_therapy"":false,""severe_autoimmune_disease_history"":false,""uncontrolled_intercurrent_illness"":false,""other_active_malignancy_requiring_tx"":false}",true,"Eligible: Histologically confirmed unresectable solid tumor, ECOG 0, excellent life expectancy, long washout period. No history of allergy to MABs or severe autoimmune disease."
NCT04306900,P013,"{""age"":72,""gender"":""M"",""tumor_type"":""Metastatic NSCLC"",""histology_confirmed"":true,""unresectable_or_metastatic"":true,""life_expectancy_weeks"":12,""ecog_performance_status"":1,""allergy_hypersensitivity_study_drug"":false,""severe_hypersensitivity_mab"":false,""investigational_agent_washout_days"":28,""high_dose_systemic_steroid_immunosuppressive_therapy"":false,""severe_autoimmune_disease_history"":false,""uncontrolled_intercurrent_illness"":false,""other_active_malignancy_requiring_tx"":false}",true,"Eligible: Metastatic NSCLC, life expectancy meets minimum (12 weeks), washout period is exactly 28 days (meets $\ge 28$ days), no high-dose systemic steroids or other immunosuppressive therapies."
NCT04306900,P014,"{""age"":45,""gender"":""F"",""tumor_type"":""Unresectable Head and Neck SCC"",""histology_confirmed"":true,""unresectable_or_metastatic"":true,""life_expectancy_weeks"":20,""ecog_performance_status"":0,""allergy_hypersensitivity_study_drug"":false,""severe_hypersensitivity_mab"":false,""investigational_agent_washout_days"":40,""high_dose_systemic_steroid_immunosuppressive_therapy"":false,""severe_autoimmune_disease_history"":false,""uncontrolled_intercurrent_illness"":false,""other_active_malignancy_requiring_tx"":false}",true,"Eligible: Unresectable solid tumor, ECOG 0, no use of steroids/immunosuppressants, no history of severe autoimmune disease, and no other active malignancy requiring ongoing treatment."
NCT04306900,P015,"{""age"":68,""gender"":""M"",""tumor_type"":""Metastatic Gastric Cancer"",""histology_confirmed"":true,""unresectable_or_metastatic"":true,""life_expectancy_weeks"":18,""ecog_performance_status"":1,""allergy_hypersensitivity_study_drug"":false,""severe_hypersensitivity_mab"":false,""investigational_agent_washout_days"":35,""high_dose_systemic_steroid_immunosuppressive_therapy"":false,""severe_autoimmune_disease_history"":false,""uncontrolled_intercurrent_illness"":false,""other_active_malignancy_requiring_tx"":false}",true,"Eligible: Metastatic solid tumor, ECOG 1, washout met, no uncontrolled intercurrent illness, no history of severe allergy to monoclonal antibodies, and meets all other inclusion criteria."
NCT01487499,P011,"{""age"":58,""gender"":""F"",""diagnosis"":""limited stage SCLC"",""disease_status"":""completed standard care, responder"",""disseminated_disease"":false,""cns_metastasis"":true,""recurrent_disease"":false,""central_tumor_obstruction"":false,""mediastinal_hilar_recurrence"":false,""prior_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false,""english_speaking"":true}",true,"Eligible: Limited stage SCLC completed standard care, responder with only CNS metastasis, no disseminated disease, suitable for bronchoscopy."
NCT01487499,P012,"{""age"":65,""gender"":""M"",""diagnosis"":""recurrent disseminated SCLC"",""disease_status"":""recurrent after standard care"",""disseminated_disease"":true,""cns_metastasis"":false,""recurrent_disease"":true,""central_tumor_obstruction"":true,""mediastinal_hilar_recurrence"":false,""prior_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false,""english_speaking"":true}",true,"Eligible: Recurrent disseminated SCLC with central tumor obstruction symptoms, no prior intratumoral cisplatin, bronchoscopy appropriate."
NCT01487499,P013,"{""age"":47,""gender"":""F"",""diagnosis"":""recurrent limited stage SCLC"",""disease_status"":""recurrent after standard care"",""disseminated_disease"":false,""cns_metastasis"":false,""recurrent_disease"":true,""central_tumor_obstruction"":false,""mediastinal_hilar_recurrence"":true,""prior_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false,""english_speaking"":true}",true,"Eligible: Recurrent limited stage SCLC with mediastinal/hilar recurrence, no prior intratumoral cisplatin, bronchoscopy feasible."
NCT01487499,P014,"{""age"":72,""gender"":""M"",""diagnosis"":""limited stage SCLC"",""disease_status"":""completed standard care, responder"",""disseminated_disease"":false,""cns_metastasis"":false,""recurrent_disease"":false,""central_tumor_obstruction"":false,""mediastinal_hilar_recurrence"":false,""prior_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false,""english_speaking"":true}",true,"Eligible: Limited stage SCLC completed standard treatment, responder with no disseminated disease, low bronchoscopy risk."
NCT01487499,P015,"{""age"":61,""gender"":""F"",""diagnosis"":""recurrent disseminated SCLC"",""disease_status"":""recurrent after standard care"",""disseminated_disease"":true,""cns_metastasis"":true,""recurrent_disease"":true,""central_tumor_obstruction"":true,""mediastinal_hilar_recurrence"":false,""prior_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false,""english_speaking"":true}",true,"Eligible: Recurrent disseminated SCLC with CNS mets and central obstruction, meets all inclusion criteria for bronchoscopic therapy."
NCT05450692,P011,"{""age"":64,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""histology_confirmed"":true,""stage"":""metastatic"",""egfr_wild_type"":true,""alk_wild_type"":true,""radiological_progression"":true,""prior_anti_pd_l1"":true,""prior_platinum_doublet"":true,""treatment_line"":2,""ecog_ps"":1,""adequate_organ_function"":true,""life_expectancy_weeks"":16,""body_weight_kg"":68,""cancer_cachexia"":false,""mixed_histology"":false,""prior_malignancy_5y"":false,""persistent_toxicity_grade"":1,""autoimmune_disorder"":false,""prior_anti_pd_l1_lines"":1,""prior_platinum_lines_metastatic"":1,""prior_atr_inhibitor"":false,""prior_immune_ae_grade"":0,""immune_discontinuation"":false,""additional_immunosuppression"":false,""current_corticosteroids_mg"":0,""contraception_used"":true}",true,"Eligible: Metastatic NSCLC with EGFR/ALK wild-type, progressed after 1st line anti-PD-L1+platinum, ECOG 1, adequate organs, no significant immune toxicities."
NCT05450692,P012,"{""age"":58,""gender"":""F"",""diagnosis"":""locally advanced NSCLC"",""histology_confirmed"":true,""stage"":""locally advanced"",""egfr_wild_type"":true,""alk_wild_type"":true,""radiological_progression"":true,""prior_anti_pd_l1"":true,""prior_platinum_doublet"":true,""treatment_line"":2,""ecog_ps"":0,""adequate_organ_function"":true,""life_expectancy_weeks"":20,""body_weight_kg"":72,""cancer_cachexia"":false,""mixed_histology"":false,""prior_malignancy_5y"":false,""persistent_toxicity_grade"":1,""autoimmune_disorder"":false,""prior_anti_pd_l1_lines"":1,""prior_platinum_lines_metastatic"":1,""prior_atr_inhibitor"":false,""prior_immune_ae_grade"":1,""immune_discontinuation"":false,""additional_immunosuppression"":false,""current_corticosteroids_mg"":0,""contraception_used"":true}",true,"Eligible: Locally advanced NSCLC with progression after 1st line immunotherapy+chemo, excellent performance status, only grade 1 immune AEs resolved."
NCT05450692,P013,"{""age"":71,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""histology_confirmed"":true,""stage"":""metastatic"",""egfr_wild_type"":true,""alk_wild_type"":true,""radiological_progression"":true,""prior_anti_pd_l1"":true,""prior_platinum_doublet"":true,""treatment_line"":3,""ecog_ps"":1,""adequate_organ_function"":true,""life_expectancy_weeks"":14,""body_weight_kg"":65,""cancer_cachexia"":false,""mixed_histology"":false,""prior_malignancy_5y"":false,""persistent_toxicity_grade"":0,""autoimmune_disorder"":false,""prior_anti_pd_l1_lines"":1,""prior_platinum_lines_metastatic"":1,""prior_atr_inhibitor"":false,""prior_immune_ae_grade"":0,""immune_discontinuation"":false,""additional_immunosuppression"":false,""current_corticosteroids_mg"":0,""contraception_used"":true}",true,"Eligible: Third-line candidate with single lines of prior anti-PD-L1 and platinum, no persistent toxicities, adequate weight and organ function."
NCT05450692,P014,"{""age"":52,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""histology_confirmed"":true,""stage"":""metastatic"",""egfr_wild_type"":true,""alk_wild_type"":true,""radiological_progression"":true,""prior_anti_pd_l1"":true,""prior_platinum_doublet"":true,""treatment_line"":2,""ecog_ps"":0,""adequate_organ_function"":true,""life_expectancy_weeks"":18,""body_weight_kg"":61,""cancer_cachexia"":false,""mixed_histology"":false,""prior_malignancy_5y"":false,""persistent_toxicity_grade"":1,""autoimmune_disorder"":false,""prior_anti_pd_l1_lines"":1,""prior_platinum_lines_metastatic"":1,""prior_atr_inhibitor"":false,""prior_immune_ae_grade"":2,""immune_discontinuation"":false,""additional_immunosuppression"":false,""current_corticosteroids_mg"":0,""contraception_used"":true}",true,"Eligible: Good candidate with grade 2 immune AEs that resolved completely, single prior immunotherapy line, no treatment discontinuation."
NCT05450692,P015,"{""age"":67,""gender"":""M"",""diagnosis"":""locally advanced NSCLC"",""histology_confirmed"":true,""stage"":""locally advanced"",""egfr_wild_type"":true,""alk_wild_type"":true,""radiological_progression"":true,""prior_anti_pd_l1"":true,""prior_platinum_doublet"":true,""treatment_line"":2,""ecog_ps"":1,""adequate_organ_function"":true,""life_expectancy_weeks"":15,""body_weight_kg"":74,""cancer_cachexia"":false,""mixed_histology"":false,""prior_malignancy_5y"":true,""prior_malignancy_details"":""prostate cancer treated 7 years ago"",""persistent_toxicity_grade"":0,""autoimmune_disorder"":false,""prior_anti_pd_l1_lines"":1,""prior_platinum_lines_metastatic"":1,""prior_atr_inhibitor"":false,""prior_immune_ae_grade"":1,""immune_discontinuation"":false,""additional_immunosuppression"":false,""current_corticosteroids_mg"":0,""contraception_used"":true}",true,"Eligible: Prior malignancy >5 years ago with curative intent, meets all NSCLC criteria: wild-type EGFR/ALK, progression after 1st line combo therapy."
NCT01064466,P011,"{""age"":58,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""biopsy_suitable"":true,""biopsy_adequate"":true,""measurable_disease"":true,""adequate_organ_function"":true,""ecog_ps"":1,""pneumonectomy"":false,""other_cancer_therapies"":false,""pregnant"":false,""breastfeeding"":false,""serious_comorbidities"":false,""multiple_cancers"":false,""drug_allergy"":false,""bleeding_tendency"":false,""prior_etoposide_toxicity"":false,""able_to_swallow"":true,""consent_signed"":true,""blood_draw_agreed"":true,""treatment_duration_days"":50}",true,"Eligible: SCLC with confirmed adequate biopsy, measurable disease, good organ function, no exclusions, suitable for 50-day etoposide treatment."
NCT01064466,P012,"{""age"":45,""gender"":""F"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""biopsy_suitable"":true,""biopsy_adequate"":true,""measurable_disease"":true,""adequate_organ_function"":true,""ecog_ps"":0,""pneumonectomy"":false,""other_cancer_therapies"":false,""pregnant"":false,""breastfeeding"":false,""serious_comorbidities"":false,""multiple_cancers"":false,""drug_allergy"":false,""bleeding_tendency"":false,""prior_etoposide_toxicity"":false,""able_to_swallow"":true,""consent_signed"":true,""blood_draw_agreed"":true,""treatment_duration_days"":60}",true,"Eligible: Young SCLC patient with excellent performance status, adequate biopsy tissue, no contraindications, compliant with study requirements."
NCT01064466,P013,"{""age"":67,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""biopsy_suitable"":true,""biopsy_adequate"":true,""measurable_disease"":true,""adequate_organ_function"":true,""ecog_ps"":1,""pneumonectomy"":false,""other_cancer_therapies"":false,""pregnant"":false,""breastfeeding"":false,""serious_comorbidities"":false,""multiple_cancers"":false,""drug_allergy"":false,""bleeding_tendency"":false,""prior_etoposide_toxicity"":false,""able_to_swallow"":true,""consent_signed"":true,""blood_draw_agreed"":true,""treatment_duration_days"":55}",true,"Eligible: Older SCLC patient meets all criteria - adequate biopsy, measurable disease, good organ function, no surgical or therapy exclusions."
NCT01064466,P014,"{""age"":52,""gender"":""F"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""biopsy_suitable"":true,""biopsy_adequate"":true,""measurable_disease"":true,""adequate_organ_function"":true,""ecog_ps"":1,""pneumonectomy"":false,""other_cancer_therapies"":false,""pregnant"":false,""breastfeeding"":false,""serious_comorbidities"":false,""multiple_cancers"":false,""drug_allergy"":false,""bleeding_tendency"":false,""prior_etoposide_toxicity"":false,""able_to_swallow"":true,""consent_signed"":true,""blood_draw_agreed"":true,""treatment_duration_days"":48}",true,"Eligible: Middle-aged SCLC patient with all inclusion criteria met, no exclusion factors, compliant with biopsy and blood draw requirements."
NCT01064466,P015,"{""age"":61,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""biopsy_suitable"":true,""biopsy_adequate"":true,""measurable_disease"":true,""adequate_organ_function"":true,""ecog_ps"":0,""pneumonectomy"":false,""other_cancer_therapies"":false,""pregnant"":false,""breastfeeding"":false,""serious_comorbidities"":false,""multiple_cancers"":false,""drug_allergy"":false,""bleeding_tendency"":false,""prior_etoposide_toxicity"":false,""able_to_swallow"":true,""consent_signed"":true,""blood_draw_agreed"":true,""treatment_duration_days"":52}",true,"Eligible: Ideal candidate with excellent performance status, confirmed SCLC biopsy, measurable disease, and willingness to complete full treatment duration."
NCT00375245,P011,"{""age"":62,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""histology_confirmed"":true,""stage"":""metastatic"",""unresectable"":true,""standard_options_exhausted"":true,""weeks_since_chemo"":6,""weeks_since_radiation"":7,""ecog_ps"":1,""life_expectancy_months"":4,""wbc_count"":4800,""anc"":2100,""platelets"":145000,""bilirubin_normal"":true,""ast_alt_2.5x_uln"":false,""triglycerides_mg_dl"":180,""creatinine_normal"":true,""recent_transfusion"":false,""brain_metastases"":false,""rapamycin_allergy"":false,""gi_malabsorption"":false,""uncontrolled_illness"":false,""immunodeficiency"":false,""hiv_art"":false,""prohibited_medications"":false,""contraception_used"":true,""consent_signed"":true}",true,"Eligible: Metastatic solid tumor with exhausted options, adequate washout, normal organ function, no CNS mets, no drug interactions."
NCT00375245,P012,"{""age"":45,""gender"":""F"",""diagnosis"":""follicular lymphoma"",""histology_confirmed"":true,""stage"":""metastatic"",""unresectable"":true,""standard_options_exhausted"":true,""weeks_since_chemo"":5,""weeks_since_radiation"":0,""ecog_ps"":1,""life_expectancy_months"":5,""wbc_count"":3200,""anc"":1200,""platelets"":68000,""bilirubin_normal"":true,""ast_alt_2.5x_uln"":false,""triglycerides_mg_dl"":220,""creatinine_normal"":true,""recent_transfusion"":false,""brain_metastases"":false,""rapamycin_allergy"":false,""gi_malabsorption"":false,""uncontrolled_illness"":false,""immunodeficiency"":false,""hiv_art"":false,""prohibited_medications"":false,""contraception_used"":true,""consent_signed"":true}",true,"Eligible: Hematologic malignancy meets phase IB criteria with adequate blood counts (ANC≥1000, PLT≥50K), no exclusions, proper washout."
NCT00375245,P013,"{""age"":58,""gender"":""M"",""diagnosis"":""pancreatic adenocarcinoma"",""histology_confirmed"":true,""stage"":""unresectable"",""unresectable"":true,""standard_options_exhausted"":true,""weeks_since_chemo"":8,""weeks_since_radiation"":10,""ecog_ps"":2,""life_expectancy_months"":6,""wbc_count"":4100,""anc"":1900,""platelets"":112000,""bilirubin_normal"":true,""ast_alt_2.5x_uln"":true,""ast_alt_value"":2.2,""triglycerides_mg_dl"":350,""creatinine_normal"":true,""recent_transfusion"":false,""brain_metastases"":false,""rapamycin_allergy"":false,""gi_malabsorption"":false,""uncontrolled_illness"":false,""immunodeficiency"":false,""hiv_art"":false,""prohibited_medications"":false,""contraception_used"":true,""consent_signed"":true}",true,"Eligible: Unresectable pancreatic cancer with adequate washout, acceptable liver enzymes (≤2.5x ULN), triglycerides controlled, no contraindications."
NCT00375245,P014,"{""age"":67,""gender"":""F"",""diagnosis"":""multiple myeloma"",""histology_confirmed"":true,""stage"":""metastatic"",""unresectable"":true,""standard_options_exhausted"":true,""weeks_since_chemo"":7,""weeks_since_radiation"":0,""ecog_ps"":1,""life_expectancy_months"":7,""wbc_count"":2800,""anc"":1100,""platelets"":75000,""bilirubin_normal"":true,""ast_alt_2.5x_uln"":false,""triglycerides_mg_dl"":280,""creatinine_clearance_ml_min"":65,""creatinine_above_normal"":true,""recent_transfusion"":false,""brain_metastases"":false,""rapamycin_allergy"":false,""gi_malabsorption"":false,""uncontrolled_illness"":false,""immunodeficiency"":false,""hiv_art"":false,""prohibited_medications"":false,""contraception_used"":true,""consent_signed"":true}",true,"Eligible: Multiple myeloma meets hematologic criteria, adequate renal function (CrCl≥60), proper washout, no prohibited medications or conditions."
NCT00375245,P015,"{""age"":53,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""histology_confirmed"":true,""stage"":""metastatic"",""unresectable"":true,""standard_options_exhausted"":true,""weeks_since_chemo"":9,""weeks_since_radiation"":8,""ecog_ps"":0,""life_expectancy_months"":8,""wbc_count"":5200,""anc"":2400,""platelets"":165000,""bilirubin_normal"":true,""ast_alt_2.5x_uln"":false,""triglycerides_mg_dl"":190,""creatinine_normal"":true,""recent_transfusion"":false,""brain_metastases"":false,""rapamycin_allergy"":false,""gi_malabsorption"":false,""uncontrolled_illness"":false,""immunodeficiency"":false,""hiv_art"":false,""prohibited_medications"":false,""contraception_used"":true,""consent_signed"":true}",true,"Eligible: Excellent performance status with metastatic melanoma, all organ functions normal, adequate treatment washout, no drug interactions or contraindications."
NCT00475657,P011,"{""age"":59,""gender"":""M"",""diagnosis"":""small cell lung cancer, extended disease"",""histology_confirmed"":true,""ecog_ps"":1,""prior_chemotherapy"":false,""prior_immunotherapy"":false,""prior_biologic_therapy"":false,""prior_radiation"":""bone marrow <25%"",""measurable_disease"":true,""adequate_organ_function"":true,""life_expectancy_weeks"":16,""contraception_used"":true,""trial_compliant"":true,""informed_consent"":true,""mixed_histology"":false,""active_infection"":false,""severe_cardiac_disease"":false,""yellow_fever_vaccine"":false,""prior_malignancy"":false,""cns_metastases"":false,""third_space_fluid"":false,""significant_weight_loss"":false,""concurrent_anti_tumor"":false,""severe_renal_failure"":false,""nsaids_use"":false,""able_take_folic_acid"":true,""able_take_b12"":true,""able_take_corticoids"":true}",true,"Eligible: Treatment-naive extensive stage SCLC, good performance status, no prior malignancies, compliant with vitamin supplements and follow-up requirements."
NCT00475657,P012,"{""age"":64,""gender"":""F"",""diagnosis"":""small cell lung cancer, extended disease"",""histology_confirmed"":true,""ecog_ps"":0,""prior_chemotherapy"":false,""prior_immunotherapy"":false,""prior_biologic_therapy"":false,""prior_radiation"":""none"",""measurable_disease"":true,""adequate_organ_function"":true,""life_expectancy_weeks"":20,""contraception_used"":true,""trial_compliant"":true,""informed_consent"":true,""mixed_histology"":false,""active_infection"":false,""severe_cardiac_disease"":false,""yellow_fever_vaccine"":false,""prior_malignancy"":false,""cns_metastases"":true,""cns_metastases_status"":""treated and stable, no corticosteroids"",""third_space_fluid"":false,""significant_weight_loss"":false,""concurrent_anti_tumor"":false,""severe_renal_failure"":false,""nsaids_use"":false,""able_take_folic_acid"":true,""able_take_b12"":true,""able_take_corticoids"":true}",true,"Eligible: Treatment-naive SCLC with treated stable CNS metastases (no corticosteroids), excellent performance status, compliant with all study requirements."
NCT00475657,P013,"{""age"":47,""gender"":""M"",""diagnosis"":""small cell lung cancer, extended disease"",""histology_confirmed"":true,""ecog_ps"":2,""prior_chemotherapy"":false,""prior_immunotherapy"":false,""prior_biologic_therapy"":false,""prior_radiation"":""bone marrow <25%"",""measurable_disease"":true,""adequate_organ_function"":true,""life_expectancy_weeks"":14,""contraception_used"":true,""trial_compliant"":true,""informed_consent"":true,""mixed_histology"":false,""active_infection"":false,""severe_cardiac_disease"":false,""yellow_fever_vaccine"":false,""prior_malignancy"":false,""cns_metastases"":false,""third_space_fluid"":false,""significant_weight_loss"":false,""concurrent_anti_tumor"":false,""severe_renal_failure"":false,""nsaids_use"":false,""able_take_folic_acid"":true,""able_take_b12"":true,""able_take_corticoids"":true}",true,"Eligible: Chemotherapy-naive extensive SCLC with acceptable ECOG 2, limited prior radiation, adequate organ function, willing to take required supplements."
NCT00475657,P014,"{""age"":71,""gender"":""F"",""diagnosis"":""small cell lung cancer, extended disease"",""histology_confirmed"":true,""ecog_ps"":1,""prior_chemotherapy"":false,""prior_immunotherapy"":false,""prior_biologic_therapy"":false,""prior_radiation"":""none"",""measurable_disease"":true,""adequate_organ_function"":true,""life_expectancy_weeks"":15,""contraception_used"":true,""trial_compliant"":true,""informed_consent"":true,""mixed_histology"":false,""active_infection"":false,""severe_cardiac_disease"":false,""yellow_fever_vaccine"":false,""prior_malignancy"":false,""cns_metastases"":false,""third_space_fluid"":false,""significant_weight_loss"":5,""concurrent_anti_tumor"":false,""severe_renal_failure"":false,""nsaids_use"":false,""able_take_folic_acid"":true,""able_take_b12"":true,""able_take_corticoids"":true}",true,"Eligible: Treatment-naive elderly patient with minimal weight loss (<10%), good organ function, no exclusion criteria, compliant with study medications."
NCT00475657,P015,"{""age"":56,""gender"":""M"",""diagnosis"":""small cell lung cancer, extended disease"",""histology_confirmed"":true,""ecog_ps"":1,""prior_chemotherapy"":false,""prior_immunotherapy"":false,""prior_biologic_therapy"":false,""prior_radiation"":""none"",""measurable_disease"":true,""adequate_organ_function"":true,""life_expectancy_weeks"":18,""contraception_used"":true,""trial_compliant"":true,""informed_consent"":true,""mixed_histology"":false,""active_infection"":false,""severe_cardiac_disease"":false,""yellow_fever_vaccine"":false,""prior_malignancy"":false,""cns_metastases"":true,""cns_metastases_status"":""treated and stable without corticosteroids"",""third_space_fluid"":false,""significant_weight_loss"":false,""concurrent_anti_tumor"":false,""severe_renal_failure"":false,""nsaids_use"":false,""able_take_folic_acid"":true,""able_take_b12"":true,""able_take_corticoids"":true}",true,"Eligible: First-line extensive SCLC candidate with stable treated brain metastases, no prior therapies, compliant with all vitamin and medication requirements."
NCT01944137,P011,"{""age"":52,""gender"":""F"",""diagnosis"":""stage II breast cancer"",""cancer_type"":""breast cancer"",""stage"":""II"",""metastatic"":false,""treatment_plan"":""neoadjuvant chemotherapy"",""chemotherapy_scheduled"":true,""curative_intent"":true,""prior_chemotherapy_cycles"":0,""english_fluent"":true,""willing_to_participate"":true}",true,"Eligible: Newly diagnosed stage II breast cancer scheduled for first-cycle neoadjuvant chemotherapy, English-speaking, willing participant."
NCT01944137,P012,"{""age"":64,""gender"":""M"",""diagnosis"":""stage III colorectal cancer"",""cancer_type"":""colorectal cancer"",""stage"":""III"",""metastatic"":false,""treatment_plan"":""adjuvant chemotherapy"",""chemotherapy_scheduled"":true,""curative_intent"":true,""prior_chemotherapy_cycles"":0,""english_fluent"":true,""willing_to_participate"":true}",true,"Eligible: New stage III colorectal cancer post-surgery, scheduled for first adjuvant chemotherapy cycle, meets all inclusion criteria."
NCT01944137,P013,"{""age"":58,""gender"":""F"",""diagnosis"":""stage I non-small cell lung cancer"",""cancer_type"":""NSCLC"",""stage"":""I"",""metastatic"":false,""treatment_plan"":""adjuvant chemotherapy"",""chemotherapy_scheduled"":true,""curative_intent"":true,""prior_chemotherapy_cycles"":0,""english_fluent"":true,""willing_to_participate"":true}",true,"Eligible: Early stage I NSCLC scheduled for first-cycle adjuvant chemotherapy after resection, English-proficient, consenting."
NCT01944137,P014,"{""age"":47,""gender"":""M"",""diagnosis"":""stage III non-small cell lung cancer"",""cancer_type"":""NSCLC"",""stage"":""III"",""metastatic"":false,""treatment_plan"":""neoadjuvant chemotherapy"",""chemotherapy_scheduled"":true,""curative_intent"":true,""prior_chemotherapy_cycles"":0,""english_fluent"":true,""willing_to_participate"":true}",true,"Eligible: Locally advanced stage III NSCLC scheduled for neoadjuvant chemotherapy as first treatment, meets all study requirements."
NCT01944137,P015,"{""age"":61,""gender"":""F"",""diagnosis"":""stage II colorectal cancer"",""cancer_type"":""colorectal cancer"",""stage"":""II"",""metastatic"":false,""treatment_plan"":""adjuvant chemotherapy"",""chemotherapy_scheduled"":true,""curative_intent"":true,""prior_chemotherapy_cycles"":0,""english_fluent"":true,""willing_to_participate"":true}",true,"Eligible: Stage II colorectal cancer post-resection, scheduled for first adjuvant chemotherapy cycle, English-speaking and compliant."
NCT03501056,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""Advanced Lung Cancer"",""muc1_positive"":true,""measurable_tumor_size_mm"":25,""cannot_tolerate_standard_tx"":true,""adjuvant_chemo_washout_wks"":5,""surgery_washout_mos"":4,""radiotherapy_washout_wks"":5,""expected_survival_wks"":15,""antitumor_drugs_washout_wks"":4,""serious_disease_conflicts"":false,""ascites_grade"":""mild"",""second_primary_tumor"":false,""t_cell_lymphoma_myeloma_immunosuppressants"":false,""systemic_autoimmune_allergies_immunocompromised"":false,""chronic_disease_stimulant_hormone_tx"":false,""active_bleeding_coagulant_abnormality"":false,""brain_dura_mets_psychogenic"":false,""gi_bleeding_6mo"":false,""severe_esophageal_varices_intervention"":false,""abdominal_complications_4wks"":false,""hiv_positive"":false,""contrast_allergy_ct_mri"":false,""experimental_drugs_4wks"":false,""pregnant_breastfeeding_contraception"":true}",true,"Eligible: Advanced lung cancer (MUC1+), measurable disease, unable to tolerate standard therapies. Meets all washout periods (chemo, RT, surgery, antitumor drugs), no moderate/severe ascites, no severe coagulopathy (PT/APTT/TT/INR normal), no CNS/GI/infectious exclusions, and willing to use contraception (if applicable)."
NCT03501056,P012,"{""age"":48,""gender"":""F"",""cancer_type"":""Advanced Lung Cancer"",""muc1_positive"":true,""measurable_tumor_size_mm"":10,""cannot_tolerate_standard_tx"":true,""adjuvant_chemo_washout_wks"":8,""surgery_washout_mos"":6,""radiotherapy_washout_wks"":7,""expected_survival_wks"":20,""antitumor_drugs_washout_wks"":5,""serious_disease_conflicts"":false,""ascites_grade"":""none"",""second_primary_tumor"":false,""t_cell_lymphoma_myeloma_immunosuppressants"":false,""systemic_autoimmune_allergies_immunocompromised"":false,""chronic_disease_stimulant_hormone_tx"":false,""active_bleeding_coagulant_abnormality"":false,""brain_dura_mets_psychogenic"":false,""gi_bleeding_6mo"":false,""severe_esophageal_varices_intervention"":false,""abdominal_complications_4wks"":false,""hiv_positive"":false,""contrast_allergy_ct_mri"":false,""experimental_drugs_4wks"":false,""pregnant_breastfeeding_contraception"":true}",true,"Eligible: Advanced MUC1+ lung cancer, measurable minimum size (10mm), cannot tolerate standard TX, excellent washouts. Not pregnant/breastfeeding, no history of GI bleeding in 6 months, and no exclusionary systemic conditions (autoimmune, immunosuppression, bleeding disorder)."
NCT03501056,P013,"{""age"":75,""gender"":""M"",""cancer_type"":""Advanced Lung Cancer"",""muc1_positive"":true,""measurable_tumor_size_mm"":50,""cannot_tolerate_standard_tx"":true,""adjuvant_chemo_washout_wks"":4,""surgery_washout_mos"":3,""radiotherapy_washout_wks"":4,""expected_survival_wks"":12,""antitumor_drugs_washout_wks"":4,""serious_disease_conflicts"":false,""ascites_grade"":""none"",""second_primary_tumor"":false,""t_cell_lymphoma_myeloma_immunosuppressants"":false,""systemic_autoimmune_allergies_immunocompromised"":false,""chronic_disease_stimulant_hormone_tx"":false,""active_bleeding_coagulant_abnormality"":false,""brain_dura_mets_psychogenic"":false,""gi_bleeding_6mo"":false,""severe_esophageal_varices_intervention"":false,""abdominal_complications_4wks"":false,""hiv_positive"":false,""contrast_allergy_ct_mri"":false,""experimental_drugs_4wks"":false,""pregnant_breastfeeding_contraception"":false}",true,"Eligible: Advanced MUC1+ lung cancer, age 75 (max allowed), meets minimum survival (12 weeks) and all minimum washout periods (4 weeks for chemo/RT/drugs, 3 months for surgery). No history of T-cell lymphoma/myeloma, and no current use of immunosuppressants or systemic hormones."
NCT03501056,P014,"{""age"":60,""gender"":""F"",""cancer_type"":""Advanced Lung Cancer"",""muc1_positive"":true,""measurable_tumor_size_mm"":30,""cannot_tolerate_standard_tx"":true,""adjuvant_chemo_washout_wks"":6,""surgery_washout_mos"":9,""radiotherapy_washout_wks"":6,""expected_survival_wks"":30,""antitumor_drugs_washout_wks"":6,""serious_disease_conflicts"":false,""ascites_grade"":""none"",""second_primary_tumor"":false,""t_cell_lymphoma_myeloma_immunosuppressants"":false,""systemic_autoimmune_allergies_immunocompromised"":false,""chronic_disease_stimulant_hormone_tx"":false,""active_bleeding_coagulant_abnormality"":false,""brain_dura_mets_psychogenic"":false,""gi_bleeding_6mo"":true,""gi_bleeding_details"":""melena 7 months ago, occult blood negative"",""severe_esophageal_varices_intervention"":false,""abdominal_complications_4wks"":false,""hiv_positive"":false,""contrast_allergy_ct_mri"":false,""experimental_drugs_4wks"":false,""pregnant_breastfeeding_contraception"":true}",true,"Eligible: Advanced MUC1+ lung cancer, cannot tolerate standard TX. GI bleeding history is $>6$ months ago (7 months) and current occult blood is negative (allowed). Complies with contraception, and no other exclusion criteria met."
NCT03501056,P015,"{""age"":55,""gender"":""M"",""cancer_type"":""Advanced Lung Cancer"",""muc1_positive"":true,""measurable_tumor_size_mm"":40,""cannot_tolerate_standard_tx"":true,""adjuvant_chemo_washout_wks"":10,""surgery_washout_mos"":12,""radiotherapy_washout_wks"":10,""expected_survival_wks"":25,""antitumor_drugs_washout_wks"":8,""serious_disease_conflicts"":false,""ascites_grade"":""none"",""second_primary_tumor"":false,""t_cell_lymphoma_myeloma_immunosuppressants"":false,""systemic_autoimmune_allergies_immunocompromised"":false,""chronic_disease_stimulant_hormone_tx"":false,""active_bleeding_coagulant_abnormality"":false,""brain_dura_mets_psychogenic"":false,""gi_bleeding_6mo"":false,""severe_esophageal_varices_intervention"":false,""abdominal_complications_4wks"":false,""hiv_positive"":false,""contrast_allergy_ct_mri"":false,""experimental_drugs_4wks"":false,""pregnant_breastfeeding_contraception"":false}",true,"Eligible: Advanced MUC1+ lung cancer, excellent washouts and expected survival. No active bleeding or coagulant function abnormality, no exclusion for second primary tumor, and no CNS or GI tract exclusions."
NCT00759824,P011,"{""age"":65,""gender"":""M"",""sclc_diagnosis"":true,""refractory_sclc"":true,""prior_chemo_platinum_etoposide"":true,""refractory_type"":""primary refractory"",""evaluable_or_measurable_lesion"":true,""karnofsky_performance_status"":80,""prior_anthracyclin_vinca_cyclophosphamide"":false,""prior_malignant_tumor_history"":false,""prior_hiv_infection"":false,""polynuclear_cells_ul"":2500,""platelet_cells_ul"":120000,""abnormal_coagulation_tests"":false,""serum_bilirubin_mg_100ml"":1.0,""transaminases_x_normal"":1.5,""serum_creatinine_mg_100ml"":1.0,""recent_mi_months"":4,""congestive_cardiac_failure_lvef"":60,""uncontrolled_cardiac_arrhythmia"":false,""uncontrolled_infectious_disease"":false,""active_epilepsy_tx"":false,""concomitant_meds_disallowed"":false,""pregnant_or_refusal_contraception"":false,""allergy_to_study_drugs"":false,""serious_medical_psychological_factors"":false}",true,"Eligible: Histologically confirmed SCLC, primary refractory after platinum/etoposide, measurable disease, KPS $\ge 60$. No prior treatment with study drugs (anthracyclin/vinca/cyclophosphamide), adequate hematologic/organ function, LVEF $\ge 50\%$, MI history $>3$ months, no active epilepsy or disallowed concomitant medications."
NCT00759824,P012,"{""age"":58,""gender"":""F"",""sclc_diagnosis"":true,""refractory_sclc"":true,""prior_chemo_platinum_etoposide"":true,""refractory_type"":""secondary refractory"",""evaluable_or_measurable_lesion"":true,""karnofsky_performance_status"":70,""prior_anthracyclin_vinca_cyclophosphamide"":false,""prior_malignant_tumor_history"":true,""prior_malignant_tumor_details"":""cured in situ carcinoma of the cervix"",""prior_hiv_infection"":false,""polynuclear_cells_ul"":3000,""platelet_cells_ul"":150000,""abnormal_coagulation_tests"":false,""serum_bilirubin_mg_100ml"":1.5,""transaminases_x_normal"":2.0,""serum_creatinine_mg_100ml"":1.5,""recent_mi_months"":12,""congestive_cardiac_failure_lvef"":55,""uncontrolled_cardiac_arrhythmia"":false,""uncontrolled_infectious_disease"":false,""active_epilepsy_tx"":false,""concomitant_meds_disallowed"":false,""pregnant_or_refusal_contraception"":false,""allergy_to_study_drugs"":false,""serious_medical_psychological_factors"":false}",true,"Eligible: SCLC, secondary refractory, measurable disease, KPS $\ge 60$. Prior in situ carcinoma of the cervix is an allowed exception. All labs meet the minimum/maximum thresholds (Bilirubin $\le 1.5$, Creatinine $\le 1.5$, Transaminases $\le 2\times$ normal, blood counts met). LVEF $\ge 50\%$, complies with contraception."
NCT00759824,P013,"{""age"":72,""gender"":""M"",""sclc_diagnosis"":true,""refractory_sclc"":true,""prior_chemo_platinum_etoposide"":true,""refractory_type"":""primary refractory"",""evaluable_or_measurable_lesion"":true,""karnofsky_performance_status"":60,""prior_anthracyclin_vinca_cyclophosphamide"":false,""prior_malignant_tumor_history"":true,""prior_malignant_tumor_details"":""non-melanoma skin cancer"",""prior_hiv_infection"":false,""polynuclear_cells_ul"":2000,""platelet_cells_ul"":100000,""abnormal_coagulation_tests"":false,""serum_bilirubin_mg_100ml"":1.2,""transaminases_x_normal"":1.8,""serum_creatinine_mg_100ml"":1.2,""recent_mi_months"":6,""congestive_cardiac_failure_lvef"":50,""uncontrolled_cardiac_arrhythmia"":false,""uncontrolled_infectious_disease"":false,""active_epilepsy_tx"":false,""concomitant_meds_disallowed"":false,""pregnant_or_refusal_contraception"":false,""allergy_to_study_drugs"":false,""serious_medical_psychological_factors"":false}",true,"Eligible: SCLC, primary refractory, KPS 60 (minimum), non-melanoma skin cancer is an allowed exception. Meets all minimum hematologic/cardiac (LVEF 50%) and organ function labs. No allergy to study drugs, no epilepsy, and no disallowed concomitant medications."
NCT00759824,P014,"{""age"":45,""gender"":""F"",""sclc_diagnosis"":true,""refractory_sclc"":true,""prior_chemo_platinum_etoposide"":true,""refractory_type"":""secondary refractory"",""evaluable_or_measurable_lesion"":true,""karnofsky_performance_status"":90,""prior_anthracyclin_vinca_cyclophosphamide"":false,""prior_malignant_tumor_history"":true,""prior_malignant_tumor_details"":""cured malignant tumor with 6 year disease-free interval"",""prior_hiv_infection"":false,""polynuclear_cells_ul"":4000,""platelet_cells_ul"":200000,""abnormal_coagulation_tests"":false,""serum_bilirubin_mg_100ml"":0.8,""transaminases_x_normal"":1.0,""serum_creatinine_mg_100ml"":0.8,""recent_mi_months"":15,""congestive_cardiac_failure_lvef"":65,""uncontrolled_cardiac_arrhythmia"":false,""uncontrolled_infectious_disease"":false,""active_epilepsy_tx"":false,""concomitant_meds_disallowed"":false,""pregnant_or_refusal_contraception"":true,""allergy_to_study_drugs"":false,""serious_medical_psychological_factors"":false}",true,"Eligible: SCLC, secondary refractory, KPS 90, cured malignant tumor $>5$ years disease-free (allowed exception). Excellent labs and cardiac function. Complies with contraception, and no history of HIV or uncontrolled infectious disease."
NCT00759824,P015,"{""age"":68,""gender"":""M"",""sclc_diagnosis"":true,""refractory_sclc"":true,""prior_chemo_platinum_etoposide"":true,""refractory_type"":""primary refractory"",""evaluable_or_measurable_lesion"":true,""karnofsky_performance_status"":80,""prior_anthracyclin_vinca_cyclophosphamide"":false,""prior_malignant_tumor_history"":false,""prior_hiv_infection"":false,""polynuclear_cells_ul"":3500,""platelet_cells_ul"":180000,""abnormal_coagulation_tests"":false,""serum_bilirubin_mg_100ml"":1.0,""transaminases_x_normal"":1.5,""serum_creatinine_mg_100ml"":1.0,""recent_mi_months"":10,""congestive_cardiac_failure_lvef"":58,""uncontrolled_cardiac_arrhythmia"":false,""uncontrolled_infectious_disease"":false,""active_epilepsy_tx"":false,""concomitant_meds_disallowed"":false,""pregnant_or_refusal_contraception"":false,""allergy_to_study_drugs"":false,""serious_medical_psychological_factors"":false}",true,"Eligible: SCLC, primary refractory, KPS 80, no history of prior disallowed treatments (anthracyclin/vinca/cyclophosphamide). All labs and cardiac function meet inclusion/exclusion criteria. No history of serious medical/psychological factors preventing adherence."
NCT00621361,P011,"{""age"":59,""gender"":""M"",""diagnosis"":""extensive stage small cell lung cancer"",""histology_confirmed"":true,""stage"":""extensive stage"",""prior_chemotherapy"":false,""prior_immunotherapy"":false,""prior_radiation"":true,""radiation_location"":""bone metastasis"",""radiation_weeks_ago"":3,""who_performance_status"":1,""brain_metastases"":false,""adequate_bone_marrow"":true,""adequate_labs"":true}",true,"Eligible: Extensive stage SCLC, no prior chemo/immunotherapy, prior radiation >2 weeks ago outside measurable field, WHO PS 1, no brain mets."
NCT00621361,P012,"{""age"":64,""gender"":""F"",""diagnosis"":""metastatic non-small cell lung cancer"",""histology_confirmed"":true,""stage"":""metastatic"",""prior_chemotherapy"":false,""prior_immunotherapy"":false,""prior_radiation"":false,""who_performance_status"":0,""brain_metastases"":false,""adequate_bone_marrow"":true,""adequate_labs"":true}",true,"Eligible: Treatment-naive metastatic NSCLC where EP is standard, excellent performance status (WHO 0), no CNS disease, normal labs."
NCT00621361,P013,"{""age"":52,""gender"":""M"",""diagnosis"":""extensive stage small cell lung cancer"",""histology_confirmed"":true,""stage"":""extensive stage"",""prior_chemotherapy"":false,""prior_immunotherapy"":false,""prior_radiation"":true,""radiation_location"":""palliative limb"",""radiation_weeks_ago"":4,""who_performance_status"":2,""brain_metastases"":false,""adequate_bone_marrow"":true,""adequate_labs"":true}",true,"Eligible: Extensive SCLC with prior palliative radiation >2 weeks ago, WHO PS 2 acceptable, no prior systemic therapy, adequate marrow function."
NCT00621361,P014,"{""age"":71,""gender"":""F"",""diagnosis"":""metastatic lung cancer"",""histology_confirmed"":true,""stage"":""metastatic"",""prior_chemotherapy"":false,""prior_immunotherapy"":false,""prior_radiation"":false,""who_performance_status"":1,""brain_metastases"":false,""adequate_bone_marrow"":true,""adequate_labs"":true}",true,"Eligible: First-line metastatic lung cancer candidate, EP appropriate, no CNS involvement, adequate organ function and performance status."
NCT00621361,P015,"{""age"":48,""gender"":""M"",""diagnosis"":""extensive stage small cell lung cancer"",""histology_confirmed"":true,""stage"":""extensive stage"",""prior_chemotherapy"":false,""prior_immunotherapy"":false,""prior_radiation"":true,""radiation_location"":""spinal cord"",""radiation_weeks_ago"":5,""who_performance_status"":1,""brain_metastases"":false,""adequate_bone_marrow"":true,""adequate_labs"":true}",true,"Eligible: Extensive SCLC with prior spinal radiation >2 weeks ago, treatment-naive for systemic therapy, WHO PS 1, no brain metastases."
NCT06749691,P011,"{""age"":62,""gender"":""M"",""diagnosis"":""extensive stage small cell lung cancer"",""prior_lines_therapy"":1,""prior_vegf_targeted"":false,""measurable_lesion"":true,""life_expectancy_weeks"":16,""severe_infection"":false,""recent_antibiotics"":false,""oral_absorption_issues"":false,""able_to_swallow"":true,""no_chronic_diarrhea"":true,""no_bowel_obstruction"":true}",true,"Eligible: Extensive stage SCLC progressed after 1st line, no prior VEGF/VEGFR inhibitors, measurable disease, good oral intake, no active infections."
NCT06749691,P012,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive stage small cell lung cancer"",""prior_lines_therapy"":2,""prior_vegf_targeted"":false,""measurable_lesion"":true,""life_expectancy_weeks"":14,""severe_infection"":false,""recent_antibiotics"":false,""oral_absorption_issues"":false,""able_to_swallow"":true,""no_chronic_diarrhea"":true,""no_bowel_obstruction"":true}",true,"Eligible: Second-line extensive SCLC candidate, within age range, adequate life expectancy, no GI issues affecting oral medication absorption."
NCT06749691,P013,"{""age"":45,""gender"":""M"",""diagnosis"":""extensive stage small cell lung cancer"",""prior_lines_therapy"":1,""prior_vegf_targeted"":false,""measurable_lesion"":true,""life_expectancy_weeks"":18,""severe_infection"":false,""recent_antibiotics"":false,""oral_absorption_issues"":false,""able_to_swallow"":true,""no_chronic_diarrhea"":true,""no_bowel_obstruction"":true}",true,"Eligible: Younger patient with extensive SCLC after first-line failure, no anti-angiogenic exposure, RECIST measurable lesions, no exclusion criteria."
NCT06749691,P014,"{""age"":71,""gender"":""F"",""diagnosis"":""extensive stage small cell lung cancer"",""prior_lines_therapy"":2,""prior_vegf_targeted"":false,""measurable_lesion"":true,""life_expectancy_weeks"":13,""severe_infection"":false,""recent_antibiotics"":false,""oral_absorption_issues"":false,""able_to_swallow"":true,""no_chronic_diarrhea"":true,""no_bowel_obstruction"":true}",true,"Eligible: Elderly patient within age limit, failed second-line therapy, no VEGF inhibitors, adequate swallowing function, suitable for oral apatinib."
NCT06749691,P015,"{""age"":68,""gender"":""M"",""diagnosis"":""extensive stage small cell lung cancer"",""prior_lines_therapy"":1,""prior_vegf_targeted"":false,""measurable_lesion"":true,""life_expectancy_weeks"":15,""severe_infection"":false,""recent_antibiotics"":false,""oral_absorption_issues"":false,""able_to_swallow"":true,""no_chronic_diarrhea"":true,""no_bowel_obstruction"":true}",true,"Eligible: Extensive SCLC progressed after initial therapy, meets all criteria including age, measurable disease, and absence of GI absorption barriers."
NCT01588821,P011,"{""age"":62,""gender"":""M"",""diagnosis"":""metastatic non-small cell lung cancer"",""histology_confirmed"":true,""cancer_type"":""solid tumor"",""breast_prostate_excluded"":true,""stage"":""metastatic"",""refractory_to_standard"":true,""bony_metastases"":true,""weeks_since_chemotherapy"":4,""weeks_since_biologics"":5,""weeks_since_radiation_bone"":3,""weeks_since_kinase_inhibitor"":3,""weeks_since_investigational"":6,""recovered_toxicities"":true,""primary_brain_tumor"":false,""active_brain_metastases"":false,""brain_metastases_status"":""treated and stable"",""uncontrolled_illness"":false,""drug_allergy"":false,""contraception_used"":true}",true,"Eligible: Metastatic NSCLC with bone metastases, refractory to standard therapy, adequate washout periods, treated stable brain mets, no exclusions."
NCT01588821,P012,"{""age"":58,""gender"":""F"",""diagnosis"":""metastatic renal cell carcinoma"",""histology_confirmed"":true,""cancer_type"":""solid tumor"",""breast_prostate_excluded"":true,""stage"":""metastatic"",""refractory_to_standard"":true,""bony_metastases"":true,""weeks_since_chemotherapy"":5,""weeks_since_biologics"":4,""weeks_since_radiation_bone"":4,""weeks_since_kinase_inhibitor"":4,""weeks_since_investigational"":7,""recovered_toxicities"":true,""primary_brain_tumor"":false,""active_brain_metastases"":false,""brain_metastases_status"":""none"",""uncontrolled_illness"":false,""drug_allergy"":false,""contraception_used"":true}",true,"Eligible: Metastatic RCC with bone involvement, progressed after standard therapies, all washout criteria met, no CNS disease, suitable candidate."
NCT01588821,P013,"{""age"":71,""gender"":""M"",""diagnosis"":""metastatic thyroid cancer"",""histology_confirmed"":true,""cancer_type"":""solid tumor"",""breast_prostate_excluded"":true,""stage"":""metastatic"",""refractory_to_standard"":true,""bony_metastases"":true,""weeks_since_chemotherapy"":6,""weeks_since_biologics"":0,""weeks_since_radiation_bone"":5,""weeks_since_kinase_inhibitor"":3,""weeks_since_investigational"":8,""recovered_toxicities"":true,""primary_brain_tumor"":false,""active_brain_metastases"":false,""brain_metastases_status"":""treated and stable"",""uncontrolled_illness"":false,""drug_allergy"":false,""contraception_used"":true}",true,"Eligible: Metastatic thyroid cancer with bone mets, failed standard treatment, adequate therapy washouts, stable treated brain metastases, compliant."
NCT01588821,P014,"{""age"":54,""gender"":""F"",""diagnosis"":""metastatic colorectal cancer"",""histology_confirmed"":true,""cancer_type"":""solid tumor"",""breast_prostate_excluded"":true,""stage"":""metastatic"",""refractory_to_standard"":true,""bony_metastases"":true,""weeks_since_chemotherapy"":4,""weeks_since_biologics"":6,""weeks_since_radiation_bone"":4,""weeks_since_kinase_inhibitor"":0,""weeks_since_investigational"":9,""recovered_toxicities"":true,""primary_brain_tumor"":false,""active_brain_metastases"":false,""brain_metastases_status"":""none"",""uncontrolled_illness"":false,""drug_allergy"":false,""contraception_used"":true}",true,"Eligible: Metastatic CRC with bone metastases, progressed on standard regimens, all washout periods respected, no contraindications."
NCT01588821,P015,"{""age"":67,""gender"":""M"",""diagnosis"":""metastatic hepatocellular carcinoma"",""histology_confirmed"":true,""cancer_type"":""solid tumor"",""breast_prostate_excluded"":true,""stage"":""metastatic"",""refractory_to_standard"":true,""bony_metastases"":true,""weeks_since_chemotherapy"":7,""weeks_since_biologics"":5,""weeks_since_radiation_bone"":6,""weeks_since_kinase_inhibitor"":4,""weeks_since_investigational"":10,""recovered_toxicities"":true,""primary_brain_tumor"":false,""active_brain_metastases"":false,""brain_metastases_status"":""treated and stable"",""uncontrolled_illness"":false,""drug_allergy"":false,""contraception_used"":true}",true,"Eligible: Metastatic HCC with bone involvement, refractory to standard therapy, meets all washout requirements, stable CNS status, no allergies."
NCT03361228,P011,"{""age"":65,""gender"":""M"",""tumor_type"":""Metastatic NSCLC (Phase 2) "",""histology_confirmed"":true,""failed_prior_standard_therapy"":true,""measurable_lesion_recist11"":true,""ecog_performance_status"":1,""prior_toxicity_resolved_grade"":1,""neuropathy_grade"":1,""adequate_organ_function"":true,""investigational_washout_wks"":3,""mab_washout_wks"":5,""chemo_targeted_washout_wks"":3,""prior_ido_arginase_inhibitor"":false,""active_autoimmune_systemic_tx_2yrs"":false,""live_vaccine_30_days"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_condition_affecting_absorption"":false}",true,"Eligible: Metastatic NSCLC, failed prior therapy, ECOG 1, measurable disease. All toxicities resolved (neuropathy Grade 1 is allowed). Meets all washout periods (Investigational $\ge 2$ weeks, MAB $\ge 4$ weeks, Chemo/Targeted $\ge 2$ weeks). No prior IDO/arginase inhibitor, no active autoimmune disease requiring systemic treatment, and no GI/urea cycle exclusions."
NCT03361228,P012,"{""age"":58,""gender"":""F"",""tumor_type"":""Advanced Melanoma (Phase 2) "",""histology_confirmed"":true,""failed_prior_standard_therapy"":true,""measurable_lesion_recist11"":true,""ecog_performance_status"":0,""prior_toxicity_resolved_grade"":0,""neuropathy_grade"":0,""adequate_organ_function"":true,""investigational_washout_wks"":6,""mab_washout_wks"":8,""chemo_targeted_washout_wks"":4,""prior_ido_arginase_inhibitor"":false,""active_autoimmune_systemic_tx_2yrs"":false,""live_vaccine_30_days"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_condition_affecting_absorption"":false}",true,"Eligible: Advanced Melanoma, failed prior therapy, ECOG 0. Excellent toxicity resolution and washout periods. No history of IDO/arginase inhibitors, no autoimmune disease requiring recent systemic therapy (replacement therapy allowed), and no GI absorption issues."
NCT03361228,P013,"{""age"":72,""gender"":""M"",""tumor_type"":""Advanced SCCHN (Phase 2) "",""histology_confirmed"":true,""failed_prior_standard_therapy"":true,""measurable_lesion_recist11"":true,""ecog_performance_status"":1,""prior_toxicity_resolved_grade"":1,""neuropathy_grade"":2,""adequate_organ_function"":true,""investigational_washout_wks"":2,""mab_washout_wks"":4,""chemo_targeted_washout_wks"":2,""prior_ido_arginase_inhibitor"":false,""active_autoimmune_systemic_tx_2yrs"":false,""live_vaccine_30_days"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_condition_affecting_absorption"":false}",true,"Eligible: Advanced SCCHN, ECOG 1. Grade 2 neuropathy is explicitly allowed. Meets minimum washout periods for all prior therapies (2 weeks for chemo/investigational, 4 weeks for MABs). Adequate organ function and no history of serotonin syndrome or urea cycle defect."
NCT03361228,P014,"{""age"":45,""gender"":""F"",""tumor_type"":""Metastatic SCLC (Phase 2) "",""histology_confirmed"":true,""failed_prior_standard_therapy"":true,""measurable_lesion_recist11"":true,""ecog_performance_status"":1,""prior_toxicity_resolved_grade"":1,""neuropathy_grade"":0,""adequate_organ_function"":true,""investigational_washout_wks"":4,""mab_washout_wks"":6,""chemo_targeted_washout_wks"":3,""prior_ido_arginase_inhibitor"":false,""active_autoimmune_systemic_tx_2yrs"":false,""live_vaccine_30_days"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_condition_affecting_absorption"":false}",true,"Eligible: Metastatic SCLC, failed prior standard therapy (patient intolerance is allowable). Meets all washout, toxicity resolution, and organ function requirements. No receipt of a live vaccine within 30 days of first dose."
NCT03361228,P015,"{""age"":68,""gender"":""M"",""tumor_type"":""Advanced Solid Tumor (Phase 1) "",""histology_confirmed"":true,""failed_prior_standard_therapy"":true,""measurable_lesion_recist11"":true,""ecog_performance_status"":0,""prior_toxicity_resolved_grade"":0,""neuropathy_grade"":0,""adequate_organ_function"":true,""investigational_washout_wks"":5,""mab_washout_wks"":5,""chemo_targeted_washout_wks"":3,""prior_ido_arginase_inhibitor"":false,""active_autoimmune_systemic_tx_2yrs"":false,""live_vaccine_30_days"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_condition_affecting_absorption"":false}",true,"Eligible: Advanced solid tumor (Phase 1), failed prior standard therapy, ECOG 0. Washout periods are met (using the 'whichever is longer/shorter' criteria for investigational/MABs, and the minimum 2-4 weeks are covered). No exclusionary GI or immune-related history."
NCT02281214,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""Metastatic Bronchial Adenocarcinoma"",""egfr_mutation_status"":""EGFR mutation positive"",""can_benefit_from_first_line_tki"":true,""survival_time_months"":6,""cerebral_metastases"":false,""benefit_from_treatment_other_diseases"":true,""pregnancy_or_breast_feeding"":false,""incapacity_to_sign_consent"":false,""deprived_of_freedom_or_tutelage"":false,""signed_informed_consent"":true,""affiliated_to_social_health_insurance"":true}",true,"Eligible: Metastatic bronchial adenocarcinoma with EGFR mutation, can benefit from first-line TKI, survival time $>3$ months. No cerebral metastases, no pregnancy/breastfeeding, and capable of signing informed consent."
NCT02281214,P012,"{""age"":58,""gender"":""F"",""cancer_type"":""Metastatic Bronchial Adenocarcinoma"",""egfr_mutation_status"":""EGFR mutation negative"",""can_benefit_from_first_line_chemo"":true,""survival_time_months"":8,""cerebral_metastases"":false,""benefit_from_treatment_other_diseases"":true,""pregnancy_or_breast_feeding"":false,""incapacity_to_sign_consent"":false,""deprived_of_freedom_or_tutelage"":false,""signed_informed_consent"":true,""affiliated_to_social_health_insurance"":true}",true,"Eligible: Metastatic bronchial adenocarcinoma with non-EGFR mutation, can benefit from first-line chemotherapy, survival time $>3$ months. No cerebral metastases, not pregnant/nursing, and is legally/psychologically capable of consent."
NCT02281214,P013,"{""age"":72,""gender"":""M"",""cancer_type"":""Epidermoid Cancer of the Lungs"",""can_benefit_from_chemotherapy"":true,""survival_time_months"":4,""cerebral_metastases"":false,""benefit_from_treatment_other_diseases"":true,""pregnancy_or_breast_feeding"":false,""incapacity_to_sign_consent"":false,""deprived_of_freedom_or_tutelage"":false,""signed_informed_consent"":true,""affiliated_to_social_health_insurance"":true}",true,"Eligible: Epidermoid cancer of the lungs, can benefit from chemotherapy, survival time 4 months ($\ge 3$ months). No cerebral metastases, capable of consent, and affiliated with social health insurance."
NCT02281214,P014,"{""age"":45,""gender"":""F"",""cancer_type"":""Metastatic Bronchial Adenocarcinoma"",""egfr_mutation_status"":""EGFR mutation positive"",""can_benefit_from_first_line_tki"":true,""survival_time_months"":12,""cerebral_metastases"":false,""benefit_from_treatment_other_diseases"":true,""pregnancy_or_breast_feeding"":false,""incapacity_to_sign_consent"":false,""deprived_of_freedom_or_tutelage"":false,""signed_informed_consent"":true,""affiliated_to_social_health_insurance"":true}",true,"Eligible: Metastatic adenocarcinoma (EGFR+), can receive TKI, excellent survival prognosis, no CNS mets, and meets all legal/social requirements (consent, insurance, not a vulnerable person)."
NCT02281214,P015,"{""age"":68,""gender"":""M"",""cancer_type"":""Epidermoid Cancer of the Lungs"",""can_benefit_from_chemotherapy"":true,""survival_time_months"":5,""cerebral_metastases"":false,""benefit_from_treatment_other_diseases"":true,""pregnancy_or_breast_feeding"":false,""incapacity_to_sign_consent"":false,""deprived_of_freedom_or_tutelage"":false,""signed_informed_consent"":true,""affiliated_to_social_health_insurance"":true}",true,"Eligible: Epidermoid cancer, can receive chemotherapy, survival time $>3$ months, no cerebral metastases, and no medical/psychiatric condition preventing treatment benefit or consent."
NCT05538130,P011,"{""age"":58,""gender"":""M"",""diagnosis"":""advanced melanoma"",""stage"":""metastatic"",""substudy"":""B"",""braf_mutation"":""V600E"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""brain_metastasis_size_cm"":2.5,""retinal_vein_occlusion"":false,""elevated_ck_disorder"":false}",true,"Eligible: Advanced melanoma with BRAF V600E mutation, measurable disease, progressed on prior therapy, brain mets <4cm, no RVO or CK disorders."
NCT05538130,P012,"{""age"":64,""gender"":""F"",""diagnosis"":""metastatic colorectal cancer"",""stage"":""metastatic"",""substudy"":""C"",""braf_alteration"":""Class II non-V600"",""measurable_disease"":true,""prior_treatment_progression"":true,""intolerant_to_soc"":true,""brain_metastases"":false,""retinal_vein_occlusion"":false,""elevated_ck_disorder"":false}",true,"Eligible: Metastatic CRC with BRAF Class II alteration, progressed/intolerant to standard care, measurable disease, no large brain mets or exclusionary conditions."
NCT05538130,P013,"{""age"":47,""gender"":""M"",""diagnosis"":""advanced non-small cell lung cancer"",""stage"":""advanced"",""substudy"":""C"",""braf_alteration"":""Class III"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""brain_metastasis_size_cm"":1.8,""retinal_vein_occlusion"":false,""elevated_ck_disorder"":false}",true,"Eligible: Advanced NSCLC with BRAF Class III alteration, measurable disease, treatment-refractory, stable small brain metastases, no ocular or neuromuscular issues."
NCT05538130,P014,"{""age"":52,""gender"":""F"",""diagnosis"":""metastatic thyroid cancer"",""stage"":""metastatic"",""substudy"":""C"",""braf_alteration"":""non-V600 Class II"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":false,""retinal_vein_occlusion"":false,""elevated_ck_disorder"":false}",true,"Eligible: Metastatic thyroid cancer with non-V600 BRAF Class II alteration, progressed on standard therapy, measurable lesions, no exclusion criteria."
NCT05538130,P015,"{""age"":61,""gender"":""M"",""diagnosis"":""advanced melanoma"",""stage"":""advanced"",""substudy"":""B"",""braf_mutation"":""V600K"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""brain_metastasis_size_cm"":3.2,""retinal_vein_occlusion"":false,""elevated_ck_disorder"":false}",true,"Eligible: Advanced melanoma with BRAF V600K mutation, measurable disease, failed prior treatments, brain metastases under 4cm, no RVO/CK history."
NCT00967577,P011,"{""age"":65,""gender"":""M"",""tumor_type"":""Advanced Urothelial Carcinoma"",""histology_confirmed"":true,""refractory_recurrent_disease"":true,""progressive_disease"":true,""prior_acute_toxicities_resolved"":true,""chemo_rt_investigational_washout_wks"":4,""psma_tissue_available"":true,""bisphosphonate_denosumab_stable_dose_4wks"":false,""contraception_used"":false,""negative_pregnancy_test"":false,""platelet_transfusions_4wks"":false,""hematopoietic_growth_factors_4wks"":false,""prior_rt_skeletal_coverage_percent"":10,""prior_89sr_153sm_tx"":false,""platelet_count_ul"":180000,""anc_ul"":2500,""hemoglobin_g_dl"":12.0,""coagulation_profile_x_uln"":1.1,""serum_creatinine_x_uln"":1.5,""ast_sgot_x_uln"":2.0,""bilirubin_total_x_uln"":1.0,""active_serious_infection"":false,""active_angina_nyha_class"":""Class II"",""ecog_performance_status"":2,""dvt_pe_1mo"":false,""other_serious_illnesses"":false,""prior_investigational_therapy_4wks"":false,""known_hiv_history"":false,""known_leukemia_mds"":false,""prior_gadolinium_allergy"":false,""life_expectancy_months"":4,""urgent_tx_anticipated_12wks"":false}",true,"Eligible: Advanced Urothelial Carcinoma, refractory and progressive, ECOG 2. Meets minimum hematologic (Platelet $\ge 150\text{k}$, ANC $\ge 2\text{k}$, Hgb $\ge 10$), renal (Creatinine $\le 2\times$ ULN), and hepatic (AST $\le 2.5\times$ ULN, Bili $\le 1.5\times$ ULN) function. All washouts met (4 weeks), RT coverage $<25\%$, no prior radiopharmaceuticals, no recent DVT/PE, and PSMA tissue is available."
NCT00967577,P012,"{""age"":48,""gender"":""F"",""tumor_type"":""Advanced NSCLC"",""histology_confirmed"":true,""refractory_recurrent_disease"":true,""progressive_disease"":true,""prior_acute_toxicities_resolved"":true,""chemo_rt_investigational_washout_wks"":6,""psma_tissue_available"":true,""bisphosphonate_denosumab_stable_dose_4wks"":true,""contraception_used"":true,""negative_pregnancy_test"":true,""platelet_transfusions_4wks"":false,""hematopoietic_growth_factors_4wks"":false,""prior_rt_skeletal_coverage_percent"":0,""prior_89sr_153sm_tx"":false,""platelet_count_ul"":200000,""anc_ul"":3000,""hemoglobin_g_dl"":13.0,""coagulation_profile_x_uln"":1.2,""serum_creatinine_x_uln"":1.0,""ast_sgot_x_uln"":1.5,""bilirubin_total_x_uln"":1.0,""active_serious_infection"":false,""active_angina_nyha_class"":""Class I"",""ecog_performance_status"":0,""dvt_pe_1mo"":false,""other_serious_illnesses"":false,""prior_investigational_therapy_4wks"":false,""known_hiv_history"":false,""known_leukemia_mds"":false,""prior_gadolinium_allergy"":false,""life_expectancy_months"":12,""urgent_tx_anticipated_12wks"":false}",true,"Eligible: Advanced NSCLC, refractory and progressive, ECOG 0. Bisphosphonate/denosumab therapy is stable and $\ge 4$ weeks prior. Meets all organ function and washout criteria, and complies with contraception/pregnancy testing."
NCT00967577,P013,"{""age"":72,""gender"":""M"",""tumor_type"":""Recurrent Head and Neck Cancer"",""histology_confirmed"":true,""refractory_recurrent_disease"":true,""progressive_disease"":true,""prior_acute_toxicities_resolved"":true,""chemo_rt_investigational_washout_wks"":4,""psma_tissue_available"":true,""bisphosphonate_denosumab_stable_dose_4wks"":false,""contraception_used"":false,""negative_pregnancy_test"":false,""platelet_transfusions_4wks"":false,""hematopoietic_growth_factors_4wks"":false,""prior_rt_skeletal_coverage_percent"":25,""prior_89sr_153sm_tx"":false,""platelet_count_ul"":150000,""anc_ul"":2000,""hemoglobin_g_dl"":10.0,""coagulation_profile_x_uln"":1.3,""serum_creatinine_x_uln"":2.0,""ast_sgot_x_uln"":2.5,""bilirubin_total_x_uln"":1.5,""active_serious_infection"":false,""active_angina_nyha_class"":""Class II"",""ecog_performance_status"":2,""dvt_pe_1mo"":false,""other_serious_illnesses"":false,""prior_investigational_therapy_4wks"":false,""known_hiv_history"":false,""known_leukemia_mds"":false,""prior_gadolinium_allergy"":false,""life_expectancy_months"":3,""urgent_tx_anticipated_12wks"":false}",true,"Eligible: Recurrent Head and Neck Cancer, progressive, ECOG 2. Prior radiation therapy covers exactly $25\%$ of the skeleton (allowed, exclusion is $>25\%$). Meets minimum hematologic/hepatic/renal/coagulation labs. Life expectancy is exactly 3 months (minimum $\ge 3$ months or $\ge 12$ weeks)."
NCT00967577,P014,"{""age"":60,""gender"":""F"",""tumor_type"":""Metastatic Breast Cancer"",""histology_confirmed"":true,""refractory_recurrent_disease"":true,""progressive_disease"":true,""prior_acute_toxicities_resolved"":true,""chemo_rt_investigational_washout_wks"":5,""psma_tissue_available"":true,""bisphosphonate_denosumab_stable_dose_4wks"":true,""contraception_used"":true,""negative_pregnancy_test"":true,""platelet_transfusions_4wks"":false,""hematopoietic_growth_factors_4wks"":false,""prior_rt_skeletal_coverage_percent"":5,""prior_89sr_153sm_tx"":false,""platelet_count_ul"":300000,""anc_ul"":4000,""hemoglobin_g_dl"":14.0,""coagulation_profile_x_uln"":1.0,""serum_creatinine_x_uln"":0.8,""ast_sgot_x_uln"":1.2,""bilirubin_total_x_uln"":0.8,""active_serious_infection"":false,""active_angina_nyha_class"":""Class I"",""ecog_performance_status"":1,""dvt_pe_1mo"":false,""other_serious_illnesses"":false,""prior_investigational_therapy_4wks"":false,""known_hiv_history"":false,""known_leukemia_mds"":false,""prior_gadolinium_allergy"":false,""life_expectancy_months"":6,""urgent_tx_anticipated_12wks"":false}",true,"Eligible: Metastatic Breast Cancer, progressive, ECOG 1. Excellent organ function, no known HIV, leukemia, or Gadolinium allergy. Complies with contraception, and no history of recent transfusions/growth factors/DVT/PE."
NCT00967577,P015,"{""age"":55,""gender"":""M"",""tumor_type"":""Advanced Pancreatic Cancer"",""histology_confirmed"":true,""refractory_recurrent_disease"":true,""progressive_disease"":true,""prior_acute_toxicities_resolved"":true,""chemo_rt_investigational_washout_wks"":4,""psma_tissue_available"":true,""bisphosphonate_denosumab_stable_dose_4wks"":false,""contraception_used"":false,""negative_pregnancy_test"":false,""platelet_transfusions_4wks"":false,""hematopoietic_growth_factors_4wks"":false,""prior_rt_skeletal_coverage_percent"":20,""prior_89sr_153sm_tx"":false,""platelet_count_ul"":160000,""anc_ul"":2200,""hemoglobin_g_dl"":10.5,""coagulation_profile_x_uln"":1.2,""serum_creatinine_x_uln"":1.8,""ast_sgot_x_uln"":2.0,""bilirubin_total_x_uln"":1.0,""active_serious_infection"":false,""active_angina_nyha_class"":""Class II"",""ecog_performance_status"":1,""dvt_pe_1mo"":false,""other_serious_illnesses"":false,""prior_investigational_therapy_4wks"":false,""known_hiv_history"":false,""known_leukemia_mds"":false,""prior_gadolinium_allergy"":false,""life_expectancy_months"":5,""urgent_tx_anticipated_12wks"":false}",true,"Eligible: Advanced Pancreatic Cancer, progressive, ECOG 1. Meets all minimum organ function criteria, all washouts met, and no history of prior cytotoxic radiopharmaceuticals (89Sr or 153Sm)."
NCT02200081,P011,"{""age"":65,""gender"":""M"",""sclc_stage"":""extensive disease"",""sclc_histology_percent"":100,""first_line_chemo_cycles"":4,""tumor_response_2_cycles"":true,""tumor_response_4_cycles"":""CR"",""brain_mets_status"":""cranial irradiation completed, no continuous steroids/anticonvulsants"",""ecog_performance_status"":0,""bilirubin_x_uln"":1.0,""ldh_x_uln"":1.2,""ap_x_uln"":1.0,""ggt_x_uln"":1.0,""albumin_x_uln"":0.9,""creatinine_urea_electrolytes_coagulation_x_uln"":1.0,""ast_alt_x_uln"":2.0,""liver_metastases_present"":false,""anc_x10_9_l"":1.8,""platelet_count_x10_9_l"":120,""leukocyte_count_x10_9_l"":4.0,""lymphocytes_x10_9_l"":1.2,""hemoglobin_g_dl"":10.0,""contraception_used"":false,""negative_pregnancy_test"":false,""signed_icf"":true}",true,"Eligible: Extensive SCLC, 4 cycles of first-line platinum chemo completed with CR. Brain metastases were treated and are stable (no continuous steroids/anticonvulsants). ECOG 0. All lab parameters (hepatic, renal, hematologic) meet the requirements."
NCT02200081,P012,"{""age"":58,""gender"":""F"",""sclc_stage"":""extensive disease"",""sclc_histology_percent"":85,""first_line_chemo_cycles"":4,""tumor_response_2_cycles"":true,""tumor_response_4_cycles"":""PR"",""brain_mets_status"":""none"",""ecog_performance_status"":1,""bilirubin_x_uln"":1.5,""ldh_x_uln"":1.5,""ap_x_uln"":1.5,""ggt_x_uln"":1.5,""albumin_x_uln"":1.5,""creatinine_urea_electrolytes_coagulation_x_uln"":1.5,""ast_alt_x_uln"":5.0,""liver_metastases_present"":true,""anc_x10_9_l"":1.5,""platelet_count_x10_9_l"":100,""leukocyte_count_x10_9_l"":3.0,""lymphocytes_x10_9_l"":1.0,""hemoglobin_g_dl"":9.0,""contraception_used"":true,""negative_pregnancy_test"":true,""signed_icf"":true}",true,"Eligible: Extensive SCLC (mixed histology, $\ge 80\%$ SCLC), achieved PR after 4 cycles. ECOG 1. Has liver metastases, so AST/ALT $\le 5.0\times$ ULN is allowed and met (exactly 5.0). All other lab parameters are at the minimum/maximum threshold (1.5$\times$ ULN for non-hepatic, minimum hematologic counts), and contraception requirements are met."
NCT02200081,P013,"{""age"":75,""gender"":""M"",""sclc_stage"":""extensive disease"",""sclc_histology_percent"":100,""first_line_chemo_cycles"":4,""tumor_response_2_cycles"":true,""tumor_response_4_cycles"":""PR"",""brain_mets_status"":""cranial irradiation completed, no continuous steroids/anticonvulsants"",""ecog_performance_status"":0,""bilirubin_x_uln"":1.0,""ldh_x_uln"":1.0,""ap_x_uln"":1.0,""ggt_x_uln"":1.0,""albumin_x_uln"":1.0,""creatinine_urea_electrolytes_coagulation_x_uln"":1.0,""ast_alt_x_uln"":2.5,""liver_metastases_present"":false,""anc_x10_9_l"":2.0,""platelet_count_x10_9_l"":150,""leukocyte_count_x10_9_l"":5.0,""lymphocytes_x10_9_l"":1.5,""hemoglobin_g_dl"":11.0,""contraception_used"":false,""negative_pregnancy_test"":false,""signed_icf"":true}",true,"Eligible: Extensive SCLC, achieved PR, ECOG 0. Brain mets treated and stable. Meets all organ function and hematology criteria well within limits (AST/ALT $\le 2.5\times$ ULN for no liver mets)."
NCT02200081,P014,"{""age"":45,""gender"":""F"",""sclc_stage"":""extensive disease"",""sclc_histology_percent"":90,""first_line_chemo_cycles"":4,""tumor_response_2_cycles"":true,""tumor_response_4_cycles"":""CR"",""brain_mets_status"":""none"",""ecog_performance_status"":1,""bilirubin_x_uln"":1.0,""ldh_x_uln"":1.0,""ap_x_uln"":1.0,""ggt_x_uln"":1.0,""albumin_x_uln"":1.0,""creatinine_urea_electrolytes_coagulation_x_uln"":1.0,""ast_alt_x_uln"":4.0,""liver_metastases_present"":true,""anc_x10_9_l"":1.6,""platelet_count_x10_9_l"":110,""leukocyte_count_x10_9_l"":3.5,""lymphocytes_x10_9_l"":1.1,""hemoglobin_g_dl"":9.5,""contraception_used"":true,""negative_pregnancy_test"":true,""signed_icf"":true}",true,"Eligible: Extensive SCLC, achieved CR after 4 cycles. Has liver mets, AST/ALT $4.0\times$ ULN (allowed, $\le 5.0\times$ ULN). Meets all hematologic minimums and contraception requirements."
NCT02200081,P015,"{""age"":68,""gender"":""M"",""sclc_stage"":""extensive disease"",""sclc_histology_percent"":100,""first_line_chemo_cycles"":4,""tumor_response_2_cycles"":true,""tumor_response_4_cycles"":""PR"",""brain_mets_status"":""none"",""ecog_performance_status"":1,""bilirubin_x_uln"":1.3,""ldh_x_uln"":1.3,""ap_x_uln"":1.3,""ggt_x_uln"":1.3,""albumin_x_uln"":1.3,""creatinine_urea_electrolytes_coagulation_x_uln"":1.3,""ast_alt_x_uln"":2.2,""liver_metastases_present"":false,""anc_x10_9_l"":2.5,""platelet_count_x10_9_l"":200,""leukocyte_count_x10_9_l"":5.0,""lymphocytes_x10_9_l"":2.0,""hemoglobin_g_dl"":12.0,""contraception_used"":false,""negative_pregnancy_test"":false,""signed_icf"":true}",true,"Eligible: Extensive SCLC, achieved PR, ECOG 1. No liver mets, AST/ALT $2.2\times$ ULN (allowed, $\le 2.5\times$ ULN). Meets all lab criteria with a wide margin."
NCT00570401,P011,"{""age"":62,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""histology_confirmed"":true,""stage"":""advanced"",""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":8,""tki_response"":""partial response"",""egfr_mutation"":true,""acquired_resistance"":true,""disease_progression"":true,""prior_biopsy"":true,""measurable_lesions"":true,""previously_irradiated"":false,""cns_lesions"":false,""karnofsky_ps"":80,""wbc_count"":4200,""hemoglobin"":10.2,""platelets"":145000,""bilirubin_mg_dl"":1.2,""ast_alt_uln"":1.8,""creatinine_mg_dl"":1.4,""qtc_ms"":420,""oral_medication_able"":true,""cardiac_history"":false,""uncontrolled_hypertension"":false,""active_infection"":false,""prohibited_medications"":false,""contraception_used"":true}",true,"Eligible: Advanced lung adenocarcinoma with EGFR mutation, prior erlotinib response then progression, adequate organ function, no cardiac contraindications, QTc normal."
NCT00570401,P012,"{""age"":58,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""histology_confirmed"":true,""stage"":""advanced"",""prior_egfr_tki"":""gefitinib"",""tki_duration_months"":7,""tki_response"":""complete response"",""egfr_mutation"":true,""acquired_resistance"":true,""disease_progression"":true,""prior_biopsy"":true,""measurable_lesions"":true,""previously_irradiated"":false,""cns_lesions"":true,""cns_symptoms"":false,""corticosteroid_dose"":""stable"",""karnofsky_ps"":90,""wbc_count"":3800,""hemoglobin"":9.8,""platelets"":112000,""bilirubin_mg_dl"":0.9,""ast_alt_uln"":1.5,""creatinine_clearance_ml_min"":68,""qtc_ms"":410,""oral_medication_able"":true,""cardiac_history"":false,""uncontrolled_hypertension"":false,""active_infection"":false,""prohibited_medications"":false,""contraception_used"":true}",true,"Eligible: EGFR-mutant adenocarcinoma with prior gefitinib response then resistance, asymptomatic CNS lesions, excellent performance status, all labs within range."
NCT00570401,P013,"{""age"":71,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""histology_confirmed"":true,""stage"":""advanced"",""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":9,""tki_response"":""partial response"",""egfr_mutation"":true,""acquired_resistance"":true,""disease_progression"":true,""prior_biopsy"":true,""measurable_lesions"":true,""previously_irradiated"":false,""cns_lesions"":false,""karnofsky_ps"":70,""wbc_count"":3500,""hemoglobin"":9.5,""platelets"":105000,""bilirubin_mg_dl"":1.1,""ast_alt_uln"":2.0,""creatinine_mg_dl"":1.6,""qtc_ms"":430,""oral_medication_able"":true,""cardiac_history"":false,""uncontrolled_hypertension"":false,""active_infection"":false,""weeks_since_chemo"":5,""weeks_since_radiation"":6,""prohibited_medications"":false,""contraception_used"":true}",true,"Eligible: Elderly patient with EGFR-mutant adenocarcinoma, prior TKI response then progression, adequate washout from prior therapies, meets all lab criteria."
NCT00570401,P014,"{""age"":54,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""histology_confirmed"":true,""stage"":""advanced"",""prior_egfr_tki"":""gefitinib"",""tki_duration_months"":6,""tki_response"":""partial response"",""egfr_mutation"":true,""acquired_resistance"":true,""disease_progression"":true,""prior_biopsy"":true,""measurable_lesions"":true,""previously_irradiated"":false,""cns_lesions"":true,""cns_symptoms"":false,""corticosteroid_dose"":""stable"",""karnofsky_ps"":85,""wbc_count"":4100,""hemoglobin"":10.1,""platelets"":128000,""bilirubin_mg_dl"":1.3,""ast_alt_uln"":1.7,""creatinine_clearance_ml_min"":72,""qtc_ms"":415,""oral_medication_able"":true,""cardiac_history"":false,""uncontrolled_hypertension"":false,""active_infection"":false,""prohibited_medications"":false,""contraception_used"":true}",true,"Eligible: EGFR-mutant adenocarcinoma with gefitinib response then acquired resistance, stable asymptomatic brain mets, all hematologic and cardiac parameters acceptable."
NCT00570401,P015,"{""age"":67,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""histology_confirmed"":true,""stage"":""advanced"",""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":10,""tki_response"":""complete response"",""egfr_mutation"":true,""acquired_resistance"":true,""disease_progression"":true,""prior_biopsy"":true,""measurable_lesions"":true,""previously_irradiated"":false,""cns_lesions"":false,""karnofsky_ps"":75,""wbc_count"":3600,""hemoglobin"":9.7,""platelets"":118000,""bilirubin_mg_dl"":1.0,""ast_alt_uln"":1.9,""creatinine_mg_dl"":1.5,""qtc_ms"":425,""oral_medication_able"":true,""cardiac_history"":false,""uncontrolled_hypertension"":false,""active_infection"":false,""weeks_since_chemo"":4,""weeks_since_radiation"":5,""prohibited_medications"":false,""contraception_used"":true}",true,"Eligible: Advanced EGFR-mutant adenocarcinoma with prior erlotinib complete response then progression, adequate treatment washout, normal QTc, no exclusion criteria."
NCT00496860,P011,"{""age"":65,""gender"":""M"",""malignancy_type"":""Metastatic Colorectal Cancer"",""histology_confirmed"":true,""evaluable_disease"":true,""incurable_disease"":true,""not_responding_to_standard_tx"":true,""hla_a21_p53_positive"":true,""prior_proleukin_1yr"":false,""concurrent_tx"":false,""major_rt_washout_wks"":5,""cytotoxic_tx_washout_wks"":5,""nitrosoureas_tx_washout_wks"":7,""mab_tx_washout_wks"":9,""life_expectancy_mos"":4,""ecog_performance_status"":1,""anc_ul"":1800,""platelets_ul"":120000,""hemoglobin_g_dl"":12.0,""serum_creatinine_x_uln"":1.2,""total_bilirubin_x_uln"":1.0,""ast_x_uln"":2.0,""alp_x_uln"":2.0,""pt_inr_x_uln"":1.2,""aptt_x_uln"":1.2,""safely_tapered_off_anti_htn"":true,""nyha_class"":""I"",""congestive_heart_failure_6mos"":false,""unstable_angina_6mos"":false,""mi_6mos"":false,""history_ventricular_arrhythmias"":false,""cardiac_stress_test_normal"":true,""pulmonary_function_fev1_percent"":80,""known_autoimmune_disease"":false,""known_hiv_positive"":false,""psychiatric_social_compliance_limit"":false,""history_cns_disease"":false,""active_systemic_infection_parental_abx"":false,""systemic_steroid_required"":false,""prior_organ_allograft"":false,""receiving_investigational_agents"":false,""chronic_asthma_medication"":false,""pregnant_or_nursing"":false,""effective_contraception_used"":false}",true,"Eligible: Metastatic Colorectal Cancer (HLA-A2.1/p53+), ECOG 1, life expectancy $>3$ months. All washout periods met ($\ge 4-8$ weeks), meets all hematologic/organ function/coagulation criteria. Cardiac status is NYHA Class I, no history of ventricular arrhythmias/recent MI/CHF, and passed required cardiac stress test. Pulmonary function normal, no CNS disease, systemic steroids, or active infection."
NCT00496860,P012,"{""age"":48,""gender"":""F"",""malignancy_type"":""Locally Advanced Breast Cancer"",""histology_confirmed"":true,""evaluable_disease"":true,""incurable_disease"":true,""not_responding_to_standard_tx"":true,""hla_a21_p53_positive"":true,""prior_proleukin_1yr"":false,""concurrent_tx"":false,""major_rt_washout_wks"":6,""cytotoxic_tx_washout_wks"":4,""nitrosoureas_tx_washout_wks"":7,""mab_tx_washout_wks"":8,""life_expectancy_mos"":6,""ecog_performance_status"":0,""anc_ul"":2000,""platelets_ul"":150000,""hemoglobin_g_dl"":11.0,""serum_creatinine_x_uln"":1.0,""total_bilirubin_x_uln"":0.8,""ast_x_uln"":1.5,""alp_x_uln"":1.5,""pt_inr_x_uln"":1.0,""aptt_x_uln"":1.0,""safely_tapered_off_anti_htn"":false,""nyha_class"":""II"",""congestive_heart_failure_6mos"":false,""unstable_angina_6mos"":false,""mi_6mos"":false,""history_ventricular_arrhythmias"":false,""cardiac_stress_test_normal"":false,""pulmonary_function_fev1_percent"":90,""known_autoimmune_disease"":false,""known_hiv_positive"":false,""psychiatric_social_compliance_limit"":false,""history_cns_disease"":false,""active_systemic_infection_parental_abx"":false,""systemic_steroid_required"":false,""prior_organ_allograft"":false,""receiving_investigational_agents"":false,""chronic_asthma_medication"":false,""pregnant_or_nursing"":false,""effective_contraception_used"":true}",true,"Eligible: Locally Advanced Breast Cancer (HLA-A2.1/p53+), ECOG 0. Meets all washout, lab, and organ function criteria. Cardiac status is NYHA Class II (allowed), no history of ventricular arrhythmias/recent MI/CHF. Not pregnant/nursing and using effective contraception."
NCT00496860,P013,"{""age"":72,""gender"":""M"",""malignancy_type"":""Metastatic Renal Cell Carcinoma"",""histology_confirmed"":true,""evaluable_disease"":true,""incurable_disease"":true,""not_responding_to_standard_tx"":true,""hla_a21_p53_positive"":true,""prior_proleukin_1yr"":false,""concurrent_tx"":false,""major_rt_washout_wks"":4,""cytotoxic_tx_washout_wks"":4,""nitrosoureas_tx_washout_wks"":6,""mab_tx_washout_wks"":8,""life_expectancy_mos"":3,""ecog_performance_status"":1,""anc_ul"":1500,""platelets_ul"":100000,""hemoglobin_g_dl"":10.0,""serum_creatinine_x_uln"":1.5,""total_bilirubin_x_uln"":1.5,""ast_x_uln"":2.5,""alp_x_uln"":2.5,""pt_inr_x_uln"":1.5,""aptt_x_uln"":1.5,""safely_tapered_off_anti_htn"":true,""nyha_class"":""II"",""congestive_heart_failure_6mos"":false,""unstable_angina_6mos"":false,""mi_6mos"":false,""history_ventricular_arrhythmias"":false,""cardiac_stress_test_normal"":true,""pulmonary_function_fev1_percent"":75,""known_autoimmune_disease"":false,""known_hiv_positive"":false,""psychiatric_social_compliance_limit"":false,""history_cns_disease"":false,""active_systemic_infection_parental_abx"":false,""systemic_steroid_required"":false,""prior_organ_allograft"":false,""receiving_investigational_agents"":false,""chronic_asthma_medication"":false,""pregnant_or_nursing"":false,""effective_contraception_used"":false}",true,"Eligible: Metastatic RCC (HLA-A2.1/p53+), life expectancy exactly 3 months (minimum). Meets all minimum hematologic/organ function/coagulation cutoffs. Cardiac stress test required due to age $>50$ and FEV1 exactly $75\%$ of predicted (minimum for PFT). No prior IL-2, CNS disease, or autoimmune disease."
NCT00496860,P014,"{""age"":55,""gender"":""F"",""malignancy_type"":""Metastatic Ovarian Cancer"",""histology_confirmed"":true,""evaluable_disease"":true,""incurable_disease"":true,""not_responding_to_standard_tx"":true,""hla_a21_p53_positive"":true,""prior_proleukin_1yr"":false,""concurrent_tx"":false,""major_rt_washout_wks"":10,""cytotoxic_tx_washout_wks"":8,""nitrosoureas_tx_washout_wks"":10,""mab_tx_washout_wks"":12,""life_expectancy_mos"":12,""ecog_performance_status"":0,""anc_ul"":3000,""platelets_ul"":200000,""hemoglobin_g_dl"":13.0,""serum_creatinine_x_uln"":1.0,""total_bilirubin_x_uln"":1.0,""ast_x_uln"":1.0,""alp_x_uln"":1.0,""pt_inr_x_uln"":1.0,""aptt_x_uln"":1.0,""safely_tapered_off_anti_htn"":false,""nyha_class"":""I"",""congestive_heart_failure_6mos"":false,""unstable_angina_6mos"":false,""mi_6mos"":false,""history_ventricular_arrhythmias"":false,""cardiac_stress_test_normal"":true,""pulmonary_function_fev1_percent"":95,""known_autoimmune_disease"":false,""known_hiv_positive"":false,""psychiatric_social_compliance_limit"":false,""history_cns_disease"":false,""active_systemic_infection_parental_abx"":false,""systemic_steroid_required"":false,""prior_organ_allograft"":false,""receiving_investigational_agents"":false,""chronic_asthma_medication"":false,""pregnant_or_nursing"":false,""effective_contraception_used"":true}",true,"Eligible: Metastatic Ovarian Cancer (HLA-A2.1/p53+), ECOG 0. Excellent organ function and cardiac status. Meets all washout criteria (especially Mab, $>8$ weeks), not on chronic asthma meds, and using effective contraception."
NCT00496860,P015,"{""age"":60,""gender"":""M"",""malignancy_type"":""Metastatic Pancreatic Cancer"",""histology_confirmed"":true,""evaluable_disease"":true,""incurable_disease"":true,""not_responding_to_standard_tx"":true,""hla_a21_p53_positive"":true,""prior_proleukin_1yr"":false,""concurrent_tx"":false,""major_rt_washout_wks"":8,""cytotoxic_tx_washout_wks"":6,""nitrosoureas_tx_washout_wks"":10,""mab_tx_washout_wks"":10,""life_expectancy_mos"":5,""ecog_performance_status"":1,""anc_ul"":2500,""platelets_ul"":180000,""hemoglobin_g_dl"":11.0,""serum_creatinine_x_uln"":1.3,""total_bilirubin_x_uln"":1.2,""ast_x_uln"":2.0,""alp_x_uln"":2.0,""pt_inr_x_uln"":1.3,""aptt_x_uln"":1.3,""safely_tapered_off_anti_htn"":false,""nyha_class"":""I"",""congestive_heart_failure_6mos"":false,""unstable_angina_6mos"":false,""mi_6mos"":false,""history_ventricular_arrhythmias"":false,""cardiac_stress_test_normal"":true,""pulmonary_function_fev1_percent"":85,""known_autoimmune_disease"":false,""known_hiv_positive"":false,""psychiatric_social_compliance_limit"":false,""history_cns_disease"":false,""active_systemic_infection_parental_abx"":false,""systemic_steroid_required"":false,""prior_organ_allograft"":false,""receiving_investigational_agents"":false,""chronic_asthma_medication"":false,""pregnant_or_nursing"":false,""effective_contraception_used"":false}",true,"Eligible: Metastatic Pancreatic Cancer (HLA-A2.1/p53+), ECOG 1. All washouts met. Stress test required due to age $>50$ and is normal. No systemic steroids, no investigational agents, and no history of HIV or prior allograft."
NCT06400472,P011,"{""age"":65,""gender"":""F"",""tumor_type"":""Ovarian Cancer (Dose Escalation)"",""known_suspected_uncontrolled_cns_mets"":false,""history_carcinomatous_meningitis"":false,""active_uncontrolled_systemic_infection"":false,""corneal_keratopathy_or_corneal_transplant"":false,""unresolved_toxicities_from_prior_tx"":false,""significant_cardiovascular_disease"":false,""qtcf_msec"":440,""history_pneumonitis_ild"":false,""pregnant_breastfeeding_planning"":false,""contraception_plan_30_days"":false}",true,"Eligible: Ovarian Cancer (allowed in escalation). QTcF $<470$ msec, no history of CNS mets/meningitis, no uncontrolled active infection, no serious unresolved toxicities from prior treatment, and no pulmonary or corneal exclusions."
NCT06400472,P012,"{""age"":58,""gender"":""F"",""tumor_type"":""Endometrial Cancer (Dose Optimization)"",""known_suspected_uncontrolled_cns_mets"":false,""history_carcinomatous_meningitis"":false,""active_uncontrolled_systemic_infection"":false,""corneal_keratopathy_or_corneal_transplant"":false,""unresolved_toxicities_from_prior_tx"":false,""significant_cardiovascular_disease"":false,""qtcf_msec"":460,""history_pneumonitis_ild"":false,""pregnant_breastfeeding_planning"":false,""contraception_plan_30_days"":false}",true,"Eligible: Endometrial Cancer (allowed in optimization). QTcF $\le 470$ msec, no significant cardiovascular disease, no history of pneumonitis/ILD, and no history of corneal issues."
NCT06400472,P013,"{""age"":72,""gender"":""M"",""tumor_type"":""NSCLC (Dose Expansion)"",""known_suspected_uncontrolled_cns_mets"":false,""history_carcinomatous_meningitis"":false,""active_uncontrolled_systemic_infection"":false,""corneal_keratopathy_or_corneal_transplant"":false,""unresolved_toxicities_from_prior_tx"":false,""significant_cardiovascular_disease"":false,""qtcf_msec"":455,""history_pneumonitis_ild"":false,""pregnant_breastfeeding_planning"":false,""contraception_plan_30_days"":false}",true,"Eligible: NSCLC (allowed in expansion). Meets all cardiac and CNS exclusion criteria. All prior toxicities are resolved, and no active uncontrolled infection."
NCT06400472,P014,"{""age"":45,""gender"":""F"",""tumor_type"":""Triple Negative Breast Cancer (Dose Expansion)"",""known_suspected_uncontrolled_cns_mets"":false,""history_carcinomatous_meningitis"":false,""active_uncontrolled_systemic_infection"":false,""corneal_keratopathy_or_corneal_transplant"":false,""unresolved_toxicities_from_prior_tx"":false,""significant_cardiovascular_disease"":false,""qtcf_msec"":430,""history_pneumonitis_ild"":false,""pregnant_breastfeeding_planning"":false,""contraception_plan_30_days"":true}",true,"Eligible: TNBC (allowed in expansion). QTcF well below threshold, no CNS/pulmonary/cardiac contraindications. Not pregnant/breastfeeding and using effective contraception."
NCT06400472,P015,"{""age"":68,""gender"":""M"",""tumor_type"":""Pancreatic Cancer (Dose Escalation)"",""known_suspected_uncontrolled_cns_mets"":false,""history_carcinomatous_meningitis"":false,""active_uncontrolled_systemic_infection"":false,""corneal_keratopathy_or_corneal_transplant"":false,""unresolved_toxicities_from_prior_tx"":false,""significant_cardiovascular_disease"":false,""qtcf_msec"":468,""history_pneumonitis_ild"":false,""pregnant_breastfeeding_planning"":false,""contraception_plan_30_days"":false}",true,"Eligible: Pancreatic Cancer (allowed in escalation). QTcF is high but $\le 470$ msec (allowed). No corneal, infection, or CNS exclusions apply."
NCT07106528,P011,"{""age"":62,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage"":""IV"",""pathology_confirmed"":true,""mixed_histology"":false,""prior_platinum_chemotherapy"":true,""progression_timing"":""during_first_line"",""tissue_available"":true,""tissue_source"":""biopsy"",""measurable_disease"":true,""ecog_ps"":1,""adequate_organ_function"":true,""cns_metastases"":true,""cns_status"":""asymptomatic and stable"",""life_expectancy_months"":4,""contraception_used"":true,""prior_second_line"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""other_malignancy_5y"":false,""treatment_compliant"":true}",true,"Eligible: ES-SCLC Stage IV progressed during first-line platinum therapy, tissue available for organoid culture, stable CNS mets, adequate organ function."
NCT07106528,P012,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage"":""IV"",""pathology_confirmed"":true,""mixed_histology"":false,""prior_platinum_chemotherapy"":true,""progression_timing"":""within_6_months_post_treatment"",""tissue_available"":true,""tissue_source"":""malignant_pleural_effusion"",""measurable_disease"":true,""ecog_ps"":0,""adequate_organ_function"":true,""cns_metastases"":false,""life_expectancy_months"":5,""contraception_used"":true,""prior_second_line"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""other_malignancy_5y"":false,""treatment_compliant"":true}",true,"Eligible: ES-SCLC with progression within 6 months of first-line platinum, malignant effusion available for organoids, excellent performance status, no CNS disease."
NCT07106528,P013,"{""age"":71,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage"":""IV"",""pathology_confirmed"":true,""mixed_histology"":false,""prior_platinum_chemotherapy"":true,""progression_timing"":""during_first_line"",""tissue_available"":true,""tissue_source"":""biopsy"",""measurable_disease"":true,""ecog_ps"":1,""adequate_organ_function"":true,""cns_metastases"":true,""cns_status"":""asymptomatic and stable"",""life_expectancy_months"":4,""contraception_used"":true,""prior_second_line"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""other_malignancy_5y"":false,""treatment_compliant"":true}",true,"Eligible: Elderly ES-SCLC patient with progression on first-line platinum, adequate biopsy tissue, stable brain metastases, meets all functional criteria."
NCT07106528,P014,"{""age"":54,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage"":""IV"",""pathology_confirmed"":true,""mixed_histology"":false,""prior_platinum_chemotherapy"":true,""progression_timing"":""within_6_months_post_treatment"",""tissue_available"":true,""tissue_source"":""malignant_pericardial_effusion"",""measurable_disease"":true,""ecog_ps"":0,""adequate_organ_function"":true,""cns_metastases"":false,""life_expectancy_months"":6,""contraception_used"":true,""prior_second_line"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""other_malignancy_5y"":false,""treatment_compliant"":true}",true,"Eligible: ES-SCLC progressed post-platinum therapy, malignant effusion available, excellent ECOG 0, no prior second-line treatment, compliant."
NCT07106528,P015,"{""age"":67,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage"":""IV"",""pathology_confirmed"":true,""mixed_histology"":false,""prior_platinum_chemotherapy"":true,""progression_timing"":""during_first_line"",""tissue_available"":true,""tissue_source"":""biopsy"",""measurable_disease"":true,""ecog_ps"":1,""adequate_organ_function"":true,""cns_metastases"":false,""life_expectancy_months"":5,""contraception_used"":true,""prior_second_line"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""other_malignancy_5y"":false,""treatment_compliant"":true}",true,"Eligible: ES-SCLC with progression during first-line platinum, sufficient biopsy tissue for organoids, adequate performance status, no exclusion criteria."